Home The Word Brain My Amedeo FAQ Privacy About


Amedeo Chinese

HSK 1 – For Medical Students & Physicians

A complete 20-lesson, 300-page Chinese HSK 1 course with a companion app in 21 languagesfree forever.

Arabic, Bengali, Dutch, English, Farsi, French, German, Hindi, Indonesian, Italian, Japanese, Korean, Portuguese, Russian, Spanish, Tagalog, Thai, Turkish, Ukrainian, Urdu, Vietnamese.

By Bernd Sebastian Kamps and Andrea Melis

  Alzheimer's Disease

  Free Subscription


Articles published in J Alzheimers Dis

Retrieve available abstracts of 1740 articles:
HTML format



Single Articles


    April 2026
  1. LEE M, Kim M
    Donepezil increases angiogenic potential in patients with Alzheimer's disease.
    J Alzheimers Dis. 2026 Apr 29:13872877261444020. doi: 10.1177/13872877261444020.
    PubMed     Abstract available


  2. ERUYSAL E, Ravdin L, Iadecola C, Ishii M, et al
    Associations of circulating resistin with Alzheimer's disease biomarkers and cognitive function in the preclinical stage of Alzheimer's disease.
    J Alzheimers Dis. 2026 Apr 28:13872877261442230. doi: 10.1177/13872877261442230.
    PubMed     Abstract available


  3. DHANA K, Aggarwal NT, Arfanakis K, Sacks FM, et al
    Dietary intervention and cognition across Alzheimer's disease biomarker levels: The MIND clinical trial.
    J Alzheimers Dis. 2026 Apr 25:13872877261442856. doi: 10.1177/13872877261442856.
    PubMed     Abstract available


  4. SUN Q, Li Y, Wang Y, Tao SS, et al
    Dysbiosis of gut microbiota synergizes with the activation of enteric glial cells to promote Alzheimer's disease.
    J Alzheimers Dis. 2026 Apr 23:13872877261441247. doi: 10.1177/13872877261441247.
    PubMed     Abstract available


  5. SANTOS LTR, Costa FL, Rosa ID, Frota AF, et al
    A metabolic-glial plasma signature defines early Alzheimer's disease: Insights from an understudied cohort.
    J Alzheimers Dis. 2026 Apr 23:13872877261441581. doi: 10.1177/13872877261441581.
    PubMed     Abstract available


  6. AGAVRILOAEI LM, Costachescu I, Szilagyi A, Gogu MR, et al
    How amyloid-beta peptide choice shapes neurochemical outcomes in intracerebral rat models of Alzheimer's disease: A systematic review.
    J Alzheimers Dis. 2026 Apr 23:13872877261443555. doi: 10.1177/13872877261443555.
    PubMed     Abstract available


  7. PIZZONI L, Piero AD, Blasutto B, Casagrande M, et al
    Accelerated long-term forgetting in Alzheimer's disease continuum: A systematic review and meta-analysis.
    J Alzheimers Dis. 2026 Apr 23:13872877261443537. doi: 10.1177/13872877261443537.
    PubMed     Abstract available


  8. KERMEL-SCHIFFMAN I, Lifshitz R, Carmel S, Bachner YG, et al
    Attitudes of older adults toward active euthanasia in advanced Alzheimer's disease.
    J Alzheimers Dis. 2026 Apr 23:13872877261444353. doi: 10.1177/13872877261444353.
    PubMed     Abstract available


  9. YE Z, Teng B, Wang S, Zhu J, et al
    Association of inflammation-related plasma proteins with vascular cognitive burden and Alzheimer's disease: A multi-method study.
    J Alzheimers Dis. 2026 Apr 23:13872877261443713. doi: 10.1177/13872877261443713.
    PubMed     Abstract available


  10. LEVINE TF, Mashinchi GM, Rodrigues J, Cross CL, et al
    Effect of sex on trajectories of verbal learning and memory and clinical symptoms in diverse Alzheimer's disease cohorts.
    J Alzheimers Dis. 2026 Apr 23:13872877261444759. doi: 10.1177/13872877261444759.
    PubMed     Abstract available


  11. XIE M, Niu X, Sun F, Shi L, et al
    Transcriptome-based identification and experimental validation of a key gene in Alzheimer's disease using dermal fibroblasts.
    J Alzheimers Dis. 2026 Apr 23:13872877261443968. doi: 10.1177/13872877261443968.
    PubMed     Abstract available


  12. CHUN H, Lee HW, Hong SB, Ha SS, et al
    Home-based transcranial photobiomodulation improves cognitive function in mild cognitive impairment due to Alzheimer's disease: A randomized, double-blind, placebo-controlled confirmatory trial.
    J Alzheimers Dis. 2026 Apr 23:13872877261443973. doi: 10.1177/13872877261443973.
    PubMed     Abstract available


  13. OTTAVIANI S, Bozzo G, De Cesari F, Peruzzo S, et al
    Frailty in early Alzheimer's disease: Complementary clinical value and prognostic significance in biomarker-defined mild cognitive impairment due to Alzheimer's disease.
    J Alzheimers Dis. 2026 Apr 21:13872877261443558. doi: 10.1177/13872877261443558.
    PubMed     Abstract available


  14. HILDEBRANDT H, Duning T, Holland-Letz M
    Is there a cognitive measure of neurodegeneration for amyloid-Abeta-ratio probable Alzheimer's disease patients?
    J Alzheimers Dis. 2026 Apr 21:13872877261444308. doi: 10.1177/13872877261444308.
    PubMed     Abstract available


  15. BHATTACHARJEE S, Choi J, Lee MQ, Kim M, et al
    Electromagnetic field induced activation of amyloid-beta degrading enzyme, neprilysin, for accelerated Alzheimer's disease therapy.
    J Alzheimers Dis. 2026 Apr 21:13872877261444315. doi: 10.1177/13872877261444315.
    PubMed     Abstract available


  16. SANCHEZ-SOBLECHERO A, Puertas-Lopez C, Ibanez-Royo MD, Retuerta-Rodriguez JJ, et al
    Offering and acceptance of plasma p-tau for the diagnosis of Alzheimer's disease: Results and insights from usual practice.
    J Alzheimers Dis. 2026 Apr 21:13872877261443556. doi: 10.1177/13872877261443556.
    PubMed     Abstract available


  17. HONG YJ, Huang SY, Hsiao IT, Wu HC, et al
    ADAS-Cog11 performance as a surrogate of tau PET burden in an Asian Alzheimer's disease cohort.
    J Alzheimers Dis. 2026 Apr 17:13872877261441801. doi: 10.1177/13872877261441801.
    PubMed     Abstract available


  18. LIU K, Sun W, Ma G, Chen F, et al
    Global burden, trends, and projections of Alzheimer's disease and other dementias attributable to high body mass index from 1990 to 2040: A comprehensive analysis of the Global Burden of Disease Study 2021.
    J Alzheimers Dis. 2026 Apr 15:13872877261439948. doi: 10.1177/13872877261439948.
    PubMed     Abstract available


  19. SAKURAI K, Kaneda D, Uchida Y, Shibata H, et al
    Intermediate structural covariance network abnormalities in argyrophilic grain disease between Alzheimer's disease and healthy controls.
    J Alzheimers Dis. 2026 Apr 15:13872877261440972. doi: 10.1177/13872877261440972.
    PubMed     Abstract available


  20. SUMMERS WK
    Even schizophrenics fear Alzheimer's disease.
    J Alzheimers Dis. 2026 Apr 15:13872877261441567. doi: 10.1177/13872877261441567.
    PubMed     Abstract available


  21. ZHANG Z, Chowdhury N, Dong J, Wu L, et al
    Systematic identification of cell-cell interactions associated with the severity of patients with Alzheimer's disease.
    J Alzheimers Dis. 2026 Apr 15:13872877261441603. doi: 10.1177/13872877261441603.
    PubMed     Abstract available


  22. YANG D, Zhang B, Wang S, Chen J, et al
    Sex-dependent role of inflammatory biomarkers in Alzheimer's disease-related cognitive performance.
    J Alzheimers Dis. 2026 Apr 15:13872877261440932. doi: 10.1177/13872877261440932.
    PubMed     Abstract available


  23. HARRINGTON EE, Bock JE
    Honor culture and cognitive aging: Honor endorsement and deficits in memory aging and Alzheimer's disease knowledge.
    J Alzheimers Dis. 2026 Apr 13:13872877261441602. doi: 10.1177/13872877261441602.
    PubMed     Abstract available


  24. LI Y, Wang G, Xiong C, Shan G, et al
    Statistical models for Alzheimer's disease clinical trials: Lessons learned from the DIAN-TU Platform Trial.
    J Alzheimers Dis. 2026 Apr 13:13872877261441645. doi: 10.1177/13872877261441645.
    PubMed     Abstract available


  25. TRAN D, Georgiadis M, DiGiacomo P, Nirschl J, et al
    Characterizing ferrous versus ferric iron in Alzheimer's disease using X-ray fluorescence imaging and XANES spectroscopy.
    J Alzheimers Dis. 2026 Apr 13:13872877261435561. doi: 10.1177/13872877261435561.
    PubMed     Abstract available


  26. CHEN Y, Zhao S, Yang F, Wang Y, et al
    The interventional effect of acupuncture on overall cognitive function in Alzheimer's disease spectrum disorders: A meta-analysis.
    J Alzheimers Dis. 2026 Apr 8:13872877261438495. doi: 10.1177/13872877261438495.
    PubMed     Abstract available


  27. HEMMY L, Cevasco-Trotter A, Silverman M, Wang S, et al
    Music therapy interest in patients with Alzheimer's disease and Alzheimer's disease related dementia: A survey study.
    J Alzheimers Dis. 2026 Apr 7:13872877261437271. doi: 10.1177/13872877261437271.
    PubMed     Abstract available


  28. SHARIF-ASKARI Z, Atoui K, El Zein W, Rizk M, et al
    From periodontitis to neurodegeneration: Can probiotics modulate the P. gingivalis-amyloid pathway in Alzheimer's disease?
    J Alzheimers Dis. 2026 Apr 6:13872877261432686. doi: 10.1177/13872877261432686.
    PubMed     Abstract available


  29. GEDA YE, Krell-Roesch J, Bekele K, Gunning JA, et al
    Time-restricted eating in Alzheimer's disease (TREAD): A call for research.
    J Alzheimers Dis. 2026 Apr 6:13872877261438520. doi: 10.1177/13872877261438520.
    PubMed     Abstract available


  30. LIU M, Bhatt K, Giaever MF, Ardekani BA, et al
    Sex differences in cognitive performance in Alzheimer's disease: Insights from the ADAS-Cog-13.
    J Alzheimers Dis. 2026 Apr 6:13872877261440125. doi: 10.1177/13872877261440125.
    PubMed     Abstract available


  31. DE LEVANTE RAPHAEL D
    Persistent functional impairment as a preclinical signal of Alzheimer's disease: Advancing dementia prognostication through the natural history of function.
    J Alzheimers Dis. 2026 Apr 6:13872877261438521. doi: 10.1177/13872877261438521.
    PubMed     Abstract available


  32. COSTA T, Liloia D, Premi E, Ashton N, et al
    A Bayesian classification model for differential diagnosis of Alzheimer's disease and frontotemporal dementia using plasma biomarkers.
    J Alzheimers Dis. 2026 Apr 6:13872877261439950. doi: 10.1177/13872877261439950.
    PubMed     Abstract available


  33. GU Q, Xie Y, Zhao Z, Zhuang Z, et al
    CeRNA regulatory network of cerebral microvascular dysfunction in early development of APP/PS1 mice model of Alzheimer's disease.
    J Alzheimers Dis. 2026 Apr 6:13872877261435563. doi: 10.1177/13872877261435563.
    PubMed     Abstract available


  34. ZOU H, Wang T, Huynh K, Meikle PJ, et al
    Plasma lipid trajectories improve prediction of future Alzheimer's disease.
    J Alzheimers Dis. 2026 Apr 6:13872877261435212. doi: 10.1177/13872877261435212.
    PubMed     Abstract available


  35. DING K, Jiang W, Lei M, Gao Y, et al
    Uncovering polygenic and local genetic overlap between sarcopenia and Alzheimer's disease.
    J Alzheimers Dis. 2026 Apr 6:13872877261436016. doi: 10.1177/13872877261436016.
    PubMed     Abstract available


  36. HAYAKAWA N, Takeda S, Takahashi H, Arisawa A, et al
    Distinct patterns of microstructural brain changes in Alzheimer's disease subtypes: Diffusion MRI metrics in braak stage-related regions.
    J Alzheimers Dis. 2026 Apr 6:13872877261436754. doi: 10.1177/13872877261436754.
    PubMed     Abstract available


  37. VIJVERBERG EGB, Scharre DW, Woodward M, Catalano S, et al
    Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease.
    J Alzheimers Dis. 2026 Apr 3:13872877261437145. doi: 10.1177/13872877261437145.
    PubMed     Abstract available


  38. QIN J, Xu X, Zou Y
    Herpes zoster, antiviral therapy, and Alzheimer's disease: Turning association into an actionable prevention pathway.
    J Alzheimers Dis. 2026 Apr 3:13872877261438524. doi: 10.1177/13872877261438524.
    PubMed     Abstract available


  39. HOILUND-CARLSEN PF, Alavi A, Costa T, Neve RL, et al
    Serious doubts about amyloid-beta (Abeta) biomarkers and anti-Abeta immunotherapy.
    J Alzheimers Dis. 2026;110:1079-1084.
    PubMed     Abstract available


  40. TAYEM AJ, Jaber AB, Altantawi AM, Masadeh NM, et al
    Increased vulnerability to low-density lipoprotein cholesterol in apolipoprotein E4-positive females: Longitudinal effects on neurodegeneration and cognition.
    J Alzheimers Dis. 2026;110:1214-1224.
    PubMed     Abstract available


  41. GOGOLA A, Cohen AD, Lopresti BJ, Ikonomovic MD, et al
    Plasma amyloid-beta predicts amyloid-beta accumulation in PET A- non-demented participants.
    J Alzheimers Dis. 2026;110:1166-1174.
    PubMed     Abstract available


  42. NEUGROSCHL J, Sewell M, Zhu C, Dauray A, et al
    Reporting of high-risk groups in research in U.S. dementia clinical trials: A systematic review.
    J Alzheimers Dis. 2026;110:1065-1071.
    PubMed     Abstract available


  43. THACKER A, Parks AL, Dohan D, Ramirez Gomez LA, et al
    A qualitative study investigating clinician experiences with lecanemab implementation across seven academic medical centers.
    J Alzheimers Dis. 2026;110:1265-1281.
    PubMed     Abstract available


  44. PROULX D, Kirk A, O'Connell M, Morgan D, et al
    Does anticholinergic medication use on presentation to a rural memory clinic predict cognitive or functional decline over one year?
    J Alzheimers Dis. 2026;110:1490-1495.
    PubMed     Abstract available


  45. PATEL H, Choi A, Weng P, Karl J, et al
    Cerebrospinal fluid amyloid-beta 42/40 ratio is associated with ganglion cell-inner plexiform layer thinning in individuals with and without amyloid pathology.
    J Alzheimers Dis. 2026;110:1438-1446.
    PubMed     Abstract available


  46. LIU Y, Shang Z, Wang J, Hou T, et al
    Lipid accumulation product index, serum inflammatory cytokines, and dementia in rural older adults: A population-based study.
    J Alzheimers Dis. 2026;110:1939-1949.
    PubMed     Abstract available


  47. TORUNSKI P, Pizzirusso G, Winblad B, Arroyo-Garcia LE, et al
    Decoding the mechanisms of amyloid-beta in synaptic toxicity.
    J Alzheimers Dis. 2026;110:1560-1583.
    PubMed     Abstract available


  48. HAYES CA, Agwu C, Dharmapuri A, Contreras JA, et al
    Contrasting associations of diastolic blood pressure with plasma amyloid, tau, and neurodegeneration biomarkers in the Health and Aging Brain Study-Health Disparities (HABS-HD).
    J Alzheimers Dis. 2026;110:1971-1984.
    PubMed     Abstract available


  49. RICE M, Willoughby-Dudley KA, Lin M, Wang H, et al
    Differential associations of cognitive screeners with biological, psychological, and cognitive factors in high-risk older adults.
    J Alzheimers Dis. 2026;110:1640-1653.
    PubMed     Abstract available


    March 2026
  50. SHAH J, Karanja W, Merali Z, Ali SK, et al
    Trends and projections for Alzheimer's disease and other dementias in Kenya: Analysis of the global burden of disease data 1990-2021 in relation to Africa and the world.
    J Alzheimers Dis. 2026 Mar 30:13872877261434256. doi: 10.1177/13872877261434256.
    PubMed     Abstract available


  51. YE X, Hu K, Liu R
    Aerobic exercise intervention in Alzheimer's disease: Proteomic insights into peripheral T cell-mediated immune pathways.
    J Alzheimers Dis. 2026 Mar 30:13872877261436840. doi: 10.1177/13872877261436840.
    PubMed     Abstract available


  52. KONG X, Han R, Fan X, Wei K, et al
    Acupuncture as an adjunct therapy for mild Alzheimer's disease: A randomized clinical trial.
    J Alzheimers Dis. 2026 Mar 30:13872877261435880. doi: 10.1177/13872877261435880.
    PubMed     Abstract available


  53. GATTO RG, Youssef H
    Influence of sex on tau distribution across Braak stages in the Alzheimer's disease spectrum.
    J Alzheimers Dis. 2026 Mar 30:13872877261433219. doi: 10.1177/13872877261433219.
    PubMed     Abstract available


  54. DIAZ CARO D, Rodriguez S, Uhlmann WR, Goldman JS, et al
    Exploring immediate responses to APOEepsilon4/epsilon4 genotype and Alzheimer's disease risk disclosure in Latinos.
    J Alzheimers Dis. 2026 Mar 30:13872877261435633. doi: 10.1177/13872877261435633.
    PubMed     Abstract available


  55. CAMARGO A, Mauro GD, Wang Z
    Cross entropy gradient analysis for Alzheimer's disease assessment.
    J Alzheimers Dis. 2026 Mar 30:13872877261431317. doi: 10.1177/13872877261431317.
    PubMed     Abstract available


  56. LABERNEDE F, Lausecker A, Sanna L, Philippi N, et al
    Language performances in dementia with Lewy bodies and Alzheimer's disease: A longitudinal comparative study of naming and fluency.
    J Alzheimers Dis. 2026 Mar 26:13872877261427500. doi: 10.1177/13872877261427500.
    PubMed     Abstract available


  57. PARK J, Kwon HJ, Joo J, Jang H, et al
    Sex-specific accelerated epigenetic aging in the Alzheimer's disease spectrum.
    J Alzheimers Dis. 2026 Mar 26:13872877261431795. doi: 10.1177/13872877261431795.
    PubMed     Abstract available


  58. KORIC L, Mourre H, Trompette C, Brillant L, et al
    Enhancing atypical Alzheimer's disease phenotyping through the oculomotor window in posterior cortical atrophy.
    J Alzheimers Dis. 2026 Mar 26:13872877261435137. doi: 10.1177/13872877261435137.
    PubMed     Abstract available


  59. GARCIA DE LA GARZA A, Wang C, Derby CA, Gao Q, et al
    Generalizability of blood-based biomarkers of Alzheimer's disease and related dementias in a multicultural cohort of older adults: The effect of adjustment for kidney function.
    J Alzheimers Dis. 2026 Mar 25:13872877261426582. doi: 10.1177/13872877261426582.
    PubMed     Abstract available


  60. TAVAN Y, Roozegar S, Mohammadi ZF, Akbari A, et al
    Aerobic exercise significantly alters Notch1 signaling in a neurotoxic hippocampal rat model of Alzheimer's disease.
    J Alzheimers Dis. 2026 Mar 25:13872877261434058. doi: 10.1177/13872877261434058.
    PubMed     Abstract available


  61. LUCA A, Piccoli T, Tomaselli A, Di Marco S, et al
    Cognitive and behavioral determinants of burden in caregivers of patients with Alzheimer's disease: A focus on sex and gender. The SexDemCare Multicentric Italian Study.
    J Alzheimers Dis. 2026 Mar 25:13872877261435213. doi: 10.1177/13872877261435213.
    PubMed     Abstract available


  62. PENNINGTON C, Apurva P, Chen A, Duncan A, et al
    Disease modifying treatments for Alzheimer's disease: Clinician perspectives.
    J Alzheimers Dis. 2026 Mar 25:13872877261429859. doi: 10.1177/13872877261429859.
    PubMed     Abstract available


  63. FISHER DW, Mehta R, Morrow CB, Kerr KF, et al
    Affective neuropsychiatric symptom metrics in the National Alzheimer's Coordinating Center dataset.
    J Alzheimers Dis. 2026 Mar 25:13872877261427462. doi: 10.1177/13872877261427462.
    PubMed     Abstract available


  64. TALLAPRAGADA B, Markovic SJ, Marston KJ, Brown BM, et al
    Composite scores to detect and monitor cognitive dysfunction in preclinical and prodromal Alzheimer's disease: A narrative review.
    J Alzheimers Dis. 2026 Mar 23:13872877261433044. doi: 10.1177/13872877261433044.
    PubMed     Abstract available


  65. RISSANEN JA, Karkkainen S, Katisko K, Vanninen A, et al
    The performance of plasma pTau181 and pTau217 in distinguishing Alzheimer's disease from various neurodegenerative disorders, psychiatric disorders, and cognitively unimpaired controls.
    J Alzheimers Dis. 2026 Mar 23:13872877261431800. doi: 10.1177/13872877261431800.
    PubMed     Abstract available


  66. ZHOU C, Ji Y, Wang Y, Liang Y, et al
    Meta-analysis of the efficacy of interventions for persons living with Alzheimer's disease: The role of music therapy.
    J Alzheimers Dis. 2026 Mar 23:13872877261433196. doi: 10.1177/13872877261433196.
    PubMed     Abstract available


  67. KAMALIZONOUZI S, Amanollahi M, Farshbafnadi M, Dolatshahi M, et al
    Association between retinal neurodegeneration assessed by optical coherence tomography and PET-detected cerebral amyloid burden in Alzheimer's disease: A systematic review.
    J Alzheimers Dis. 2026 Mar 23:13872877261433198. doi: 10.1177/13872877261433198.
    PubMed     Abstract available



  68. Corrigendum to "Neuropsychiatric signs and symptoms clusters and regional amyloid on (18)F-FC119S PET in Alzheimer's disease".
    J Alzheimers Dis. 2026 Mar 22:13872877261423686. doi: 10.1177/13872877261423686.
    PubMed    


  69. VERMA K, Kumar S
    From autopsy to PET to cerebrospinal fluid to blood: Quantifying reference-standard dependence in Alzheimer's disease amyloid biomarker validation.
    J Alzheimers Dis. 2026 Mar 22:13872877261430858. doi: 10.1177/13872877261430858.
    PubMed     Abstract available


  70. DAMODARASAMY M, Hernandez GJ, Johnson RS, Keene CD, et al
    Lecanemab alters basement membrane collagen IV in viable microvessels isolated from brains with high Alzheimer's disease neuropathology.
    J Alzheimers Dis. 2026 Mar 20:13872877261433167. doi: 10.1177/13872877261433167.
    PubMed     Abstract available


  71. JIAN JM, Li XP, Xie JH, Hu JN, et al
    Chronic high-altitude hypoxia exacerbates cognitive impairment and Alzheimer's disease pathology.
    J Alzheimers Dis. 2026 Mar 20:13872877261431844. doi: 10.1177/13872877261431844.
    PubMed     Abstract available


  72. ZHU W, Li H, Wang K, Sun M, et al
    Evidence integration of acupuncture for prevention and treatment of Alzheimer's disease and mild cognitive impairment from a neuroimaging perspective.
    J Alzheimers Dis. 2026 Mar 20:13872877261420235. doi: 10.1177/13872877261420235.
    PubMed     Abstract available


  73. MESSAOUDI SA, Alsaleh A, AlSalem LA, Rameshbabu S, et al
    Association of genetic variants in cyclin-dependent kinase 5 with Alzheimer's disease in a Saudi cohort.
    J Alzheimers Dis. 2026 Mar 18:13872877261427358. doi: 10.1177/13872877261427358.
    PubMed     Abstract available


  74. PANDEY JP, Namboodiri AM, Nietert PJ
    Immunoglobulin allotypes and RELN alleles and humoral immunity to HSV1 in patients with Alzheimer's disease and matched controls.
    J Alzheimers Dis. 2026 Mar 18:13872877261431862. doi: 10.1177/13872877261431862.
    PubMed     Abstract available


  75. CANET G, Lucey BP, Blessing EM, Planel E, et al
    Lifelong heat exposure as a potential contributor to Alzheimer's disease resilience.
    J Alzheimers Dis. 2026 Mar 18:13872877261433226. doi: 10.1177/13872877261433226.
    PubMed     Abstract available


  76. MA J, Zhou S, Zhu W, Tao Y, et al
    Periodontitis associated with multi-region brain functional alterations and cognitive impairment: A cross-sectional study in normal cognition, amnestic mild cognitive impairment, and Alzheimer's disease.
    J Alzheimers Dis. 2026 Mar 16:13872877261426906. doi: 10.1177/13872877261426906.
    PubMed     Abstract available


  77. CHEN YJ, Gaba A, Yang HW, Maher M, et al
    Associations between polygenic risk scores for Alzheimer's disease and postoperative delirium risk.
    J Alzheimers Dis. 2026 Mar 16:13872877261430955. doi: 10.1177/13872877261430955.
    PubMed     Abstract available


  78. GAO P, Chen B, Xu D, Wang Q, et al
    Differential effects of PSEN1 mutations (p.P117L with ataxia and p.P264L without ataxia) in early-onset Alzheimer's disease.
    J Alzheimers Dis. 2026 Mar 16:13872877261430771. doi: 10.1177/13872877261430771.
    PubMed     Abstract available


  79. KIM MG, Woo SH, Kim GW, Choi HK, et al
    Efficacy and safety of Woohwangchungsimwon in combination with donepezil for behavioral and psychological symptoms of dementia in probable Alzheimer's disease: An assessor-blinded randomized controlled trial.
    J Alzheimers Dis. 2026 Mar 16:13872877261431692. doi: 10.1177/13872877261431692.
    PubMed     Abstract available


  80. HU S, Ge J, Wang G, Zhao M, et al
    Plasma biomarker changes following deep cervical lymphatic venous anastomosis: An exploratory study in Alzheimer's disease using single-molecule array technology.
    J Alzheimers Dis. 2026 Mar 16:13872877261431355. doi: 10.1177/13872877261431355.
    PubMed     Abstract available


  81. JIANG X, Lv G, Xiong X, Yuan J, et al
    Cost-effectiveness of traditional and novel neurotherapeutic agents for Alzheimer's disease: A systematic review.
    J Alzheimers Dis. 2026 Mar 16:13872877261430376. doi: 10.1177/13872877261430376.
    PubMed     Abstract available


  82. YUAN M, Zhou HY
    CTAD 2025: Key trends redefining therapeutic and diagnostic strategies in Alzheimer's disease.
    J Alzheimers Dis. 2026 Mar 15:13872877261430764. doi: 10.1177/13872877261430764.
    PubMed     Abstract available


  83. LIU A, Xing L, Li J, Yao M, et al
    The interplay between mitophagy and ferroptosis in Alzheimer's disease: Mechanisms and therapeutic implications.
    J Alzheimers Dis. 2026 Mar 13:13872877261420211. doi: 10.1177/13872877261420211.
    PubMed     Abstract available


  84. PENG T, Xu P, Guo X, Lin J, et al
    Integrated network toxicology and computational profiling of acetyl tributyl citrate-related mechanisms in Alzheimer's disease.
    J Alzheimers Dis. 2026 Mar 13:13872877261423948. doi: 10.1177/13872877261423948.
    PubMed     Abstract available


  85. LAVROVA A, Satoh R, Tosakulwong N, Weigand SD, et al
    FDG-PET imaging to identify brain regions associated with Alzheimer's disease-related TDP-43 proteinopathy: A predictive model using penalized logistic regression analysis.
    J Alzheimers Dis. 2026 Mar 13:13872877261421241. doi: 10.1177/13872877261421241.
    PubMed     Abstract available


  86. WEI D, Dal H, Dalman C, Karlsson H, et al
    Association between arsenic exposure and the risk of Alzheimer's disease: A cohort study in Sweden.
    J Alzheimers Dis. 2026 Mar 13:13872877261427465. doi: 10.1177/13872877261427465.
    PubMed     Abstract available


  87. FAUCHER C, Thienel R, Behler A, Gomez L, et al
    The relationship between napping and memory varies as a function of genetic risk for Alzheimer's disease.
    J Alzheimers Dis. 2026 Mar 13:13872877261427707. doi: 10.1177/13872877261427707.
    PubMed     Abstract available


  88. ARIYATH A, Hone E, Fernando WMADB, Pedrini S, et al
    USP14 inhibitor IU1 alleviates amyloid-beta mediated toxicity in Alzheimer's disease cell and worm models.
    J Alzheimers Dis. 2026 Mar 13:13872877261422775. doi: 10.1177/13872877261422775.
    PubMed     Abstract available


  89. ROCHAIS C, Lecoutey C, Culley G, Curel T, et al
    An efficient step-by-step approach to select pleiotropic drug candidates against Alzheimer's disease: The discovery of neocopride.
    J Alzheimers Dis. 2026 Mar 13:13872877261424925. doi: 10.1177/13872877261424925.
    PubMed     Abstract available


  90. BOTCHWAY BOA, Kousiappa I, Koupparis A, Papacostas S, et al
    From brain waves to heartbeats: Exploring the combined role of electroencephalography and heart-rate variability in Alzheimer's disease diagnosis and management.
    J Alzheimers Dis. 2026 Mar 13:13872877261428636. doi: 10.1177/13872877261428636.
    PubMed     Abstract available


  91. YIRUN A, Cakir DA, Erdemli Kose SB, Ozyurt AB, et al
    Determination of the effects of Herpes simplex glycoprotein B on epigenetic alterations in in vitro models of Alzheimer's disease.
    J Alzheimers Dis. 2026 Mar 13:13872877261427784. doi: 10.1177/13872877261427784.
    PubMed     Abstract available


  92. SCARAMUZZI GF, Manippa V, Taurisano P
    Re-tuning the brain: The promise of 40 Hz sensory stimulation in Alzheimer's disease.
    J Alzheimers Dis. 2026 Mar 12:13872877261429856. doi: 10.1177/13872877261429856.
    PubMed     Abstract available


  93. ALKAM T, Tarshizi E, Van Benschoten AH
    Detecting multimorbidity patterns in Alzheimer's disease using unsupervised machine learning: A nationwide emergency department study (2007-2022).
    J Alzheimers Dis. 2026 Mar 12:13872877261430952. doi: 10.1177/13872877261430952.
    PubMed     Abstract available


  94. REN Y, Saleem K, Patel PJ, Lee YH, et al
    Diminished activity-dependent neuroprotective protein (ADNP) contributes to complement gene elevation in Alzheimer's disease.
    J Alzheimers Dis. 2026 Mar 12:13872877261427770. doi: 10.1177/13872877261427770.
    PubMed     Abstract available


  95. YANG F, Xu B, Lin J, Zheng D, et al
    Early detection of Alzheimer's disease based on leveraging multimodal features of the clock drawing test.
    J Alzheimers Dis. 2026 Mar 12:13872877261423940. doi: 10.1177/13872877261423940.
    PubMed     Abstract available


  96. ZHANG Y, Zhang D, Xiao H
    Regulated neuronal death in Alzheimer's disease: Crosstalk and convergence of apoptosis, pyroptosis, senescence, and ferroptosis.
    J Alzheimers Dis. 2026 Mar 11:13872877261430002. doi: 10.1177/13872877261430002.
    PubMed     Abstract available


  97. ZHOU H, Zhao X, Li Y, Wang Y, et al
    Nicotinamide mononucleotide supplementation modulates gut microbiota and metabolites to mitigate Alzheimer's disease pathology in APP/PS1 mice.
    J Alzheimers Dis. 2026 Mar 10:13872877261422502. doi: 10.1177/13872877261422502.
    PubMed     Abstract available


  98. LIU R, Qi X, Luo H, Liu Y, et al
    Edentulism and risk of all-cause dementia and Alzheimer's disease: A competing risk analysis by cognitive status.
    J Alzheimers Dis. 2026 Mar 10:13872877261424215. doi: 10.1177/13872877261424215.
    PubMed     Abstract available


  99. KE Z, Wang B, Liang R
    Modulation of mitochondrial quality by exercise mimetics: A potential strategy for the prevention and treatment of Alzheimer's disease.
    J Alzheimers Dis. 2026 Mar 10:13872877261424276. doi: 10.1177/13872877261424276.
    PubMed     Abstract available


  100. ROS F, Martinez Lozano MD, Arnau J, Martinez J, et al
    Decreased interleukin-8 levels in the peripheral blood of Alzheimer's disease patients.
    J Alzheimers Dis. 2026 Mar 10:13872877261428052. doi: 10.1177/13872877261428052.
    PubMed     Abstract available


  101. LV M, Wang Q, Yu G, Chen J, et al
    Choroid plexus-glymphatic axis disruption in Alzheimer's disease: Cerebrospinal fluid expansion as a mediator of metabolic dysfunction and cognitive decline.
    J Alzheimers Dis. 2026 Mar 6:13872877261426578. doi: 10.1177/13872877261426578.
    PubMed     Abstract available


  102. BALSLIEMKE AL, Ahlemeyer B, Schmidl E, Acker T, et al
    Region-specific ups and downs in mitochondrial numerical densities during Alzheimer's disease progression: A pilot study in human brains.
    J Alzheimers Dis. 2026 Mar 6:13872877261418994. doi: 10.1177/13872877261418994.
    PubMed     Abstract available


  103. LI Z, Wang D, Xia F, Liu Y, et al
    Identification of causally linked blood biomarkers for Alzheimer's disease via reverse transcriptome-wide Mendelian randomization.
    J Alzheimers Dis. 2026 Mar 6:13872877261422501. doi: 10.1177/13872877261422501.
    PubMed     Abstract available


  104. GIBBS D, Black B, Petersen M, Johnson L, et al
    Exploring feature importance in machine learning for neuroimaging traits in Alzheimer's disease across a multiethnic cohort.
    J Alzheimers Dis. 2026 Mar 6:13872877261426563. doi: 10.1177/13872877261426563.
    PubMed     Abstract available


  105. DRISCOLL I, Wilson RE, Johnson SC, Asthana S, et al
    Age-related alterations in plasma biomarkers of relevance to Alzheimer's disease are attenuated in KLOTHO KL-VS heterozygotes.
    J Alzheimers Dis. 2026 Mar 6:13872877261422411. doi: 10.1177/13872877261422411.
    PubMed     Abstract available


  106. YANG Y, Yang F, Yao M, Li L, et al
    Decoding the key mechanisms of ferroptosis and inflammation: Emerging therapeutic targets for Alzheimer's disease.
    J Alzheimers Dis. 2026 Mar 6:13872877261427028. doi: 10.1177/13872877261427028.
    PubMed     Abstract available


  107. LIU Y, Zhong R, Li Q, Wang Y, et al
    The role of ionotropic glutamate receptors in Alzheimer's disease: A scientometric analysis.
    J Alzheimers Dis. 2026 Mar 3:13872877261423577. doi: 10.1177/13872877261423577.
    PubMed     Abstract available


  108. HADA K, Murata Y, Ohi Y, Hashimoto S, et al
    Involvement of orexin nerves in early stage of Alzheimer's disease model mice and preventive effect of orexin receptor antagonists.
    J Alzheimers Dis. 2026;110:588-604.
    PubMed     Abstract available


  109. LINGLER JH
    Leading by example: How the Webster team's systematic review quietly rebuked the field's preoccupation with biomarker "disclosure," and why it matters.
    J Alzheimers Dis. 2026;110:86-88.
    PubMed     Abstract available


  110. ALAFUZOFF I, Libard S
    Incidence of altered proteins in the aging brain: Implications for biological diagnostic markers.
    J Alzheimers Dis. 2026;110:397-408.
    PubMed     Abstract available


  111. UEDA M, Suzuki T, Yoshimizu T, Konuma T, et al
    Cerebral glucose uptake and cognitive functions: A phenome-wide Mendelian randomization study.
    J Alzheimers Dis. 2026;110:895-908.
    PubMed     Abstract available


  112. TORRES ER, Lopez ED, McBurrows L, Kollmorgen G, et al
    Physical activity across the life course and neural biomarkers.
    J Alzheimers Dis. 2026;110:810-820.
    PubMed     Abstract available


  113. DORFSMAN DA, Cai D, Hamilton-Nelson KL, Adams LD, et al
    Educational attainment is associated with reduced functional decline in Puerto Ricans with elevated pTau181.
    J Alzheimers Dis. 2026;110:685-695.
    PubMed     Abstract available


  114. MAZZEO S, Lassi M, Padiglioni S, Vergani AA, et al
    Towards the development of a management protocol for subjective cognitive decline: Insights from a cross-sectional and longitudinal analysis of multimodal data from a memory clinic.
    J Alzheimers Dis. 2026;110:728-745.
    PubMed     Abstract available


    February 2026
  115. BISSAR N, Kassir R, Missilmani F, Salem-Sokhn E, et al
    Association of post-transcriptional regulatory gene single nucleotide polymorphisms with Alzheimer's disease.
    J Alzheimers Dis. 2026 Feb 27:13872877261424256. doi: 10.1177/13872877261424256.
    PubMed     Abstract available


  116. KIM M, Byun MS, Yi D, Ahn H, et al
    APOE4-dependent association between metformin use and Alzheimer's disease-related cortical thickness in older adults with type 2 diabetes.
    J Alzheimers Dis. 2026 Feb 27:13872877261418688. doi: 10.1177/13872877261418688.
    PubMed     Abstract available


  117. NOVAK DA, Saleem N, Gerhardt PC, Maestas D, et al
    Alzheimer's disease in patients prescribed statins: A real-world data analysis of U.S. patient health records.
    J Alzheimers Dis. 2026 Feb 27:13872877261424220. doi: 10.1177/13872877261424220.
    PubMed     Abstract available


  118. NDIONUKA IB
    Alzheimer's disease and dementia care in Nigeria: Challenges, realities, and the call for a national strategy.
    J Alzheimers Dis. 2026 Feb 26:13872877261424254. doi: 10.1177/13872877261424254.
    PubMed     Abstract available


  119. NIXON AG, Hong NS, Agha BM, Ham JR, et al
    The effects of chronic cannabidiol administration on brain pathology and behavioral deficits found in the tau P301s-line PS19 mouse model of Alzheimer's disease.
    J Alzheimers Dis. 2026 Feb 24:13872877261421654. doi: 10.1177/13872877261421654.
    PubMed     Abstract available


  120. FUJISAWA C, Fujisawa H, Matsui Y, Sugimoto T, et al
    Activities of daily living, behavioral and psychological symptoms of dementia, and cognitive and physical function according to thyroid function in Alzheimer's disease.
    J Alzheimers Dis. 2026 Feb 24:13872877261424207. doi: 10.1177/13872877261424207.
    PubMed     Abstract available


  121. ROMANO D, Tosi G
    Divergent network trajectories in mild cognitive impairment: Converters versus non-converters to Alzheimer's disease.
    J Alzheimers Dis. 2026 Feb 24:13872877261423962. doi: 10.1177/13872877261423962.
    PubMed     Abstract available


  122. HAKIM M, Ranjan R, Ken-Dror G, Yusuf MA, et al
    Next-generation sequencing study identifies the first genes associated with Alzheimer's disease in Bangladeshi population: The CARED study.
    J Alzheimers Dis. 2026 Feb 23:13872877261419066. doi: 10.1177/13872877261419066.
    PubMed     Abstract available


  123. INAGAWA Y, Kamiya T, Miyagi Y, Inagawa S, et al
    Evaluation of the effects of lecanemab treatment on brain atrophy using voxel-based specific regional analysis system for Alzheimer's disease.
    J Alzheimers Dis. 2026 Feb 23:13872877261422452. doi: 10.1177/13872877261422452.
    PubMed     Abstract available


  124. ZHANG S, Xue G, Zhang M, Ding N, et al
    Research progress on the role of acupuncture in Alzheimer's disease based on the PI3K/AKT/mTOR signaling pathway.
    J Alzheimers Dis. 2026 Feb 22:13872877261418553. doi: 10.1177/13872877261418553.
    PubMed     Abstract available


  125. LI X, Zhang Y, Shi X, Li D, et al
    A novel presenilin 1 nucleotide mutation (M139I) and its pathological function in a Chinese family with early-onset Alzheimer's disease.
    J Alzheimers Dis. 2026 Feb 18:13872877261418314. doi: 10.1177/13872877261418314.
    PubMed     Abstract available


  126. BAFAIL DA
    The cognitive neutrality of common antidiabetic medications in older adults: A propensity score-matched cohort analysis from the National Alzheimer's Coordinating Center database.
    J Alzheimers Dis. 2026 Feb 17:13872877251410210. doi: 10.1177/13872877251410210.
    PubMed     Abstract available


  127. KUMAR GA, Pravallika P, Thirumalai V, Bukke SPN, et al
    Persicaria hydropiper attenuates oxidative stress and reactive oxygen species, and inhibits amyloid-beta/tau in SH-SY5Y cell lines via multiple pathways of Alzheimer's disease.
    J Alzheimers Dis. 2026 Feb 13:13872877261418555. doi: 10.1177/13872877261418555.
    PubMed     Abstract available


  128. ZHANG Y, Wang J, Yuan J, Li S, et al
    FA-2-b-beta modulates HMGB1/NF-kappaB/NLRP3 signaling to alleviate neuroinflammation in Alzheimer's disease.
    J Alzheimers Dis. 2026 Feb 10:13872877261418300. doi: 10.1177/13872877261418300.
    PubMed     Abstract available


  129. ELUGBADEBO O, Farombi T, Arulogun O, Nichols M, et al
    Recruiting and retaining persons with suspected Alzheimer's disease and related dementias for genetic studies in selected African countries: Lived realities of researchers.
    J Alzheimers Dis. 2026 Feb 9:13872877261416066. doi: 10.1177/13872877261416066.
    PubMed     Abstract available


  130. BRENOWITZ WD, Ehrlich JR, Deal JA, Yaffe K, et al
    Introduction to Supplemental Issue: Sensory loss in Alzheimer's disease and related dementias.
    J Alzheimers Dis. 2026 Feb 5:13872877261418685. doi: 10.1177/13872877261418685.
    PubMed     Abstract available


  131. TRIPANPITAK K, Wolf A, Kapitonova M, Umeda S, et al
    Biomarkers for Alzheimer's disease and mild cognitive impairment: Recent advances in task-based EEG.
    J Alzheimers Dis. 2026 Feb 4:13872877251413700. doi: 10.1177/13872877251413700.
    PubMed     Abstract available


  132. EMEKEEVA DD, Chen J, Yang Y, Yang J, et al
    Mapping protein variants associated with Alzheimer's disease by mass-spectrometry based de novo sequencing assisted strategy.
    J Alzheimers Dis. 2026 Feb 3:13872877251414414. doi: 10.1177/13872877251414414.
    PubMed     Abstract available


  133. GUO F, Sheng ZH, Li T, Huang LY, et al
    Associations of plasma sphingomyelin SM (d18:1/24:0) with Alzheimer's disease pathology and cognition in non-demented adults.
    J Alzheimers Dis. 2026 Feb 2:13872877251415349. doi: 10.1177/13872877251415349.
    PubMed     Abstract available


  134. CHEN H, Zhang H, Yang M, Xie Q, et al
    Association between apolipoprotein E gene polymorphisms and serum lipid indicators and Alzheimer's disease risk.
    J Alzheimers Dis. 2026 Feb 2:13872877261416064. doi: 10.1177/13872877261416064.
    PubMed     Abstract available


  135. GARCIA-CARLOS CA, Salas-Gallardo A, Gonzalez-Pereyra P, Basurto-Islas G, et al
    Amyloid-beta and phosphorylated-tau accumulation in retrosplenial cortex of young Alzheimer's disease model: Impact on network activity.
    J Alzheimers Dis. 2026 Feb 2:13872877261417377. doi: 10.1177/13872877261417377.
    PubMed     Abstract available


  136. HARRIS M, Bateman JR, Shaaban CE, Becker J, et al
    Certainty-weighted recognition memory: Potential applications for early detection and metacognition.
    J Alzheimers Dis. 2026;109:1380-1390.
    PubMed     Abstract available


  137. LEE LH, Chou CJ, Shih YC, Fang YM, et al
    Relationship between amyloid burden, cholinergic integrity, and cognitive function.
    J Alzheimers Dis. 2026;109:1319-1330.
    PubMed     Abstract available


  138. AHMED A, Khan H, Shen Y, Xu S, et al
    Neuroprotective potential of Rhus coriaria: Insights into acetylcholinesterase inhibition and amyloid-beta modulation.
    J Alzheimers Dis. 2026;109:1053-1067.
    PubMed     Abstract available


  139. FUJITA K, Kaneda D, Sakurai K, Matsubara T, et al
    A gray matter volume network in pathologically confirmed cases of argyrophilic grain disease: An exploratory analysis.
    J Alzheimers Dis. 2026;109:1925-1930.
    PubMed     Abstract available


  140. MARCOLINI S, Mondragon JD, van Roon AM, Tegegne BS, et al
    Limited evidence for heart rate variability as a predictor of cognitive and pathophysiological brain markers.
    J Alzheimers Dis. 2026;109:1723-1732.
    PubMed     Abstract available


  141. MANIPPA V
    Gamma sensory stimulation: Investigating human brain response to optimize clinical translation.
    J Alzheimers Dis. 2026;109:1628-1629.
    PubMed     Abstract available


  142. DELGADO-ALVAREZ A, Delgado-Alonso C, Valles-Salgado M, Gonzalez-Baz V, et al
    Diagnostic performance of the Mini-Mental State Examination and three cross-cultural screening tests in majority and diverse populations.
    J Alzheimers Dis. 2026;109:1615-1620.
    PubMed     Abstract available


    January 2026
  143. MICHOPOULOU S, Prosser A, O'Brien N, Dickson J, et al
    Alzheimer's disease diagnosis support for brain perfusion SPECT scans in a real-world clinical cohort.
    J Alzheimers Dis. 2026 Jan 30:13872877251413790. doi: 10.1177/13872877251413790.
    PubMed     Abstract available


  144. PREVOT E, Shand C, Oxtoby N
    How reproducible are data-driven subtypes of Alzheimer's disease atrophy?
    J Alzheimers Dis. 2026 Jan 28:13872877251415019. doi: 10.1177/13872877251415019.
    PubMed     Abstract available


  145. SHA L, Wu M, Sun S, Xie Y, et al
    Subcutaneous transplantation of mesenchymal stem cell spheroids ameliorates cognitive deficits in Alzheimer's disease.
    J Alzheimers Dis. 2026 Jan 28:13872877261418164. doi: 10.1177/13872877261418164.
    PubMed     Abstract available


  146. WANG S, Wang C, Hong H, Tang C, et al
    An integrative multi-omics study reveals glutamine metabolism dysregulation connecting Alzheimer's disease and age-related macular degeneration.
    J Alzheimers Dis. 2026 Jan 28:13872877261418263. doi: 10.1177/13872877261418263.
    PubMed     Abstract available


  147. DAS G, Raghunathan R, Wang L, Wan Z, et al
    Retinal Muller glia alterations and their impact on ocular glymphatic clearance in an Alzheimer's disease mouse model.
    J Alzheimers Dis. 2026 Jan 28:13872877261418165. doi: 10.1177/13872877261418165.
    PubMed     Abstract available


  148. HO BL, Liu CF, Huang YB, Huang LC, et al
    Treatment persistence with acetylcholinesterase inhibitors in Alzheimer's disease: Real-world evidence from a retrospective cohort study.
    J Alzheimers Dis. 2026 Jan 28:13872877251415021. doi: 10.1177/13872877251415021.
    PubMed     Abstract available


  149. SHINAGAWA S, Nagata T, Noto S, Yamato K, et al
    Caregiver burden and quality of life associated with behavioral and psychological symptoms of Alzheimer's disease: A web-based cross-sectional survey study.
    J Alzheimers Dis. 2026 Jan 28:13872877261415637. doi: 10.1177/13872877261415637.
    PubMed     Abstract available


  150. BYEON JH, Lee D, Shin EJ, Park EM, et al
    Validation of a web-based cognitive test for early detection of Alzheimer's disease.
    J Alzheimers Dis. 2026 Jan 28:13872877261415925. doi: 10.1177/13872877261415925.
    PubMed     Abstract available


  151. TIWARI P, Gupta A, Kaushik M, Dwivedi R, et al
    Association of yoga with cognitive and gut microbiome changes in Alzheimer's disease: An exploratory case-control study.
    J Alzheimers Dis. 2026 Jan 28:13872877261415612. doi: 10.1177/13872877261415612.
    PubMed     Abstract available


  152. XU C, Zhang K, Shi W, Mubarik S, et al
    Analysis of trends and driving factors in burden of Alzheimer's disease and other dementias from 1990 to 2021 and projections for 2050: A comprehensive perspective based on GBD 2021.
    J Alzheimers Dis. 2026 Jan 28:13872877261415634. doi: 10.1177/13872877261415634.
    PubMed     Abstract available


  153. SCOLLARD P, Mukherjee S, Choi SE, Lee ML, et al
    Heterogeneous patterns of cognitive decline in Alzheimer's disease across three domains of cognition.
    J Alzheimers Dis. 2026 Jan 28:13872877251414975. doi: 10.1177/13872877251414975.
    PubMed     Abstract available


  154. FULOP T, Cohen AA, Frost EH, Levesque S, et al
    Unmasking the hidden catalyst: How infections trigger Alzheimer's disease.
    J Alzheimers Dis. 2026 Jan 27:13872877251415571. doi: 10.1177/13872877251415571.
    PubMed     Abstract available


  155. LI J, Yue H, Lian T, Qi J, et al
    The roles of helicobacter pylori infection on the pathogenesis of Alzheimer's disease: Gut-brain axis dysfunction and blood-brain barrier disruption.
    J Alzheimers Dis. 2026 Jan 27:13872877251412234. doi: 10.1177/13872877251412234.
    PubMed     Abstract available


  156. ZHANG L, Hu J, Zhang T, Gao H, et al
    The role of HDAC6-mediated Prx2 acetylation in neuronal apoptosis related to Alzheimer's disease.
    J Alzheimers Dis. 2026 Jan 27:13872877251414961. doi: 10.1177/13872877251414961.
    PubMed     Abstract available


  157. VINIKOOR-IMLER L, Yue EX, Boroje I, Sanchez-Solino O, et al
    Comorbidities associated with mild cognitive impairment and Alzheimer's disease in the United States.
    J Alzheimers Dis. 2026 Jan 27:13872877251411451. doi: 10.1177/13872877251411451.
    PubMed     Abstract available


  158. YOKOI K, Tsujimoto M, Suzuki K, Takeda A, et al
    Antiseizure therapy attenuates cognitive decline in Alzheimer's disease: A retrospective cohort study.
    J Alzheimers Dis. 2026 Jan 22:13872877251414147. doi: 10.1177/13872877251414147.
    PubMed     Abstract available


  159. PATEL PJ, Yan Z
    Epigenomic aberrations of histone methylation in prefrontal cortex of humans with mild cognitive impairment and Alzheimer's disease.
    J Alzheimers Dis. 2026 Jan 21:13872877251414887. doi: 10.1177/13872877251414887.
    PubMed     Abstract available


  160. WAN Z, Feng X, Chou J, Zhou X, et al
    Sex- and brain region-specific gene expression in Alzheimer's disease.
    J Alzheimers Dis. 2026 Jan 21:13872877251413797. doi: 10.1177/13872877251413797.
    PubMed     Abstract available


  161. CUSTODIO B, Montesinos R, Bayona W, Rojas Benites MJ, et al
    Perceptions of Peruvian neurologists toward the implementation of anti-amyloid drugs for early Alzheimer's disease in the departments of neurology.
    J Alzheimers Dis. 2026 Jan 21:13872877251410959. doi: 10.1177/13872877251410959.
    PubMed     Abstract available


  162. DALY T
    Nothing about us without us? Using public consensus for priority setting in Alzheimer's disease research.
    J Alzheimers Dis. 2026 Jan 20:13872877261415592. doi: 10.1177/13872877261415592.
    PubMed     Abstract available


  163. WANG EJ, Oguztuzun C, Xu R, Gao Z, et al
    Comparative evaluation of large language models in retrieving known and predicting novel drug combinations.
    J Alzheimers Dis. 2026 Jan 20:13872877261415635. doi: 10.1177/13872877261415635.
    PubMed     Abstract available


  164. ROTH S, Yan J, Patru MM, Mattke S, et al
    The capacity for Alzheimer's disease confirmatory testing in the United States: The current situation and simulations for future increase.
    J Alzheimers Dis. 2026 Jan 20:13872877251406909. doi: 10.1177/13872877251406909.
    PubMed     Abstract available


  165. FRANCIS L, Beiser A, Lu S, Kujawa SG, et al
    Hearing loss in the young-old is associated with increased risk for Alzheimer's disease and vascular dementia.
    J Alzheimers Dis. 2026 Jan 20:13872877251407211. doi: 10.1177/13872877251407211.
    PubMed     Abstract available


  166. THORNTON JM, Stevenson JL
    Mites, microbes, and neurodegeneration: A unified environmental hypothesis for Parkinson's disease, Alzheimer's disease, and Lewy body dementia.
    J Alzheimers Dis. 2026 Jan 13:13872877251412923. doi: 10.1177/13872877251412923.
    PubMed     Abstract available


  167. YUAN J, Hu Y, Feng F, Hou B, et al
    Prevalence of subjective cognitive decline with Alzheimer's disease neuropathology in a community-based Chinese cohort.
    J Alzheimers Dis. 2026 Jan 13:13872877251411413. doi: 10.1177/13872877251411413.
    PubMed     Abstract available


  168. ANDIN U, Lifvergren S, Zetterberg H, Blennow K, et al
    Cerebrospinal fluid levels of neurogranin and YKL-40 in mild cognitive impairment due to Alzheimer's disease or vascular dementia.
    J Alzheimers Dis. 2026 Jan 13:13872877251411336. doi: 10.1177/13872877251411336.
    PubMed     Abstract available


  169. TEIPEL S, Konig A, Brem AK, Perry G, et al
    Recommendations for reporting findings from analyses using artificial intelligence and machine learning in the Journal of Alzheimer's Disease.
    J Alzheimers Dis. 2026 Jan 13:13872877251413701. doi: 10.1177/13872877251413701.
    PubMed     Abstract available


  170. YANG Y, Kwak YT
    Neuropsychiatric signs and symptoms clusters and regional amyloid on (18)F-FC119S PET in Alzheimer's disease.
    J Alzheimers Dis. 2026 Jan 13:13872877251411433. doi: 10.1177/13872877251411433.
    PubMed     Abstract available


  171. ALKAM T, Tarshizi E, Van Benschoten AH
    Flagging high-risk comorbidities in Alzheimer's disease emergency department visits: A machine learning analysis of mortality outcomes.
    J Alzheimers Dis. 2026 Jan 13:13872877251409332. doi: 10.1177/13872877251409332.
    PubMed     Abstract available


  172. HEO RJ, Negida A, Barrett MJ, Chrenka EA, et al
    Cholinesterase inhibitors for patients with dementia: Patterns of prescribing and disparities in treatment.
    J Alzheimers Dis. 2026 Jan 13:13872877251411418. doi: 10.1177/13872877251411418.
    PubMed     Abstract available


  173. WANG X, Ye T, Dai B, Zhang J, et al
    Sex-specific patterns in tau spreading throughout the Braak stages in the Alzheimer's disease spectrum.
    J Alzheimers Dis. 2026 Jan 13:13872877251406131. doi: 10.1177/13872877251406131.
    PubMed     Abstract available


  174. ABEDIN MJ, Kastanenka KV
    The role of astrocytes in Alzheimer's disease: Pathophysiology, biomarkers, and therapeutic potential.
    J Alzheimers Dis. 2026 Jan 13:13872877251411561. doi: 10.1177/13872877251411561.
    PubMed     Abstract available


  175. SINGH P, Rath SL
    Unraveling the impact of risk factors on the ferroptosis-Alzheimer's disease link for early detection.
    J Alzheimers Dis. 2026 Jan 7:13872877251411331. doi: 10.1177/13872877251411331.
    PubMed     Abstract available


  176. GIUFFRE GM, Battisti F, Tudor AM, Lenkowicz J, et al
    Redefining management of mild cognitive impairment and Alzheimer's disease through the shift from clinical to clinical-biological diagnosis: Insights from a single-center experience.
    J Alzheimers Dis. 2026 Jan 5:13872877251411461. doi: 10.1177/13872877251411461.
    PubMed     Abstract available


  177. LIU Y, Su H, Guan T, Li X, et al
    Risk prediction of progression from normal cognitive function to Alzheimer's disease in elderly aged 65 and above based on deep learning methods.
    J Alzheimers Dis. 2026 Jan 5:13872877251410937. doi: 10.1177/13872877251410937.
    PubMed     Abstract available


  178. FINNO CJ, Ghosh S, Rodriguez V, Valenzuela A, et al
    Microglial transcriptional profiles of a transgenic rat model closely model Alzheimer's disease.
    J Alzheimers Dis. 2026 Jan 5:13872877251410206. doi: 10.1177/13872877251410206.
    PubMed     Abstract available


  179. IBRAHIM FOUAD G, Ando H, Ichihara G
    Investigating gender differences in Alzheimer's disease.
    J Alzheimers Dis. 2026 Jan 5:13872877251410204. doi: 10.1177/13872877251410204.
    PubMed     Abstract available


  180. YANG JW, Jiang J
    Association between varicella-zoster virus and Alzheimer's disease: A systematic review and meta-analysis of comprehensive evidence from infection, treatment to prevention.
    J Alzheimers Dis. 2026 Jan 5:13872877251411573. doi: 10.1177/13872877251411573.
    PubMed     Abstract available


  181. SHOJI M, Kawarabayashi T, Nakamura T, Sugawara T, et al
    Drebrin is a novel biomarker of cognitive deterioration in Alzheimer's disease.
    J Alzheimers Dis. 2026 Jan 2:13872877251404412. doi: 10.1177/13872877251404412.
    PubMed     Abstract available


  182. ROYALL DR, Palmer RF
    Affliction class moderates the impact of neurodegeneration: Implications for A/T/N.
    J Alzheimers Dis. 2026;109:960-971.
    PubMed     Abstract available


  183. SERRA L, Bonarota S, Di Domenico C, Caruso G, et al
    Surface-based but not voxel-based morphometry reveals structural abnormalities in individuals with subjective cognitive decline.
    J Alzheimers Dis. 2026;109:781-798.
    PubMed     Abstract available


  184. RABL M, Zullo L, Wehrli J, Hossel K, et al
    Omics-AD-A multimodal biomarker study on cognitive decline and neuropsychiatric symptoms: Design and cohort characteristics.
    J Alzheimers Dis. 2026;109:889-901.
    PubMed     Abstract available


  185. ALVAREZ-PEREZ Y, Duarte-Diaz A, Molina Y, Figueroa-Lamas N, et al
    Underexplored moderating effects of sex in subjective cognitive decline: A systematic review and evidence gap.
    J Alzheimers Dis. 2026;109:604-618.
    PubMed     Abstract available


  186. AGUADO C, Alfaro-Ruiz R, Martin-Belmonte A, Puertas-Avendano R, et al
    Disruption of Ca(V)2.3 channels in the brain of the 5xFAD mice.
    J Alzheimers Dis. 2026;109:699-717.
    PubMed     Abstract available


    December 2025
  187. AZAMI H, McAndrews MP, Rostaghi M, Zomorrodi R, et al
    Multiscale dispersion entropy of resting-state EEG in older adults with Alzheimer's disease, mild cognitive impairment, and remitted major depressive disorder.
    J Alzheimers Dis. 2025 Dec 30:13872877251410962. doi: 10.1177/13872877251410962.
    PubMed     Abstract available


  188. BOTELLA M, Estanga A, Ros N, Saldias J, et al
    Neuropsychiatric signatures across the Alzheimer's disease continuum in Down syndrome and sporadic forms: A biomarker-driven comparison.
    J Alzheimers Dis. 2025 Dec 30:13872877251407121. doi: 10.1177/13872877251407121.
    PubMed     Abstract available


  189. SUN L, Wei G, Ji F, Ding Y, et al
    Proteome-wide association study identifies novel Alzheimer's disease-associated proteins.
    J Alzheimers Dis. 2025 Dec 29:13872877251409352. doi: 10.1177/13872877251409352.
    PubMed     Abstract available


  190. NAKANO M, Kondo K, Ishiki K, Moniruzzaman M, et al
    Plasma biomarkers for Alzheimer's disease in middle-aged and older Japanese men: A population-based cross-sectional study.
    J Alzheimers Dis. 2025 Dec 29:13872877251409337. doi: 10.1177/13872877251409337.
    PubMed     Abstract available


  191. HU Y, Lu X, Han Z, Shi Y, et al
    Hong Kong Brief Cognitive Test for identifying symptomatic Alzheimer's disease and other types of dementia.
    J Alzheimers Dis. 2025 Dec 29:13872877251405903. doi: 10.1177/13872877251405903.
    PubMed     Abstract available


  192. YOSHIDA Y, Michihata N, Tanito M, Hiratsuka Y, et al
    Association between open angle glaucoma and early onset Alzheimer's disease.
    J Alzheimers Dis. 2025 Dec 29:13872877251410501. doi: 10.1177/13872877251410501.
    PubMed     Abstract available


  193. OSO TA, Ahmed MM, Okesanya OJ, Adebayo UO, et al
    Exploring the gut-brain-microbiome axis in Alzheimer's disease: Integrating metagenomics, metabolomics, and artificial intelligence for next-generation biomarker discovery.
    J Alzheimers Dis. 2025 Dec 29:13872877251407700. doi: 10.1177/13872877251407700.
    PubMed     Abstract available


  194. GARRAHY JP
    Proposed unified model of late-onset Alzheimer's disease: Chronic astrocytic and neuronal bioenergetic failure.
    J Alzheimers Dis. 2025 Dec 29:13872877251404970. doi: 10.1177/13872877251404970.
    PubMed     Abstract available


  195. FASSBENDER RV, Kehm C, Otta AL, Fink GR, et al
    Repetitive transcranial magnetic stimulation enhances alpha power in Alzheimer's disease patients.
    J Alzheimers Dis. 2025 Dec 29:13872877251406972. doi: 10.1177/13872877251406972.
    PubMed     Abstract available


  196. ZHAO B, Geng C, Zhou S, Wei T, et al
    Inflammation as a mediator of air pollution's role in Alzheimer's disease and related dementias.
    J Alzheimers Dis. 2025 Dec 29:13872877251408422. doi: 10.1177/13872877251408422.
    PubMed     Abstract available


  197. SURESH S, Maffei L, Bauermeister S, Raymont V, et al
    Blood biomarkers for diagnosis and differential diagnosis of Alzheimer's disease in real-world clinical populations: A systematic review.
    J Alzheimers Dis. 2025 Dec 29:13872877251408510. doi: 10.1177/13872877251408510.
    PubMed     Abstract available


  198. MOREAU A, Philippi N
    Screening for Alzheimer's disease: Strength in numbers.
    J Alzheimers Dis. 2025 Dec 29:13872877251407711. doi: 10.1177/13872877251407711.
    PubMed     Abstract available


  199. LANGE R, Aveneau C, Wallon D, Degos B, et al
    Do sex differences in dementia with Lewy bodies arise from Alzheimer's disease biological profile?
    J Alzheimers Dis. 2025 Dec 29:13872877251407708. doi: 10.1177/13872877251407708.
    PubMed     Abstract available


  200. YEDOR LM, Chambers KO, Moran-Garrido M, Perfetto S, et al
    Serum long-chain omega-3 and omega-6 fatty acids differentially predict brain atrophy, white matter hyperintensities, and lacunes in individuals with cerebral small vessel disease with or without Alzheimer's disease.
    J Alzheimers Dis. 2025 Dec 24:13872877251401572. doi: 10.1177/13872877251401572.
    PubMed     Abstract available


  201. DUAN C, Zhu M, Li X, Yue L, et al
    Influencing factors of depressive and anxiety symptoms among caregivers of Alzheimer's disease patients: A cross-sectional study.
    J Alzheimers Dis. 2025 Dec 22:13872877251405492. doi: 10.1177/13872877251405492.
    PubMed     Abstract available


  202. KHURSHID Z, Farrell JJ, Tong T, Zhu C, et al
    Multi-ancestry exome-wide study identifies variants associated with Alzheimer's disease protection.
    J Alzheimers Dis. 2025 Dec 22:13872877251405497. doi: 10.1177/13872877251405497.
    PubMed     Abstract available


  203. FENG T, Chen W, Bian Z, Sun H, et al
    Protective effects of Dendrobium nobile Lindl. alkaloids in a novel mouse model of Alzheimer's disease with chronic cerebral hypoperfusion.
    J Alzheimers Dis. 2025 Dec 22:13872877251406645. doi: 10.1177/13872877251406645.
    PubMed     Abstract available


  204. JI Y, Cui X, Ding Z, Wang X, et al
    Reveal the mechanism of action of donepezil combined with nimodipine in the treatment of Alzheimer's disease via metabolomics and lipidomics analyses in rats.
    J Alzheimers Dis. 2025 Dec 22:13872877251407109. doi: 10.1177/13872877251407109.
    PubMed     Abstract available


  205. SOLFRIZZI V, Imbimbo BP
    Comparing clinical effect sizes of Souvenaid(TM), lecanemab, and donanemab in early Alzheimer's disease.
    J Alzheimers Dis. 2025 Dec 22:13872877251406221. doi: 10.1177/13872877251406221.
    PubMed     Abstract available


  206. ROGERS JT, Tsurumi A, Arai K, Wang C, et al
    A hemochromatosis allele that protects against Alzheimer's disease injury: A role for H-ferritin.
    J Alzheimers Dis. 2025 Dec 22:13872877251404974. doi: 10.1177/13872877251404974.
    PubMed     Abstract available


  207. ABLONA KAG, Cenina ARF
    Diagnostic accuracy of Alzheimer's Questionnaire in identifying dementia among Filipinos in a tertiary hospital.
    J Alzheimers Dis. 2025 Dec 22:13872877251405290. doi: 10.1177/13872877251405290.
    PubMed     Abstract available


  208. PERBET R, Wiedmer AE, Quitot N, Bhavsar H, et al
    Seed-competent tau oligomers' activity correlates with the rate of progression in sporadic Alzheimer's disease patients.
    J Alzheimers Dis. 2025 Dec 22:13872877251400798. doi: 10.1177/13872877251400798.
    PubMed     Abstract available


  209. YOKOI T
    Need for analysis of linguistic factors for elucidating the pathogenesis of Alzheimer's disease: A position paper.
    J Alzheimers Dis. 2025 Dec 19:13872877251407350. doi: 10.1177/13872877251407350.
    PubMed     Abstract available


  210. MUTHURAMALINGAM K, Lee HJ
    Carbon nanomaterials for tau targeting in Alzheimer's disease: Theranostic strategies and clinical prospects.
    J Alzheimers Dis. 2025 Dec 19:13872877251407702. doi: 10.1177/13872877251407702.
    PubMed     Abstract available


  211. BOCCARDI V
    From risk to prevention: Clinical and public health strategies to reduce Alzheimer's disease burden.
    J Alzheimers Dis. 2025 Dec 16:13872877251407715. doi: 10.1177/13872877251407715.
    PubMed     Abstract available


  212. LENG L, Liao Z, Lu P, Sun Y, et al
    Real-world experience with baseline characteristics and safety of lecanemab for Alzheimer's disease in Eastern China.
    J Alzheimers Dis. 2025 Dec 15:13872877251406619. doi: 10.1177/13872877251406619.
    PubMed     Abstract available


  213. WANG W, Wei X, Sun Z, Zhang X, et al
    Uncovering the toxicological impact of benzo[a]pyrene on Alzheimer's disease via network toxicology, machine learning, and single-cell transcriptomics.
    J Alzheimers Dis. 2025 Dec 12:13872877251405468. doi: 10.1177/13872877251405468.
    PubMed     Abstract available


  214. TSAI A, Gunn-Sandell LB, Wyman-Chick KA, Wang Y, et al
    Sex differences for symptoms prior to dementia onset in people with Lewy body pathology compared to pure Alzheimer's disease pathology.
    J Alzheimers Dis. 2025 Dec 12:13872877251405437. doi: 10.1177/13872877251405437.
    PubMed     Abstract available


  215. AKAIKE S, Ogata A, Nakagawa Y, Ura S, et al
    The Visual Image Simple Recognition Test, a language-minimized recognition test: Psychometric and clinical evaluation in Alzheimer's disease.
    J Alzheimers Dis. 2025 Dec 12:13872877251405433. doi: 10.1177/13872877251405433.
    PubMed     Abstract available


  216. SOLTYS A, Wnuk M
    Types of caregivers for people with Alzheimer's disease in the context of their value system and personality traits.
    J Alzheimers Dis. 2025 Dec 12:13872877251406616. doi: 10.1177/13872877251406616.
    PubMed     Abstract available


  217. BATLLE P, Darcy M, Levine M, Hamzi B, et al
    Benchmarking Gaussian processes for prediction and data assimilation of Alzheimer's disease progression.
    J Alzheimers Dis. 2025 Dec 12:13872877251404082. doi: 10.1177/13872877251404082.
    PubMed     Abstract available


  218. VILLAREJO GALENDE A, Gonzalez-Sanchez M, Hilario A, Llamas-Velasco S, et al
    Severe symptomatic amyloid-related imaging abnormalities in Alzheimer's disease: Two case reports and systematic review of reported cases.
    J Alzheimers Dis. 2025 Dec 12:13872877251404505. doi: 10.1177/13872877251404505.
    PubMed     Abstract available


  219. CHOI YH, Kim H, Hong S, Baek C, et al
    Deep-learning analysis of speech using mel-spectrograms for the assessment of mild cognitive impairment and Alzheimer's disease.
    J Alzheimers Dis. 2025 Dec 12:13872877251401202. doi: 10.1177/13872877251401202.
    PubMed     Abstract available


  220. GUY TO, Ghanem A, Berry DS, Hernandez NC, et al
    Blood-based Alzheimer's disease biomarkers and cognitive decline in essential tremor.
    J Alzheimers Dis. 2025 Dec 12:13872877251404035. doi: 10.1177/13872877251404035.
    PubMed     Abstract available


  221. NAKAMURA Y, Kurokawa T, Terashima S, Nishimura A, et al
    Efficacy and safety of a novel, extended-release rivastigmine transdermal patch (TW-4752N) in patients with Alzheimer's disease: A 24-week randomized, double-blind trial with a 28-week open-label extension.
    J Alzheimers Dis. 2025 Dec 9:13872877251401601. doi: 10.1177/13872877251401601.
    PubMed     Abstract available


  222. DU E, Tian J
    Hippocampal transcriptome-wide association analysis of shared genetic risks between posttraumatic stress disorder and Alzheimer's disease.
    J Alzheimers Dis. 2025 Dec 9:13872877251400775. doi: 10.1177/13872877251400775.
    PubMed     Abstract available


  223. ASIH PR, Morris CW, Wang H, Pedrini S, et al
    Plasma soluble TREM2 is associated with plasma pTau-181 and pTau-231 in cognitively normal older adults at risk of Alzheimer's disease.
    J Alzheimers Dis. 2025 Dec 9:13872877251400780. doi: 10.1177/13872877251400780.
    PubMed     Abstract available


  224. ASNACIOS S, Staneva G, Thon G, Vannier F, et al
    Alzheimer's disease amyloid-beta affects membrane structure and mechanical properties of human neural progenitors.
    J Alzheimers Dis. 2025 Dec 9:13872877251398058. doi: 10.1177/13872877251398058.
    PubMed     Abstract available


  225. ZHANG S, Wang T, Xue G, Zheng R, et al
    Dysregulated mTOR signaling in Alzheimer's disease: Linking pathogenic mechanisms to emerging therapeutic strategies.
    J Alzheimers Dis. 2025 Dec 8:13872877251400667. doi: 10.1177/13872877251400667.
    PubMed     Abstract available


  226. KIANI I, Mohseni G, Hassani T, Taghilou A, et al
    Posterior cingulate cortex atrophy across the Alzheimer's disease spectrum: A cross-sectional MRI study linking volumetrics to cognitive decline.
    J Alzheimers Dis. 2025 Dec 8:13872877251401612. doi: 10.1177/13872877251401612.
    PubMed     Abstract available


  227. KANDEEL M, Mahmoud M
    Comparative efficacy and safety of different brexpiprazole doses for agitation in Alzheimer's disease: A systematic review and network meta-analysis.
    J Alzheimers Dis. 2025 Dec 8:13872877251404500. doi: 10.1177/13872877251404500.
    PubMed     Abstract available


  228. GIERZYNSKI TF, Reader JM, Flores B, Fox-Fuller JT, et al
    Experiences of participant burden in an Alzheimer's disease research center longitudinal cohort.
    J Alzheimers Dis. 2025 Dec 4:13872877251400787. doi: 10.1177/13872877251400787.
    PubMed     Abstract available


  229. STEFANOVA NA, Maksimova KY, Tyumentsev MA, Telegina DV, et al
    The early postnatal synapse assembly and expression profiles of synapse-related genes in a sporadic Alzheimer's disease-like pathology.
    J Alzheimers Dis. 2025 Dec 4:13872877251396932. doi: 10.1177/13872877251396932.
    PubMed     Abstract available


  230. LUCA A, Luca M, Olgiati P, Ferri R, et al
    Sex-specific sleep disturbances worsen psychiatric symptoms and cognitive decline in individuals with Alzheimer's disease.
    J Alzheimers Dis. 2025 Dec 4:13872877251400783. doi: 10.1177/13872877251400783.
    PubMed     Abstract available


  231. DYBING KM, Gao S, Saykin AJ, Risacher SL, et al
    No significant associations between history of head injury and Alzheimer's disease fluid biomarkers in older adults.
    J Alzheimers Dis. 2025 Dec 4:13872877251401201. doi: 10.1177/13872877251401201.
    PubMed     Abstract available


  232. DONG XY, Han Y, Wang TB, Han YB, et al
    Mediators between gut microbiota and Alzheimer's disease: A mediation Mendelian randomization study.
    J Alzheimers Dis. 2025 Dec 3:13872877251401157. doi: 10.1177/13872877251401157.
    PubMed     Abstract available


  233. WU X, Tsuchiya I, Aung KZ, Qiao Q, et al
    Genetic association analyses of cognitive performance across multi-ancestry older adults: Application of Tobit models.
    J Alzheimers Dis. 2025;108:1312-1327.
    PubMed     Abstract available


  234. D'ANSELMO A, Prete G, Di Crosta A, Bristot L, et al
    Increased pre-alpha functional connectivity in dementia with Lewy bodies.
    J Alzheimers Dis. 2025;108:1132-1143.
    PubMed     Abstract available


  235. SATO K, Ihara R, Niimi Y, Suzuki K, et al
    Property difference in Mini-Mental State Examination Serial Sevens and World Backwards: Analysis using item response theory.
    J Alzheimers Dis. 2025;108:1015-1022.
    PubMed     Abstract available


  236. VIADA C, Fors M, Capote E, Santiesteban Y, et al
    Bayesian predictive probability for binary outcomes in neurodegenerative diseases.
    J Alzheimers Dis. 2025;108:1222-1230.
    PubMed     Abstract available


  237. LEE JJ, Xiong J, Phan TX, Reeder JE, et al
    Impaired cooperation and prosocial learning during trust game in behavioral variant frontotemporal dementia.
    J Alzheimers Dis. 2025;108:1807-1818.
    PubMed     Abstract available


  238. IMPERIALE D, Marcinno A, Atzori C, Angeloro DP, et al
    Plasma pTau217/Abeta(42) and pTau217 outperform pTau181/Abeta(42) and pTau181 in predicting cerebrospinal fluid amyloid positivity: A real-world retrospective study.
    J Alzheimers Dis. 2025;108:1961-1971.
    PubMed     Abstract available


  239. TAKAHASHI RH, Yokotsuka M, Nakamura A, Nagao T, et al
    One of the binding proteins for administered amyloid-beta appears to be anti-Abeta IgG antibody in amyloid plaques.
    J Alzheimers Dis. 2025;108:1614-1625.
    PubMed     Abstract available


  240. AZEVEDO CV, Otaviano SFSD, Campos HC, Figueiredo EV, et al
    Distinct effects of long-term resistance exercise on cognitive deficits, neurotrophins, and amyloid pathology in male and female APP/PS1 mice.
    J Alzheimers Dis. 2025;108:1790-1806.
    PubMed     Abstract available


  241. HELLQUIST E, Janelidze S, Weidung B, Franzon K, et al
    Plasma p-tau(217) correlates strongly with cerebrospinal fluid Abeta(42) and increases over a ten-year period in amyloid-positive, non-demented very old men.
    J Alzheimers Dis. 2025;108:1778-1789.
    PubMed     Abstract available


  242. SHI Y, Ma H, Li H, Wang Y, et al
    Sennoside A alleviating cognitive impairment in APP/PS1 mice via balancing microbiome metabolism.
    J Alzheimers Dis. 2025;108:1659-1676.
    PubMed     Abstract available


  243. TIKKANEN V, Paajanen TI, Heikkinen AL, Solje E, et al
    Combining a computerized cognitive test with serum biomarkers improves detection of early-onset neurodegenerative disorders.
    J Alzheimers Dis. 2025;108:1647-1658.
    PubMed     Abstract available


  244. TSENG P
    Does weak gamma entrainment still work? Rethinking the comfort-efficacy trade-off in 40 Hz sensory stimulation.
    J Alzheimers Dis. 2025;108:1517-1519.
    PubMed     Abstract available


    November 2025
  245. ZHOU W, Lin H, Huang X, Zhou X, et al
    Identification and validation of PANoptosis-related genes in Alzheimer's disease.
    J Alzheimers Dis. 2025 Nov 27:13872877251396927. doi: 10.1177/13872877251396927.
    PubMed     Abstract available


  246. USHER MR, Aybar-Torres AA, Jin L
    Identification of common human TMEM173 genotypes associated with Alzheimer's disease.
    J Alzheimers Dis. 2025 Nov 27:13872877251396973. doi: 10.1177/13872877251396973.
    PubMed     Abstract available


  247. CHACON T, Hernandez-Hincapie H
    Relationship periodontitis and Alzheimer's disease: Relevant aspects from an epigenetic view.
    J Alzheimers Dis. 2025 Nov 26:13872877251397406. doi: 10.1177/13872877251397406.
    PubMed     Abstract available


  248. AFRIDI MA, Khalid MM, Din RU
    Multi-modal approaches to Alzheimer's disease diagnosis: Combining cognitive assessments with biomarkers and imaging.
    J Alzheimers Dis. 2025 Nov 24:13872877251394315. doi: 10.1177/13872877251394315.
    PubMed     Abstract available


  249. PANZA F, Lozupone M, Resta E, Quarto S, et al
    Gustatory dysfunction and oral frailty: Emerging implications for Alzheimer's disease.
    J Alzheimers Dis. 2025 Nov 24:13872877251392552. doi: 10.1177/13872877251392552.
    PubMed     Abstract available



  250. Corrigendum to 'Autoantibodies in Alzheimer's disease: Multifaceted roles and therapeutic horizons'.
    J Alzheimers Dis. 2025 Nov 24:13872877251401326. doi: 10.1177/13872877251401326.
    PubMed    


  251. VON SALZEN D, Senn K, Cho HK, Cahill CM, et al
    PROTEIMERs as catalytic inhibitors of APP mRNA translation: Toward a new therapeutic for Alzheimer's disease.
    J Alzheimers Dis. 2025 Nov 19:13872877251393907. doi: 10.1177/13872877251393907.
    PubMed     Abstract available


  252. WANG K, Zhu Y, Albert M, Miller M, et al
    Modeling the age-specific incidence of mild cognitive impairment incorporating the time-varying relationship of Alzheimer's disease biomarkers over 28 years.
    J Alzheimers Dis. 2025 Nov 19:13872877251393729. doi: 10.1177/13872877251393729.
    PubMed     Abstract available


  253. UCHEAGWU VA, Morgan D, Rose S, Odilora C, et al
    Alzheimer's Disease Biomarker-Nigeria (ADIBIO-N): Cohort description and baseline data report.
    J Alzheimers Dis. 2025 Nov 18:13872877251394384. doi: 10.1177/13872877251394384.
    PubMed     Abstract available


  254. GEORGESCU MF
    Agitation and neuropsychiatric symptoms in Alzheimer's disease: Potential for reverse causal associations.
    J Alzheimers Dis. 2025 Nov 17:13872877251396056. doi: 10.1177/13872877251396056.
    PubMed     Abstract available


  255. BRAMEN JE, Siddarth P, Popa ES, Kress GT, et al
    A multi-modal medical management and lifestyle intervention increase cerebral blood flow and lowers diabetic risk in persons with early Alzheimer's disease: Mid-trial results from the PREVENTION trial.
    J Alzheimers Dis. 2025 Nov 16:13872877251388933. doi: 10.1177/13872877251388933.
    PubMed     Abstract available


  256. BOSIRE EN, Kamau LW, Kiio C, Blackmon K, et al
    Community perceptions and willingness to donate biospecimen for Alzheimer's disease research in Nairobi, Kenya.
    J Alzheimers Dis. 2025 Nov 12:13872877251389227. doi: 10.1177/13872877251389227.
    PubMed     Abstract available


  257. BOUTIN S, Houze B, Pichet Binette A, Brambati SM, et al
    Uncovering pathology, subjective cognitive complaints, and sex in early Alzheimer's disease.
    J Alzheimers Dis. 2025 Nov 11:13872877251393268. doi: 10.1177/13872877251393268.
    PubMed     Abstract available


  258. VRANCEANU AM, Szapary CL, Cornelius T, Monin JK, et al
    Behavioral dyadic interventions in the context of Alzheimer's disease and related dementia: A call to action.
    J Alzheimers Dis. 2025 Nov 10:13872877251392184. doi: 10.1177/13872877251392184.
    PubMed     Abstract available


  259. DUBOIS KN, Pal S, Reader JM, Jackman B, et al
    Evaluation of a panel of plasma biomarkers for Alzheimer's disease in a diverse research cohort.
    J Alzheimers Dis. 2025 Nov 10:13872877251393405. doi: 10.1177/13872877251393405.
    PubMed     Abstract available


  260. HAMDI A, Stathopoulou P, Gharbi A, Saadouli I, et al
    Salivary microbiome dysbiosis in patients with Alzheimer's disease.
    J Alzheimers Dis. 2025 Nov 10:13872877251393229. doi: 10.1177/13872877251393229.
    PubMed     Abstract available


  261. SONG W, Fang M, Geng Z, Pang X, et al
    Mechanistic study of Alzheimer's disease with behavioral and psychological symptoms based on electroencephalography microstates.
    J Alzheimers Dis. 2025 Nov 10:13872877251393715. doi: 10.1177/13872877251393715.
    PubMed     Abstract available


  262. FRANCIA M, Ramesh N, Boltz T, Bot M, et al
    Integrative analysis of cerebrospinal fluid biomarkers, metabolomics, and polygenic risk reveals novel metabolite associations with Alzheimer's disease.
    J Alzheimers Dis. 2025 Nov 7:13872877251389924. doi: 10.1177/13872877251389924.
    PubMed     Abstract available


  263. GARCIA-CHIALVA DE, Itzcovich T, Cifarelli D, Apecetche M, et al
    Clinical and functional evidence supporting the pathogenicity of the novel PSEN1 p.R358P variant in early-onset Alzheimer's disease.
    J Alzheimers Dis. 2025 Nov 6:13872877251392236. doi: 10.1177/13872877251392236.
    PubMed     Abstract available


  264. WANG X, Yang X, Duan M, Duan H, et al
    Mitochondrial energy metabolism and Alzheimer's disease: Identifying key differentially expressed genes in blood.
    J Alzheimers Dis. 2025 Nov 6:13872877251387584. doi: 10.1177/13872877251387584.
    PubMed     Abstract available


  265. SHAW BC, Kaiser KE, Smith BC, Timken JP, et al
    Astrocytes upregulate interleukin-15 in response to neuroinflammation during Alzheimer's disease.
    J Alzheimers Dis. 2025 Nov 5:13872877251393275. doi: 10.1177/13872877251393275.
    PubMed     Abstract available


  266. ZENG Z, Dai M, Jing Y, Zhao K, et al
    Exploring toxicity and mechanisms of DDTs in Alzheimer's disease through network toxicology and molecular docking insights.
    J Alzheimers Dis. 2025 Nov 5:13872877251393503. doi: 10.1177/13872877251393503.
    PubMed     Abstract available


  267. CAO Y, Liu S, He Z, Pan W, et al
    Unfriendly dialogue of gut microbiota and lipid metabolism in Alzheimer's disease.
    J Alzheimers Dis. 2025 Nov 5:13872877251391771. doi: 10.1177/13872877251391771.
    PubMed     Abstract available


  268. WEBSTER H, Zelinsky M, Rico V, Martinez K, et al
    Reconciling recommendations for ethical sharing of biomarker results with Alzheimer's disease research participants: A systematic review and qualitative synthesis.
    J Alzheimers Dis. 2025 Nov 5:13872877251392555. doi: 10.1177/13872877251392555.
    PubMed     Abstract available


  269. FERNANDEZ FX, Grandner MA
    Amyloid-beta as a cytokine-like somnogen: Rethinking its role in sleep homeostasis and Alzheimer's disease.
    J Alzheimers Dis. 2025 Nov 5:13872877251392186. doi: 10.1177/13872877251392186.
    PubMed     Abstract available


  270. ALSHAHERI DURAZO A, McDonough IM
    Midlife brain vulnerability: Sex differences in functional magnetic resonance imaging and Alzheimer's disease risk.
    J Alzheimers Dis. 2025 Nov 5:13872877251392238. doi: 10.1177/13872877251392238.
    PubMed     Abstract available


  271. GU H, Yu K, Zhou J, Chu B, et al
    Perturbations in lipid metabolism mediate the relationship between cholecystectomy and dementia: A mediation Mendelian randomization study.
    J Alzheimers Dis. 2025;108:324-333.
    PubMed     Abstract available


  272. ABBATE C, Gallucci A
    The study of plaques and tangles makes few and inaccurate predictions about the main features of cognitive disorders: A narrative review.
    J Alzheimers Dis. 2025;108:5-18.
    PubMed     Abstract available


  273. XUE D, Blue EE, Wood AC, Rotter JI, et al
    Risk score roulette: A cautionary tale of polygenic risk score reliability.
    J Alzheimers Dis. 2025;108:65-70.
    PubMed     Abstract available


  274. SHINOZAKI M, Hishida H, Gondo Y, Yamamoto M, et al
    Machine learning model for predicting the conversion to dementia using the Cube Copying Test.
    J Alzheimers Dis. 2025;108.
    PubMed     Abstract available


  275. HUANG Y, Li Z, Liu F, Li B, et al
    Application of machine learning in EEG-based dementia diagnosis: Classification and differential diagnosis.
    J Alzheimers Dis. 2025;108.
    PubMed     Abstract available


  276. DUBBELMAN MA, Elias U, Palmer P, Dafni-Merom A, et al
    Investigating the associations between tau and mental orientation among cognitively unimpaired individuals.
    J Alzheimers Dis. 2025;108.
    PubMed     Abstract available


  277. LIBON DJ, Swenson R, Langford DT, Cosentino S, et al
    Precision neurocognition: An emerging diagnostic paradigm leveraging digital cognitive assessment technology.
    J Alzheimers Dis. 2025;108.
    PubMed     Abstract available


  278. SINGH D, Grazia A, Reiz A, Hermann A, et al
    A computational ontology framework for the synthesis of multi-level pathology reports from brain MRI scans.
    J Alzheimers Dis. 2025;108.
    PubMed     Abstract available


  279. SILVA-SPINOLA A, Baldeiras I, Santana I, Arrais JP, et al
    Predicting progression of mild cognitive impairment patients through four distinctive subgroups obtained by unsupervised learning algorithms.
    J Alzheimers Dis. 2025;108.
    PubMed     Abstract available


  280. LAUBER MV, Bellitti M, Kapadia K, Jasodanand VH, et al
    Global amyloid burden enhances network efficiency of tau propagation in the brain.
    J Alzheimers Dis. 2025;108.
    PubMed     Abstract available


  281. CHEN Z, Qi B, Jing B, Dong R, et al
    A multi-modal and multi-stage region of interest-based fusion network convolutional neural network model to differentiate progressive mild cognitive impairment from stable mild cognitive impairment.
    J Alzheimers Dis. 2025;108.
    PubMed     Abstract available


  282. IWAME S, Izu K, Murata Y, Taniguchi M, et al
    Impairment in re-learning of olfactory behaviors in mice expressing intracellular amyloid-beta protein oligomers.
    J Alzheimers Dis. 2025;108:805-823.
    PubMed     Abstract available


  283. MAO R, Zhao S, Chen J, Wang L, et al
    Identification of novel biomarkers for cognitive function via an integrative analysis.
    J Alzheimers Dis. 2025;108:931-947.
    PubMed     Abstract available


  284. BROWN K, Shutes-David A, Wilson K, Shao Y, et al
    Machine learning-based risk scores are associated with conversion to dementia in Veterans.
    J Alzheimers Dis. 2025;108:873-882.
    PubMed     Abstract available


  285. SIMON ZD, McFarland KN, Golde TE, Chakrabarty P, et al
    Sex-dependent effect of amyloidosis on functional network 'hub' topology is associated with downregulated neuronal gene signatures in the APPswe/PSEN1dE9 double transgenic mouse.
    J Alzheimers Dis. 2025;108:893-913.
    PubMed     Abstract available


  286. SAHIN MZ, Yildirim A
    Gonadal hormones and aquaporin-4: Preclinical insights into glymphatic regulation and amyloid clearance.
    J Alzheimers Dis. 2025;108:461-469.
    PubMed     Abstract available


    October 2025
  287. MICHELUTTI M, Cenacchi V, Lombardo T, Palacino F, et al
    Regional gyrification alterations and metabolic correlates in biologically defined Alzheimer's disease using a multimodal approach.
    J Alzheimers Dis. 2025 Oct 29:13872877251390876. doi: 10.1177/13872877251390876.
    PubMed     Abstract available


  288. BANERJEE A, Yang F, Dutta J, Cacciola A, et al
    Atrophy patterns of deep gray matter nuclei in Alzheimer's disease and frontotemporal dementia.
    J Alzheimers Dis. 2025 Oct 29:13872877251390386. doi: 10.1177/13872877251390386.
    PubMed     Abstract available


  289. KIM M, Kwon H, Sohn S, Lee WJ, et al
    Alzheimer's disease diagnosis and treatment: From pathophysiological insights to therapeutic advances in the era of precision neurology (2025 review).
    J Alzheimers Dis. 2025 Oct 29:13872877251391820. doi: 10.1177/13872877251391820.
    PubMed     Abstract available


  290. SINGH S, Kumar U
    Brain region-specific dopamine receptor changes and astrocyte activation influence tau pathology through CDK5 in Alzheimer's disease models.
    J Alzheimers Dis. 2025 Oct 29:13872877251389961. doi: 10.1177/13872877251389961.
    PubMed     Abstract available


  291. CURY RM, da Silva T, Cezar-Dos-Santos F, Fakih YRC, et al
    A randomized clinical trial of low-dose cannabis extract in Alzheimer's disease.
    J Alzheimers Dis. 2025 Oct 29:13872877251389608. doi: 10.1177/13872877251389608.
    PubMed     Abstract available


  292. JIAO Y, Ding Y, Luo N, Niu M, et al
    MicroRNA biomarkers in cerebrospinal fluid and plasma predicting cognitive decline in Alzheimer's disease.
    J Alzheimers Dis. 2025 Oct 29:13872877251390836. doi: 10.1177/13872877251390836.
    PubMed     Abstract available


  293. CHOI YJ, Oh DJ, Han JW, Kim KW, et al
    Development and validation of a weighted Subjective Memory Complaints Questionnaire (SMCQ-R) for early symptomatic Alzheimer's disease detection.
    J Alzheimers Dis. 2025 Oct 28:13872877251390383. doi: 10.1177/13872877251390383.
    PubMed     Abstract available


  294. SONG W, Gong C, Li Y, Yang D, et al
    Alzheimer's disease pathogenesis and the role of APOE epsilon4 in remodeling functional gradients of the default mode network.
    J Alzheimers Dis. 2025 Oct 27:13872877251389965. doi: 10.1177/13872877251389965.
    PubMed     Abstract available


  295. YANG H, You X, Yue C, Yu X, et al
    Uncovering the cytophenotypic and transcriptomic features of natural killer cells derived from peripheral blood of patients with Alzheimer's disease.
    J Alzheimers Dis. 2025 Oct 27:13872877251390553. doi: 10.1177/13872877251390553.
    PubMed     Abstract available


  296. SAAK TM, Tervo JP, Motter JN, Overdevest JB, et al
    Expanding the scope of olfactory evaluation in Alzheimer's disease and related dementias (ADRD): A narrative review of the role for odor memory and recognition in AD/ADRD.
    J Alzheimers Dis. 2025 Oct 27:13872877251389113. doi: 10.1177/13872877251389113.
    PubMed     Abstract available


  297. ZHANG Y, Dong X, Yang Y, Wang X, et al
    Caregiving burden, disease-related knowledge, and quality of life among primary caregivers in Alzheimer's disease: A cross-sectional study.
    J Alzheimers Dis. 2025 Oct 24:13872877251390494. doi: 10.1177/13872877251390494.
    PubMed     Abstract available


  298. JIN H, He J, Zhang W, Wang Y, et al
    The association between Alzheimer-associated neuronal thread protein (AD7c-NTP) and plasma inflammatory cytokine levels in individuals with cognitive impairment and demographically-matched controls.
    J Alzheimers Dis. 2025 Oct 24:13872877251389239. doi: 10.1177/13872877251389239.
    PubMed     Abstract available


  299. MULLINS CA, Gannaban RB, Kramer A, Shah H, et al
    Early branched-chain amino acid reduction delays the onset of cognitive decline in a mouse model of Alzheimer's disease.
    J Alzheimers Dis. 2025 Oct 24:13872877251389236. doi: 10.1177/13872877251389236.
    PubMed     Abstract available


  300. KETATA I, Ellouz E
    Artificial intelligence-driven eye tracker models for Alzheimer's disease diagnosis: A systematic review and meta-analysis.
    J Alzheimers Dis. 2025 Oct 24:13872877251389145. doi: 10.1177/13872877251389145.
    PubMed     Abstract available


  301. KHALSA DS, Lavretsky H, Reddy MY, Fenn A, et al
    Air pollution and Alzheimer's disease prevention: The science and a prevention plan.
    J Alzheimers Dis. 2025 Oct 24:13872877251386482. doi: 10.1177/13872877251386482.
    PubMed     Abstract available


  302. BEN ZAKEN K, Mesfin S, Bloch N, Samson AO, et al
    Virtual screening of drugs against multiple targets of Alzheimer's disease.
    J Alzheimers Dis. 2025 Oct 23:13872877251387167. doi: 10.1177/13872877251387167.
    PubMed     Abstract available


  303. DRZYMALLA E, Avery C, Palta P, Reiner AP, et al
    Association between neutrophil to lymphocyte ratio and Alzheimer's disease in large biobank cohorts.
    J Alzheimers Dis. 2025 Oct 23:13872877251386813. doi: 10.1177/13872877251386813.
    PubMed     Abstract available


  304. WANG XY, Jia YJ, Zhang J, Chen JF, et al
    Therapeutic potential of 40 Hz flickering light stimulation in Alzheimer's disease: Mechanisms, evidence, and controversies.
    J Alzheimers Dis. 2025 Oct 22:13872877251388664. doi: 10.1177/13872877251388664.
    PubMed     Abstract available


  305. LEE J, Kim YJ, Kim W, Cho S, et al
    Cumulative burden of lifestyle risk factors on Alzheimer's disease in older Korean adults: A nationwide retrospective cohort study.
    J Alzheimers Dis. 2025 Oct 22:13872877251386889. doi: 10.1177/13872877251386889.
    PubMed     Abstract available


  306. LI C, Feng L, Li M, Dai C, et al
    Research progress on the regulation of Nrf2/HO-1 signaling pathway by traditional Chinese medicine in the treatment of Alzheimer's disease.
    J Alzheimers Dis. 2025 Oct 22:13872877251389011. doi: 10.1177/13872877251389011.
    PubMed     Abstract available


  307. SOSA PEREZ S, Urrutia Amable N, Viada Gonzalez CE, Lorenzo-Luaces P, et al
    NeuroEPO plus (NeuralCIM((R))) in Alzheimer's disease: Post-trial observational follow-up study.
    J Alzheimers Dis. 2025 Oct 22:13872877251386885. doi: 10.1177/13872877251386885.
    PubMed     Abstract available


  308. AVENEAU C, Lamy E, Grassin-Delyle S, Sanchez-Ortiz M, et al
    Cerebrospinal fluid acetylcholine is not a reliable diagnostic marker for Alzheimer's disease and dementia with Lewy bodies.
    J Alzheimers Dis. 2025 Oct 22:13872877251387159. doi: 10.1177/13872877251387159.
    PubMed     Abstract available


  309. MUNOZ-MUSAT E, Le Prince G, Delmaire C, Paquet C, et al
    Cerebellar atrophy in biologically confirmed Alzheimer's disease: Associations with amyloidopathy measured by cerebrospinal fluid biomarkers.
    J Alzheimers Dis. 2025 Oct 17:13872877251386085. doi: 10.1177/13872877251386085.
    PubMed     Abstract available


  310. GABRIEL V, Chabran E, Sourty M, Cretin B, et al
    Salience and frontoparietal network impairments across disease stages in dementia with Lewy bodies: A comparative functional MRI study with Alzheimer's disease.
    J Alzheimers Dis. 2025 Oct 17:13872877251386844. doi: 10.1177/13872877251386844.
    PubMed     Abstract available


  311. PEREZ-NAVARRO LM, Lopez-Alvarenga JC
    A molecular renaissance in Alzheimer's disease research: The rise of systems biology and spatial omics.
    J Alzheimers Dis. 2025 Oct 17:13872877251387169. doi: 10.1177/13872877251387169.
    PubMed     Abstract available


  312. BI X, Xiao X, Zhou L, Liu Q, et al
    Exploring multitarget molecular mechanisms of cannabidiol in Alzheimer's disease treatment using molecular simulations and modeling.
    J Alzheimers Dis. 2025 Oct 17:13872877251386440. doi: 10.1177/13872877251386440.
    PubMed     Abstract available


  313. YE H, Zhuang C, Jin Z, Hu Y, et al
    VEGFB is a potential therapeutic target for Alzheimer's disease: Insights from integrative multi-omics analysis.
    J Alzheimers Dis. 2025 Oct 17:13872877251385244. doi: 10.1177/13872877251385244.
    PubMed     Abstract available


  314. RUBENSTEIN E, Tewolde S, Michals A, Fortea J, et al
    Novel predictors of Alzheimer's disease in Down syndrome identified using machine learning.
    J Alzheimers Dis. 2025 Oct 17:13872877251385423. doi: 10.1177/13872877251385423.
    PubMed     Abstract available


  315. CHAITHRA PM, Rakshith BS, Logesh S, Kanthesh BM, et al
    Nutraceuticals intervention in Alzheimer's disease: From farm to pharma.
    J Alzheimers Dis. 2025 Oct 17:13872877251385216. doi: 10.1177/13872877251385216.
    PubMed     Abstract available


  316. ZOU M, Yu H, Zhou R, Lu Y, et al
    Association between dental floss use, dental visits, and a five-year Alzheimer's disease risk prediction score among United States adults aged 65 years and older.
    J Alzheimers Dis. 2025 Oct 16:13872877251386836. doi: 10.1177/13872877251386836.
    PubMed     Abstract available


  317. AIELLO EN, Gendarini C, Cocuzza A, Romandini A, et al
    Semantic and phonemic advantages in Alzheimer's disease and behavioral variant-frontotemporal dementia: Insights from the Fluency Type Index.
    J Alzheimers Dis. 2025 Oct 16:13872877251386438. doi: 10.1177/13872877251386438.
    PubMed     Abstract available


  318. ARRIOLA-INFANTE JE, Garcia-Roldan E, Garcia-Solis D, Lojo-Ramirez JA, et al
    Alternative TMA-93 version demonstrates comparable performance and discriminative accuracy in early Alzheimer's disease.
    J Alzheimers Dis. 2025 Oct 16:13872877251386479. doi: 10.1177/13872877251386479.
    PubMed     Abstract available


  319. BESSER LM, Baig M, Henriquez AM, Tolea M, et al
    Sociodemographic correlates of cognition and Alzheimer's disease and vascular biomarkers among middle to older age participants in the Healthy Brain Initiative.
    J Alzheimers Dis. 2025 Oct 15:13872877251386378. doi: 10.1177/13872877251386378.
    PubMed     Abstract available


  320. KELSEY PT, Selbaek G, Lovheim H, Asvold BO, et al
    Helicobacter pylori and Alzheimer's disease risk: The HUNT study.
    J Alzheimers Dis. 2025 Oct 15:13872877251386015. doi: 10.1177/13872877251386015.
    PubMed     Abstract available


  321. ZHAO M, Yang J, Cheng H, Fan Y, et al
    Altered brain morphometry and its association with cognitive decline and APOE gene in normal people at risk for Alzheimer's disease.
    J Alzheimers Dis. 2025 Oct 10:13872877251384967. doi: 10.1177/13872877251384967.
    PubMed     Abstract available


  322. KENNEMER AA, Gao Z, Davis PB, Kaelber DC, et al
    Timing of neurorehabilitation and subsequent Alzheimer's disease risk in patients with moderate to severe traumatic brain injury: A nationwide retrospective cohort study in the United States.
    J Alzheimers Dis. 2025 Oct 9:13872877251385262. doi: 10.1177/13872877251385262.
    PubMed     Abstract available


  323. HANSON M, Liu Y, Ozawa T, Yin H, et al
    Potential barriers to timely Alzheimer's disease diagnosis and treatment: Tracer delivery and patient travel to amyloid PET scanners in the United States.
    J Alzheimers Dis. 2025 Oct 9:13872877251385118. doi: 10.1177/13872877251385118.
    PubMed     Abstract available


  324. WEISS S, Harris K, Carney OL, Maza VI, et al
    Initial development of the writing to heal app: A structured writing series for caregivers of spouses living with Alzheimer's disease and related dementias.
    J Alzheimers Dis. 2025 Oct 9:13872877251378478. doi: 10.1177/13872877251378478.
    PubMed     Abstract available


  325. TEIPEL S, Singh D, Dubbelman MA, Pan G, et al
    Early detection of Alzheimer's disease: From multiplex assays and imaging to point of care devices and AI-based functional monitoring.
    J Alzheimers Dis. 2025 Oct 7:13872877251383339. doi: 10.1177/13872877251383339.
    PubMed     Abstract available


  326. LYU J, Zhang W, De J, Shan B, et al
    The impact of music-based intervention on cognitive function and brain functional magnetic resonance imaging in people with mild Alzheimer's disease.
    J Alzheimers Dis. 2025 Oct 3:13872877251379419. doi: 10.1177/13872877251379419.
    PubMed     Abstract available


  327. BOONGIRD C, Anothaisintawee T, Tearneukit W, Wongpipathpong W, et al
    Bridging the gap: Efficacy of combined therapies for cognitive, behavioral, and functional outcomes in Alzheimer's disease - results from a systematic review and network meta-analysis.
    J Alzheimers Dis. 2025 Oct 3:13872877251378354. doi: 10.1177/13872877251378354.
    PubMed     Abstract available


  328. CHEN C, Babulal GM
    Longitudinal associations between plasma biomarkers and changes in naturalistic driving behaviors in older adults.
    J Alzheimers Dis. 2025;107:1275-1284.
    PubMed     Abstract available


  329. AGBOJI A
    Navigating life after diagnosis: Insights from people with early-stage dementia.
    J Alzheimers Dis. 2025;107:997-998.
    PubMed     Abstract available


  330. DUCHESNE S, Potvin O, Hudon C, Bocti C, et al
    A brain health framework with application to the study of neurodegeneration.
    J Alzheimers Dis. 2025;107:960-972.
    PubMed     Abstract available


  331. THO CHU TQ, Morimoto K, Kowa H
    Cognitive performance and blood biomarkers: Insights into their relationship and predicting high Amyloid Probability Score in cognitively impaired older adults.
    J Alzheimers Dis. 2025;107:1661-1673.
    PubMed     Abstract available


  332. HALE MR, Langhough R, Basche KE, Betthauser TJ, et al
    Linking silent pause locations in speech to amyloid and tau deposition in cognitively unimpaired individuals.
    J Alzheimers Dis. 2025;107:1481-1497.
    PubMed     Abstract available


  333. SAIDO TC, Iwata N
    The tale of donanemab: God is in the details.
    J Alzheimers Dis. 2025;107:1364-1373.
    PubMed     Abstract available


  334. SPEH A, Boada M, Jessen F, Visser PJ, et al
    Cardiovascular health and cognition in older adults: Variations across recruitment models and European countries in the MOPEAD project.
    J Alzheimers Dis. 2025;107:1530-1538.
    PubMed     Abstract available


  335. WALTERS ME, Small BJ, Andel R, Lerch O, et al
    Differential MRI atrophy profiles and incident dementia: A cross-national comparison.
    J Alzheimers Dis. 2025;107:1539-1554.
    PubMed     Abstract available


  336. JUNG J, Ko H, Kim H, Lee H, et al
    Exposure to ambient carbon monoxide and cognitive decrease in a memory clinic.
    J Alzheimers Dis. 2025;107:1637-1644.
    PubMed     Abstract available


  337. BOCCALINI C, Garibotto V
    Is early-phase amyloid PET ready for use as neurodegeneration marker?
    J Alzheimers Dis. 2025;107:1411-1414.
    PubMed     Abstract available


  338. SALEMME S, Chiari A, Zamboni G, Tondelli M, et al
    Deciphering the A-T+ enigma: Clinical relevance or diagnostic noise?
    J Alzheimers Dis. 2025;107:1404-1405.
    PubMed     Abstract available


    September 2025
  339. TANAKA E, Nihashi T, Kato T, Arahata Y, et al
    Modulation of middle-latency somatosensory evoked magnetic field waveforms associated with the pathophysiological states of Alzheimer's disease.
    J Alzheimers Dis. 2025 Sep 26:13872877251379466. doi: 10.1177/13872877251379466.
    PubMed     Abstract available


  340. HOU H, Yu J, Hao S, Zhang X, et al
    Electroencephalography microstates as biomarkers for screening Alzheimer's disease: Feasibility analysis and a machine learning classification scheme.
    J Alzheimers Dis. 2025 Sep 26:13872877251379072. doi: 10.1177/13872877251379072.
    PubMed     Abstract available


  341. MUKESHA D, Sarter M, Dubray M, Durand F, et al
    Targeted serum metabolomic profiling and machine learning approach in Alzheimer's disease using the Alzheimer's disease diagnostics clinical study (ADDIA) cohort.
    J Alzheimers Dis. 2025 Sep 26:13872877251378653. doi: 10.1177/13872877251378653.
    PubMed     Abstract available


  342. ROJAS-ALVAREZ A, Chung H, Cabrero Castro JE, Umucu E, et al
    Profile and disparities in health outcomes for older adults with dual diagnoses of diabetes and Alzheimer's disease.
    J Alzheimers Dis. 2025 Sep 25:13872877251380260. doi: 10.1177/13872877251380260.
    PubMed     Abstract available


  343. RICO V, Zelinsky M, Ford PJ, Leverenz J, et al
    Recommended approaches to sharing individual research results in Alzheimer's disease research: A multidisciplinary expert Delphi consensus.
    J Alzheimers Dis. 2025 Sep 25:13872877251379076. doi: 10.1177/13872877251379076.
    PubMed     Abstract available


  344. FAIZAN ALI M, Ahmad H, Fawzi Hemida M, Faizan Tahir M, et al
    Aging, Alzheimer's disease, and stroke: A 25-year longitudinal analysis of U.S. mortality trends.
    J Alzheimers Dis. 2025 Sep 24:13872877251380689. doi: 10.1177/13872877251380689.
    PubMed     Abstract available


  345. NASERRAMEZANI Z, Palizvan MR, Ganji A, Ghazavi A, et al
    Synergistic neuroprotection of chitosan-cannabidiol nanoparticles in a rat model of Alzheimer's disease: Amelioration of cognitive deficits and neuroinflammation.
    J Alzheimers Dis. 2025 Sep 24:13872877251379420. doi: 10.1177/13872877251379420.
    PubMed     Abstract available


  346. QI T, Feng Y, Kononenko N, Ising C, et al
    Axonal degeneration and retinal neurovascular dysfunction in the TgF344-AD rat model of Alzheimer's disease.
    J Alzheimers Dis. 2025 Sep 23:13872877251379844. doi: 10.1177/13872877251379844.
    PubMed     Abstract available


  347. BOROJE I, Sanchez-Solino O, Yue EX, Vinikoor-Imler L, et al
    Medication prescriptions among patients with mild cognitive impairment and Alzheimer's disease: A large nationwide electronic health record cohort study.
    J Alzheimers Dis. 2025 Sep 22:13872877251376032. doi: 10.1177/13872877251376032.
    PubMed     Abstract available


  348. YAN Y, Pan Y, Lu S, Kou J, et al
    Gut microbiota-mediated targeting of EHMT2 in individuals of European ancestry: A novel therapeutic approach for Alzheimer's disease.
    J Alzheimers Dis. 2025 Sep 22:13872877251372945. doi: 10.1177/13872877251372945.
    PubMed     Abstract available


  349. LI J, Yi Y, Gao X, Ren Y, et al
    High brain network dynamics mediate audiovisual integration deficits and cognitive impairment in Alzheimer's disease.
    J Alzheimers Dis. 2025 Sep 22:13872877251376717. doi: 10.1177/13872877251376717.
    PubMed     Abstract available


  350. SUBRAMANIAN ML, Sampani K, Ness S, Tuz-Zahra F, et al
    Biomarkers for Alzheimer's disease are upregulated in patients with diabetic retinopathy.
    J Alzheimers Dis. 2025 Sep 22:13872877251378759. doi: 10.1177/13872877251378759.
    PubMed     Abstract available


  351. ONUH VC
    Advancing Alzheimer's disease treatment: A literature review on senolytic intervention.
    J Alzheimers Dis. 2025 Sep 22:13872877251376540. doi: 10.1177/13872877251376540.
    PubMed     Abstract available


  352. GITLIN-LEIGH G, Wilson J, Howard R, Howard R, et al
    Effects of monoclonal antibody therapies on depression in Parkinson's disease and Alzheimer's disease: Systematic review and meta-analysis.
    J Alzheimers Dis. 2025 Sep 19:13872877251378156. doi: 10.1177/13872877251378156.
    PubMed     Abstract available


  353. SU X, Chen H, Cao J, Zhang Y, et al
    The effect of deprivation of whisker stimulation on cognition and synaptic plasticity in male and female Alzheimer's disease mice.
    J Alzheimers Dis. 2025 Sep 19:13872877251379079. doi: 10.1177/13872877251379079.
    PubMed     Abstract available


  354. DONG M, Qian Y, Geng Y, Wang R, et al
    HIF-1alpha-induced microglia-mediated neuroinflammation is involved in Alzheimer's disease: Evidence from single-cell transcriptomic analysis.
    J Alzheimers Dis. 2025 Sep 19:13872877251378007. doi: 10.1177/13872877251378007.
    PubMed     Abstract available


  355. WANG W, Liu H, Chen Y, Xiong Z, et al
    Identifying differential brain structures and genetic mechanisms between Alzheimer's disease and idiopathic normal pressure hydrocephalus.
    J Alzheimers Dis. 2025 Sep 17:13872877251379046. doi: 10.1177/13872877251379046.
    PubMed     Abstract available


  356. MAO C, Zou Y, Wang T, Sha L, et al
    Comparison of diagnostic accuracy of Alzheimer's disease cerebrospinal fluid core biomarkers using INNOTEST, Lumipulse G, and Elecsys assays: Insights from the PUMCH dementia cohort study.
    J Alzheimers Dis. 2025 Sep 17:13872877251379084. doi: 10.1177/13872877251379084.
    PubMed     Abstract available


  357. DENG T, Duan J, Yu W, Deng Z, et al
    Education as a domain-specific moderator: Shaping the impact of cerebral structural changes on clinical manifestations in Alzheimer's disease.
    J Alzheimers Dis. 2025 Sep 17:13872877251379078. doi: 10.1177/13872877251379078.
    PubMed     Abstract available


  358. LIU Y, Chen Y, Chen Z, Wan H, et al
    Tau seeding activity in Alzheimer's disease: Characteristics, factors, and applications.
    J Alzheimers Dis. 2025 Sep 17:13872877251378772. doi: 10.1177/13872877251378772.
    PubMed     Abstract available


  359. KITAYAMA Y, Nakano Y, Hirano S, Hanayama S, et al
    Multimodal neuroimaging related to cerebrospinal fluid biomarkers and cognitive function in Alzheimer's disease.
    J Alzheimers Dis. 2025 Sep 17:13872877251376601. doi: 10.1177/13872877251376601.
    PubMed     Abstract available


  360. LEE J, Kim CW, Kim Y, Lee S, et al
    Environmental noise exposure and a new biomarker of Alzheimer's disease: A pilot study.
    J Alzheimers Dis. 2025 Sep 16:13872877251376920. doi: 10.1177/13872877251376920.
    PubMed     Abstract available


  361. SHAKER A, Ljunggren G, Vossen LE, Religa D, et al
    Impact of socio-economic and patient-centered characteristics on access to Alzheimer's disease medication in primary care: A population-based study in the Stockholm county, Sweden.
    J Alzheimers Dis. 2025 Sep 16:13872877251375900. doi: 10.1177/13872877251375900.
    PubMed     Abstract available


  362. HAALAND B, Dickson SP, Santana AF, Tanzi RE, et al
    Efficacy of AD04, an aluminum-based vaccine adjuvant, in patients with early Alzheimer's disease: Post hoc analysis of AFF006 (NCT01117818), a proof-of-concept, phase 2 randomized controlled trial.
    J Alzheimers Dis. 2025 Sep 15:13872877251375985. doi: 10.1177/13872877251375985.
    PubMed     Abstract available


  363. LI H, Wu Y, Huang T, Sun Y, et al
    Development of a risk prediction model for Alzheimer's disease based on the UK Biobank prospective study.
    J Alzheimers Dis. 2025 Sep 15:13872877251375473. doi: 10.1177/13872877251375473.
    PubMed     Abstract available


  364. CARDOSO S, Montalvo A, Maroco J, Silva D, et al
    Long-term predictive accuracy of the 'mild cognitive impairment due to Alzheimer's disease' criteria.
    J Alzheimers Dis. 2025 Sep 15:13872877251375927. doi: 10.1177/13872877251375927.
    PubMed     Abstract available


  365. CHEN H, Guo Y, Zhang Z, Huang W, et al
    Neurovascular coupling dysfunction associated with cognition and glial fibrillary acidic protein along the Alzheimer's disease continuum.
    J Alzheimers Dis. 2025 Sep 12:13872877251375476. doi: 10.1177/13872877251375476.
    PubMed     Abstract available


  366. XU J, Sun A, Yang Y, Shi Y, et al
    Real-world observations on neuroinflammation-related drug responses in Alzheimer's disease.
    J Alzheimers Dis. 2025 Sep 12:13872877251376291. doi: 10.1177/13872877251376291.
    PubMed     Abstract available


  367. KAKKAR A, Singh H, Singh BK, Kumar A, et al
    Neuroinflammation and Alzheimer's disease: Unravelling the molecular mechanisms.
    J Alzheimers Dis. 2025 Sep 12:13872877251374353. doi: 10.1177/13872877251374353.
    PubMed     Abstract available


  368. FAKOREDE S, Sodiq TA, Ajagbe AO, Adeleke AJ, et al
    Interplay of Glut1 alteration and Alzheimer's disease: A narrative review on glucose transport and energy metabolism.
    J Alzheimers Dis. 2025 Sep 12:13872877251377793. doi: 10.1177/13872877251377793.
    PubMed     Abstract available


  369. ZHOU Y, Su T, Yuan M, Li WL, et al
    A new lens on Alzheimer's disease: Insights into the Edinger-Westphal nucleus and its circuits.
    J Alzheimers Dis. 2025 Sep 11:13872877251372587. doi: 10.1177/13872877251372587.
    PubMed     Abstract available


  370. CHATTERJEE P, Ivanic S, Southon A, McCarthy C, et al
    Real world diagnostic performance of plasma p-tau217 for early-onset Alzheimer's disease in a cognitive disorders tertiary care setting.
    J Alzheimers Dis. 2025 Sep 11:13872877251376694. doi: 10.1177/13872877251376694.
    PubMed     Abstract available


  371. MOTOLESE F, Norata D, Iaccarino G, Sapio E, et al
    Predicting cognitive decline in Alzheimer's disease: A real-life proof-of-principle study on multimodal assessment.
    J Alzheimers Dis. 2025 Sep 10:13872877251376676. doi: 10.1177/13872877251376676.
    PubMed     Abstract available


  372. TARAGANO F, Seinhart D, Epstein P, Sylvestre V, et al
    A real-world study on the safety and efficacy of therapeutic plasma exchange in patients with Alzheimer's disease.
    J Alzheimers Dis. 2025 Sep 10:13872877251375430. doi: 10.1177/13872877251375430.
    PubMed     Abstract available


  373. SCHAFFNER E, Sandoz M, Chatton P, Iglesias K, et al
    Tense production in French-speaking participants with Alzheimer's disease: What about discourse? Contribution of a storytelling-in-sequence task.
    J Alzheimers Dis. 2025 Sep 9:13872877251376028. doi: 10.1177/13872877251376028.
    PubMed     Abstract available


  374. ARSLAN B, Zetterberg H, Ashton NJ
    Integrating kidney function assessment into the clinical interpretation of plasma Alzheimer's disease biomarkers.
    J Alzheimers Dis. 2025 Sep 9:13872877251375101. doi: 10.1177/13872877251375101.
    PubMed     Abstract available


  375. KATSUMI Y
    Alterations of the brain functional organization in young-onset Alzheimer's disease: Is it a matter of "time"?
    J Alzheimers Dis. 2025 Sep 9:13872877251375094. doi: 10.1177/13872877251375094.
    PubMed     Abstract available


  376. HAYES CA, Odden MC, Thorpe RJ Jr
    Application of modified Poisson regression for risk estimation of major neuropathology outcomes: National Alzheimer's coordinating center.
    J Alzheimers Dis. 2025 Sep 9:13872877251375099. doi: 10.1177/13872877251375099.
    PubMed     Abstract available


  377. WANG L, Zuo X, Xu M, Hu Q, et al
    Interaction between gut microbiota and Alzheimer's disease: Re-analysis of the same sample.
    J Alzheimers Dis. 2025 Sep 4:13872877251367359. doi: 10.1177/13872877251367359.
    PubMed     Abstract available


  378. LIU G, Sun Y
    Harnessing nanoparticles for Alzheimer's disease: Innovations in drug delivery and pathology-specific treatments.
    J Alzheimers Dis. 2025 Sep 3:13872877251374149. doi: 10.1177/13872877251374149.
    PubMed     Abstract available


  379. ZHU Y, Chen Q, Chen F, Lu J, et al
    Functional connectivity signatures of olfactory networks linked to cognitive risk: A functional MRI study in subjective cognitive decline at risk for Alzheimer's disease.
    J Alzheimers Dis. 2025 Sep 3:13872877251373017. doi: 10.1177/13872877251373017.
    PubMed     Abstract available


  380. JIANG X, Liu Y, Lu Q, Liu J, et al
    Identification of exosome-related genes in Alzheimer's disease: Evidence from transcriptomic and Mendelian randomization analyses.
    J Alzheimers Dis. 2025 Sep 3:13872877251372065. doi: 10.1177/13872877251372065.
    PubMed     Abstract available


  381. STREIBER AM, Neitzel J, Yaqub A, Vernooij MW, et al
    Arteriosclerosis in the heart-brain axis and Alzheimer's disease plasma markers in the Rotterdam Study.
    J Alzheimers Dis. 2025 Sep 3:13872877251372641. doi: 10.1177/13872877251372641.
    PubMed     Abstract available


  382. SU FJ, Li YC, Shi XC, Yi C, et al
    Visual Cognitive Assessment Test correlates with brain amyloid status in Alzheimer's disease-related mild cognitive impairment.
    J Alzheimers Dis. 2025 Sep 1:13872877251371718. doi: 10.1177/13872877251371718.
    PubMed     Abstract available


  383. KRAMER M, Alekseyenko AV, Mollalo A
    The role of built and social environments in Alzheimer's disease dementia prevalence in the United States: A machine learning approach.
    J Alzheimers Dis. 2025 Sep 1:13872877251372144. doi: 10.1177/13872877251372144.
    PubMed     Abstract available


  384. TANG Q, Zhang X, Zhang C, Lang Q, et al
    Optimized sequential classification models for mild cognitive impairment screening based on handwriting and speech data.
    J Alzheimers Dis. 2025;107:112-127.
    PubMed     Abstract available


  385. STROPE TA, Troutwine B, Hauger BM, Smith KP, et al
    Amyloid-beta protein precursor modulates mitophagy and mitochondrial function through its cellular localization.
    J Alzheimers Dis. 2025;107:277-293.
    PubMed     Abstract available


  386. MOSER VA
    The gap between amyloid pathology and cognition.
    J Alzheimers Dis. 2025;107:46-48.
    PubMed     Abstract available


  387. JIANG D, Yue A, Nan H, Hou J, et al
    Plasma glial fibrillary acidic protein and neurological diseases: A bidirectional Mendelian randomization study.
    J Alzheimers Dis. 2025;107:806-818.
    PubMed     Abstract available


  388. ZHANG J, Wang C, Chang K, Peng T, et al
    A novel traditional Chinese medicine formula restores sleep and cognitive function in APP/PS1 mice by targeting glycolytic pathways and neuroinflammatory responses.
    J Alzheimers Dis. 2025;107:617-627.
    PubMed     Abstract available


    August 2025
  389. CHEN J, Lin B, Seow E, Kim S, et al
    Prediction of infusion capacity to deliver Alzheimer's disease treatments in the United States relative to expected demand.
    J Alzheimers Dis. 2025 Aug 29:13872877251372129. doi: 10.1177/13872877251372129.
    PubMed     Abstract available


  390. LIN H, Huang Z, Lu J, Wang J, et al
    The asymmetry of tau deposition and its correlation with cerebral metabolic asymmetry in Alzheimer's disease.
    J Alzheimers Dis. 2025 Aug 29:13872877251372523. doi: 10.1177/13872877251372523.
    PubMed     Abstract available


  391. CHEN Y, Dong C, Chen J, Li Q, et al
    Clinical observations on treating Alzheimer's disease with umbilical cord blood mononuclear cells.
    J Alzheimers Dis. 2025 Aug 28:13872877251366669. doi: 10.1177/13872877251366669.
    PubMed     Abstract available


  392. JIANG C, Qi J, Zou H, Lopez O, et al
    Impact of antidiabetic therapy on cognitive function in patients with type 2 diabetes and Alzheimer's disease: A comprehensive analysis.
    J Alzheimers Dis. 2025 Aug 25:13872877251365662. doi: 10.1177/13872877251365662.
    PubMed     Abstract available


  393. SAMPATH R, Baskar M
    Biomarker extraction-based Alzheimer's disease stage detection using optimized deep learning approach.
    J Alzheimers Dis. 2025 Aug 19:13872877251360394. doi: 10.1177/13872877251360394.
    PubMed     Abstract available


  394. GIM J
    Revisiting APOE: Insights from rare variants and the expanding landscape of Alzheimer's disease genetics.
    J Alzheimers Dis. 2025 Aug 17:13872877251366662. doi: 10.1177/13872877251366662.
    PubMed     Abstract available


  395. KONISHI K, Spets DS, Fisher P, Aroner S, et al
    Sex differences in the impact of genetic and clinical risk factors for Alzheimer's disease in midlife.
    J Alzheimers Dis. 2025 Aug 17:13872877251366701. doi: 10.1177/13872877251366701.
    PubMed     Abstract available


  396. GHOSH D, Pal S, Lutz M, Luo S, et al
    Ensemble survival analysis for preclinical cognitive decline prediction in Alzheimer's disease using longitudinal biomarkers.
    J Alzheimers Dis. 2025 Aug 14:13872877251365621. doi: 10.1177/13872877251365621.
    PubMed     Abstract available


  397. SHELTON M, Kerns KA, Shirali S, Castora FJ, et al
    Integrating mitochondrial gene expression data to model the effects of respirasome supercomplex formation on reactive oxygen species production in Alzheimer's disease models.
    J Alzheimers Dis. 2025 Aug 13:13872877251362889. doi: 10.1177/13872877251362889.
    PubMed     Abstract available


  398. JIANG F, Wang N, Meng Q
    From APOE to cellular changes: Unraveling the multidimensional mechanisms of blood-brain barrier damage in Alzheimer's disease.
    J Alzheimers Dis. 2025 Aug 13:13872877251360321. doi: 10.1177/13872877251360321.
    PubMed     Abstract available


  399. PFLANZER H, Kerns KA, Knoble J, Gershon BS, et al
    Mitochondrial energy production genes affecting reactive oxygen species and ATP synthesis, inflammatory pathways, and neuron viability are differentially expressed in brains of Alzheimer's disease patients.
    J Alzheimers Dis. 2025 Aug 13:13872877251362884. doi: 10.1177/13872877251362884.
    PubMed     Abstract available


  400. ZHANG X, Sun Z, Wu D, Shi X, et al
    Effects of cerebellar intermittent theta-burst stimulation on patients with Alzheimer's disease: A randomized controlled trial.
    J Alzheimers Dis. 2025 Aug 13:13872877251366656. doi: 10.1177/13872877251366656.
    PubMed     Abstract available


  401. XIE F, Ye Y, Hao J, Liu H, et al
    Surgical advances in the treatment of Alzheimer's disease: A comprehensive review.
    J Alzheimers Dis. 2025 Aug 13:13872877251364397. doi: 10.1177/13872877251364397.
    PubMed     Abstract available


  402. MERVOSH N, Bilici N, Wisniewski T, Devi G, et al
    Reducing ARIA risk in Alzheimer's disease: Real-world impact of APOE genotype-guided slow titration with aducanumab and lecanemab.
    J Alzheimers Dis. 2025 Aug 13:13872877251366657. doi: 10.1177/13872877251366657.
    PubMed     Abstract available


  403. MOTAGHI M, Potvin O, Duchesne S
    Commonalities in cortical neurodegeneration between type 2 diabetes and Alzheimer's disease.
    J Alzheimers Dis. 2025 Aug 10:13872877251365671. doi: 10.1177/13872877251365671.
    PubMed     Abstract available


  404. QI J, He M, Lian T, Wang S, et al
    Correlations of retinal morphology with clinical symptoms, blood-brain barrier, and brain structure in patients with Alzheimer's disease.
    J Alzheimers Dis. 2025 Aug 8:13872877251364736. doi: 10.1177/13872877251364736.
    PubMed     Abstract available


  405. CABAN M, Tran E, Meng A, Wetmore JB, et al
    Planning for the future following receipt of Alzheimer's disease risk estimate among Latinos in New York City.
    J Alzheimers Dis. 2025 Aug 8:13872877251365571. doi: 10.1177/13872877251365571.
    PubMed     Abstract available


  406. WANG H, Liu J, Tian YR, Zhu F, et al
    The effects of Honokiol on the liver of Alzheimer's disease mice by upregulating SIRT3.
    J Alzheimers Dis. 2025 Aug 8:13872877251362185. doi: 10.1177/13872877251362185.
    PubMed     Abstract available


  407. PRATT T, Lee A, Zheng J, Tavacoli F, et al
    Distinct glial functions are associated with Alzheimer's disease based on cell-type- and pathway-specific polygenic risk score analysis.
    J Alzheimers Dis. 2025 Aug 8:13872877251362258. doi: 10.1177/13872877251362258.
    PubMed     Abstract available


  408. ZHAO R, Bai W, Tian Z, Li X, et al
    Cistanche flavonoids activate the Keap1-Nrf2-ARE signaling pathway in improving cognitive dysfunction in Alzheimer's disease: A review.
    J Alzheimers Dis. 2025 Aug 8:13872877251361053. doi: 10.1177/13872877251361053.
    PubMed     Abstract available


  409. ROBINSON JEYAPAUL S, Kombaiya S, Jeya Kumar AK, Stanley VJ, et al
    Ensemble deep learning model for early diagnosis and classification of Alzheimer's disease using MRI scans.
    J Alzheimers Dis. 2025 Aug 8:13872877251359950. doi: 10.1177/13872877251359950.
    PubMed     Abstract available


  410. LV Y, Xiang Y, Fu W, Li B, et al
    Global burden trends of Alzheimer's disease and other dementias attributable to smoking from 1990 to 2021.
    J Alzheimers Dis. 2025 Aug 6:13872877251365284. doi: 10.1177/13872877251365284.
    PubMed     Abstract available


  411. GUO X, Fu H, Qin M, Kan J, et al
    Multi-omics profiling reveals two distinct trajectories in the progression from mild cognitive impairment to Alzheimer's disease.
    J Alzheimers Dis. 2025 Aug 6:13872877251365210. doi: 10.1177/13872877251365210.
    PubMed     Abstract available


  412. KITAGAWA K, Yoshizawa H, Toi S, Todo K, et al
    Utility of combination of Mini-Mental State Examination and Montreal Cognitive Assessment to predict incident Alzheimer's disease dementia in patients at high vascular risks.
    J Alzheimers Dis. 2025 Aug 6:13872877251365629. doi: 10.1177/13872877251365629.
    PubMed     Abstract available


  413. YAO R, Ouyang Z, Xu T, Zhu Y, et al
    Immune system-associated genes in patients with Alzheimer's disease.
    J Alzheimers Dis. 2025 Aug 6:13872877251364396. doi: 10.1177/13872877251364396.
    PubMed     Abstract available


  414. CHEN X, Zhou S, Wang W, Gao Z, et al
    Sex differences in white matter amplitude of low-frequency fluctuation associated with cognitive performance across the Alzheimer's disease continuum.
    J Alzheimers Dis. 2025 Aug 5:13872877251364722. doi: 10.1177/13872877251364722.
    PubMed     Abstract available


  415. XIA Y, Sha L, Tao M, Peng A, et al
    Cognitive and spatial patterns of amyloid-beta burden in Alzheimer's disease with epilepsy.
    J Alzheimers Dis. 2025 Aug 4:13872877251360425. doi: 10.1177/13872877251360425.
    PubMed     Abstract available


  416. CANOVAS R, Doecke JD, Fowler CJ, Fripp J, et al
    Association of plastic-associated chemicals with Alzheimer's disease amyloid-beta and cognitive status.
    J Alzheimers Dis. 2025 Aug 3:13872877251364559. doi: 10.1177/13872877251364559.
    PubMed     Abstract available


  417. PANG R, Wang J, Kanekar S, Karunanayaka P, et al
    Linking genetics to MRI-DTI: HFE polymorphism delays Alzheimer's disease white matter degeneration in APOE4 carriers.
    J Alzheimers Dis. 2025 Aug 3:13872877251363211. doi: 10.1177/13872877251363211.
    PubMed     Abstract available


  418. AYELE BA, Whitehead PL, Pascual J, Gu T, et al
    Exploring the stability of Alzheimer's disease plasma biomarkers stored for extended periods at -20 degrees C: Implications for resource-constrained environments.
    J Alzheimers Dis. 2025 Aug 3:13872877251364899. doi: 10.1177/13872877251364899.
    PubMed     Abstract available


  419. BARBOUR AJ
    Screening antiseizure medications to break the cycle between neuronal hyperexcitability and Alzheimer's disease.
    J Alzheimers Dis. 2025 Aug 3:13872877251364556. doi: 10.1177/13872877251364556.
    PubMed     Abstract available


  420. AKUSHEVICH I, Yashkin A, Tupler LA, Ouyang M, et al
    The absolute and relative concentration-response patterns of exposure to ambient air pollutants and the risk of Alzheimer's disease.
    J Alzheimers Dis. 2025 Aug 1:13872877251362785. doi: 10.1177/13872877251362785.
    PubMed     Abstract available


  421. ZANINI L, D'Antonio F, Di Vita A, Talarico G, et al
    Sensitivity and vagal reactivity to C-tactile-mediated affective touch in mild cognitive impairment due to Alzheimer's disease.
    J Alzheimers Dis. 2025 Aug 1:13872877251362249. doi: 10.1177/13872877251362249.
    PubMed     Abstract available


  422. WOOD KA, Chen X, Ko YA, Wharton W, et al
    National Alzheimer's Coordinating Center cerebral neuropathology and cognitive function in atrial fibrillation.
    J Alzheimers Dis. 2025 Aug 1:13872877251364508. doi: 10.1177/13872877251364508.
    PubMed     Abstract available


  423. ANSCHUETZ A, Schwab K, Harrington CR, Wischik CM, et al
    Proteomic and non-proteomic changes of presynaptic proteins in animal models of Alzheimer's disease: A meta-analysis 2015-2023.
    J Alzheimers Dis. 2025 Aug 1:13872877251362212. doi: 10.1177/13872877251362212.
    PubMed     Abstract available


  424. PARK J, Abner EL, Wang P, Liu C, et al
    Estimation of events in cohort studies based on probability of cognitive impairment.
    J Alzheimers Dis. 2025;106:1097-1107.
    PubMed     Abstract available


  425. PARK YJ, Seo SW, Choi SH, Moon SY, et al
    Machine learning-based prediction of amyloid positivity using early-phase F-18 flutemetamol PET.
    J Alzheimers Dis. 2025;106:1198-1211.
    PubMed     Abstract available



  426. Cyrus A. Raji, MD, PhD, is the recipient of the 2025 Mark A. Smith Alzheimer Award.
    J Alzheimers Dis. 2025;106:1217-1218.
    PubMed    


    July 2025
  427. PRAJAPAT M, Sarma P, Kaur G, Choudhary G, et al
    Therapeutic potential of 6BIO and DKK1-LRP6 inhibitor in Wnt/beta-catenin pathway modulation for amyloid-beta-induced Alzheimer's disease model.
    J Alzheimers Dis. 2025 Jul 30:13872877251362787. doi: 10.1177/13872877251362787.
    PubMed     Abstract available


  428. KUECK PJ, Honea RA, Kemna RE, Burns JM, et al
    Brain-derived neurotrophic factor and its relationship to known biomarkers of Alzheimer's disease.
    J Alzheimers Dis. 2025 Jul 30:13872877251362487. doi: 10.1177/13872877251362487.
    PubMed     Abstract available


  429. KIM J, Yang HJ, Park S, Kim BS, et al
    Gait speed and muscle mass as dual mediators in the link between white matter hyperintensities and Alzheimer's disease.
    J Alzheimers Dis. 2025 Jul 30:13872877251362424. doi: 10.1177/13872877251362424.
    PubMed     Abstract available


  430. MILES LA, Masters CL
    The structural foundations of anti-amyloid-beta immunotherapies: Unravelling antibody-antigen interactions in Alzheimer's disease treatment.
    J Alzheimers Dis. 2025 Jul 30:13872877251361049. doi: 10.1177/13872877251361049.
    PubMed     Abstract available


  431. WANG H, Yang Q, Ge C, Liu J, et al
    Integrated transcriptomic and proteomic analysis identifies FBXW7 as a key regulator of tau homeostasis in Alzheimer's disease.
    J Alzheimers Dis. 2025 Jul 29:13872877251361042. doi: 10.1177/13872877251361042.
    PubMed     Abstract available


  432. IKANGA J, Jean K, Medina P, Patel SS, et al
    Neurodegenerative plasma biomarkers for prediction of hippocampal atrophy in older adults with suspected Alzheimer's disease in Kinshasa, Democratic Republic of Congo.
    J Alzheimers Dis. 2025 Jul 29:13872877251360697. doi: 10.1177/13872877251360697.
    PubMed     Abstract available


  433. SHI L, Tian X, Lu X, Yih B, et al
    Frailty in Alzheimer's disease: A bibliometric analysis of research hotspots, emerging trends, and knowledge structure.
    J Alzheimers Dis. 2025 Jul 28:13872877251362665. doi: 10.1177/13872877251362665.
    PubMed     Abstract available



  434. Cyrus A. Raji, MD, PhD, is the recipient of the 2025 Mark A. Smith Alzheimer Award.
    J Alzheimers Dis. 2025 Jul 28:13872877251361092. doi: 10.1177/13872877251361092.
    PubMed    


  435. XIONG C, Lu R, Bui Q, Popp B, et al
    Person-specific digital measurements of air pollutant exposure and biomarkers of Alzheimer's disease: Findings from a pilot study.
    J Alzheimers Dis. 2025 Jul 27:13872877251362667. doi: 10.1177/13872877251362667.
    PubMed     Abstract available


  436. HSIAO CH, Wu CE, Wang CM, Lin TY, et al
    Intracerebral hemorrhage risk in Alzheimer's disease patients on anticoagulants: A nationwide cohort study.
    J Alzheimers Dis. 2025 Jul 27:13872877251362362. doi: 10.1177/13872877251362362.
    PubMed     Abstract available


  437. ALABDULJABBAR A, Khan SU, Altherwy YN, Almarshad F, et al
    A novel multimodal medical image fusion model for Alzheimer's and glioma disease detection based on hybrid fusion strategies in non-subsampled shearlet transform domain.
    J Alzheimers Dis. 2025 Jul 27:13872877251362498. doi: 10.1177/13872877251362498.
    PubMed     Abstract available


  438. PRABHU SS, Burrage EN, Coblentz T, Ball S, et al
    Mid-life exposure to chronic stress accelerates cerebrovascular dysfunction and upregulates oxidative stress in Alzheimer's disease mice.
    J Alzheimers Dis. 2025 Jul 27:13872877251362204. doi: 10.1177/13872877251362204.
    PubMed     Abstract available


  439. RICH A, Oh H
    Distinctive volumetric associations between plasma p-tau181 and hippocampal formation structures across the Alzheimer's disease continuum.
    J Alzheimers Dis. 2025 Jul 27:13872877251361354. doi: 10.1177/13872877251361354.
    PubMed     Abstract available


  440. CHONG JR, Hye A, Boada M, Svenningsson P, et al
    Cerebrospinal fluid biomarkers of Alzheimer's disease in Lewy body diseases: The performance of fully automated immunoassays.
    J Alzheimers Dis. 2025 Jul 27:13872877251360404. doi: 10.1177/13872877251360404.
    PubMed     Abstract available


  441. MORYS F, Liu L, Senkevich K, Gan-Or Z, et al
    Obesity-related brain atrophy is independent of Alzheimer's disease protein pathways.
    J Alzheimers Dis. 2025 Jul 27:13872877251359680. doi: 10.1177/13872877251359680.
    PubMed     Abstract available


  442. ARAI H, Aiba S, Arai R
    Safety of switching from lecanemab to donanemab in 20 consecutive patients with Alzheimer's disease.
    J Alzheimers Dis. 2025 Jul 24:13872877251361051. doi: 10.1177/13872877251361051.
    PubMed     Abstract available


  443. BENGISU S, Savas M, Ustel DA, Begen SK, et al
    The discriminant ability of the Eating Assessment Tool-10 to detect dysphagia and aspiration according to the stage of Alzheimer's disease.
    J Alzheimers Dis. 2025 Jul 23:13872877251362229. doi: 10.1177/13872877251362229.
    PubMed     Abstract available


  444. WANG X, Wang M, Wang H, Yin G, et al
    Drug repurposing for Alzheimer's disease integrating transcriptome-wide association study and biological network analysis.
    J Alzheimers Dis. 2025 Jul 22:13872877251360009. doi: 10.1177/13872877251360009.
    PubMed     Abstract available


  445. PEREIRA DA SILVA AM, Falcao L, Virgilio F, Rodrigues Menezes I, et al
    Efficacy and APOE epsilon4-stratified risk of donanemab in Alzheimer's disease: A systematic review and meta-analysis of randomized clinical trials.
    J Alzheimers Dis. 2025 Jul 21:13872877251361044. doi: 10.1177/13872877251361044.
    PubMed     Abstract available


  446. YIN M, Ding S, Zhao M, Liu J, et al
    The global, regional, and national burden and attributable risk factors of Alzheimer's disease and other dementias, 1990-2021: A systematic analysis for the Global Burden of Disease Study.
    J Alzheimers Dis. 2025 Jul 21:13872877251360221. doi: 10.1177/13872877251360221.
    PubMed     Abstract available


  447. ALZHRANI AJ, Stockfelt L, Xu Y, Harari F, et al
    Long-term exposure to air pollution and validated cases of Alzheimer's disease and vascular dementia in the Malmo diet and cancer cohort.
    J Alzheimers Dis. 2025 Jul 21:13872877251360225. doi: 10.1177/13872877251360225.
    PubMed     Abstract available


  448. LUO X, Hong H, Wang S, Li K, et al
    Assessment of diffusivity along the perivascular space in early- and late-onset Alzheimer's disease.
    J Alzheimers Dis. 2025 Jul 21:13872877251360416. doi: 10.1177/13872877251360416.
    PubMed     Abstract available


  449. QIU Y, Bao J, Wang T, Shang L, et al
    Global and regional white matter hyperintensities in Alzheimer's disease: Exploring etiologies and cognitive correlates.
    J Alzheimers Dis. 2025 Jul 21:13872877251360239. doi: 10.1177/13872877251360239.
    PubMed     Abstract available


  450. HUANG Y, Xu T, Wang L, Xiang R, et al
    Application of machine learning reveals diagnostic biomarkers related to pyroptosis in Alzheimer's disease and analysis of immune infiltration.
    J Alzheimers Dis. 2025 Jul 20:13872877251360033. doi: 10.1177/13872877251360033.
    PubMed     Abstract available


  451. SENRA H, Costa MC, Pereira I, Agostinho D, et al
    Predicting diagnostic conversion from mild cognitive impairment to Alzheimer's disease: A Bayesian hierarchical model approach using ADNI patient data.
    J Alzheimers Dis. 2025 Jul 20:13872877251360228. doi: 10.1177/13872877251360228.
    PubMed     Abstract available


  452. PASTERIS M, Cakir S, Bellizzi A, Sariyer IK, et al
    Alternative splicing in Alzheimer's disease: Mechanisms, therapeutic implications, and 3D modeling approaches.
    J Alzheimers Dis. 2025 Jul 20:13872877251359633. doi: 10.1177/13872877251359633.
    PubMed     Abstract available


  453. LI Q, Koehler S, Koenig A, Dyrba M, et al
    Associations between digital speech features of automated cognitive tasks and trajectories of brain atrophy and cognitive decline in early Alzheimer's disease.
    J Alzheimers Dis. 2025 Jul 20:13872877251359967. doi: 10.1177/13872877251359967.
    PubMed     Abstract available


  454. WEI C, Wang J, Xue Y, Jiang J, et al
    Characterizing structure-function coupling in subjective memory complaints of preclinical Alzheimer's disease.
    J Alzheimers Dis. 2025 Jul 17:13872877251360259. doi: 10.1177/13872877251360259.
    PubMed     Abstract available


  455. VARANGIS E, Liu J, Miao Y, Zhu X, et al
    Neural flexibility is higher in Alzheimer's disease and predicts Alzheimer's disease transition.
    J Alzheimers Dis. 2025 Jul 17:13872877251360025. doi: 10.1177/13872877251360025.
    PubMed     Abstract available


  456. GE L, Zhu L, Su C, Jin Z, et al
    Exploring causal gut-brain axes in Alzheimer's disease using mediation Mendelian randomization analysis.
    J Alzheimers Dis. 2025 Jul 15:13872877251360004. doi: 10.1177/13872877251360004.
    PubMed     Abstract available


  457. ABBATE C, Gallucci A
    New Alzheimer's association workgroup criteria underestimate syndromes in Alzheimer's disease definition.
    J Alzheimers Dis. 2025 Jul 15:13872877251359642. doi: 10.1177/13872877251359642.
    PubMed     Abstract available


  458. FU Y, Jiang L, Detre J, Wang Z, et al
    Alzheimer's disease classification using mutual information generated graph convolutional network for functional MRI.
    J Alzheimers Dis. 2025 Jul 15:13872877251350306. doi: 10.1177/13872877251350306.
    PubMed     Abstract available


  459. TAHAMI MONFARED AA, Hummel N, Kopiec A, Chandak A, et al
    Integrating intangible costs into societal cost estimates of Alzheimer's disease.
    J Alzheimers Dis. 2025 Jul 13:13872877251351591. doi: 10.1177/13872877251351591.
    PubMed     Abstract available


  460. EDMUNDS KJ, Nelson AR, Brach TL, Glittenberg M, et al
    Depression modifies age-associated [(11)C]PiB-PET amyloid burden in a cohort enriched with risk for Alzheimer's disease.
    J Alzheimers Dis. 2025 Jul 10:13872877251353098. doi: 10.1177/13872877251353098.
    PubMed     Abstract available


  461. GAMM S, Ummel D, Vasil N, Grenier S, et al
    The need to adapt after Alzheimer's disease diagnosis: Coping strategies used to maintain identity and quality of life.
    J Alzheimers Dis. 2025 Jul 7:13872877251351596. doi: 10.1177/13872877251351596.
    PubMed     Abstract available


  462. HOILUND-CARLSEN PF, Alavi A, Costa T, Neve RL, et al
    Is US residence a risk factor for Alzheimer's disease?
    J Alzheimers Dis. 2025 Jul 3:13872877251356682. doi: 10.1177/13872877251356682.
    PubMed     Abstract available


  463. PALEY JL, Scheiffele GD, Li Y, Shaaban CE, et al
    Neighborhood deprivation and mortality among people with Alzheimer's disease and related dementia.
    J Alzheimers Dis. 2025 Jul 2:13872877251352120. doi: 10.1177/13872877251352120.
    PubMed     Abstract available


  464. HSU YH, Huang SM, Kuo LW, Yang JJ, et al
    Diagnostic utility of the item-specific Encoding Deficit Index in relation to medial temporal lobe atrophy in early-stage Alzheimer's disease.
    J Alzheimers Dis. 2025 Jul 2:13872877251351612. doi: 10.1177/13872877251351612.
    PubMed     Abstract available


  465. BOSE C, Hindle A, Smith SC, Strickland J, et al
    Low-dose dietary vorinostat increases brain histone acetylation levels and reduces oxidative stress in an Alzheimer's disease mouse model.
    J Alzheimers Dis. 2025 Jul 1:13872877251352107. doi: 10.1177/13872877251352107.
    PubMed     Abstract available


  466. WALCZAK K, Kolodziejczyk W, Pszczolowska M, Kozlowska M, et al
    Klotho protein in Alzheimer's disease: Diet leading to immortality?
    J Alzheimers Dis. 2025 Jul 1:13872877251350125. doi: 10.1177/13872877251350125.
    PubMed     Abstract available


  467. LIU SK, Cao H, Yang X, Zhou X, et al
    An ABCA1 missense variant decreases cholesterol efflux and confers Alzheimer's disease risk in the Chinese population.
    J Alzheimers Dis. 2025 Jul 1:13872877251350722. doi: 10.1177/13872877251350722.
    PubMed     Abstract available


  468. RICCHI I, Griffa A, Corredor-Jerez R, Richiardi J, et al
    The complementary role of automated brain volumetry to stratify ADNI participants within the ATN framework.
    J Alzheimers Dis. 2025;106:245-258.
    PubMed     Abstract available


  469. LOJO-RAMIREZ JA, Fernandez-Rodriguez P, Guerra-Gomez M, Marin-Cabanas AM, et al
    Evaluation of early-phase (18)F-Florbetaben PET as a surrogate biomarker of neurodegeneration: In-depth comparison with (18)F-FDG PET at group and single patient level.
    J Alzheimers Dis. 2025;106:304-316.
    PubMed     Abstract available


  470. YIN A, Gui Y, Wan L, Cai Q, et al
    p53 SUMOylation promotes neurogenesis defects in APP/PS1 mice.
    J Alzheimers Dis. 2025;106:352-362.
    PubMed     Abstract available


  471. SEKIKAWA A, Higashiyama A, Lopresti BJ, Ihara M, et al
    An inverse association of cerebral amyloid-beta deposition and serum docosahexaenoic acid levels in cognitively normal older adults in Japan.
    J Alzheimers Dis. 2025;106:378-386.
    PubMed     Abstract available


  472. ANDERSEN LSN, Simonsen AH, Vogel A, McWilliam OH, et al
    Isolated elevation of 181p-tau in the cerebrospinal fluid is associated with distinct clinical features: Findings from a Danish memory clinic cohort.
    J Alzheimers Dis. 2025;106:111-119.
    PubMed     Abstract available


  473. ZHAI A, Zou R, Lv T, Yang S, et al
    Genetic association of social participation with cognitive function: A bidirectional Mendelian randomization study.
    J Alzheimers Dis. 2025;106:259-270.
    PubMed     Abstract available


  474. CAI Y, Wang X, Xiang Y, Wang Z, et al
    Codonopsis pilosula polysaccharides alleviate neuronal apoptosis induced by endoplasmic reticulum stress-activated PERK-ATF4-CHOP signaling in APP/PS1 mice.
    J Alzheimers Dis. 2025;106:317-330.
    PubMed     Abstract available


  475. LIU J, Duangjan C, Phan NM, Curran SP, et al
    Loss of WDR23 slows the rate of age-related cognitive decline with elevated amyloid burden.
    J Alzheimers Dis. 2025;106:218-229.
    PubMed     Abstract available


  476. SALVIONI CHIABOTTI P, Nasuti M, Rouaud O, Allali G, et al
    Posterior cortical atrophy in the age of anti-amyloid treatments: An 11-year retrospective study of eligible patients from the Leenaards Memory Center.
    J Alzheimers Dis. 2025;106:512-517.
    PubMed     Abstract available


  477. SINGHRAO SK
    Porphyromonas gingivalis-lipopolysaccharide and amyloid-beta: A dangerous liaison for impairing memory?
    J Alzheimers Dis. 2025;106:537-539.
    PubMed     Abstract available


  478. SUZUMURA S, Sugioka J, Sakurai K, Osawa A, et al
    Finger motor skills and related brain regions in patients with cognitive disorder.
    J Alzheimers Dis. 2025;106:634-645.
    PubMed     Abstract available


  479. ALISHAHI F, Beam CR, Gatz M, Schneider LS, et al
    High precision and cost-effective multiplex quantification of amyloid-beta40, amyloid-beta42, p181Tau, p217Tau, neurofilament light chain, and glial fibrillary acidic protein from plasma and serum.
    J Alzheimers Dis. 2025;106:739-755.
    PubMed     Abstract available


    June 2025
  480. SARAIVA JA, Becker M, Dyrba M, Bolukbas B, et al
    Electroencephalogram features support the retrogenesis hypothesis of Alzheimer's disease: Exploratory comparison of brain changes in aging and childhood.
    J Alzheimers Dis. 2025 Jun 30:13872877251352119. doi: 10.1177/13872877251352119.
    PubMed     Abstract available


  481. SATO K, Niimi Y, Ihara R, Iwata A, et al
    Effect of corrections for renal function on plasma phosphorylated tau performance for Alzheimer's disease.
    J Alzheimers Dis. 2025 Jun 30:13872877251350718. doi: 10.1177/13872877251350718.
    PubMed     Abstract available


  482. WANG G, Chen T, O'Gorman J, Li Y, et al
    Harnessing greater statistical power: Comprehensive evaluation of disease modifying treatment effects across all or multiple post-baseline visits compared to the last visit for Alzheimer's disease clinical trials.
    J Alzheimers Dis. 2025 Jun 30:13872877251352189. doi: 10.1177/13872877251352189.
    PubMed     Abstract available


  483. SHANG ZT, Huang XY, Xiong LL, Xu ZC, et al
    Methanol extract from miracle fruit seeds mitigates Alzheimer's disease and enhance autophagy via suppressing the AKT/mTOR signal pathway.
    J Alzheimers Dis. 2025 Jun 30:13872877251352545. doi: 10.1177/13872877251352545.
    PubMed     Abstract available


  484. ESLICK S, Austin G, Ferguson JJ, Garg ML, et al
    Blood biomarkers of Alzheimer's disease in Australians habitually consuming various plant-based diets.
    J Alzheimers Dis. 2025 Jun 30:13872877251351549. doi: 10.1177/13872877251351549.
    PubMed     Abstract available


  485. KIM S, Wang SM, Kang DW, Kim S, et al
    Impact of type 2 diabetes mellitus on differential cerebellar volume reduction in Alzheimer's disease trajectory.
    J Alzheimers Dis. 2025 Jun 27:13872877251352208. doi: 10.1177/13872877251352208.
    PubMed     Abstract available


  486. JAMISON D, Kadamangudi S, Tumurbaatar B, Zhang WR, et al
    Comparative analysis of brain-derived tau oligomer interactomes in Alzheimer's disease, non-demented with Alzheimer's neuropathology, and primary age-related tauopathy: Implications for neurodegeneration and cognitive resilience.
    J Alzheimers Dis. 2025 Jun 27:13872877251352382. doi: 10.1177/13872877251352382.
    PubMed     Abstract available


  487. ZHANG QN, Yu LK, Zhang XY, Wu Y, et al
    LCN2 of cerebrospinal fluid: A potential biomarker for diagnosis and disease progression in Alzheimer's disease.
    J Alzheimers Dis. 2025 Jun 27:13872877251352411. doi: 10.1177/13872877251352411.
    PubMed     Abstract available


  488. CHEN F, Deng H, Zhang Q, Liu Y, et al
    Utility of machine learning algorithms in classification of progressive cognitive impairment in Alzheimer's disease: A retrospective cohort based on China.
    J Alzheimers Dis. 2025 Jun 27:13872877251352510. doi: 10.1177/13872877251352510.
    PubMed     Abstract available


  489. POPP ZT, Ang TFA, Hwang PH, Au R, et al
    Association between education and rate of cognitive decline among individuals with Alzheimer's disease: A multi-national European observational study.
    J Alzheimers Dis. 2025 Jun 26:13872877251352216. doi: 10.1177/13872877251352216.
    PubMed     Abstract available


  490. WADLEY VG, Zhang Y, Bull T, Barba C, et al
    Daily function outcomes in adults with mild cognitive impairment due to Alzheimer's disease after two years of processing speed training versus a control training protocol.
    J Alzheimers Dis. 2025 Jun 26:13872877251351341. doi: 10.1177/13872877251351341.
    PubMed     Abstract available


  491. XIA X, Duffner LA, Bintener C, Bradshaw A, et al
    Diagnostic and prognostic multimodal prediction models in Alzheimer's disease: A scoping review.
    J Alzheimers Dis. 2025 Jun 26:13872877251351630. doi: 10.1177/13872877251351630.
    PubMed     Abstract available


  492. SIRIWARDHANA C, Carrazana E, Liow K
    Racial and socioeconomic influences on the interplay between Alzheimer's disease-related dementia and cardio-cerebrovascular disease in an aging population.
    J Alzheimers Dis. 2025 Jun 26:13872877251351216. doi: 10.1177/13872877251351216.
    PubMed     Abstract available


  493. GARRAHY JP
    Astrocytic lipidopathy and bioenergetic failure in ApoE4-associated late-onset Alzheimer's disease: A unifying hypothesis.
    J Alzheimers Dis. 2025 Jun 26:13872877251350338. doi: 10.1177/13872877251350338.
    PubMed     Abstract available


  494. KATABATHULA S, Gurney M, Perry G, Davis PB, et al
    Identifying patients with mild cognitive impairment at high risk of transitioning to Alzheimer's disease using routinely collected data.
    J Alzheimers Dis. 2025 Jun 25:13872877251351622. doi: 10.1177/13872877251351622.
    PubMed     Abstract available


  495. WANG W, Davis PB, Qi X, Gurney M, et al
    Associations of semaglutide with Alzheimer's disease-related dementias in patients with type 2 diabetes: A real-world target trial emulation study.
    J Alzheimers Dis. 2025 Jun 24:13872877251351329. doi: 10.1177/13872877251351329.
    PubMed     Abstract available


  496. ASANTE J JR, Nagel CL, Barger SW
    Prescription-based association of P-glycoprotein substrates with Alzheimer's disease risk: A nested case-control study.
    J Alzheimers Dis. 2025 Jun 23:13872877251351629. doi: 10.1177/13872877251351629.
    PubMed     Abstract available


  497. TIAN J, Meka SS, Wang T, Guo L, et al
    Vulnerability of mitochondrial OXPHOS complexes in the arcuate nucleus of the hypothalamus of Alzheimer's disease.
    J Alzheimers Dis. 2025 Jun 22:13872877251352209. doi: 10.1177/13872877251352209.
    PubMed     Abstract available


  498. GONG J, Li S, Han X, Wang P, et al
    Autoantibodies in Alzheimer's disease: Multifaceted roles and therapeutic horizons.
    J Alzheimers Dis. 2025 Jun 22:13872877251350292. doi: 10.1177/13872877251350292.
    PubMed     Abstract available


  499. NAKAMURA K, Tagai K, Shinotoh H, Hirano S, et al
    Concurrent Alzheimer's disease pathologies in Lewy body diseases affect cognition and glucose metabolism in the posterior cingulate gyrus: A multimodal PET study.
    J Alzheimers Dis. 2025 Jun 20:13872877251351220. doi: 10.1177/13872877251351220.
    PubMed     Abstract available


  500. HOILUND-CARLSEN PF, Barrio JR
    History repeats itself: A new trivializing term for a potentially life-threatening side effect of antibody Alzheimer's disease therapy.
    J Alzheimers Dis. 2025 Jun 19:13872877251350295. doi: 10.1177/13872877251350295.
    PubMed     Abstract available


  501. LIN PJ, Riley AG, Synnott PG, Frangiosa TL, et al
    Health utilities in Alzheimer's disease: A survey of patients and caregivers in the United States.
    J Alzheimers Dis. 2025 Jun 19:13872877251350381. doi: 10.1177/13872877251350381.
    PubMed     Abstract available


  502. CHENG M, Wei YD, Zheng X, Gao XR, et al
    Bibliometric analysis of the interplay between Alzheimer's disease and type 2 diabetes mellitus: Trends, hotspots, and emerging research areas.
    J Alzheimers Dis. 2025 Jun 17:13872877251351042. doi: 10.1177/13872877251351042.
    PubMed     Abstract available


  503. JOHNSON IP, Peterson TM, Gudsnuk K, Keene CD, et al
    Presence of Alzheimer's disease variants in circular RNA of PSEN1 and PSEN2.
    J Alzheimers Dis. 2025 Jun 16:13872877251350112. doi: 10.1177/13872877251350112.
    PubMed     Abstract available


  504. MICHAEL GC
    Knowledge and attitudes about Alzheimer's disease in Nigerian geriatric outpatients: The role of primary care professionals.
    J Alzheimers Dis. 2025 Jun 16:13872877251350293. doi: 10.1177/13872877251350293.
    PubMed     Abstract available


  505. ZAWAR I, Kapur J
    Seizing the link: Exploring the potential association between anti-seizure medications and Alzheimer's disease.
    J Alzheimers Dis. 2025 Jun 16:13872877251350291. doi: 10.1177/13872877251350291.
    PubMed     Abstract available


  506. VANNINI P, Zamboni G
    To know or to not know: The importance of assessing awareness of cognitive function in the early stages of Alzheimer's disease.
    J Alzheimers Dis. 2025 Jun 16:13872877251350138. doi: 10.1177/13872877251350138.
    PubMed     Abstract available


  507. MARIZZONI M, Coppola L, Festari C, Luongo D, et al
    Circulating short chain fatty acids in Alzheimer's disease: A cross-sectional observational study.
    J Alzheimers Dis. 2025 Jun 12:13872877251337773. doi: 10.1177/13872877251337773.
    PubMed     Abstract available


  508. WANG DW, Qin XT, Wang G, Liu J, et al
    Effect of comprehensive geriatric assessment intervention on serum S100beta levels and clinical outcomes in patients with Alzheimer's disease.
    J Alzheimers Dis. 2025 Jun 10:13872877251344544. doi: 10.1177/13872877251344544.
    PubMed     Abstract available


  509. KNOX KM, Davidson S, Lehmann LM, Skinner E, et al
    Alzheimer's disease-associated genotypes differentially influence chronic evoked seizure outcomes and antiseizure medicine efficacy in aged mice.
    J Alzheimers Dis. 2025 Jun 3:13872877251343321. doi: 10.1177/13872877251343321.
    PubMed     Abstract available


  510. YU K, Jiang R, Zhou D, Zhao Z, et al
    Therapeutic targets for Alzheimer's disease: Proteome-wide Mendelian randomization and colocalization analyses.
    J Alzheimers Dis. 2025 Jun 2:13872877251344572. doi: 10.1177/13872877251344572.
    PubMed     Abstract available


  511. KIM HN, Jang WH, Kang NS, Kim S, et al
    Pterosin D-activated protein kinase A mitigates Alzheimer's disease in 5xFAD mice.
    J Alzheimers Dis. 2025 Jun 2:13872877251344627. doi: 10.1177/13872877251344627.
    PubMed     Abstract available


  512. YANG D, Hou N, Jia M
    Multicomponent exercise interventions for older adults with Alzheimer's disease: A systematic review and meta-analytical perspective.
    J Alzheimers Dis. 2025 Jun 2:13872877251346989. doi: 10.1177/13872877251346989.
    PubMed     Abstract available


  513. PEREIRA ME, de Souza JV, Gomar GG, Kruk IL, et al
    Glutathione peroxidase activity in Alzheimer's disease patients: A systematic review and meta-analysis.
    J Alzheimers Dis. 2025 Jun 2:13872877251346981. doi: 10.1177/13872877251346981.
    PubMed     Abstract available


  514. LI L, Wang Y, Feng Q, Ma C, et al
    Role of astroglia and microglia in Alzheimer's disease and multiple therapeutic interventions.
    J Alzheimers Dis. 2025 Jun 2:13872877251335572. doi: 10.1177/13872877251335572.
    PubMed     Abstract available


  515. ALKAM T, Tarshizi E, Van Benschoten AH
    Large language models for Alzheimer's disease drug discovery.
    J Alzheimers Dis. 2025 Jun 2:13872877251346890. doi: 10.1177/13872877251346890.
    PubMed     Abstract available


  516. WANG Z, Wang Q, Fu C, Li X, et al
    The fall-dementia connection: Synergistic effects of falls with genetic and health risk factors.
    J Alzheimers Dis. 2025;105:990-999.
    PubMed     Abstract available


  517. LI J, Zhang F, Eisel UL
    Adverse events associated with lecanemab: A disproportionality analysis of data from the FDA adverse event reporting system.
    J Alzheimers Dis. 2025;105:849-859.
    PubMed     Abstract available


  518. SAEZ-CALVERAS N, Ishii M
    Hydrate to keep the amyloid away.
    J Alzheimers Dis. 2025;105:759-761.
    PubMed     Abstract available


    May 2025
  519. LOFFREDO L, Alfano AR, Ettorre E, Desideri G, et al
    Effect of the probiotic Escherichia coli Nissle 1917 on serum levels of NADPH oxidase-2 and lipopolysaccharide in patients with Alzheimer's disease.
    J Alzheimers Dis. 2025 May 27:13872877251345157. doi: 10.1177/13872877251345157.
    PubMed     Abstract available


  520. GUZMAN-VELEZ E, Aguillon D, Rivera-Hernandez A, Baena AY, et al
    Association among cardiorespiratory fitness, plasma biomarkers of pathology and astrocyte reactivity, and cognition in autosomal-dominant Alzheimer's disease.
    J Alzheimers Dis. 2025 May 27:13872877251344327. doi: 10.1177/13872877251344327.
    PubMed     Abstract available


  521. LIANG J, Wang Q, Wang J, Shao Y, et al
    Individual electric field in cortical white matter is correlated with cognitive improvement in patients with mild cognitive impairment due to Alzheimer's disease after repetitive transcranial magnetic stimulation treatment.
    J Alzheimers Dis. 2025 May 27:13872877251344599. doi: 10.1177/13872877251344599.
    PubMed     Abstract available


  522. LU P, Chen M, Chen L, Lin F, et al
    Translational computerized clinical decision support systems for Alzheimer's disease: A systematic review.
    J Alzheimers Dis. 2025 May 25:13872877251343241. doi: 10.1177/13872877251343241.
    PubMed     Abstract available


  523. SACU S, Slattery CF, Friston KJ, Paterson RW, et al
    Neural mechanisms of disease pathology and cognition in young-onset Alzheimer's disease variants.
    J Alzheimers Dis. 2025 May 22:13872877251344325. doi: 10.1177/13872877251344325.
    PubMed     Abstract available


  524. PANDEY JP, Kimball C, Nietert PJ
    Epistatic effects of immunoglobulin KM (kappa marker) allotypes and APOE epsilon4 allele on the risk of Alzheimer's disease.
    J Alzheimers Dis. 2025 May 22:13872877251343315. doi: 10.1177/13872877251343315.
    PubMed     Abstract available


  525. LIU H, Li Y, Sun Z, Xu X, et al
    Altered hemispheres lateralization of brain functional gradients in Alzheimer's disease.
    J Alzheimers Dis. 2025 May 22:13872877251339761. doi: 10.1177/13872877251339761.
    PubMed     Abstract available


  526. MENG X, Gong Y, Xiao F, Cao Z, et al
    Curcumin's multi-target mechanisms in the treatment of Alzheimer's disease and creative modification techniques.
    J Alzheimers Dis. 2025 May 21:13872877251344188. doi: 10.1177/13872877251344188.
    PubMed     Abstract available


  527. ISHIMARU D, Satake Y, Kanemoto H, Taomoto D, et al
    Thieves in the delusions of theft in patients with Alzheimer's disease living alone: A case series.
    J Alzheimers Dis. 2025 May 21:13872877251343313. doi: 10.1177/13872877251343313.
    PubMed     Abstract available


  528. LI Y, Yao YL, Wu Y
    Causal relationships between plasma proteins and Alzheimer's disease using bidirectional Mendelian randomization.
    J Alzheimers Dis. 2025 May 21:13872877251345151. doi: 10.1177/13872877251345151.
    PubMed     Abstract available


  529. MIYASHITA A, Obinata A, Hara N, Mitsumori R, et al
    Association of rare APOE missense variants with Alzheimer's disease in the Japanese population.
    J Alzheimers Dis. 2025 May 21:13872877251340710. doi: 10.1177/13872877251340710.
    PubMed     Abstract available


  530. LANDRY A, Elsliger S, Gaudet J, Al-Shamaa S, et al
    Psychological impact of biomarker-assisted diagnosis of Alzheimer's disease.
    J Alzheimers Dis. 2025 May 21:13872877251341587. doi: 10.1177/13872877251341587.
    PubMed     Abstract available


  531. NONG Y, Kim JS, Jia L, Arancio O, et al
    The interaction between neurotransmitter receptor activity and amyloid-beta pathology in Alzheimer's disease.
    J Alzheimers Dis. 2025 May 19:13872877251342273. doi: 10.1177/13872877251342273.
    PubMed     Abstract available


  532. GIAQUINTO F, Iaia M, Rizzi E, Macchitella L, et al
    Cognitive training for Alzheimer's disease and other forms of dementia: Insights from a systematic review and Bayesian meta-analysis.
    J Alzheimers Dis. 2025 May 13:13872877251334795. doi: 10.1177/13872877251334795.
    PubMed     Abstract available


  533. QIN Q, Xia X, Qu J, Guan Z, et al
    Blood biomarkers of amyloid and tau pathologies, brain degeneration, inflammation, and oxidative stress in early- and late-onset Alzheimer's disease.
    J Alzheimers Dis. 2025 May 8:13872877251340955. doi: 10.1177/13872877251340955.
    PubMed     Abstract available


  534. CUMBO E, Migliore D
    Differential effects of antidepressants on cognition in Alzheimer's disease with depression: A sub-group analysis of an open-label, observational study.
    J Alzheimers Dis. 2025 May 7:13872877251340084. doi: 10.1177/13872877251340084.
    PubMed     Abstract available


  535. NYONGESA CA, Hogarth M, Pa J
    Artificial intelligence-driven natural language processing for identifying linguistic patterns in Alzheimer's disease and mild cognitive impairment: A study of lexical, syntactic, and cohesive features of speech through picture description tasks.
    J Alzheimers Dis. 2025 May 7:13872877251339756. doi: 10.1177/13872877251339756.
    PubMed     Abstract available


  536. ZHANG J, Liu T, Wu H, Wei J, et al
    Identification of NDUFV2, NDUFS7, OPA1, and NDUFA1 as biomarkers for Alzheimer's disease: Insights from oxidative stress and mitochondrial dysfunction in the hippocampus.
    J Alzheimers Dis. 2025 May 7:13872877251339771. doi: 10.1177/13872877251339771.
    PubMed     Abstract available


  537. VON GAL A, Papa D, D'Auria M, Piccardi L, et al
    Disruptive resting state networks characterizing depressive comorbidity in Alzheimer's disease and mild cognitive impairment.
    J Alzheimers Dis. 2025 May 6:13872877251337770. doi: 10.1177/13872877251337770.
    PubMed     Abstract available


  538. WANG T, Jiang H, Zheng R, Zhang C, et al
    Trends and research focus on autophagy in Alzheimer's disease (2003-2023): A bibliometric study.
    J Alzheimers Dis. 2025 May 6:13872877251336442. doi: 10.1177/13872877251336442.
    PubMed     Abstract available


  539. KORIATH CA, Perneczky R
    Obesity and Alzheimer's disease dementia: Examining inflammatory links to cognitive decline and neuropsychiatric symptoms.
    J Alzheimers Dis. 2025 May 6:13872877251338467. doi: 10.1177/13872877251338467.
    PubMed     Abstract available


  540. WU R, Guo J, Liu Y, Huang S, et al
    Angiogenesis promotion of the transplantation of human amniotic mesenchymal stem cells via the Ang-1/Tie-2 signaling pathways in Alzheimer's disease model.
    J Alzheimers Dis. 2025 May 5:13872877251338687. doi: 10.1177/13872877251338687.
    PubMed     Abstract available


  541. SANDBERG A, Puttagunta S, Duval N, Fleming H, et al
    Immunocal((R)), a cysteine-rich whey protein, rescues reelin and reduces amyloid plaque burden in a transgenic amyloid-beta protein precursor (hAbetaPP(SweInd)) mouse model of Alzheimer's disease.
    J Alzheimers Dis. 2025 May 5:13872877251338323. doi: 10.1177/13872877251338323.
    PubMed     Abstract available


  542. NAGATA T, Nakajima S, Kito S, Shinagawa S, et al
    Correlations between agitation and other neuropsychiatric symptoms in each stage of Alzheimer's disease: A re-analysis of CATIE-AD.
    J Alzheimers Dis. 2025 May 5:13872877251340402. doi: 10.1177/13872877251340402.
    PubMed     Abstract available


  543. ITO K, Washimi Y, Kato T, Suzuki K, et al
    (18)F-FDG PET for the differential diagnosis of Alzheimer's disease and frontotemporal lobar degeneration: A multicenter prospective study in Japan.
    J Alzheimers Dis. 2025 May 5:13872877251338691. doi: 10.1177/13872877251338691.
    PubMed     Abstract available


  544. LI MJ, Lan MN, Du YX, Liu Y, et al
    EPRCN exerts neuroprotective function by regulating gut microbiota and restoring gut immune homeostasis in Alzheimer's disease model mice.
    J Alzheimers Dis. 2025 May 5:13872877251339762. doi: 10.1177/13872877251339762.
    PubMed     Abstract available


  545. MO D, Li X, He J, Lin X, et al
    Chronic gingivitis increases the risk of early-onset Alzheimer's disease.
    J Alzheimers Dis. 2025 May 4:13872877251336259. doi: 10.1177/13872877251336259.
    PubMed     Abstract available


  546. VOGELS L, Mohammadi R, Schoonhoven M, Birbil SI, et al
    Modeling Alzheimer's disease: Bayesian copula graphical model from demographic, cognitive, and neuroimaging data.
    J Alzheimers Dis. 2025 May 4:13872877251337944. doi: 10.1177/13872877251337944.
    PubMed     Abstract available


  547. YANG YH, Chang HW, Chien CF, Hour TC, et al
    Investigating the effects of 40 Hz sound stimulation on Alzheimer's disease pathways: Modulation of amyloid-beta42 secretion, tau phosphorylation, phagocytosis, and autophagy.
    J Alzheimers Dis. 2025 May 4:13872877251339774. doi: 10.1177/13872877251339774.
    PubMed     Abstract available


  548. BAO W, Bi H, Chao L, Jiang Y, et al
    Identifying the mediating role of brain atrophy on the relationship between DNA damage repair pathway and Alzheimer's disease: A Mendelian randomization analysis and mediation analysis.
    J Alzheimers Dis. 2025 May 2:13872877251333811. doi: 10.1177/13872877251333811.
    PubMed     Abstract available


  549. URSO D, Introna A, Gnoni V, Giugno A, et al
    Donanemab eligibility in early Alzheimer's disease: A real-world study.
    J Alzheimers Dis. 2025 May 1:13872877251331243. doi: 10.1177/13872877251331243.
    PubMed     Abstract available


  550. LOBUE C, Stopschinski BE, Calveras NS, Salter A, et al
    A preliminary study on plasma markers across cognitive stages and links to a history of mild traumatic brain injury.
    J Alzheimers Dis. 2025;105:49-55.
    PubMed     Abstract available


  551. HOILUND-CARLSEN PF, Werner TJ, Alavi A
    The unsafe profile of lecanemab.
    J Alzheimers Dis. 2025;105:62-64.
    PubMed     Abstract available


  552. LABONTE J, Sugarman MA, Pettway E, Zetterberg H, et al
    Sex differences on tau, astrocytic, and neurodegenerative plasma biomarkers.
    J Alzheimers Dis. 2025;105:443-452.
    PubMed     Abstract available


  553. ZHAI Y, Lu K, Yuan Y, Zhang Z, et al
    Semaglutide improves cognitive function and neuroinflammation in APP/PS1 transgenic mice by activating AMPK and inhibiting TLR4/NF-kappaB pathway.
    J Alzheimers Dis. 2025;105:416-432.
    PubMed     Abstract available


  554. BARTOLINI E, Di Crosta A, La Malva P, Marin A, et al
    Gamma oscillation modulation for cognitive impairment: A systematic review.
    J Alzheimers Dis. 2025;105:331-350.
    PubMed     Abstract available


  555. COOPER JK
    Differences between East and West may affect dementia studies: Thoughts from the KSA dementia prevalence study.
    J Alzheimers Dis. 2025;105:368-369.
    PubMed     Abstract available


    April 2025
  556. HEINZE T, Tuchtenhagen M, Knuppel S, Weber D, et al
    EPIC-Potsdam sub-cohort study: The early role of trace elements, oxidative stress, and anthropometrics in Alzheimer's disease and dementia onset.
    J Alzheimers Dis. 2025 Apr 23:13872877251333726. doi: 10.1177/13872877251333726.
    PubMed     Abstract available


  557. ZHANG W, Teng F, Lan X, Liu P, et al
    A novel finding relates to the involvement of ATF3/DOCK8 in Alzheimer's disease pathogenesis.
    J Alzheimers Dis. 2025 Apr 23:13872877251336266. doi: 10.1177/13872877251336266.
    PubMed     Abstract available


  558. JEONG H, Kim D, Na S, Kim B, et al
    Repeated neuromodulation with low-intensity focused ultrasound in patients with Alzheimer's disease.
    J Alzheimers Dis. 2025 Apr 23:13872877251333614. doi: 10.1177/13872877251333614.
    PubMed     Abstract available


  559. WEI S, Li C, Li W, Yuan F, et al
    Glial changes and gene expression in Alzheimer's disease from snRNA-Seq and spatial transcriptomics.
    J Alzheimers Dis. 2025 Apr 23:13872877251330320. doi: 10.1177/13872877251330320.
    PubMed     Abstract available


  560. HE F, Shi WJ, Liu W, Fan JX, et al
    A mass-producible macaque model displays a durable Alzheimer-like cognitive deficit and hallmark amyloid-beta/tau/neurofilament light chain pathologies.
    J Alzheimers Dis. 2025 Apr 23:13872877251334316. doi: 10.1177/13872877251334316.
    PubMed     Abstract available


  561. SINGH-REILLY N, Graff-Radford J, Li D, Mielke MM, et al
    Abeta(42/40) and p-tau 181 as disease biomarkers in atypical Alzheimer's disease.
    J Alzheimers Dis. 2025 Apr 23:13872877251333450. doi: 10.1177/13872877251333450.
    PubMed     Abstract available


  562. GHANBARIAN E, Khorsand B, Petersen KK, Nallapu BT, et al
    Cerebrospinal fluid inflammatory cytokines as prognostic indicators for cognitive decline across Alzheimer's disease spectrum.
    J Alzheimers Dis. 2025 Apr 22:13872877251335915. doi: 10.1177/13872877251335915.
    PubMed     Abstract available


  563. KSHIRSAGAR S, Deshmukh H, Reddy AP, Reddy AP, et al
    Grounding as a complementary intervention for Alzheimer's disease: Mechanisms, evidence, and potential therapeutic applications.
    J Alzheimers Dis. 2025 Apr 22:13872877251334666. doi: 10.1177/13872877251334666.
    PubMed     Abstract available


  564. CHEN HM, Shen K, Ji L, McGrath C, et al
    Patterns and trends in the burden of Alzheimer's disease and related dementias in China (1990-2021) and predictions to 2040.
    J Alzheimers Dis. 2025 Apr 22:13872877251333108. doi: 10.1177/13872877251333108.
    PubMed     Abstract available


  565. STAMATELOS P, Beratis IN, Hatzaki P, Economou A, et al
    Mild cognitive impairment, Alzheimer's disease dementia, and predictors of driving cessation: A 7-year longitudinal prospective study.
    J Alzheimers Dis. 2025 Apr 22:13872877251333705. doi: 10.1177/13872877251333705.
    PubMed     Abstract available


  566. WANG S, Ni J, Wei M, Li T, et al
    Impact of obesity on neuropsychiatric symptoms in Alzheimer's disease: Insights from the ADNI cohort.
    J Alzheimers Dis. 2025 Apr 22:13872877251331974. doi: 10.1177/13872877251331974.
    PubMed     Abstract available


  567. JAMAL R, Shaikh MA, Taleuzzaman M, Haque Z, et al
    Key biomarkers in Alzheimer's disease: Insights for diagnosis and treatment strategies.
    J Alzheimers Dis. 2025 Apr 21:13872877251330500. doi: 10.1177/13872877251330500.
    PubMed     Abstract available


  568. MALEK J, Levchenko A, Robinson JO, Fong J, et al
    Dilemmas in diagnosing Alzheimer's disease: The peril and promise of self-fulfilling prophecies.
    J Alzheimers Dis. 2025 Apr 21:13872877251331236. doi: 10.1177/13872877251331236.
    PubMed     Abstract available


  569. KIM H, Kulshreshtha A, Alonso A, Goldstein FC, et al
    The association between pulse wave velocity and cerebrospinal fluid biomarkers for Alzheimer's disease.
    J Alzheimers Dis. 2025 Apr 21:13872877251331235. doi: 10.1177/13872877251331235.
    PubMed     Abstract available


  570. SUN J, Teng F, Cao Y, Pei H, et al
    Peripheral blood immune cell phenotypes and Alzheimer's disease: A mediation Mendelian randomization study.
    J Alzheimers Dis. 2025 Apr 15:13872877251330503. doi: 10.1177/13872877251330503.
    PubMed     Abstract available


  571. ASHMAWY RE, Okesanya OJ, Ukoaka BM, Daniel FM, et al
    Exploring the efficacy and safety of lecanemab in the management of early Alzheimer's disease: A systematic review of clinical evidence.
    J Alzheimers Dis. 2025 Apr 15:13872877251331640. doi: 10.1177/13872877251331640.
    PubMed     Abstract available


  572. SEGIET N, Poczatek G, Drzazga J, Laskowska-Wronarowicz A, et al
    Effectiveness of structured cognitive intervention among patients diagnosed with late-onset Alzheimer's disease: Report from a pilot study.
    J Alzheimers Dis. 2025 Apr 15:13872877251331184. doi: 10.1177/13872877251331184.
    PubMed     Abstract available


  573. SAAOUD F, Liu L, Xu K, Lu Y, et al
    Alzheimer's disease as an auto-innate immune pathology with potential cell trans-differentiation and enhanced trained immunity in 3xTg-AD mouse model.
    J Alzheimers Dis. 2025 Apr 15:13872877251329583. doi: 10.1177/13872877251329583.
    PubMed     Abstract available


  574. PARKS AL, Thacker A, Dohan D, Gomez LAR, et al
    A qualitative study of people with Alzheimer's disease in a memory clinic considering lecanemab treatment.
    J Alzheimers Dis. 2025 Apr 10:13872877251329519. doi: 10.1177/13872877251329519.
    PubMed     Abstract available


  575. TONG H, Petyuk VA, Sendtner M, Sood A, et al
    Alzheimer's disease-related cortical proteins modify the association of brain insulin signaling with cognitive decline.
    J Alzheimers Dis. 2025 Apr 4:13872877251319463. doi: 10.1177/13872877251319463.
    PubMed     Abstract available


  576. KARKKAINEN V, Saari T, Hannonen S, Rusanen M, et al
    Altered tear fluid protein expression in persons with mild Alzheimer's disease in proteins involved in oxidative stress, protein synthesis, and energy metabolism.
    J Alzheimers Dis. 2025 Apr 4:13872877251326868. doi: 10.1177/13872877251326868.
    PubMed     Abstract available


  577. MARTINEZ JE, Bocanegra Y, Baena A, Langella S, et al
    Religious stress coping is associated with lower entorhinal tau pathology and better memory performance in autosomal dominant Alzheimer's disease.
    J Alzheimers Dis. 2025 Apr 3:13872877251331569. doi: 10.1177/13872877251331569.
    PubMed     Abstract available


  578. CORDEIRO AMT, Singulani MP, Talib LL, Forlenza OV, et al
    Down syndrome and Alzheimer's disease: Oxidative stress in the neurodegenerative process.
    J Alzheimers Dis. 2025 Apr 3:13872877251326291. doi: 10.1177/13872877251326291.
    PubMed     Abstract available


  579. DEVERKA PA, Arias JJ, Lin GA, Zwerling J, et al
    Alzheimer's disease blood-based biomarker testing: A stakeholder-informed assessment of coverage considerations.
    J Alzheimers Dis. 2025 Apr 1:13872877251329394. doi: 10.1177/13872877251329394.
    PubMed     Abstract available


  580. WANG Y, Wu Z, Zheng Y, Wang H, et al
    Unraveling the genetic underpinnings of mitochondrial traits and associated circulating inflammatory proteins in Alzheimer's disease: Mitochondrial HtrA2-T cell CD5 negative axis.
    J Alzheimers Dis. 2025 Apr 1:13872877251329517. doi: 10.1177/13872877251329517.
    PubMed     Abstract available


  581. ASADA T, Kakuma T, Tanaka M, Araki W, et al
    A statistical method for predicting amyloid-beta deposits from severity, extend, and ratio indices of the (99m)Tc-ECD SPECT.
    J Alzheimers Dis. 2025;104:1281-1289.
    PubMed     Abstract available


  582. WANG J, Wang DZ, Li BH, Yang S, et al
    Elevated circulating cathepsin S levels are associated with cognitive decline and neurodegeneration in a cohort of patients reporting memory complaints.
    J Alzheimers Dis. 2025;104:1147-1153.
    PubMed     Abstract available


  583. BECKER C, Herschung L, Gomm W, Haenisch B, et al
    Dementia diagnosis and prescription of antidementia drugs: An analysis of German claims data (2006-2016).
    J Alzheimers Dis. 2025;104:698-708.
    PubMed     Abstract available


  584. XU S, Fan Y, Mao C, Hu Z, et al
    Multimodal magnetic resonance imaging analysis of early mild cognitive impairment.
    J Alzheimers Dis. 2025;104:1013-1027.
    PubMed     Abstract available


  585. FURUYA Y, Sato K, Niimi Y, Ihara R, et al
    Cognitive function instrument-based anosognosia to predict amyloid status.
    J Alzheimers Dis. 2025;104:995-1000.
    PubMed     Abstract available


    March 2025
  586. GONG C, Song W, Zhu Z, Yang D, et al
    APOE epsilon4 influences the dynamic functional connectivity variability and cognitive performance in Alzheimer's disease.
    J Alzheimers Dis. 2025 Mar 28:13872877251322687. doi: 10.1177/13872877251322687.
    PubMed     Abstract available


  587. VANNINEN A, Erkkila L, Kokkola T, Selander T, et al
    Effect of ventricular volume on cerebrospinal fluid Alzheimer's disease biomarkers in patients with idiopathic normal pressure hydrocephalus.
    J Alzheimers Dis. 2025 Mar 28:13872877251329081. doi: 10.1177/13872877251329081.
    PubMed     Abstract available


  588. BELFORT T, Nogueira ML, Gaigher J, Rangel R, et al
    Comparing patterns of impairment in social cognition between young-onset and late-onset Alzheimer's disease.
    J Alzheimers Dis. 2025 Mar 28:13872877251323046. doi: 10.1177/13872877251323046.
    PubMed     Abstract available


  589. RUAN T, Ling Y, Wu C, Niu Y, et al
    Abnormal epigenetic modification of lysosome and lipid regulating genes in Alzheimer's disease.
    J Alzheimers Dis. 2025 Mar 28:13872877251322955. doi: 10.1177/13872877251322955.
    PubMed     Abstract available


  590. SHEN Y, Nie Q, Xiang W, Chen S, et al
    The relationship between Alzheimer's disease and intracerebral hemorrhage based on Mendelian randomization.
    J Alzheimers Dis. 2025 Mar 28:13872877251323294. doi: 10.1177/13872877251323294.
    PubMed     Abstract available


  591. XUE RJ, Gao PY, Chen YM, Liu Y, et al
    Associations between plasma complement C1q and cerebrospinal fluid biomarkers of Alzheimer's disease pathology in cognitively intact adults: The CABLE study.
    J Alzheimers Dis. 2025 Mar 26:13872877251322808. doi: 10.1177/13872877251322808.
    PubMed     Abstract available


  592. WANG S, Luo G, Sun G, Zhang M, et al
    A polymorphism in the BIN1 gene influences its expression and is associated with the risk of Alzheimer's disease: An integrated analysis.
    J Alzheimers Dis. 2025 Mar 26:13872877251326273. doi: 10.1177/13872877251326273.
    PubMed     Abstract available


  593. HOWARD KA, Massimo LM, Witrick B, Zhang L, et al
    Investigation of risk of Alzheimer's disease diagnosis and survival based on variation to life experiences used to operationalize cognitive reserve.
    J Alzheimers Dis. 2025 Mar 26:13872877251326818. doi: 10.1177/13872877251326818.
    PubMed     Abstract available


  594. ROBERTS H, Fang Y, Quinn K, Hill T, et al
    Lifespan of male and female APP/PS1 and APP(NL-F/NL-F) mouse models of Alzheimer's disease.
    J Alzheimers Dis. 2025 Mar 26:13872877251325878. doi: 10.1177/13872877251325878.
    PubMed     Abstract available


  595. JEONG S, Lin L, Leone AP, Hsu YH, et al
    Type 2 diabetes and late-onset Alzheimer's disease and related dementia: A longitudinal cohort study integrating polygenic risk score.
    J Alzheimers Dis. 2025 Mar 25:13872877251326107. doi: 10.1177/13872877251326107.
    PubMed     Abstract available


  596. SCHAEFER SY, Reed AM, Duff K
    Validating a brief performance-based measure of cognition and daily functioning in amnestic mild cognitive impairment and mild Alzheimer's disease.
    J Alzheimers Dis. 2025 Mar 25:13872877251320379. doi: 10.1177/13872877251320379.
    PubMed     Abstract available


  597. SLADE B, Williams B, Engelbrecht R, Ciorciari J, et al
    Improving executive functioning and reducing the risk of Alzheimer's disease with music therapy: A narrative review of potential neural mechanisms.
    J Alzheimers Dis. 2025 Mar 24:13872877251327762. doi: 10.1177/13872877251327762.
    PubMed     Abstract available


  598. DE RIJKE TJ, Vasseur D, van der Flier WM, Minkman MM, et al
    Exploring interdisciplinary perspectives on the implementation of personalized medicine and patient-orchestrated care in Alzheimer's disease: A qualitative study within the ABOARD research project.
    J Alzheimers Dis. 2025 Mar 21:13872877251326166. doi: 10.1177/13872877251326166.
    PubMed     Abstract available


  599. SORDU P, Alaylioglu M, Samanci B, Bulu E, et al
    Cerebrospinal fluid HSP90AA1, HSPA4, and STUB1/CHIP levels in Alzheimer's disease, mild cognitive impairment, and frontotemporal dementia.
    J Alzheimers Dis. 2025 Mar 21:13872877251329540. doi: 10.1177/13872877251329540.
    PubMed     Abstract available


  600. KRAAKE S, Luppa M, Saur D, Dietzel J, et al
    Social functioning in individuals with Alzheimer's disease and the situation of caregivers.
    J Alzheimers Dis. 2025 Mar 21:13872877251326029. doi: 10.1177/13872877251326029.
    PubMed     Abstract available


  601. WILLIAMS JP, Zhu Y, Singh RK, Beyene K, et al
    The effect of anti-seizure medications on Alzheimer's disease (AD) risk and AD-related symptoms: A scoping review.
    J Alzheimers Dis. 2025 Mar 21:13872877251324663. doi: 10.1177/13872877251324663.
    PubMed     Abstract available


  602. ARRIOLA-INFANTE JE, Garcia-Roldan E, Garcia-Solis D, Marin-Cabanas AM, et al
    TMA-93 (binding by images): Cutoffs optimization based on Alzheimer's disease biomarkers.
    J Alzheimers Dis. 2025 Mar 21:13872877251325759. doi: 10.1177/13872877251325759.
    PubMed     Abstract available


  603. MACIVER MB, Pearce RA
    Reduced GABA(A, slow) synaptic inhibition in Alzheimer's disease.
    J Alzheimers Dis. 2025 Mar 21:13872877251328940. doi: 10.1177/13872877251328940.
    PubMed     Abstract available


  604. YANG B, Teymur A, Tang C, Wu T, et al
    V-set and immunoglobulin domain containing 4 as a potential predictor of Alzheimer's disease and advanced aging.
    J Alzheimers Dis. 2025 Mar 21:13872877251329463. doi: 10.1177/13872877251329463.
    PubMed     Abstract available


  605. RICHTER N, Breidenbach L, Schmieschek MH, Heiss WD, et al
    Alzheimer-typical temporo-parietal atrophy and hypoperfusion are associated with a more significant cholinergic impairment in amnestic neurodegenerative syndromes.
    J Alzheimers Dis. 2025 Mar 21:13872877251324080. doi: 10.1177/13872877251324080.
    PubMed     Abstract available


  606. LI F, Zheng M, Jia J
    Validate association of gene loci and establish genetic risk prediction models for late-onset Alzheimer's disease in Chinese populations.
    J Alzheimers Dis. 2025 Mar 21:13872877251326283. doi: 10.1177/13872877251326283.
    PubMed     Abstract available


  607. XU X, Mo X, Zhang W, Liu D, et al
    Local and distant atrophy mediate the relationship between tau pathology and cognition in temporoparietal region in Alzheimer's disease.
    J Alzheimers Dis. 2025 Mar 21:13872877251322539. doi: 10.1177/13872877251322539.
    PubMed     Abstract available


  608. ABDULLAH L, Zhou Z, Hall J, Petersen M, et al
    Association of Alzheimer's disease biomarkers with low premorbid intellectual functioning in a multi-ethnic community-dwelling cohort: A cross-sectional study of HABS-HD.
    J Alzheimers Dis. 2025 Mar 21:13872877251322966. doi: 10.1177/13872877251322966.
    PubMed     Abstract available


  609. VASILEVA-METODIEV SZ, Spargo D, Klein EG, Quevenco FC, et al
    Diagnostic journey and management of patients with mild cognitive impairment and Alzheimer's disease dementia: A multinational, real-world survey.
    J Alzheimers Dis. 2025 Mar 20:13872877251322978. doi: 10.1177/13872877251322978.
    PubMed     Abstract available


  610. AYAZ G, Sordu P, Kucuksezer UC, Hanagasi H, et al
    Association of glycoprotein 1b and miR-26a-5p levels with platelet function in Alzheimer's disease.
    J Alzheimers Dis. 2025 Mar 20:13872877251326204. doi: 10.1177/13872877251326204.
    PubMed     Abstract available


  611. HU D, Chen M, Li X, Daley S, et al
    ApoE epsilon4-dependent Alteration of CXCR3 (+) CD127(+) CD4(+) T cells associates with elevated plasma neurofilament light chain in Alzheimer's disease.
    J Alzheimers Dis. 2025 Mar 20:13872877251320123. doi: 10.1177/13872877251320123.
    PubMed     Abstract available


  612. KATONOVA A, Andel R, Jurasova V, Veverova K, et al
    Associations of KLOTHO-VS heterozygosity and alpha-Klotho protein with cerebrospinal fluid Alzheimer's disease biomarkers.
    J Alzheimers Dis. 2025 Mar 20:13872877251326199. doi: 10.1177/13872877251326199.
    PubMed     Abstract available


  613. FUSEYA K, Mimura Y, Nakajima S, Mimura M, et al
    A systematic review and meta-analysis on the characteristics of transcranial magnetic stimulation treatment protocols for patients with Alzheimer's disease.
    J Alzheimers Dis. 2025 Mar 20:13872877251325887. doi: 10.1177/13872877251325887.
    PubMed     Abstract available


  614. WIMO A, Handels R, Blennow K, Kirsebom KB, et al
    Cost-effectiveness of diagnosing and treating patients with early Alzheimer's disease with anti-amyloid treatment in a clinical setting.
    J Alzheimers Dis. 2025 Mar 20:13872877251323231. doi: 10.1177/13872877251323231.
    PubMed     Abstract available


  615. ALAMI M, Zerif E, Khalil A, Hajji N, et al
    Neuroprotective effects of SGLT2 inhibitors empagliflozin and dapagliflozin on Abeta(1-42)-induced neurotoxicity and neuroinflammation in cellular models of Alzheimer's disease.
    J Alzheimers Dis. 2025 Mar 20:13872877251329474. doi: 10.1177/13872877251329474.
    PubMed     Abstract available


  616. GUI S, Zeng F, Wu Z, Nonaka S, et al
    Lipopolysaccharides from Porphyromonas gingivalis indirectly induce neuronal GSK3beta-dependent synaptic defects and cause cognitive decline in a low-amyloid-beta-concentration environment in Alzheimer's disease.
    J Alzheimers Dis. 2025 Mar 20:13872877251326879. doi: 10.1177/13872877251326879.
    PubMed     Abstract available


  617. LALIVE HM, Griffa A, Pini L, Rouaud O, et al
    Biomarkers do not paint the whole picture: The role of clinical expertise and advanced neuroimaging for Alzheimer's disease diagnosis.
    J Alzheimers Dis. 2025 Mar 20:13872877251328953. doi: 10.1177/13872877251328953.
    PubMed     Abstract available


  618. MEWS MA, Naj AC, Griswold AJ, Below JE, et al
    Brain and blood transcriptome-wide association studies identify five novel genes associated with Alzheimer's disease.
    J Alzheimers Dis. 2025 Mar 20:13872877251326288. doi: 10.1177/13872877251326288.
    PubMed     Abstract available


  619. CHEN YH, Wang ZB, Liu XP, Mao ZQ, et al
    Cerebrospinal fluid LMO4 as a synaptic biomarker linked to Alzheimer's disease pathology and cognitive decline.
    J Alzheimers Dis. 2025 Mar 19:13872877251326286. doi: 10.1177/13872877251326286.
    PubMed     Abstract available


  620. LEI S, Liu Y
    Identifying microglia-derived NFKBIA as a potential contributor to the pathogenesis of Alzheimer's disease and age-related macular degeneration.
    J Alzheimers Dis. 2025 Mar 19:13872877251326267. doi: 10.1177/13872877251326267.
    PubMed     Abstract available


  621. SIMMATIS LE, Russo EE, Steininger T, Riddell H, et al
    EEG biomarkers for Alzheimer's disease: A novel automated pipeline for detecting and monitoring disease progression.
    J Alzheimers Dis. 2025 Mar 18:13872877251327754. doi: 10.1177/13872877251327754.
    PubMed     Abstract available


  622. DZIANOK P, Wojciechowski J, Wolak T, Kublik E, et al
    Alzheimer's disease-like features in resting state EEG/fMRI of cognitively intact and healthy middle-aged APOE/PICALM risk carriers.
    J Alzheimers Dis. 2025 Mar 17:13872877251317489. doi: 10.1177/13872877251317489.
    PubMed     Abstract available


  623. ZHANG Z, Cui L, Huang L, Guan YH, et al
    Development and validation of the Chinese Naming Test (CNT): Diagnostic efficacy and correlation with Alzheimer's disease biomarkers.
    J Alzheimers Dis. 2025 Mar 17:13872877251324100. doi: 10.1177/13872877251324100.
    PubMed     Abstract available


  624. LU Y, Li D, Yu Y, Wang Q, et al
    Cerebrospinal fluid VGF is associated with the onset and progression of Alzheimer's disease.
    J Alzheimers Dis. 2025 Mar 17:13872877251323002. doi: 10.1177/13872877251323002.
    PubMed     Abstract available


  625. ZEISS CJ, Huttner A, Nairn AC, Arnsten A, et al
    The neuropathologic basis for translational biomarker development in the macaque model of late-onset Alzheimer's disease.
    J Alzheimers Dis. 2025 Mar 17:13872877251323787. doi: 10.1177/13872877251323787.
    PubMed     Abstract available


  626. YANG Y, Li Y, Chen Y
    Changes in transcriptional regulation in the temporal lobe in patients with Alzheimer's disease.
    J Alzheimers Dis. 2025 Mar 17:13872877251322536. doi: 10.1177/13872877251322536.
    PubMed     Abstract available


  627. ZHANG C, Tai Y, Kong M, Jia P, et al
    Synergistic associations of amyloid-beta and phosphorylated tau with tau aggregation and cognitive decline in Alzheimer's disease.
    J Alzheimers Dis. 2025 Mar 17:13872877251322196. doi: 10.1177/13872877251322196.
    PubMed     Abstract available


  628. LIN YJ, Liu Y, Sheng ZH, Fu Y, et al
    The associations of cerebrospinal fluid ApoE and C1q with Alzheimer's disease biomarkers.
    J Alzheimers Dis. 2025 Mar 17:13872877251320419. doi: 10.1177/13872877251320419.
    PubMed     Abstract available


  629. ISHIKAWA-TAKATA K, Fujiwara K, Tanaka T, Nakamura K, et al
    Associations of dietary protein and amino acid intakes with disability-adjusted life years for Alzheimer's disease in Japanese people.
    J Alzheimers Dis. 2025 Mar 14:13872877251319535. doi: 10.1177/13872877251319535.
    PubMed     Abstract available


  630. PIERCE ME, Logue M, Sherva R, Miller M, et al
    Association of Alzheimer's disease genetic risk with age-dependent changes in plasma amyloid-beta(42:40) in Veterans.
    J Alzheimers Dis. 2025 Mar 14:13872877251321183. doi: 10.1177/13872877251321183.
    PubMed     Abstract available


  631. WANG D, Scalici A, Wang Y, Lin H, et al
    Frequency of variants in Mendelian Alzheimer's disease genes within the Alzheimer's Disease Sequencing Project.
    J Alzheimers Dis. 2025 Mar 14:13872877251320375. doi: 10.1177/13872877251320375.
    PubMed     Abstract available


  632. TREMBLAY C, Shakir N, Zhang N, Adler CH, et al
    Associations between neuropsychiatric symptoms and pathology in clinicopathologically defined Alzheimer's disease, Alzheimer's disease with Lewy bodies, and dementia with Lewy bodies.
    J Alzheimers Dis. 2025 Mar 14:13872877251320670. doi: 10.1177/13872877251320670.
    PubMed     Abstract available


  633. ALVES L, Hashiguchi D, Loss CM, van Praag H, et al
    Vascular dysfunction in Alzheimer's disease: Exploring the potential of aerobic and resistance exercises as therapeutic strategies.
    J Alzheimers Dis. 2025 Mar 13:13872877251321118. doi: 10.1177/13872877251321118.
    PubMed     Abstract available


  634. BARRETT-YOUNG A, Reuben A, Caspi A, Cheyne K, et al
    Measures of retinal health successfully capture risk for Alzheimer's disease and related dementias at midlife.
    J Alzheimers Dis. 2025 Mar 3:13872877251321114. doi: 10.1177/13872877251321114.
    PubMed     Abstract available


  635. SHARDELL M, Chen C
    Genetic geroscience and Alzheimer's disease: The pleiotropy is the point!
    J Alzheimers Dis. 2025 Mar 3:13872877251321182. doi: 10.1177/13872877251321182.
    PubMed     Abstract available


  636. ZEGARRA-VALDIVIA JA, Shany-Ur T, Rijpma MG, Callahan P, et al
    Validation of the Cognitive-Emotional Perspective Taking test in patients with neurodegeneration.
    J Alzheimers Dis. 2025 Mar 3:13872877251317683. doi: 10.1177/13872877251317683.
    PubMed     Abstract available


  637. MORITO T, Watamura N, Sasaguri H, Tomita T, et al
    Experimental basis for generating nonhuman primate models of frontotemporal dementia and Alzheimer's disease.
    J Alzheimers Dis. 2025 Mar 2:13872877251321116. doi: 10.1177/13872877251321116.
    PubMed     Abstract available


  638. WANG SY, Huang ZH, Duan R, Fu XX, et al
    IL-34/TREM2 modulates microglia-mediated inflammation and provides neuroprotection in a mouse model of sporadic Alzheimer's disease.
    J Alzheimers Dis. 2025 Mar 2:13872877251320418. doi: 10.1177/13872877251320418.
    PubMed     Abstract available


  639. YANG J, Ding H, Li Y, Ang TFA, et al
    Association of mid-age Life's Essential 8 score with digital cognitive performance and incident Alzheimer's disease: The Framingham Heart Study.
    J Alzheimers Dis. 2025 Mar 2:13872877251317734. doi: 10.1177/13872877251317734.
    PubMed     Abstract available


  640. BOHN L, Zheng Y, McFall GP, Andrew MK, et al
    Frailty in motion: Amnestic mild cognitive impairment and Alzheimer's disease cohorts display heterogeneity in multimorbidity classification and longitudinal transitions.
    J Alzheimers Dis. 2025 Mar 2:13872877251319547. doi: 10.1177/13872877251319547.
    PubMed     Abstract available


  641. KIM JW, Byun MS, Yi D, Jung JH, et al
    Daily fluid intake and brain amyloid deposition: A cohort study.
    J Alzheimers Dis. 2025;104:138-149.
    PubMed     Abstract available


  642. YANG Q, Yang H, Long W, Zuo S, et al
    Rapid cognitive assessment: Accuracy and discriminant validity of Mini-Cog and process-based Clock Drawing Test.
    J Alzheimers Dis. 2025;104:200-208.
    PubMed     Abstract available


  643. SALMAN Y, Huyghe L, Quenon L, Ghysens O, et al
    Autopsy-proven patient with corticobasal degeneration presenting with visuo-constructive disorders as initial symptoms: How advanced MRI sequences can help clinical practice.
    J Alzheimers Dis. 2025;104:158-172.
    PubMed     Abstract available


  644. PARK SA, An YS, Park YJ, Lee JY, et al
    Comparative analysis of Elecsys and ELISA for differentiating amyloid-PET status in a Korean memory clinic based on cerebrospinal fluid biomarkers.
    J Alzheimers Dis. 2025;104:232-244.
    PubMed     Abstract available


  645. KUMAR WS, Bhutare SR, Sinha N, Issac TG, et al
    Bayesian network modeling of statistical dependency within cognitive domains and clinical dementia severity ratings for Western and Indian cohorts.
    J Alzheimers Dis. 2025;104:221-231.
    PubMed     Abstract available


  646. LIGUORI C
    Obstructive sleep apnea is a common diagnosis in patients admitted at the memory clinic: Please screen for it!
    J Alzheimers Dis. 2025;104:40-42.
    PubMed     Abstract available


  647. D'ANTONIO F, Vivacqua G, Serrentino M, Nalepa M, et al
    Salivary biomarkers for the molecular diagnosis of dementia with Lewy bodies.
    J Alzheimers Dis. 2025;104:452-462.
    PubMed     Abstract available


  648. HAJJAR SH, Alsaad SM, AlFouzan MA, Rohaiem SN, et al
    Dementia prevalence within the Kingdom of Saudi Arabia National Guard Health System (2015-2023): An exploratory epidemiological study.
    J Alzheimers Dis. 2025;104:488-497.
    PubMed     Abstract available


  649. ZHU S, Ni J, Long S, Teng Y, et al
    Androgen deprivation therapy and dementia risk: An updated and dose-response meta-analysis.
    J Alzheimers Dis. 2025;104:547-562.
    PubMed     Abstract available


  650. JANG JW, Lee SH, Kim T, Lee E, et al
    Hearing loss and the risk of dementia: A longitudinal analysis of the Korean National Health Insurance Service Senior Cohort.
    J Alzheimers Dis. 2025;104:364-373.
    PubMed     Abstract available


  651. MAYAN I, Roth H, Ghosh D, Whitson HE, et al
    Genetic and biomarker disclosure process in a memory and aging study.
    J Alzheimers Dis. 2025;104:312-318.
    PubMed     Abstract available


    February 2025
  652. CHRISTIMANN G, Rocha G, Sattler JAG
    Bioactive compounds and dietary patterns in Alzheimer's disease.
    J Alzheimers Dis. 2025 Feb 26:13872877251319048. doi: 10.1177/13872877251319048.
    PubMed     Abstract available


  653. RENTOUMI V, Vassiliou E, Pittaras N, Demiraj A, et al
    Linguistic cues for automatic assessment of Alzheimer's disease across languages.
    J Alzheimers Dis. 2025 Feb 25:13872877251319401. doi: 10.1177/13872877251319401.
    PubMed     Abstract available


  654. BRADEN-KUHLE PN, Lacy VA, Brice KN, Bertrand ME, et al
    A Mediterranean-style diet protects against cognitive and behavioral deficits, adiposity, and Alzheimer's disease-related markers, compared to a macronutrient-matched typical American diet in C57BL/6J mice.
    J Alzheimers Dis. 2025 Feb 25:13872877251319467. doi: 10.1177/13872877251319467.
    PubMed     Abstract available


  655. STOJANOVIC M, Millar PR, McKay NS, Aschenbrenner AJ, et al
    The associations between attentional control, episodic memory, and Alzheimer's disease biomarkers of tau and neurodegeneration.
    J Alzheimers Dis. 2025 Feb 24:13872877251316801. doi: 10.1177/13872877251316801.
    PubMed     Abstract available


  656. ALHARBI AA, Alatwi HE, Albulaihe H, Algarzae NK, et al
    Alzheimer's disease in the Kingdom of Saudi Arabia: Current perspectives and genetic insights.
    J Alzheimers Dis. 2025 Feb 24:13872877251316122. doi: 10.1177/13872877251316122.
    PubMed     Abstract available


  657. RANDLOVA K, Pazitny P, Kandilaki D
    Institutionalization of persons with Alzheimer's disease in the Czech and Slovak Republics.
    J Alzheimers Dis. 2025 Feb 24:13872877251317987. doi: 10.1177/13872877251317987.
    PubMed     Abstract available


  658. WANG H, Qin N, Maimaitiaili D, Wu J, et al
    Transcranial electrical stimulation as a therapeutic strategy for Alzheimer's disease: Current uses and challenges.
    J Alzheimers Dis. 2025 Feb 24:13872877251315777. doi: 10.1177/13872877251315777.
    PubMed     Abstract available


  659. GAO X, Sun Z, Hu J, Li Y, et al
    Identification of the enzymatic cleavage relationship between anti-aging protein alpha-Klotho and Alzheimer's disease biomarker BACE1.
    J Alzheimers Dis. 2025 Feb 24:13872877251317730. doi: 10.1177/13872877251317730.
    PubMed     Abstract available


  660. LIN SW, Hsu YH, Yang JJ, Tu MC, et al
    A higher vertebrobasilar pulsatility index is associated with lower parietal perfusion in Alzheimer's disease.
    J Alzheimers Dis. 2025 Feb 24:13872877251314140. doi: 10.1177/13872877251314140.
    PubMed     Abstract available


  661. DONG YT, Luo X, Zhang LL, Gong YM, et al
    Genetic colocalization of cathepsins H, D, and L1 with Alzheimer's disease: Implications for biomarker and therapeutic target discovery.
    J Alzheimers Dis. 2025 Feb 21:13872877251314058. doi: 10.1177/13872877251314058.
    PubMed     Abstract available


  662. FIALA M, Hammock BD, Hwang SH, Whitelegge J, et al
    Inhibitors of soluble epoxide hydrolase and cGAS/STING repair defects in amyloid-beta clearance underlying vascular complications of Alzheimer's disease.
    J Alzheimers Dis. 2025 Feb 17:13872877241305965. doi: 10.1177/13872877241305965.
    PubMed     Abstract available


  663. WEISS JN, Eber D
    Earlier diagnosis of Alzheimer's disease by dynamic light scattering spectroscopy.
    J Alzheimers Dis. 2025 Feb 16:13872877251319352. doi: 10.1177/13872877251319352.
    PubMed     Abstract available


  664. CHEN ZQ, Wang MT, Tan CR, Huang S, et al
    Clinical relevance of plasma ADAM-17 with cognition and neurodegeneration in Alzheimer's disease.
    J Alzheimers Dis. 2025 Feb 16:13872877251317659. doi: 10.1177/13872877251317659.
    PubMed     Abstract available


  665. MICHELUTTI M, Urso D, Tafuri B, Gnoni V, et al
    Structural covariance network patterns linked to neuropsychiatric symptoms in biologically defined Alzheimer's disease: Insights from the mild behavioral impairment checklist.
    J Alzheimers Dis. 2025 Feb 16:13872877251316794. doi: 10.1177/13872877251316794.
    PubMed     Abstract available


  666. CLAUS JJ, Rosbergen MT, Roshchupkin GV, Ikram MA, et al
    Validation of a novel neuroimaging signature for dementia and clinical Alzheimer's disease in the population-based Rotterdam study.
    J Alzheimers Dis. 2025 Feb 16:13872877251315044. doi: 10.1177/13872877251315044.
    PubMed     Abstract available


  667. KASAHARA H, Ikeda M, Makioka K, Nakamura T, et al
    White matter lesions rather than amyloid-beta burden are associated with cognitive decline in Alzheimer's disease.
    J Alzheimers Dis. 2025 Feb 16:13872877251316516. doi: 10.1177/13872877251316516.
    PubMed     Abstract available


  668. PAN N, Liu S, Ge X, Zheng Y, et al
    Association of hippocampal atrophy with tau pathology of temporal regions in preclinical Alzheimer's disease.
    J Alzheimers Dis. 2025 Feb 16:13872877251314785. doi: 10.1177/13872877251314785.
    PubMed     Abstract available


  669. XAVIER C, Pinto N
    Navigating the blurred boundary: Neuropathologic changes versus clinical symptoms in Alzheimer's disease, and its consequences for research in genetics.
    J Alzheimers Dis. 2025 Feb 16:13872877251317543. doi: 10.1177/13872877251317543.
    PubMed     Abstract available


  670. ONIFADE IA, Umar HI, Aborode AT, Awaji AA, et al
    In silico study of selected alkaloids as dual inhibitors of beta- and gamma-secretases for Alzheimer's disease.
    J Alzheimers Dis. 2025 Feb 16:13872877241313049. doi: 10.1177/13872877241313049.
    PubMed     Abstract available


  671. NETSYK O, Korol SV, Li JP, Birnir B, et al
    GABA-activated slow spontaneous inhibitory postsynaptic currents are decreased in dorsal hippocampal dentate gyrus granule cells in an aged mouse model of Alzheimer's disease.
    J Alzheimers Dis. 2025 Feb 16:13872877251317608. doi: 10.1177/13872877251317608.
    PubMed     Abstract available


  672. SHENG ZH, Liu JY, Ma JY, Mi YC, et al
    Frailty increases the risk of Alzheimer's disease in non-demented individuals: A longitudinal cohort study.
    J Alzheimers Dis. 2025 Feb 16:13872877241309081. doi: 10.1177/13872877241309081.
    PubMed     Abstract available


  673. CAI C, Kato T, Arahata Y, Takeda A, et al
    Altered functional connectivity between primary visual cortex and cerebellum in Alzheimer's disease.
    J Alzheimers Dis. 2025 Feb 16:13872877241303849. doi: 10.1177/13872877241303849.
    PubMed     Abstract available


  674. WILLIAMS LA, Terhorst L, Williams IC, Skidmore E, et al
    Perceived risk of Alzheimer's disease: Insights into the Black and African American male perspective.
    J Alzheimers Dis. 2025 Feb 9:13872877251317151. doi: 10.1177/13872877251317151.
    PubMed     Abstract available


  675. WEN C, Gan JH, Liu S, Lu H, et al
    Enlarged perivascular spaces correlate with blood-brain barrier leakage and cognitive impairment in Alzheimer's disease.
    J Alzheimers Dis. 2025 Feb 9:13872877251317220. doi: 10.1177/13872877251317220.
    PubMed     Abstract available


  676. SILVA RPDS, Barbosa BJAP
    Exploring the potential of acupuncture as a complementary treatment for Alzheimer's disease: Pushing the boundaries forward.
    J Alzheimers Dis. 2025 Feb 9:13872877251316572. doi: 10.1177/13872877251316572.
    PubMed     Abstract available


  677. TAWEEPHOL T, Pongpitakmetha T, Booncharoen K, Khieukhajee J, et al
    Short communication: Evaluating roles of plasma glial fibrillary acidic protein as Alzheimer's disease biomarker in real-world multi-center memory clinics in Thailand.
    J Alzheimers Dis. 2025 Feb 9:13872877251316546. doi: 10.1177/13872877251316546.
    PubMed     Abstract available


  678. LU C, Zhou J
    Analysis of the causal relationship between five chosen factors and early-onset Alzheimer's disease: A Mendelian randomization study.
    J Alzheimers Dis. 2025 Feb 9:13872877241310248. doi: 10.1177/13872877241310248.
    PubMed     Abstract available


  679. NDUKWE K, Serrano PA, Rockwell P, Xie L, et al
    Brain-penetrant histone deacetylase inhibitor RG2833 improves spatial memory in females of an Alzheimer's disease rat model.
    J Alzheimers Dis. 2025 Feb 9:13872877251314777. doi: 10.1177/13872877251314777.
    PubMed     Abstract available


  680. TIAN Q, Dong Q, Su Z, Liu Y, et al
    Association of body weight and serum uric acid with Alzheimer's disease biomarkers and cognitive impairment.
    J Alzheimers Dis. 2025 Feb 9:13872877251315011. doi: 10.1177/13872877251315011.
    PubMed     Abstract available


  681. PRIGATANO GP, Braga LW, McElvogue M, Coddaire K, et al
    Motor correlates of finger tapping variability in subjective memory complaints, mild cognitive impairment and probable Alzheimer's disease.
    J Alzheimers Dis. 2025 Feb 7:13872877241312984. doi: 10.1177/13872877241312984.
    PubMed     Abstract available


  682. GUO R, Li D, Li F, Ji L, et al
    Effects of whole-head 810 nm near-infrared therapy on cognitive and neuropsychiatric symptoms in Alzheimer's disease: A pilot study.
    J Alzheimers Dis. 2025 Feb 5:13872877251313819. doi: 10.1177/13872877251313819.
    PubMed     Abstract available


  683. RAMIREZ-GOMEZ J, Dalal S, Devara D, Sharma B, et al
    MicroRNA-based recent research developments in Alzheimer's disease.
    J Alzheimers Dis. 2025 Feb 2:13872877241313397. doi: 10.1177/13872877241313397.
    PubMed     Abstract available


  684. KHALED M, Al-Jamal H, Matar D, Ibrahim A, et al
    Unveiling the link between APOE epsilon4, environmental factors, and Alzheimer's disease in North Lebanon: A case-control study.
    J Alzheimers Dis. 2025 Feb 2:13872877241307307. doi: 10.1177/13872877241307307.
    PubMed     Abstract available


  685. YANG X, Wang J, Jia X, Yang Y, et al
    Microglial polarization in Alzheimer's disease: Mechanisms, implications, and therapeutic opportunities.
    J Alzheimers Dis. 2025 Feb 2:13872877241313223. doi: 10.1177/13872877241313223.
    PubMed     Abstract available


  686. S M, Roy D, Menon AJ, G S, et al
    Exploring predementia: Understanding the characteristics of subjective cognitive decline plus from India.
    J Alzheimers Dis. 2025;103:966-973.
    PubMed     Abstract available


  687. GE W, Yan Y, Hu Y, Lin S, et al
    Unveiling the safety profile of lecanemab: A comprehensive analysis of adverse events using FDA adverse event reporting system data.
    J Alzheimers Dis. 2025;103:844-855.
    PubMed     Abstract available


  688. LI D, An B, Men L, Glittenberg M, et al
    The association of high-density lipoprotein cargo proteins with brain volume in older adults in the Atherosclerosis Risk in Communities (ARIC).
    J Alzheimers Dis. 2025;103:724-734.
    PubMed     Abstract available


  689. WANG Y, Zhu L, He K, Cui L, et al
    Urinary formic acid is associated with cerebral amyloid deposition and glucose metabolism in memory clinic patients.
    J Alzheimers Dis. 2025;103:1102-1111.
    PubMed     Abstract available


    January 2025
  690. ZHANG E, Dai F, Tao L, Chen Y, et al
    Immune cells: Mediators in the metabolites and Alzheimer's disease.
    J Alzheimers Dis. 2025 Jan 29:13872877241313140. doi: 10.1177/13872877241313140.
    PubMed     Abstract available


  691. ZHANG L, An H, Zhen R, Zhang T, et al
    Di Huang Yi Zhi Fang improves cognitive function in APP/PS1 mice by inducing neuronal mitochondrial autophagy through the PINK1-parkin pathway.
    J Alzheimers Dis. 2025 Jan 28:13872877241299832. doi: 10.1177/13872877241299832.
    PubMed     Abstract available


  692. ROVETA F, Rubino E, Marcinno A, Grassini A, et al
    Diagnostic performance of plasma biomarkers for Alzheimer's disease using a fully automated platform: A real-world clinical study.
    J Alzheimers Dis. 2025 Jan 26:13872877241313145. doi: 10.1177/13872877241313145.
    PubMed     Abstract available


  693. ASHFORD JW
    The VA Million Veteran Program, Alzheimer's disease, and genetics: Important steps forward but many steps still to go on the march to control dementia and Alzheimer's disease.
    J Alzheimers Dis. 2025 Jan 26:13872877241313398. doi: 10.1177/13872877241313398.
    PubMed     Abstract available


  694. SIRIWARDHANA C, Carrazana E, Liow K
    Survival disparities among Alzheimer's disease patients in Hawaii.
    J Alzheimers Dis. 2025 Jan 26:13872877251314144. doi: 10.1177/13872877251314144.
    PubMed     Abstract available


  695. GALVIN JE, Kleiman MJ, Estes PW, Harris HM, et al
    Cognivue Clarity((R)) characterizes amyloid status and preclinical Alzheimer's disease in biomarker confirmed cohorts in the Bio-Hermes Study.
    J Alzheimers Dis. 2025 Jan 26:13872877251314117. doi: 10.1177/13872877251314117.
    PubMed     Abstract available


  696. GILLMAN A, Bourgeat P, Cox T, Villemagne VL, et al
    Digital detector PET/CT increases Centiloid measures of amyloid in Alzheimer's disease: A head-to-head comparison of cameras.
    J Alzheimers Dis. 2025 Jan 26:13872877241313063. doi: 10.1177/13872877241313063.
    PubMed     Abstract available


  697. TOLEA MI, Rosenfeld A, Roy SV, Besser LM, et al
    Gait, balance, and physical performance as markers of early Alzheimer's disease and related dementia risk.
    J Alzheimers Dis. 2025 Jan 26:13872877241313144. doi: 10.1177/13872877241313144.
    PubMed     Abstract available


  698. SHAO J, Youngblood H, Yang L
    Targeting SPI1 to mitigate amyloid-beta pathology in Alzheimer's disease.
    J Alzheimers Dis. 2025 Jan 26:13872877251316593. doi: 10.1177/13872877251316593.
    PubMed     Abstract available


  699. CROOKE PS 3RD, Tossberg JT, Aune TM
    Increased unedited Alu RNA patterns found in cortex extracellular vesicles in Alzheimer's disease resemble hippocampus vasculature Alu RNA editing patterns but not cortex Alu RNA editing patterns.
    J Alzheimers Dis. 2025 Jan 26:13872877241313054. doi: 10.1177/13872877241313054.
    PubMed     Abstract available


  700. PETKUS AJ, Sonti AN, Montoya L, Rowe B, et al
    Sequence of decline on the NIH-toolbox cognitive battery in a predominantly Latino sample with autosomal dominant Alzheimer's disease.
    J Alzheimers Dis. 2025 Jan 26:13872877241312934. doi: 10.1177/13872877241312934.
    PubMed     Abstract available


  701. FU XX, Wei B, Huang ZH, Duan R, et al
    Modulation of mitochondrial functions contributes to the protection of lamotrigine against Alzheimer's disease.
    J Alzheimers Dis. 2025 Jan 21:13872877251314847. doi: 10.1177/13872877251314847.
    PubMed     Abstract available


  702. YANG H, Ning Y, Chen M, Jia J, et al
    SGLT2 inhibition, circulating biomarkers, and Alzheimer's disease: A Mendelian randomization study.
    J Alzheimers Dis. 2025 Jan 21:13872877241309674. doi: 10.1177/13872877241309674.
    PubMed     Abstract available


  703. WANG Z, Liang Q, Lin Z, Li H, et al
    Potential role of formononetin as a novel natural agent in Alzheimer's disease and osteoporosis comorbidity.
    J Alzheimers Dis. 2025 Jan 19:13872877241299104. doi: 10.1177/13872877241299104.
    PubMed     Abstract available


  704. KJAERGAARD D, Simonsen AH, Waldemar G, Nielsen TR, et al
    Ethnic and racial influences on blood biomarkers for Alzheimer's disease: A systematic review.
    J Alzheimers Dis. 2025 Jan 15:13872877241299047. doi: 10.1177/13872877241299047.
    PubMed     Abstract available


  705. DAVID S, Costa AS, Hohenfeld C, Romanzetti S, et al
    Modulating effects of fitness and physical activity on Alzheimer's disease: Implications from a six-month randomized controlled sports intervention.
    J Alzheimers Dis. 2025 Jan 15:13872877241303764. doi: 10.1177/13872877241303764.
    PubMed     Abstract available


  706. TAUFEEQ M, Choudhury A, Hussain A, Alajmi MF, et al
    Discovering potential ERK1 inhibitors from natural products for therapeutic targeting of Alzheimer's disease.
    J Alzheimers Dis. 2025 Jan 15:13872877241309592. doi: 10.1177/13872877241309592.
    PubMed     Abstract available


  707. YANG W, Yu W, Lv Y
    Neuroprotective effects of chitinase-1 and calcitonin gene-related peptide on Alzheimer's disease by promoting lysosomal function.
    J Alzheimers Dis. 2025 Jan 15:13872877241307257. doi: 10.1177/13872877241307257.
    PubMed     Abstract available


  708. LI Y, Sanjay AB, Manchella M, Mishra A, et al
    Effect of genetic and vascular risk factors on rates of cognitive decline in early-onset and late-onset Alzheimer's disease.
    J Alzheimers Dis. 2025 Jan 12:13872877241307321. doi: 10.1177/13872877241307321.
    PubMed     Abstract available


  709. RUIZ-URIBE NE, Manser P, Butcher B, Li Y, et al
    Cross-sectional and prognostic associations of baseline [(18)F]GTP1 tau PET signal and white matter lesion volumes for cognitive and functional decline in prodromal-to-mild Alzheimer's disease.
    J Alzheimers Dis. 2025 Jan 12:13872877241302497. doi: 10.1177/13872877241302497.
    PubMed     Abstract available


  710. XING H, Kant S, Kanuparthy M, Harris D, et al
    Impaired cerebral microvascular reactivity and endothelial SK channel activity in a streptozotocin-treated mouse model of Alzheimer's disease.
    J Alzheimers Dis. 2025 Jan 10:13872877241309120. doi: 10.1177/13872877241309120.
    PubMed     Abstract available


  711. HAN X, Li Y, Wang J, Liu X, et al
    Associations between lifelong cognitive reserve, Alzheimer's disease-related plasma biomarkers, and cognitive function in dementia-free older adults: A population-based study.
    J Alzheimers Dis. 2025 Jan 10:13872877241306448. doi: 10.1177/13872877241306448.
    PubMed     Abstract available


  712. XU F, Shi J
    Insulin signaling and oxidative stress: Bridging the gap between type 2 diabetes mellitus and Alzheimer's disease.
    J Alzheimers Dis. 2025 Jan 10:13872877241307404. doi: 10.1177/13872877241307404.
    PubMed     Abstract available


  713. SHAH J, Krell-Roesch J, Forzani E, Knopman DS, et al
    Predicting cognitive decline from neuropsychiatric symptoms and Alzheimer's disease biomarkers: A machine learning approach to a population-based data.
    J Alzheimers Dis. 2025 Jan 10:13872877241306654. doi: 10.1177/13872877241306654.
    PubMed     Abstract available


  714. WAN T, Wang C
    SMOC2 promotes microglia activity and neuroinflammation in Alzheimer's disease.
    J Alzheimers Dis. 2025 Jan 10:13872877241307337. doi: 10.1177/13872877241307337.
    PubMed     Abstract available


  715. MATSUNAGA M, Tanihara S, He Y, Yatsuya H, et al
    Sex-specific association of comorbid heart failure on mortality after Alzheimer's disease diagnosis in older adults aged 75 years and above: A health insurance claims data analysis in Japan.
    J Alzheimers Dis. 2025 Jan 10:13872877241305813. doi: 10.1177/13872877241305813.
    PubMed     Abstract available


  716. DA SILVA PINTO GM, de Souza Crepalde LO, Scalli ACAM, de Oliveira MPB, et al
    Body composition differences in older adults with and without Alzheimer's disease: A systematic review and meta-analysis of observational studies.
    J Alzheimers Dis. 2025 Jan 10:13872877241304603. doi: 10.1177/13872877241304603.
    PubMed     Abstract available


  717. ALGHAMDI A, de Vos S, Bos JH, Schuiling-Veninga CC, et al
    A matched case-control study on polypharmacy and co-medications one year before drug treatment for Alzheimer's disease.
    J Alzheimers Dis. 2025 Jan 10:13872877241305799. doi: 10.1177/13872877241305799.
    PubMed     Abstract available


  718. LI S, Wang Y, Liang X, Li Y, et al
    Autophagy intersection: Unraveling the role of the SNARE complex in lysosomal fusion in Alzheimer's disease.
    J Alzheimers Dis. 2025 Jan 9:13872877241307403. doi: 10.1177/13872877241307403.
    PubMed     Abstract available


  719. BARKER-HALISKI M
    Seizing the opportunity to therapeutically address neuronal hyperexcitability in Alzheimer's disease.
    J Alzheimers Dis. 2025 Jan 9:13872877241305740. doi: 10.1177/13872877241305740.
    PubMed     Abstract available


  720. SU S, Huang R, Liu Y
    The effects of transcranial direct current stimulation on global cognition in patients with Alzheimer's disease: An update meta-analysis.
    J Alzheimers Dis. 2025 Jan 9:13872877241298303. doi: 10.1177/13872877241298303.
    PubMed     Abstract available


  721. WANG X, Chen L, Li W, He Z, et al
    Association of dipeptidyl peptidase-4 with Alzheimer's disease: A new therapeutic prospect.
    J Alzheimers Dis. 2025 Jan 8:13872877241304673. doi: 10.1177/13872877241304673.
    PubMed     Abstract available


  722. GRAU-JURADO P, Mostafaei S, Xu H, Mo M, et al
    Medications and cognitive decline in Alzheimer's disease: Cohort cluster analysis of 15,428 patients.
    J Alzheimers Dis. 2025 Jan 8:13872877241307870. doi: 10.1177/13872877241307870.
    PubMed     Abstract available


  723. GOODING DC, Van Hulle CA, Zuelsdorff M, Lewis JP, et al
    Perceptions about preclinical Alzheimer's disease biomarker collection procedure influences willingness to participate: Findings from an ethnoracially diverse study.
    J Alzheimers Dis. 2025 Jan 8:13872877241307255. doi: 10.1177/13872877241307255.
    PubMed     Abstract available


  724. WANG P, Dong YL, Li SS, Jin Y, et al
    Integrating network pharmacology and component analysis to investigate the potential mechanisms of Sheng-Hui-Yi-Zhi decoction in the treatment of Alzheimer's disease.
    J Alzheimers Dis. 2025 Jan 8:13872877241305744. doi: 10.1177/13872877241305744.
    PubMed     Abstract available


  725. MERRITT VC, Zhang R, Sherva R, Ly MT, et al
    Curation and validation of electronic medical record-based dementia diagnoses in the VA Million Veteran Program.
    J Alzheimers Dis. 2025;103:180-193.
    PubMed     Abstract available


  726. IMPERIALE D, Atzori C, Angeloro DP, Murgioni A, et al
    Real-life reliability of plasma pTau181, Abeta(42)/Abeta(40), and pTau181/Abeta(42) measured by Lumipulse G600II in predicting cerebrospinal fluid amyloid status.
    J Alzheimers Dis. 2025;103:305-315.
    PubMed     Abstract available


  727. ENGEL MG, Narayan S, Cui MH, Branch CA, et al
    Intranasal long R3 insulin-like growth factor-1 treatment promotes amyloid plaque remodeling in cerebral cortex but fails to preserve cognitive function in male 5XFAD mice.
    J Alzheimers Dis. 2025;103:113-126.
    PubMed     Abstract available


  728. CHEN X, Lin C, He C, Li K, et al
    Icariin improves learning and memory function by enhancing HRD1-mediated ubiquitination of amyloid precursor protein in APP/PS1 mice.
    J Alzheimers Dis. 2025;103:616-626.
    PubMed     Abstract available


  729. WITBRACHT M, Xu Y, Morgan OB, Salazar CR, et al
    Research Attitudes Questionnaire scores and retention in a recruitment registry.
    J Alzheimers Dis. 2025;103:406-418.
    PubMed     Abstract available


  730. HEDDERICH DM, Opfer R, Kruger J, Spies L, et al
    Clinical validation of artificial intelligence-based single-subject morphometry without normative reference database.
    J Alzheimers Dis. 2025;103:542-551.
    PubMed     Abstract available


  731. WEINSTEIN AM, Fang F, Chang CH, Cohen A, et al
    Multimodal neuroimaging biomarkers and subtle cognitive decline in a population-based cohort without dementia.
    J Alzheimers Dis. 2025;103:570-581.
    PubMed     Abstract available


  732. LIM YY, Mills A, Norfolk M, Rosenich E, et al
    Factors influencing rates of unsupervised assessment of short-term learning in cognitively unimpaired adults.
    J Alzheimers Dis. 2025;103:441-451.
    PubMed     Abstract available


  733. JAHANI I, Jahani A, Delrobaei M, Khadem A, et al
    Classifying cognitive impairment based on FDG-PET and combined T1-MRI and rs-fMRI: An ADNI study.
    J Alzheimers Dis. 2025;103:452-464.
    PubMed     Abstract available


  734. WEINSTEIN AM, Gogniat MA, Butters MA
    The importance of cognitive correlates of plasma amyloid-beta 42/40.
    J Alzheimers Dis. 2025;103:353-355.
    PubMed     Abstract available


    December 2024
  735. BENNETT CG, Guttmann RP, Hackney ME, Amin R, et al
    Impacts of adapted dance on mood and physical function among persons living with Alzheimer's disease.
    J Alzheimers Dis. 2024 Dec 23:13872877241298529. doi: 10.1177/13872877241298529.
    PubMed     Abstract available


  736. HORSTKOTTER D
    Alzheimer's disease prediction and prevention in a public health perspective: Ethical considerations and collaborations beyond the biomedical paradigm.
    J Alzheimers Dis. 2024 Dec 23:13872877241308299. doi: 10.1177/13872877241308299.
    PubMed     Abstract available


  737. VIGNOLO J, Jacus JP, Darnaud T, Cuervo-Lombard CV, et al
    Exploratory study of French healthcare workers' experiences of anosognosia in Alzheimer's disease and related disorders.
    J Alzheimers Dis. 2024 Dec 19:13872877241307045. doi: 10.1177/13872877241307045.
    PubMed     Abstract available


  738. BOADA M, Neve A, Das B, Wojtowicz J, et al
    Long-term safety of gantenerumab in participants with Alzheimer's disease: A phase III, open-label extension study (SCarlet RoAD).
    J Alzheimers Dis. 2024 Dec 16:13872877241303644. doi: 10.1177/13872877241303644.
    PubMed     Abstract available


  739. GARCIA-LLUCH G, Marseglia A, Royo LM, Albiach JP, et al
    Associations between antidiabetic medications and cerebrospinal fluid biomarkers of Alzheimer's disease.
    J Alzheimers Dis. 2024 Dec 16:13872877241304995. doi: 10.1177/13872877241304995.
    PubMed     Abstract available


  740. PLUTA R, Kocki J, Bogucki J, Bogucka-Kocka A, et al
    Apolipoprotein (APOA1, APOE, CLU) genes expression in the CA3 region of the hippocampus in an ischemic model of Alzheimer's disease with survival up to 2 years.
    J Alzheimers Dis. 2024 Dec 16:13872877241303950. doi: 10.1177/13872877241303950.
    PubMed     Abstract available


  741. NAZARETH CCG, Scalli ACAM, de Oliveira MPB, Gomes AFS, et al
    Differences in lean mass and sarcopenia between individuals with Alzheimer's disease and those without dementia: A systematic review and meta-analysis of observational studies.
    J Alzheimers Dis. 2024 Dec 16:13872877241299051. doi: 10.1177/13872877241299051.
    PubMed     Abstract available


  742. LI D, Liu X, Yu J, Zhang Y, et al
    Item response theory for the color-picture version of Boston naming test in a Chinese sample with neurodegenerative diseases.
    J Alzheimers Dis. 2024 Dec 16:13872877241305820. doi: 10.1177/13872877241305820.
    PubMed     Abstract available


  743. OKAFOR M, Yang Z, Vickers KL, Sanders K, et al
    Technology literacy and access to digital resources for remote assessment among adults enrolled in Alzheimer's disease research.
    J Alzheimers Dis. 2024 Dec 11:13872877241297496. doi: 10.1177/13872877241297496.
    PubMed     Abstract available


  744. MAKI Y, Ubuka T, Yamane Y
    The importance of non-pharmacological interventions to improve cognitive reserve prior to the administration of a drug against the causative agent of Alzheimer's disease.
    J Alzheimers Dis. 2024 Dec 5:13872877241301806. doi: 10.1177/13872877241301806.
    PubMed     Abstract available


  745. SMITH ML, Wilson AD, Knebl J, Hilsabeck RC, et al
    Utilization and perceived usefulness of monitoring technology for family caregivers of people living with Alzheimer's disease and related dementias.
    J Alzheimers Dis. 2024 Dec 5:13872877241300078. doi: 10.1177/13872877241300078.
    PubMed     Abstract available


  746. ZENG J, Gao Z, Xiong X, Hou X, et al
    The effects of two Alzheimer's disease related genes APOE and MAPT in healthy young adults: An attentional blink study.
    J Alzheimers Dis. 2024 Dec 5:13872877241299124. doi: 10.1177/13872877241299124.
    PubMed     Abstract available


  747. ANGELOPOULOU E, Papageorgiou SG
    Telemedicine in Alzheimer's disease and other dementias: Where we are?
    J Alzheimers Dis. 2024 Dec 5:13872877241298295. doi: 10.1177/13872877241298295.
    PubMed     Abstract available


  748. ZHANG P, Liu Y, Jin X, Hu Z, et al
    Alzheimer's disease-like pathology induced by Porphyromonas gingivalis in middle-aged mice is mediated by NLRP3 inflammasome via the microbiota-gut-brain axis.
    J Alzheimers Dis. 2024 Dec 5:13872877241302498. doi: 10.1177/13872877241302498.
    PubMed     Abstract available


  749. XU L, Chen K, Mueller KD, Liss J, et al
    Articulatory precision from connected speech as a marker of cognitive decline in Alzheimer's disease risk-enriched cohorts.
    J Alzheimers Dis. 2024 Dec 5:13872877241300149. doi: 10.1177/13872877241300149.
    PubMed     Abstract available


  750. BARNES DE, Balderson BH, Shulman L, Rosenberg DE, et al
    The Systematic Multi-domain Alzheimer's Risk Reduction Trial (SMARRT) intervention: A personalized approach to dementia risk reduction.
    J Alzheimers Dis. 2024 Dec 3:13872877241296161. doi: 10.1177/13872877241296161.
    PubMed     Abstract available


  751. TAO M, Cui L, Du Y, Liu X, et al
    Analysis of eye movement features in patients with Alzheimer's disease based on intelligent eye movement analysis and evaluation system.
    J Alzheimers Dis. 2024 Dec 1:13872877241297416. doi: 10.1177/13872877241297416.
    PubMed     Abstract available


  752. SHIR D, Shiner T, Bregman N
    Anti-amyloid treatments for Alzheimer's disease: A study on physicians' perspectives.
    J Alzheimers Dis. 2024;102:627-632.
    PubMed     Abstract available


  753. CANEVELLI M, Ancidoni A, Valletta M, Toccaceli Blasi M, et al
    Reporting of comorbidities and health status of participants in clinical trials testing amyloid- and tau-targeting monoclonal antibodies for Alzheimer's disease: A systematic review.
    J Alzheimers Dis. 2024;102:587-596.
    PubMed     Abstract available


  754. KISELICA AM, Atkinas KJ, Han SD, Diaz-Orueta U, et al
    Reactions of clinical neuropsychologists to the Alzheimer's Association workgroup's draft diagnostic and staging criteria for Alzheimer's disease.
    J Alzheimers Dis. 2024;102:877-884.
    PubMed     Abstract available


  755. OLIVER A, Wildschut T, Redhead ES, Parker MO, et al
    Benefits of nostalgic landmarks for people living with Alzheimer's disease.
    J Alzheimers Dis. 2024;102:683-702.
    PubMed     Abstract available


  756. ANDRES P, Flores-Vazquez JF, Enriquez-Geppert S
    Associating faces with names and meals as a biomarker of early AD in cognitively healthy individuals.
    J Alzheimers Dis. 2024;102:639-641.
    PubMed     Abstract available


  757. SOINIEMI L, Solje E, Suominen AL, Kanninen KM, et al
    The association between oral diseases and neurodegenerative disorders.
    J Alzheimers Dis. 2024;102:577-586.
    PubMed     Abstract available


  758. PEETHAMBARAN MALLIKA A
    Tri-culture modeling of neuroinflammation, neurodegeneration, and neuroprotection.
    J Alzheimers Dis. 2024;102:742-744.
    PubMed     Abstract available


  759. GAN J, Zeng Y, Huang G, Wang XD, et al
    The updated prevalence and risk factors of dementia in old adults in China: A cross-sectional study.
    J Alzheimers Dis. 2024;102:1209-1223.
    PubMed     Abstract available


    November 2024
  760. BENKE T, Karagiannis G
    Memory anosognosia in early Alzheimer's disease: A memory clinic study.
    J Alzheimers Dis. 2024 Nov 29:13872877241302423. doi: 10.1177/13872877241302423.
    PubMed     Abstract available


  761. CASTELLANI RJ
    Biomarker-only diagnosis of Alzheimer's disease: Not ready for prime time.
    J Alzheimers Dis. 2024 Nov 29:13872877241301805. doi: 10.1177/13872877241301805.
    PubMed     Abstract available


  762. JUDAY TR, Holub A, Mattke S, Betts KA, et al
    Real-world diagnostic, referral, and treatment patterns in early Alzheimer's disease among community-based practices in the United States.
    J Alzheimers Dis. 2024 Nov 29:13872877241297128. doi: 10.1177/13872877241297128.
    PubMed     Abstract available


  763. BECHI GABRIELLI G, D'Antonio F, Di Vita A, Margiotta R, et al
    Mind's eye in the Alzheimer's disease spectrum continuum.
    J Alzheimers Dis. 2024 Nov 29:13872877241299134. doi: 10.1177/13872877241299134.
    PubMed     Abstract available


  764. UNERI A, McArdle CJ, Deng Z, Barth SH, et al
    DJ-1-mediated repression of the RNA-binding protein FMRP is predicted to impact known Alzheimer's disease-related protein networks.
    J Alzheimers Dis. 2024 Nov 29:13872877241291175. doi: 10.1177/13872877241291175.
    PubMed     Abstract available


  765. MALIK R, Beaton D, Ahmed J, Nho K, et al
    A DAT1 gene and APOE epsilon4 interaction is associated with apathy and structural brain changes in mild cognitive impairment and Alzheimer's disease.
    J Alzheimers Dis. 2024 Nov 29:13872877241299785. doi: 10.1177/13872877241299785.
    PubMed     Abstract available


  766. AKHTAR SN, Tran TD, Chen YH, Lu Q, et al
    Spatial and planar profiling of Rac1/Cdc42 signaling in Alzheimer's disease brain.
    J Alzheimers Dis. 2024 Nov 29:13872877241291076. doi: 10.1177/13872877241291076.
    PubMed     Abstract available


  767. RAO S, Forns J, Danysh HE, Calingaert B, et al
    Natural history and clinical outcomes in patients with Alzheimer's disease-related psychosis by antipsychotic treatment status in the United States.
    J Alzheimers Dis. 2024 Nov 27:13872877241297361. doi: 10.1177/13872877241297361.
    PubMed     Abstract available


  768. BERNARD MA, Boutajangout A, Debure L, Ahmed W, et al
    The relationship between anxiety and levels of Alzheimer's disease plasma biomarkers.
    J Alzheimers Dis. 2024 Nov 27:13872877241295324. doi: 10.1177/13872877241295324.
    PubMed     Abstract available


  769. PRABHA S, Sajad M, Anjum F, Hassan MI, et al
    Investigating gene expression datasets of hippocampus tissue to discover Alzheimer's disease-associated molecular markers.
    J Alzheimers Dis. 2024 Nov 27:13872877241297335. doi: 10.1177/13872877241297335.
    PubMed     Abstract available


  770. ORJUELA AL, Pecchio M, Cruz-Mora J, Emani LS, et al
    The role of carotenoids from red mamey fruit (Pouteria sapota) against amyloid-beta monomers in Alzheimer's disease: Computational analysis and ADMET prediction.
    J Alzheimers Dis. 2024 Nov 26:13872877241291172. doi: 10.1177/13872877241291172.
    PubMed     Abstract available


  771. BAGHERI S, Rashno M, Salehi I, Karimi SA, et al
    Protective effects of geraniol in a male rat model of Alzheimer's disease: A behavioral, biochemical, and histological study.
    J Alzheimers Dis. 2024 Nov 25:13872877241290695. doi: 10.1177/13872877241290695.
    PubMed     Abstract available


  772. FERRARO PM, Filippi L, Ponzano M, Signori A, et al
    Clinical and biological underpinnings of longitudinal atrophy pattern progression in Alzheimer's disease.
    J Alzheimers Dis. 2024 Nov 25:13872877241299843. doi: 10.1177/13872877241299843.
    PubMed     Abstract available


  773. LIU W, Chen S, Rao X, Chen X, et al
    Exploring the role of miR-125b-5p as a pro-inflammatory factor in Alzheimer's disease pathology.
    J Alzheimers Dis. 2024 Nov 25:13872877241297178. doi: 10.1177/13872877241297178.
    PubMed     Abstract available


  774. GAO Z, Zhu W, Li Y, Ye W, et al
    Identification and cognitive function prediction of Alzheimer's disease based on multivariate pattern analysis of hippocampal volumes.
    J Alzheimers Dis. 2024 Nov 25:13872877241296130. doi: 10.1177/13872877241296130.
    PubMed     Abstract available


  775. PAN H, Wang G, Bi Z, Lai C, et al
    Identification of key neutrophil extracellular trap genes in Alzheimer's disease.
    J Alzheimers Dis. 2024 Nov 25:13872877241295374. doi: 10.1177/13872877241295374.
    PubMed     Abstract available


  776. WEISS JN
    Dynamic light scattering of the eye in the diagnosis of Alzheimer's disease.
    J Alzheimers Dis. 2024 Nov 25:13872877241301802. doi: 10.1177/13872877241301802.
    PubMed     Abstract available


  777. SHIBATA H, Uchida Y, Kan H, Sakurai K, et al
    Deep-learning assessment of hippocampal magnetic susceptibility in Alzheimer's disease.
    J Alzheimers Dis. 2024 Nov 25:13872877241300278. doi: 10.1177/13872877241300278.
    PubMed     Abstract available


  778. SANTOS VD, Costa AC, Junior NC, Delaere FJ, et al
    Virtual reality interventions and their effects on the cognition of individuals with Alzheimer's disease: A systematic review and meta-analysis.
    J Alzheimers Dis. 2024 Nov 25:13872877241299037. doi: 10.1177/13872877241299037.
    PubMed     Abstract available


  779. KOLLING LJ, Chimenti MS, Marcinkiewcz CA
    Spatial differences in gene expression across the dorsal raphe nucleus in a model of early Alzheimer's disease.
    J Alzheimers Dis. 2024 Nov 25:13872877241299119. doi: 10.1177/13872877241299119.
    PubMed     Abstract available


  780. XIYANG Y, Gao J, Ding M, Ren X, et al
    Exacerbated mitochondrial dynamic abnormalities without evident tau pathology in rapidly progressive Alzheimer's disease.
    J Alzheimers Dis. 2024 Nov 25:13872877241295403. doi: 10.1177/13872877241295403.
    PubMed     Abstract available


  781. BUONGIORNO M, Sanchez-Benavides G, Marzal-Espi C, Giraldo DM, et al
    Blood-brain barrier permeable beta-blockers association with Alzheimer's disease cerebrospinal fluid biomarkers levels in non-demented individuals.
    J Alzheimers Dis. 2024 Nov 25:13872877241293812. doi: 10.1177/13872877241293812.
    PubMed     Abstract available


  782. MARTINEZ-LOPEZ S, Tabone M, Clemente-Velasco S, Gonzalez-Soltero MDR, et al
    A systematic review of lifestyle-based interventions for managing Alzheimer's disease: Insights from randomized controlled trials.
    J Alzheimers Dis. 2024 Nov 25:13872877241292829. doi: 10.1177/13872877241292829.
    PubMed     Abstract available


  783. PAJAVAND AM, Grothe MJ, De Schotten MT, Giorgi FS, et al
    Structural white matter connectivity differences independent of gray matter loss in mild cognitive impairment with neuropsychiatric symptoms: Early indicators of Alzheimer's disease using network-based statistics.
    J Alzheimers Dis. 2024 Nov 22:13872877241288710. doi: 10.1177/13872877241288710.
    PubMed     Abstract available


  784. WANG LY, Hu H, Sheng ZH, Hu HY, et al
    Associations among healthy lifestyle characteristics, neuroinflammation, and cerebrospinal fluid core biomarkers of Alzheimer's disease in cognitively intact adults: The CABLE study.
    J Alzheimers Dis. 2024 Nov 19:13872877241291969. doi: 10.1177/13872877241291969.
    PubMed     Abstract available


  785. KARKKAINEN V, Hannonen S, Rusanen M, Lehtola JM, et al
    Tear fluid reflects the altered protein expressions of Alzheimer's disease patients in proteins involved in protein repair and clearance system or the regulation of cytoskeleton.
    J Alzheimers Dis. 2024 Nov 18:13872877241295315. doi: 10.1177/13872877241295315.
    PubMed     Abstract available


  786. RIGHI D, Manco C, Pardini M, Stufano A, et al
    Investigating interleukin-8 in Alzheimer's disease: A comprehensive review.
    J Alzheimers Dis. 2024 Nov 18:13872877241298973. doi: 10.1177/13872877241298973.
    PubMed     Abstract available


  787. SHAO K, Chen X, Yu X, Yang J, et al
    Functional connectivity changes in two cortico-hippocampal networks of Alzheimer's disease continuum and their correlations with cognition: A SILCODE study.
    J Alzheimers Dis. 2024 Nov 15:13872877241291236. doi: 10.1177/13872877241291236.
    PubMed     Abstract available


  788. KE C, Shan S, Yu J, Wei X, et al
    Acupuncture for patients with Alzheimer's disease: An evidence map of randomized controlled trials, systematic reviews, and meta-analysis.
    J Alzheimers Dis. 2024 Nov 14:13872877241295400. doi: 10.1177/13872877241295400.
    PubMed     Abstract available


  789. AGBOJI A, Freeman S, Banner D, Armstrong J, et al
    The prevalence and risk factors of apathy among the Canadian long-term care residents with Alzheimer's disease and related dementias.
    J Alzheimers Dis. 2024 Nov 14:JAD240370. doi: 10.3233/JAD-240370.
    PubMed     Abstract available


  790. SCHEINMAN SB, Dong H
    The impact of sex on memory during aging and Alzheimer's disease progression: Epigenetic mechanisms.
    J Alzheimers Dis. 2024 Nov 14:13872877241288709. doi: 10.1177/13872877241288709.
    PubMed     Abstract available


  791. CHAO SP, Lin WC, Lu CH, Wu HC, et al
    Changes in plasma biomarkers differentiate clinical stages of Alzheimer's disease using immunomagnetic reduction assays.
    J Alzheimers Dis. 2024 Nov 13:JAD240690. doi: 10.3233/JAD-240690.
    PubMed     Abstract available


  792. SCHROEDER KM, Afonso AS, Wang H, Grace S, et al
    Demographics, comorbidities, and comedications in newly diagnosed patients with Alzheimer's disease and related dementias: Findings from United States Medicare claims data.
    J Alzheimers Dis. 2024 Nov 13:JAD231488. doi: 10.3233/JAD-231488.
    PubMed     Abstract available


  793. BEHL S, Slomkowski M, Chen D, Chang D, et al
    Brexpiprazole for the treatment of agitation associated with dementia due to Alzheimer's disease: A 12-week, active-treatment, extension trial.
    J Alzheimers Dis. 2024 Nov 13:JAD240491. doi: 10.3233/JAD-240491.
    PubMed     Abstract available


  794. LEWIS JM, Harris DA, Kosmatka J, Mikrut E, et al
    Single step capture and assessment of multiple plasma extracellular vesicle biomarkers in Alzheimer's disease detection.
    J Alzheimers Dis. 2024 Nov 13:13872877241291964. doi: 10.1177/13872877241291964.
    PubMed     Abstract available


  795. MOSS DE, Perez RG
    The phospho-tau cascade, basal forebrain neurodegeneration, and dementia in Alzheimer's disease: Anti-neurodegenerative benefits of acetylcholinesterase inhibitors.
    J Alzheimers Dis. 2024 Nov 12:13872877241289602. doi: 10.1177/13872877241289602.
    PubMed     Abstract available


  796. SUZUKI H, Tagai K, Ono M, Shimizu H, et al
    Distinct tau pathologies in the nucleus basalis of Meynert between early-onset and late-onset Alzheimer's disease patients revealed by positron emission tomography.
    J Alzheimers Dis. 2024 Nov 11:13872877241297382. doi: 10.1177/13872877241297382.
    PubMed     Abstract available


  797. MAYR E, Rotter J, Kuhrt H, Winter K, et al
    Detection of molecular markers of ferroptosis in human Alzheimer's disease brains.
    J Alzheimers Dis. 2024 Nov 11:13872877241296563. doi: 10.1177/13872877241296563.
    PubMed     Abstract available


  798. PAN M, Lai D, Unverzagt F, Apostolova L, et al
    Genetic variants for Alzheimer's disease and comorbid conditions.
    J Alzheimers Dis. 2024 Nov 10:13872877241289054. doi: 10.1177/13872877241289054.
    PubMed     Abstract available


  799. MAHAJAN K, Sharma S, Gautam RK, Goyal R, et al
    Insights on therapeutic approaches of natural anti-Alzheimer's agents in the management of Alzheimer's disease: A future perspective.
    J Alzheimers Dis. 2024 Nov 10:13872877241296557. doi: 10.1177/13872877241296557.
    PubMed     Abstract available


  800. AAZAD AA, Choudhury A, Hussain A, AlAjmi MF, et al
    Exploring phytochemical inhibitors of protein kinase C alpha for therapeutic targeting of Alzheimer's disease.
    J Alzheimers Dis. 2024 Nov 10:13872877241289620. doi: 10.1177/13872877241289620.
    PubMed     Abstract available


  801. REN C, Wang WQ, Li HH, Li BY, et al
    Valuing the importance of sex differences in prodromal Alzheimer's disease based on structural magnetic resonance imaging.
    J Alzheimers Dis. 2024 Nov 8:13872877241289790. doi: 10.1177/13872877241289790.
    PubMed     Abstract available


  802. GARCIA-ALBERCA JM, De La Guia P, Gris E, Mendoza S, et al
    Real-world assessment of caregiver preference and compliance to treatment with twice-weekly versus daily rivastigmine patches in Alzheimer's disease.
    J Alzheimers Dis. 2024 Nov 5:13872877241292018. doi: 10.1177/13872877241292018.
    PubMed     Abstract available


  803. DEJAKAISAYA H, Lin R, Harutyunyan A, Chan J, et al
    Effect of ceftriaxone on the glutamate-glutamine cycle and seizure susceptibility of Tg2576 mouse model of Alzheimer's disease.
    J Alzheimers Dis. 2024 Nov 3:13872877241289053. doi: 10.1177/13872877241289053.
    PubMed     Abstract available


  804. CHEN X, Hu F, Chi Q, Rao C, et al
    The study of Alzheimer's disease risk diagnosis based on natural killer cell marker genes in the multi-omics data.
    J Alzheimers Dis. 2024 Nov 3:13872877241295316. doi: 10.1177/13872877241295316.
    PubMed     Abstract available


  805. GESSI S, Mirandola P, Merighi S
    Keep neuroinflammation in mind when addressing Alzheimer's disease: A microglia perspective.
    J Alzheimers Dis. 2024 Nov 3:13872877241290693. doi: 10.1177/13872877241290693.
    PubMed     Abstract available


  806. ABDELRAOUF K, Farrag HS, El-Ganzuri MA, El-Sayed WM, et al
    A new bithiophene inhibited amyloid-beta accumulation and enhanced cognitive function in the hippocampus of aluminum-induced Alzheimer's disease in adult rats.
    J Alzheimers Dis. 2024 Nov 3:13872877241295405. doi: 10.1177/13872877241295405.
    PubMed     Abstract available


  807. ZHAO Y, Villasante-Tezanos A, Miranda-Morales EG, Pappolla MA, et al
    Discovery of novel metabolic biomarkers in blood serum for diagnosis of Alzheimer's disease.
    J Alzheimers Dis. 2024;102:237-253.
    PubMed     Abstract available


  808. MATIAS-GUIU JA, Alvarez-Sabin J, Botia E, Casado-Naranjo I, et al
    Perceptions of key informant neurologists before implementing anti-amyloid drugs in the Spanish departments of neurology.
    J Alzheimers Dis. 2024;102:207-217.
    PubMed     Abstract available


  809. PAPOTTI B, Palumbo M, Adorni MP, Elviri L, et al
    Influence of APOE4 genotype on PCSK9-lipids association in cerebrospinal fluid and serum of patients in the Alzheimer's disease continuum.
    J Alzheimers Dis. 2024;102:162-172.
    PubMed     Abstract available


  810. JURASOVA V, Andel R, Katonova A, Nolan R, et al
    Is KIBRA polymorphism associated with memory performance and cognitive impairment in Alzheimer's disease?
    J Alzheimers Dis. 2024;102:218-227.
    PubMed     Abstract available


  811. KHAN SU, Albanyan A, Bilal M, Ullah S, et al
    A genetic programming Rician noise reduction and explainable deep learning model for Alzheimer's diseases severity prediction.
    J Alzheimers Dis. 2024;102:129-142.
    PubMed     Abstract available


  812. ISHII K, Yamada T, Hanaoka K, Kaida H, et al
    Regional differences in glucose metabolic decline and tau deposition in the Alzheimer's continuum brain.
    J Alzheimers Dis. 2024;102:228-236.
    PubMed     Abstract available


  813. ZHANG Z, Sheng Z, Liu J, Zhang D, et al
    The association of the triglyceride-glucose index with Alzheimer's disease and its potential mechanisms.
    J Alzheimers Dis. 2024;102:77-88.
    PubMed     Abstract available


  814. GAO Z, Dorney I, Davis PB, Kaelber DC, et al
    Association between selective serotonin reuptake inhibitors and mortality following COVID-19 among patients with Alzheimer's disease.
    J Alzheimers Dis. 2024;102:99-109.
    PubMed     Abstract available


  815. SERRA L, Bonarota S, Di Domenico C, Caruso G, et al
    The funnel effect of reserves prompted by leisure activities across the Alzheimer's disease continuum.
    J Alzheimers Dis. 2024;102:181-194.
    PubMed     Abstract available


  816. KANG L, Zhang X, Guan J, Huang K, et al
    Early Alzheimer's disease diagnosis via handwriting with self-attention mechanisms.
    J Alzheimers Dis. 2024;102:173-180.
    PubMed     Abstract available


  817. BEDER N, Belkhelfa M, Leklou H
    Involvement of inflammasomes in the pathogenesis of Alzheimer's disease.
    J Alzheimers Dis. 2024;102:11-29.
    PubMed     Abstract available


  818. BESSER LM, Fuentes AJ, Zhang JN, O'Shea DM, et al
    Intersectionality of gender with social determinants of health and asymptomatic Alzheimer's disease neuropathology.
    J Alzheimers Dis. 2024;102:110-118.
    PubMed     Abstract available


  819. CALVO N, McFall GP, Ramana S, Galper M, et al
    Associated risk and resilience factors of Alzheimer's disease in women with early bilateral oophorectomy: Data from the UK Biobank.
    J Alzheimers Dis. 2024;102:119-128.
    PubMed     Abstract available


  820. LECLERC H, Lee AK, Kunicki ZJ, Alber J, et al
    Added value of inflammatory plasma biomarkers to pathologic biomarkers in predicting preclinical Alzheimer's disease.
    J Alzheimers Dis. 2024;102:89-98.
    PubMed     Abstract available


  821. ABDULLAH L, Zhang F, Hall J, O'Bryant S, et al
    Neurofilament light and cognition in community-dwelling non-Hispanic Blacks.
    J Alzheimers Dis. 2024;102:60-66.
    PubMed     Abstract available


  822. LIN Y, Kuo SH
    The emerging role of the cerebellum in neurodegeneration linked to cognitive impairment.
    J Alzheimers Dis. 2024;102:30-32.
    PubMed     Abstract available


  823. LIU Z, Hu B, Tang J, Liu X, et al
    Frontiers and hotspots evolution between air pollution and Alzheimer's disease: A bibliometric analysis from 2013 to 2023.
    J Alzheimers Dis. 2024;102:257-274.
    PubMed     Abstract available


  824. CHEN H, Wang L, Chen F, Sun W, et al
    Performance of the Benton Judgment of Line Orientation test across patients with different types of dementia.
    J Alzheimers Dis. 2024;102:437-448.
    PubMed     Abstract available


  825. DOS SANTOS JR, Catalao CHR, Vulczak A, Azzolini AECS, et al
    Voluntary wheel running decreases amyloidogenic pathway and rescues cognition and mitochondrial energy metabolism in middle-aged female 3xTg-AD mouse model of Alzheimer's disease.
    J Alzheimers Dis. 2024;102:424-436.
    PubMed     Abstract available


  826. TANG M, Guo JJ, Guo RX, Xu SJ, et al
    Progress of research and application of non-pharmacologic intervention in Alzheimer's disease.
    J Alzheimers Dis. 2024;102:275-294.
    PubMed     Abstract available


  827. ZHANG X, Lv R, Sun Y, Liu TC, et al
    The safety and effectiveness of 40 Hz gamma-tACS in Alzheimer's disease: A meta-analysis.
    J Alzheimers Dis. 2024;102:295-307.
    PubMed     Abstract available


  828. FINDLEY CA, McFadden SA, Hill T, Peck MR, et al
    Sexual dimorphism, altered hippocampal glutamatergic neurotransmission, and cognitive impairment in APP knock-in mice.
    J Alzheimers Dis. 2024;102:491-505.
    PubMed     Abstract available


  829. CIESLA M, Toro-Serey C, Jannati A, Banks RE, et al
    Detecting functional impairment with the Digital Clock and Recall.
    J Alzheimers Dis. 2024;102:329-337.
    PubMed     Abstract available


  830. COOK N, Driscoll I, Gaitan JM, Glittenberg M, et al
    Amyloid-beta positivity is less prevalent in cognitively unimpaired KLOTHO KL-VS heterozygotes.
    J Alzheimers Dis. 2024;102:480-490.
    PubMed     Abstract available


    September 2024
  831. CHAN CK, Lane KA, Gao S, Adeoye-Olatunde OA, et al
    Referral Sources Across Racial and Ethnic Groups at Alzheimer's Disease Research Centers.
    J Alzheimers Dis. 2024 Sep 30. doi: 10.3233/JAD-240485.
    PubMed     Abstract available


  832. WANG N, Tai HC, Tzeng IS
    Non-Pharmacological Exercise Randomized Controlled Trials in Alzheimer's Disease.
    J Alzheimers Dis. 2024 Sep 20. doi: 10.3233/JAD-240418.
    PubMed     Abstract available


  833. DEL TREDICI K, Schon M, Feldengut S, Ghebremedhin E, et al
    Early CA2 Tau Inclusions Do Not Distinguish an Age-Related Tauopathy from Early Alzheimer's Disease.
    J Alzheimers Dis. 2024 Sep 18. doi: 10.3233/JAD-240483.
    PubMed     Abstract available


  834. MATTKE S, Tang Y, Hanson M, von Arnim CAF, et al
    Current Capacity for Diagnosing Alzheimer's Disease in Germany and Implications for Wait Times.
    J Alzheimers Dis. 2024 Sep 17. doi: 10.3233/JAD-240728.
    PubMed     Abstract available


  835. LIU XL, Yeerlan J, Liu Z, Bai Y, et al
    Past, Present, and Future of Liver-Brain Axis in Alzheimer's Disease: A Bibliometric Review.
    J Alzheimers Dis. 2024 Sep 17. doi: 10.3233/JAD-240688.
    PubMed     Abstract available


  836. NOWELL J, Raza S, Livingston NR, Sivanathan S, et al
    Do Tau Deposition and Glucose Metabolism Dissociate in Alzheimer's Disease Trajectory?
    J Alzheimers Dis. 2024 Sep 17. doi: 10.3233/JAD-240434.
    PubMed     Abstract available


  837. BABULAL GM, Zha W, Trani JF, Guerra JL, et al
    Identifying Gaps and Barriers in Alzheimer's Disease and Related Dementia Research and Management in Low- and Middle-Income Countries: A Survey of Health Professionals and Researchers.
    J Alzheimers Dis. 2024 Sep 16. doi: 10.3233/JAD-240650.
    PubMed     Abstract available


  838. UTYRO O, Wloczkowska-Lapinska O, Jakubowski H
    Association of GLOD4 with Alzheimer's Disease in Humans and Mice.
    J Alzheimers Dis. 2024 Sep 16. doi: 10.3233/JAD-240512.
    PubMed     Abstract available


  839. RAJAMAKI B, Braithwaite B, Hartikainen S, Tolppanen AM, et al
    Identifying Comorbidity Patterns in People with and without Alzheimer's Disease Using Latent Dirichlet Allocation.
    J Alzheimers Dis. 2024 Sep 16. doi: 10.3233/JAD-240490.
    PubMed     Abstract available


  840. ABI-GHANEM C, Salinero AE, Smith RM, Kelly RD, et al
    Effects of Menopause and High Fat Diet on Metabolic Outcomes in a Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2024 Sep 16. doi: 10.3233/JAD-231332.
    PubMed     Abstract available


  841. MENDEZ-BARRIO C, Medina-Rodriguez M, Mendoza-Vazquez G, Garcia-Roldan E, et al
    Prodromal Alzheimer's Disease: Global Cognition, Cue Efficiency, and Cerebrospinal Fluid Neurofilament Light Values Predict Short-Term Conversion to Dementia.
    J Alzheimers Dis. 2024 Sep 14. doi: 10.3233/JAD-240689.
    PubMed     Abstract available


  842. PARK J, Oh JP, Ku K, Jin Y, et al
    Preventing Donepezil-Induced Adverse Effects Through N-acetylcysteine Co-Administration.
    J Alzheimers Dis. 2024 Sep 13. doi: 10.3233/JAD-240709.
    PubMed     Abstract available


  843. MANAKKADAN A, Krishnan D, Rui Xia Ang S, Sajikumar S, et al
    Slow Release of Hydrogen Sulfide in CA1 Hippocampal Neurons Rescues Long-Term Synaptic Plasticity and Associativity in an Amyloid-beta Induced Model of Alzheimer's Disease.
    J Alzheimers Dis. 2024 Sep 13. doi: 10.3233/JAD-240456.
    PubMed     Abstract available


  844. SCHICKTANZ S, Alpinar-Segawa Z, Ulitsa N, Perry J, et al
    Moving Towards Ethical-Practical Recommendations for Alzheimer's Disease Prediction: Addressing Interindividual, Interprofessional, and Societal Aspects.
    J Alzheimers Dis. 2024 Sep 13. doi: 10.3233/JAD-231137.
    PubMed     Abstract available


  845. VYHNALEK M, Laczo M, Laczo J
    Diagnosis of Alzheimer's Disease in Clinical Practice: Time to Incorporate Biomarkers?
    J Alzheimers Dis. 2024 Sep 12. doi: 10.3233/JAD-240660.
    PubMed     Abstract available


  846. WANG T, Yan S, Shan Y, Xing Y, et al
    Altered Neuronal Activity Patterns of the Prefrontal Cortex in Alzheimer's Disease After Transcranial Alternating Current Stimulation: A Resting-State fMRI Study.
    J Alzheimers Dis. 2024 Sep 12. doi: 10.3233/JAD-240400.
    PubMed     Abstract available


  847. SPENCER FSE, Elsworthy RJ, Breen L, Bishop J, et al
    The Relationship Between Physical Activity and Non-Modifiable Risk Factors on Alzheimer's Disease and Brain Health Markers: A UK Biobank Study.
    J Alzheimers Dis. 2024 Sep 12. doi: 10.3233/JAD-240269.
    PubMed     Abstract available


  848. WANG Q, Fu M, Gao L, Yuan X, et al
    A Drug Repositioning Approach Reveals Ergotamine May Be a Potential Drug for the Treatment of Alzheimer's Disease.
    J Alzheimers Dis. 2024 Sep 12. doi: 10.3233/JAD-240235.
    PubMed     Abstract available


  849. SELIGMANN B, Camiolo S, Hernandez M, Yeakley JM, et al
    Molecular Gene Expression Testing to Identify Alzheimer's Disease with High Accuracy from Fingerstick Blood.
    J Alzheimers Dis. 2024 Sep 11. doi: 10.3233/JAD-240174.
    PubMed     Abstract available


  850. BOLSHAKOV AP, Gerasimov K, Dobryakova YV
    Alzheimer's Disease: An Attempt of Total Recall.
    J Alzheimers Dis. 2024 Sep 7. doi: 10.3233/JAD-240620.
    PubMed     Abstract available


  851. LIU S, Maruff P, Fedyashov V, Masters CL, et al
    A Data-Driven Cognitive Composite Sensitive to Amyloid-beta for Preclinical Alzheimer's Disease.
    J Alzheimers Dis. 2024 Sep 6. doi: 10.3233/JAD-231319.
    PubMed     Abstract available


  852. BUTLER T, Tey SR, Galvin JE, Perry G, et al
    Endocrine Dyscrasia in the Etiology and Therapy of Alzheimer's Disease.
    J Alzheimers Dis. 2024 Sep 4. doi: 10.3233/JAD-240334.
    PubMed     Abstract available


  853. GUO H, Sun S, Yang Y, Ma R, et al
    A Novel Score to Predict Individual Risk for Future Alzheimer's Disease: A Longitudinal Study of the ADNI Cohort.
    J Alzheimers Dis. 2024 Sep 3. doi: 10.3233/JAD-240532.
    PubMed     Abstract available


  854. GUO F, Tan MS, Hu H, Ou YN, et al
    sTREM2 Mediates the Correlation Between BIN1 Gene Polymorphism and Tau Pathology in Alzheimer's Disease.
    J Alzheimers Dis. 2024 Sep 3. doi: 10.3233/JAD-240372.
    PubMed     Abstract available


  855. CARDOSO R, Teunissen CE, Oliveira CR
    Enhancing Alzheimer's Disease Diagnosis and Care by Focusing on Plasma Biomarkers for Identifying Mild Cognitive Impairment.
    J Alzheimers Dis. 2024 Sep 2. doi: 10.3233/JAD-240724.
    PubMed     Abstract available


  856. ZHANG X, You J, Qao Q, Qi X, et al
    Correlation Between the Fractional Amplitude of Low-Frequency Fluctuation and Cognitive Defects in Alzheimer's Disease.
    J Alzheimers Dis. 2024 Sep 2. doi: 10.3233/JAD-231040.
    PubMed     Abstract available


    August 2024
  857. KRESHPA W, Raffa S, Girtler N, Brugnolo A, et al
    Limbic Network Derangement Mediates Unawareness of Apathy in Mild Cognitive Impairment due to Alzheimer's Disease: Clues from [18F]FDG PET Voxel-Wise Analysis.
    J Alzheimers Dis. 2024 Aug 31. doi: 10.3233/JAD-240430.
    PubMed     Abstract available


  858. ZHAO H, Yuan H, Wang E
    Causal Effects of Kidney Function and Chronic Kidney Disease on Alzheimer's Disease by Analyzing Large-Scale Genome-Wide Association Study Datasets.
    J Alzheimers Dis. 2024 Aug 30. doi: 10.3233/JAD-240807.
    PubMed     Abstract available


  859. GIUDICESSI A, McDowell CP, Martinez JE, Baena A, et al
    Cognitive Outcomes in Autosomal-Dominant Alzheimer's Disease: A Comprehensive Review from a Colombian Kindred with the Presenilin-1 E280A Mutation.
    J Alzheimers Dis. 2024 Aug 30. doi: 10.3233/JAD-240360.
    PubMed     Abstract available


  860. HANYU H, Koyama Y, Umekida K, Watanabe S, et al
    Path Integration Detects Prodromal Alzheimer's Disease and Predicts Cognitive Decline.
    J Alzheimers Dis. 2024 Aug 30. doi: 10.3233/JAD-240347.
    PubMed     Abstract available


  861. CHEN Y, Ji X, Bao Z
    Identification of the Shared Gene Signatures Between Alzheimer's Disease and Diabetes-Associated Cognitive Dysfunction by Bioinformatics Analysis Combined with Biological Experiment.
    J Alzheimers Dis. 2024 Aug 29. doi: 10.3233/JAD-240353.
    PubMed     Abstract available


  862. MACCIONI RB, Prieto R
    Understanding the Human Being from a Quantum Perspective: Lessons to Elucidate Alzheimer's Disease Pathogenesis.
    J Alzheimers Dis. 2024 Aug 28. doi: 10.3233/JAD-240864.
    PubMed    


  863. NAGATA T, Nakajima S, Kito S, Shinagawa S, et al
    The Association Between Distinct Delusional Ideations and Depressive Symptoms in Alzheimer's Disease: A Re-Analysis of CATIE-AD.
    J Alzheimers Dis. 2024 Aug 28. doi: 10.3233/JAD-240702.
    PubMed     Abstract available


  864. GUTIERREZ J, Kurz C, Sandoval C, Edmonds R, et al
    Impact of Preanalytical Procedures on Complement Biomarkers in Cerebrospinal Fluid and Plasma from Controls and Alzheimer's Disease Patients.
    J Alzheimers Dis. 2024 Aug 28. doi: 10.3233/JAD-240287.
    PubMed     Abstract available


  865. HUYNH ALH, Wang Y, Ma L, Low YLC, et al
    A Comparison of an Australian Observational Longitudinal Alzheimer's Disease Cohort to Community-Based Australian Data.
    J Alzheimers Dis. 2024 Aug 28. doi: 10.3233/JAD-240241.
    PubMed     Abstract available


  866. SOUZA NAP, Simoes Neto JP, Dourado MCN
    The Relationship Between Decision-Making Capacity and Awareness in People with Young-Onset Alzheimer's Disease.
    J Alzheimers Dis. 2024 Aug 26. doi: 10.3233/JAD-231324.
    PubMed     Abstract available


  867. GIAQUINTO F, Lorenzini P, Salvi E, Carnevale G, et al
    The Profile of the Italian Centers for Cognitive Disorders and Dementia in the Context of New Drugs in Alzheimer's Disease.
    J Alzheimers Dis. 2024 Aug 24. doi: 10.3233/JAD-240594.
    PubMed     Abstract available


  868. SUN W, Chen Y, Yang Y, Wang P, et al
    Characteristics and Transcriptomic Analysis of Cholinergic Neurons Derived from Induced Pluripotent Stem Cells with APP Mutation in Alzheimer's Disease.
    J Alzheimers Dis. 2024 Aug 24. doi: 10.3233/JAD-240299.
    PubMed     Abstract available


  869. SILVA-RUDBERG JA, Mecca AP
    Diffusion Imaging of Gray Matter Microstructure in Alzheimer's Disease.
    J Alzheimers Dis. 2024 Aug 23. doi: 10.3233/JAD-240673.
    PubMed     Abstract available


  870. PERREIRA KM, Hotz VJ, Duke NN, Aiello AE, et al
    The Add Health Parent Study: A Biosocial Resource for the Study of Multigenerational Racial/Ethnic Disparities in Alzheimer's Disease and Alzheimer's Disease-Related Dementias.
    J Alzheimers Dis. 2024 Aug 23. doi: 10.3233/JAD-240201.
    PubMed     Abstract available


  871. WEI W, Jiang Y, Hu G, He Y, et al
    Recent Advances of Mitochondrial Alterations in Alzheimer's Disease: A Perspective of Mitochondrial Basic Events.
    J Alzheimers Dis. 2024 Aug 23. doi: 10.3233/JAD-240092.
    PubMed     Abstract available


  872. CHEN J, Yang J, Shen D, Wang X, et al
    A Predictive Model of the Progression to Alzheimer's Disease in Patients with Mild Cognitive Impairment Based on the MRI Enlarged Perivascular Spaces.
    J Alzheimers Dis. 2024 Aug 22. doi: 10.3233/JAD-240523.
    PubMed     Abstract available


  873. JANN K, Cen S, Santos M, Aksman L, et al
    Effect of Genetic Risk on the Relationship Between rs-fMRI Complexity and Tau and Amyloid PET in Alzheimer's Disease.
    J Alzheimers Dis. 2024 Aug 22. doi: 10.3233/JAD-240459.
    PubMed     Abstract available


  874. NATARAJ A, Kala A, Pena SLP, Jezek K, et al
    Impaired Dynamics of Positional and Contextual Neural Coding in an Alzheimer's Disease Rat Model.
    J Alzheimers Dis. 2024 Aug 22. doi: 10.3233/JAD-231386.
    PubMed     Abstract available


  875. UH K, Monarch K, Reese ED, Rodriguez K, et al
    Impaired Skeletal Development by Disruption of Presenilin-1 in Pigs and Generation of Novel Pig Models for Alzheimer's Disease.
    J Alzheimers Dis. 2024 Aug 21. doi: 10.3233/JAD-231297.
    PubMed     Abstract available


  876. QI H, Zhu X, Ren Y, Zhang X, et al
    A Study of Assisted Screening for Alzheimer's Disease Based on Handwriting and Gait Analysis.
    J Alzheimers Dis. 2024 Aug 17. doi: 10.3233/JAD-240362.
    PubMed     Abstract available


  877. NEVE A, Das B, Wojtowicz J, Huang Z, et al
    Long-Term Safety of Gantenerumab in Participants with Alzheimer's Disease: A Phase III, Double-Blind, and Open-Label Extension Study (Marguerite RoAD).
    J Alzheimers Dis. 2024 Aug 17. doi: 10.3233/JAD-240221.
    PubMed     Abstract available


  878. AVELAR-PEREIRA B, Phillips CM, Hosseini SMH
    Convergence of Accelerated Brain Volume Decline in Normal Aging and Alzheimer's Disease Pathology.
    J Alzheimers Dis. 2024 Aug 17. doi: 10.3233/JAD-231458.
    PubMed     Abstract available


  879. ILARDI CR, Menichelli A, Michelutti M, Cattaruzza T, et al
    On the Clinimetrics of the Montreal Cognitive Assessment: Cutoff Analysis in Patients with Mild Cognitive Impairment due to Alzheimer's Disease.
    J Alzheimers Dis. 2024 Aug 12. doi: 10.3233/JAD-240339.
    PubMed     Abstract available


  880. KOHLER K, Macheda T, Hobbs MM, Maisel MT, et al
    Exposure to Lead in Drinking Water Causes Cognitive Impairment via an Alzheimer's Disease Gene-Dependent Mechanism in Adult Mice.
    J Alzheimers Dis. 2024 Aug 8. doi: 10.3233/JAD-240640.
    PubMed     Abstract available


  881. DUITS FH, Nilsson J, Zetterberg H, Blennow K, et al
    Serial Cerebrospinal Fluid Sampling Reveals Trajectories of Potential Synaptic Biomarkers in Early Stages of Alzheimer's Disease.
    J Alzheimers Dis. 2024 Aug 8. doi: 10.3233/JAD-240610.
    PubMed     Abstract available


  882. KALTSA M, Tsolaki A, Lazarou I, Mittas I, et al
    Assessing the Linguistic Capacity Across Alzheimer's Disease and Its Preclinical Stages: Evidence from Narrative Macrostructure in Elderly Speakers of Greek.
    J Alzheimers Dis. 2024 Aug 8. doi: 10.3233/JAD-240496.
    PubMed     Abstract available


  883. L'ESPERANCE OJ, McGhee J, Davidson G, Niraula S, et al
    Functional Connectivity Favors Aberrant Visual Network c-Fos Expression Accompanied by Cortical Synapse Loss in a Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2024 Aug 7. doi: 10.3233/JAD-240776.
    PubMed     Abstract available


  884. WING JJ, Rajczyk JI, Burke JF
    Geographic Variation of Prevalence of Alzheimer's Disease and Related Dementias in Central Appalachia.
    J Alzheimers Dis. 2024 Aug 7. doi: 10.3233/JAD-240528.
    PubMed     Abstract available


  885. GRANT WB
    A Brief History of the Progress in Our Understanding of Genetics and Lifestyle, Especially Diet, in the Risk of Alzheimer's Disease.
    J Alzheimers Dis. 2024 Aug 6. doi: 10.3233/JAD-240658.
    PubMed     Abstract available


  886. BUCHMAN AS, Yu L, Oveisgharan S, Zammit AR, et al
    Parkinson's Disease and Other Alzheimer's Disease and Related Dementia Pathologies and the Progression of Parkinsonism in Older Adults.
    J Alzheimers Dis. 2024 Aug 6. doi: 10.3233/JAD-240593.
    PubMed     Abstract available


  887. RUSTAMZADEH A, Tafakhori A, Ariaei A, Heydari M, et al
    Targeting Caspases 3/6 and Cathepsins L/B May Decrease Laminopathy-Induced Apoptosis in Alzheimer's Disease.
    J Alzheimers Dis. 2024 Aug 5. doi: 10.3233/JAD-240413.
    PubMed     Abstract available


  888. ORIA RB, Smith CJ, Ashford JW, Vitek MP, et al
    Pros and Cons of APOE4 Homozygosity and Effects on Neuroplasticity, Malnutrition, and Infections in Early Life Adversity, Alzheimer's Disease, and Alzheimer's Prevention.
    J Alzheimers Dis. 2024 Aug 1. doi: 10.3233/JAD-240888.
    PubMed     Abstract available


  889. HAN BL, Ma LZ, Han SL, Mi YC, et al
    Explore the Role of Frailty as a Contributor to the Association Between AT(N) Profiles and Cognition in Alzheimer's Disease.
    J Alzheimers Dis. 2024 Aug 1. doi: 10.3233/JAD-231489.
    PubMed     Abstract available


    July 2024
  890. IBAN-ARIAS R, Wang SH, Soares Dias Portela A, Yang EJ, et al
    Exposure to the World Center Particulate Matter Alters the Gut-Brain Axis in Early Onset Alzheimer's Disease Mice.
    J Alzheimers Dis. 2024 Jul 30. doi: 10.3233/JAD-240635.
    PubMed     Abstract available


  891. WANG H, Li J, Tu W, Wang Z, et al
    Identification of Blood Biomarkers Related to Energy Metabolism and Construction of Diagnostic Prediction Model Based on Three Independent Alzheimer's Disease Cohorts.
    J Alzheimers Dis. 2024 Jul 29. doi: 10.3233/JAD-240301.
    PubMed     Abstract available


  892. KASHIBAYASHI T, Kanemoto H, Takahashi R, Fujito R, et al
    Neural Basis of Agitated Behaviors in Patients with Amnestic Mild Cognitive Impairment and Alzheimer's Disease.
    J Alzheimers Dis. 2024 Jul 27. doi: 10.3233/JAD-240256.
    PubMed     Abstract available


  893. BOCCARDI V, Ruggiero C, Cecchetti R, Mecocci P, et al
    Geroscience and the Fight Against Alzheimer's Disease: Between Myth and Reality.
    J Alzheimers Dis. 2024 Jul 26. doi: 10.3233/JAD-240582.
    PubMed     Abstract available


  894. WANG W, Zhao F, Torres S, Harris PLR, et al
    Space-Like Irradiation Exacerbated Cognitive Deficits and Amyloid Pathology in CRND8 Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2024 Jul 26. doi: 10.3233/JAD-240570.
    PubMed     Abstract available


  895. LEE JH, Jia J, Ji Y, Kandiah N, et al
    A Framework for Best Practices and Readiness in the Advent of Anti-Amyloid Therapy for Early Alzheimer's Disease in Asia.
    J Alzheimers Dis. 2024 Jul 23. doi: 10.3233/JAD-240684.
    PubMed     Abstract available


  896. LIU Y, Xu W, Yang P, Liu X, et al
    Revealing Molecular Patterns of Alzheimer's Disease Risk Gene Expression Signatures in COVID-19 Brains.
    J Alzheimers Dis. 2024 Jul 23. doi: 10.3233/JAD-240609.
    PubMed     Abstract available


  897. AVILA J
    Delaying Brain Aging or Decreasing Tau Levels as Strategies to Prevent Alzheimer's Disease: In Memoriam of Mark A. Smith.
    J Alzheimers Dis. 2024 Jul 20. doi: 10.3233/JAD-240500.
    PubMed     Abstract available


  898. LIU Y, He B, Du K, Zheng J, et al
    Periphery Biomarkers Predicting Conversion of Type 2 Diabetes to Pre-Alzheimer-Like Cognitive Decline: A Multicenter Follow-Up Study.
    J Alzheimers Dis. 2024 Jul 19. doi: 10.3233/JAD-240455.
    PubMed     Abstract available


  899. BUTTERFIELD DA
    Activation of the Neuronal Cell Cycle in Brains in Amnestic Mild Cognitive Impairment: Early Involvement in the Progression of Alzheimer's Disease.
    J Alzheimers Dis. 2024 Jul 12. doi: 10.3233/JAD-240615.
    PubMed     Abstract available


  900. MANDAL PK, Maroon JC, Samkaria A, Arora Y, et al
    Iron Chelators and Alzheimer's Disease Clinical Trials.
    J Alzheimers Dis. 2024 Jul 12. doi: 10.3233/JAD-240605.
    PubMed     Abstract available


  901. AMARAL-CARVALHO V, Bento Lima-Silva T, Inacio Mariano L, Cruz de Souza L, et al
    Improved Accuracy of the Addenbrooke's Cognitive Examination-Revised in the Diagnosis of Mild Cognitive Impairment, Mild Dementia Due to Alzheimer's Disease and Behavioral Variant Frontotemporal Dementia Using Mokken Scale Analysis.
    J Alzheimers Dis. 2024 Jul 12. doi: 10.3233/JAD-240554.
    PubMed     Abstract available


  902. WANG RT, Sun Z, Tan CC, Tan L, et al
    Dynamic Features of Body Mass Index in Late Life Predict Cognitive Trajectories and Alzheimer's Disease: A Longitudinal Study.
    J Alzheimers Dis. 2024 Jul 12. doi: 10.3233/JAD-240292.
    PubMed     Abstract available


  903. BOCTI C
    Is Simpler Always Better? The Case for Going Beyond the Amyloid Hypothesis in Alzheimer's Disease.
    J Alzheimers Dis. 2024 Jul 9. doi: 10.3233/JAD-240488.
    PubMed     Abstract available


  904. ELMAN JA, Schork NJ, Rangan AV
    Exploring the Genetic Heterogeneity of Alzheimer's Disease: Evidence for Genetic Subtypes.
    J Alzheimers Dis. 2024 Jul 8. doi: 10.3233/JAD-231252.
    PubMed     Abstract available


  905. REIVE BS, Lau V, Sanchez-Lafuente CL, Henri-Bhargava A, et al
    The Inflammation-Induced Dysregulation of Reelin Homeostasis Hypothesis of Alzheimer's Disease.
    J Alzheimers Dis. 2024 Jul 5. doi: 10.3233/JAD-240088.
    PubMed     Abstract available


  906. PORTAL B, Sodergren M, Pares I Borrell T, Giraud R, et al
    Early Astrocytic Dysfunction Is Associated with Mistuned Synapses as well as Anxiety and Depressive-Like Behavior in the AppNL-F Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2024 Jul 4. doi: 10.3233/JAD-231461.
    PubMed     Abstract available



  907. Erratum to: Tubastatin A/ACY-1215 Improves Cognition in Alzheimer's Disease Transgenic Mice.
    J Alzheimers Dis. 2024 Jul 2. doi: 10.3233/JAD-249014.
    PubMed    


    June 2024
  908. JIN H, Yang Q, Chen G, Zhang W, et al
    Effects of Hepatorenal Function on Urinary Alzheimer-Associated Neuronal Thread Protein: A Laboratory-Based Cross-Sectional Study Among the Older Chinese Population.
    J Alzheimers Dis. 2024 Jun 29. doi: 10.3233/JAD-240148.
    PubMed     Abstract available


  909. ZHANG YH, Zhao P, Gao HL, Zhong ML, et al
    Screening Targets and Therapeutic Drugs for Alzheimer's Disease Based on Deep Learning Model and Molecular Docking.
    J Alzheimers Dis. 2024 Jun 29. doi: 10.3233/JAD-231389.
    PubMed     Abstract available



  910. Erratum to: Insulin-Related Biomarkers in Cerebrospinal Fluid in Mild Cognitive Impairment and Alzheimer's Disease: A Systematic Review.
    J Alzheimers Dis. 2024 Jun 28. doi: 10.3233/JAD-249011.
    PubMed    


  911. GARCIA-MARTINEZ M, Pozueta-Cantudo A, Lage C, Martinez-Dubarbie F, et al
    LAM Test: A New Cognitive Marker for Early Detection in Preclinical Alzheimer's Disease.
    J Alzheimers Dis. 2024 Jun 28. doi: 10.3233/JAD-240067.
    PubMed     Abstract available


  912. ZHUANG X, Cordes D, Bender AR, Nandy R, et al
    Classifying Alzheimer's Disease Neuropathology Using Clinical and MRI Measurements.
    J Alzheimers Dis. 2024 Jun 28. doi: 10.3233/JAD-231321.
    PubMed     Abstract available


  913. PUZZO D
    Beyond Amyloid-beta: Reevaluating Its Physiological Role to Find Safe Therapies Against Alzheimer's Disease.
    J Alzheimers Dis. 2024 Jun 27. doi: 10.3233/JAD-240406.
    PubMed     Abstract available


  914. COIMBRA JRM, Resende R, Custodio JBA, Salvador JAR, et al
    BACE1 Inhibitors for Alzheimer's Disease: Current Challenges and Future Perspectives.
    J Alzheimers Dis. 2024 Jun 22. doi: 10.3233/JAD-240146.
    PubMed     Abstract available


  915. SAKHAROVA T, Mao S, Osadchuk M
    Updated Models of Alzheimer's Disease with Deep Neural Networks.
    J Alzheimers Dis. 2024 Jun 21. doi: 10.3233/JAD-240183.
    PubMed     Abstract available


  916. PERRY G, Castellani R
    Alzheimer's Disease: Are We There Yet?
    J Alzheimers Dis. 2024 Jun 20. doi: 10.3233/JAD-249012.
    PubMed    


  917. LOBUE C, McClintock SM, Chiang HS, Helphrey J, et al
    A Critical Review of Noninvasive Brain Stimulation Technologies in Alzheimer's Dementia and Primary Progressive Aphasia.
    J Alzheimers Dis. 2024 Jun 20. doi: 10.3233/JAD-240230.
    PubMed     Abstract available


  918. HU Y, Wang X, Zhao Z, Liu M, et al
    The Downregulation of ITGAX Exacerbates Amyloid-beta Plaque Deposition in Alzheimer's Disease by Increasing Polarization of M1 Microglia.
    J Alzheimers Dis. 2024 Jun 20. doi: 10.3233/JAD-240118.
    PubMed     Abstract available


  919. GARERI P, Cotroneo AM, Montella R, Gaglianone M, et al
    Citicoline: A Cholinergic Precursor with a Pivotal Role in Dementia and Alzheimer's Disease.
    J Alzheimers Dis. 2024 Jun 15. doi: 10.3233/JAD-240497.
    PubMed     Abstract available


  920. DESAI S, Chen IY, Hom C, Doran E, et al
    Insomnia Symptoms Are Associated with Measures of Functional Deterioration and Dementia Status in Adults with Down Syndrome at High Risk for Alzheimer's Disease.
    J Alzheimers Dis. 2024 Jun 14. doi: 10.3233/JAD-220750.
    PubMed     Abstract available


  921. CABALLERO HS, McFall GP, Gee M, MacDonald S, et al
    Cognitive Speed in Neurodegenerative Disease: Comparing Mean Rate and Inconsistency Within and Across the Alzheimer's and Lewy Body Spectra in the COMPASS-ND Study.
    J Alzheimers Dis. 2024 Jun 12. doi: 10.3233/JAD-240210.
    PubMed     Abstract available


  922. CHEN X, Walton K, Brodaty H, Chalton K, et al
    Polyphenols and Diets as Current and Potential Nutrition Senotherapeutics in Alzheimer's Disease: Findings from Clinical Trials.
    J Alzheimers Dis. 2024 Jun 12. doi: 10.3233/JAD-231222.
    PubMed     Abstract available


  923. CANDEIAS E, Pereira-Santos AR, Empadinhas N, Cardoso SM, et al
    The Gut-Brain Axis in Alzheimer's and Parkinson's Diseases: The Catalytic Role of Mitochondria.
    J Alzheimers Dis. 2024 Jun 8. doi: 10.3233/JAD-240524.
    PubMed     Abstract available


  924. SHAMSI A, Furkan M, Khan MS, Yadav DK, et al
    Computational Screening of Repurposed Drugs for HMG-CoA Synthase 2 in Alzheimer's Disease.
    J Alzheimers Dis. 2024 Jun 8. doi: 10.3233/JAD-240376.
    PubMed     Abstract available


  925. CHANDLER JM, Ye W, Mi X, Doty EG, et al
    Potential Impact of Slowing Disease Progression in Early Symptomatic Alzheimer's Disease on Patient Quality of Life, Caregiver Time, and Total Societal Costs: Estimates Based on Findings from GERAS-US Study.
    J Alzheimers Dis. 2024 Jun 8. doi: 10.3233/JAD-231166.
    PubMed     Abstract available


  926. LALIVE HM, Griffa A, Carlier S, Nasuti M, et al
    Amnestic Syndrome in Memory Clinics: Similar Morphological Brain Patterns in Older Adults with and without Alzheimer's Disease.
    J Alzheimers Dis. 2024 Jun 7. doi: 10.3233/JAD-240026.
    PubMed     Abstract available


  927. CHEN YH, Wang ZB, Liu XP, Mao ZQ, et al
    Plasma Insulin Predicts Early Amyloid-beta Pathology Changes in Alzheimer's Disease.
    J Alzheimers Dis. 2024 Jun 5. doi: 10.3233/JAD-240289.
    PubMed     Abstract available


  928. LI D, Xie Q, Xie J, Ni M, et al
    Cerebrospinal Fluid Proteomics Identifies Potential Biomarkers for Early-Onset Alzheimer's Disease.
    J Alzheimers Dis. 2024 Jun 5. doi: 10.3233/JAD-240022.
    PubMed     Abstract available


  929. LI JG, Mutreja Y, Servili M, Leone A, et al
    The Anti-Neuroinflammatory Effect of Extra-Virgin Olive Oil in the Triple Transgenic Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2024 Jun 4. doi: 10.3233/JAD-240374.
    PubMed     Abstract available



  930. Erratum to: Self-Reported Late-Life Hypertension Is Associated with a Healthy Cognitive Status and Reduced Alzheimer's Disease Pathology Burden.
    J Alzheimers Dis. 2024 Jun 3. doi: 10.3233/JAD-249010.
    PubMed    


  931. SUN CK, Guo F, Ou YN, Zhang MZ, et al
    Association Between Carotid Plaque and Alzheimer's Disease Cerebrospinal Fluid Biomarkers and Cognitive Function in Cognitively Intact Adults: The CABLE Study.
    J Alzheimers Dis. 2024 Jun 1. doi: 10.3233/JAD-240131.
    PubMed     Abstract available


  932. LIANG X, Wang Y, Li S, Fan J, et al
    Enhancing Rab7 Activity by Inhibiting TBC1D5 Expression Improves Mitophagy in Alzheimer's Disease Models.
    J Alzheimers Dis. 2024 Jun 1. doi: 10.3233/JAD-231300.
    PubMed     Abstract available


  933. FUKUI Y, Tadokoro K, Hamada M, Asada K, et al
    A Novel Peptidome Technology for the Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease by Selected Reaction Monitoring.
    J Alzheimers Dis. 2024 Jun 1. doi: 10.3233/JAD-230915.
    PubMed     Abstract available


    May 2024
  934. TAYLOR J, Jaros M, Chen C, Harrison J, et al
    Plasma pTau181 Predicts Clinical Progression in a Phase 2 Randomized Controlled Trial of the 11beta-HSD1 Inhibitor Xanamem(R) for Mild Alzheimer's Disease.
    J Alzheimers Dis. 2024 May 31. doi: 10.3233/JAD-231456.
    PubMed     Abstract available


  935. CANTERO-FORTIZ Y, Cano A, Boada M
    Unraveling the Tau Puzzle: A Brief Discussion on Biomarkers in Alzheimer's Disease.
    J Alzheimers Dis. 2024 May 30. doi: 10.3233/JAD-240055.
    PubMed     Abstract available


  936. ZHAO A, Balcer LJ, Himali JJ, O'Donnell A, et al
    Association of Loneliness with Functional Connectivity MRI, Amyloid-beta PET, and Tau PET Neuroimaging Markers of Vulnerability for Alzheimer's Disease.
    J Alzheimers Dis. 2024 May 28. doi: 10.3233/JAD-231425.
    PubMed     Abstract available


  937. ILBOUDO Y, Yoshiji S, Lu T, Butler-Laporte G, et al
    Vitamin D, Cognition, and Alzheimer's Disease: Observational and Two-Sample Mendelian Randomization Studies.
    J Alzheimers Dis. 2024 May 27. doi: 10.3233/JAD-221223.
    PubMed     Abstract available


  938. DUCHESNE S, Rousseau LS, Belzile-Marsolais F, Welch LA, et al
    A Scoping Review of Alzheimers Disease Hypotheses: An Array of Uni- and Multi-Factorial Theories.
    J Alzheimers Dis. 2024 May 24. doi: 10.3233/JAD-230772.
    PubMed     Abstract available


  939. GENG Z, Wu Y, Liu J, Zhan Y, et al
    A Study on the Effect of Executive Control Network Functional Connection on the Therapeutic Efficacy of Repetitive Transcranial Magnetic Stimulation in Alzheimer's Disease.
    J Alzheimers Dis. 2024 May 24. doi: 10.3233/JAD-231449.
    PubMed     Abstract available


  940. AGUILAR BJ, Jasuja GK, Li X, Shishova E, et al
    Prevalence of Mild Cognitive Impairment and Alzheimer's Disease Identified in Veterans in the United States.
    J Alzheimers Dis. 2024 May 23. doi: 10.3233/JAD-240027.
    PubMed     Abstract available


  941. HERMES S, Cady J, Armentrout S, O'Connor J, et al
    Epistatic Features and Machine Learning Improve Alzheimer's Disease Risk Prediction Over Polygenic Risk Scores.
    J Alzheimers Dis. 2024 May 23. doi: 10.3233/JAD-230236.
    PubMed     Abstract available


  942. STARMANS NLP, Kappelle LJ, Muller M, Staals J, et al
    Blood Pressure Variability and Plasma Biomarkers of Neuronal Injury and Alzheimer's Disease: A Clinic-Based Study of Patients with Diseases Along the Heart-Brain Axis.
    J Alzheimers Dis. 2024 May 21. doi: 10.3233/JAD-240119.
    PubMed     Abstract available


  943. CHAI YL, Strohm L, Zhu Y, Chia RSL, et al
    Extracellular Vesicle-Enriched miRNA-Biomarkers Show Improved Utility for Detecting Alzheimer's Disease Dementia and Medial Temporal Atrophy.
    J Alzheimers Dis. 2024 May 21. doi: 10.3233/JAD-230572.
    PubMed     Abstract available


  944. NING M, An L, Dong L, Zhu R, et al
    Causal Associations Between Gut Microbiota, Gut Microbiota-Derived Metabolites, and Alzheimer's Disease: A Multivariable Mendelian Randomization Study.
    J Alzheimers Dis. 2024 May 20. doi: 10.3233/JAD-240082.
    PubMed     Abstract available


  945. PRZYBYSZEWSKI AW, Chudzik A
    How to Cure Alzheimer's Disease.
    J Alzheimers Dis. 2024 May 18. doi: 10.3233/JAD-240231.
    PubMed     Abstract available


  946. GAMM S, Ummel D, Vasil N, Grenier S, et al
    Getting Insight to the Lived Emotional Experience of People with Alzheimer's Disease Shortly After Diagnosis: A Phenomenological Approach.
    J Alzheimers Dis. 2024 May 18. doi: 10.3233/JAD-231403.
    PubMed     Abstract available


  947. ZENG B, Tang C, Wang J, Yang Q, et al
    Pharmacologic and Nutritional Interventions for Early Alzheimer's Disease: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials.
    J Alzheimers Dis. 2024 May 17. doi: 10.3233/JAD-240161.
    PubMed     Abstract available


  948. PLUTA R, Bogucka-Kocka A, Bogucki J, Kocki J, et al
    Apoptosis, Autophagy, and Mitophagy Genes in the CA3 Area in an Ischemic Model of Alzheimer's Disease with 2-Year Survival.
    J Alzheimers Dis. 2024 May 16. doi: 10.3233/JAD-240401.
    PubMed     Abstract available


  949. COSTANTINI E, Carrarini C, Calisi D, De Rosa M, et al
    Search in the Periphery for Potential Inflammatory Biomarkers of Dementia with Lewy Bodies and Alzheimer's Disease.
    J Alzheimers Dis. 2024 May 16. doi: 10.3233/JAD-231471.
    PubMed     Abstract available


  950. KURIHARA M, Kondo S, Ohse K, Nojima H, et al
    Relationship Between Cerebrospinal Fluid Alzheimer's Disease Biomarker Values Measured via Lumipulse Assays and Conventional ELISA: Single-Center Experience and Systematic Review.
    J Alzheimers Dis. 2024 May 15. doi: 10.3233/JAD-240185.
    PubMed     Abstract available


  951. WEGNER P, Balabin H, Ay MC, Bauermeister S, et al
    Semantic Harmonization of Alzheimer's Disease Datasets Using AD-Mapper.
    J Alzheimers Dis. 2024 May 15. doi: 10.3233/JAD-240116.
    PubMed     Abstract available


  952. NAKAYA M, Sato N, Matsuda H, Maikusa N, et al
    Assessment of Gray Matter Microstructural Alterations in Alzheimer's Disease by Free Water Imaging.
    J Alzheimers Dis. 2024 May 15. doi: 10.3233/JAD-231416.
    PubMed     Abstract available


  953. STAM CJ, de Haan W
    Network Hyperexcitability in Early-Stage Alzheimer's Disease: Evaluation of Functional Connectivity Biomarkers in a Computational Disease Model.
    J Alzheimers Dis. 2024 May 15. doi: 10.3233/JAD-230825.
    PubMed     Abstract available


  954. MCINTIRE LB
    Prognostic Power? Do the Plasma Biomarkers, Neurofilament Light and Phospho-Tau 181, Improve Prediction of Progression to Alzheimer's Disease Using a Machine Learning Approach in the ADNI Cohort?
    J Alzheimers Dis. 2024 May 14. doi: 10.3233/JAD-240126.
    PubMed     Abstract available


  955. IRFAN B, Ankouni G, Reader J, Seraji-Bozorgzad N, et al
    Alzheimer's Disease and Related Dementias in Muslim Women: Recommendations for Culturally Sensitive Care.
    J Alzheimers Dis. 2024 May 13. doi: 10.3233/JAD-240064.
    PubMed     Abstract available


  956. ZAKRZEWSKI JJ, Davis JD, Gemelli ZT, Korthauer LE, et al
    Understanding Health Beliefs and Health Behaviors in Older Adults at Risk for Alzheimer's Disease.
    J Alzheimers Dis. 2024 May 13. doi: 10.3233/JAD-230977.
    PubMed     Abstract available


  957. SATO K, Niimi Y, Ihara R, Suzuki K, et al
    Simplifying Alzheimer's Disease Monitoring: A Novel Machine-Learning Approach to Estimate the Clinical Dementia Rating Sum of Box Changes Using the Mini-Mental State Examination and Functional Activities Questionnaire.
    J Alzheimers Dis. 2024 May 11. doi: 10.3233/JAD-231426.
    PubMed     Abstract available


  958. CHONG JSX, Tan YJ, Koh AJ, Ting SKS, et al
    Plasma Neurofilament Light Relates to Divergent Default and Salience Network Connectivity in Alzheimer's Disease and Behavioral Variant Frontotemporal Dementia.
    J Alzheimers Dis. 2024 May 11. doi: 10.3233/JAD-231251.
    PubMed     Abstract available


  959. GUO ZX, Liu F, Wang FY, Ou YN, et al
    CAIDE Score, Alzheimer's Disease Pathology, and Cognition in Cognitively Normal Adults: The CABLE Study.
    J Alzheimers Dis. 2024 May 10. doi: 10.3233/JAD-240005.
    PubMed     Abstract available


  960. MCLAREN AMR, Kawaja MD
    Olfactory Dysfunction and Alzheimer's Disease: A Review.
    J Alzheimers Dis. 2024 May 10. doi: 10.3233/JAD-231377.
    PubMed     Abstract available


  961. WU C, Ruan T, Yuan Y, Xu C, et al
    Alterations in Synaptic Connectivity and Synaptic Transmission in Alzheimer's Disease with High Physical Activity.
    J Alzheimers Dis. 2024 May 10. doi: 10.3233/JAD-240123.
    PubMed     Abstract available


  962. ZUPANIC E, Emersic A, Wimo A, Winblad B, et al
    Slovenian Memory Clinic Organization with the Introduction of Potential New Alzheimer's Disease Treatment.
    J Alzheimers Dis. 2024 May 9. doi: 10.3233/JAD-240190.
    PubMed     Abstract available


  963. XIE L, Raj Y, Varathan P, He B, et al
    Deep Trans-Omic Network Fusion for Molecular Mechanism of Alzheimer's Disease.
    J Alzheimers Dis. 2024 May 9. doi: 10.3233/JAD-240098.
    PubMed     Abstract available


  964. ZHU M, Liu Y, Chen C, Chen H, et al
    TLR4/Rac1/NLRP3 Pathway Mediates Amyloid-beta-Induced Neuroinflammation in Alzheimer's Disease.
    J Alzheimers Dis. 2024 May 8. doi: 10.3233/JAD-240012.
    PubMed     Abstract available


  965. GIRALDO-BERRIO D, Jimenez-Del-Rio M, Velez-Pardo C
    Sildenafil Reverses the Neuropathological Alzheimer's Disease Phenotype in Cholinergic-Like Neurons Carrying the Presenilin 1 E280A Mutation.
    J Alzheimers Dis. 2024 May 8. doi: 10.3233/JAD-231169.
    PubMed     Abstract available


    April 2024
  966. XU J, Chen Y, Shi Y, Sun A, et al
    Associations Between Neuroinflammation-Related Conditions and Alzheimer's Disease: A Study of US Insurance Claims Data.
    J Alzheimers Dis. 2024 Apr 30. doi: 10.3233/JAD-231286.
    PubMed     Abstract available


  967. WU B, Chen M, Meng L, Tian Q, et al
    Osteoclasts Link Dysregulated Peripheral Degradation Processes and Accelerated Progression in Alzheimer's Disease.
    J Alzheimers Dis. 2024 Apr 29. doi: 10.3233/JAD-240096.
    PubMed     Abstract available


  968. LI Y, Yang Z, Zhang Y, Liu F, et al
    Genetic Screening of Patients with Sporadic Alzheimer's Disease and Frontotemporal Lobar Degeneration in the Chinese Population.
    J Alzheimers Dis. 2024 Apr 29. doi: 10.3233/JAD-231361.
    PubMed     Abstract available


  969. GALE SA
    Language and Meaning: Asymptomatic Alzheimer's Disease in the Clinic and Society.
    J Alzheimers Dis. 2024 Apr 27. doi: 10.3233/JAD-240195.
    PubMed     Abstract available


  970. OHNO M
    A Strategy for Allowing Earlier Diagnosis and Rigorous Evaluation of BACE1 Inhibitors in Preclinical Alzheimer's Disease.
    J Alzheimers Dis. 2024 Apr 27. doi: 10.3233/JAD-231451.
    PubMed     Abstract available


  971. HORVATH A, Quinlan P, Eckerstrom C, Aberg ND, et al
    The Associations Between Serum Insulin-like Growth Factor-I, Brain White Matter Volumes, and Cognition in Mild Cognitive Impairment and Alzheimer's Disease.
    J Alzheimers Dis. 2024 Apr 27. doi: 10.3233/JAD-231026.
    PubMed     Abstract available



  972. Erratum to: Loss in PKC Epsilon Causes Downregulation of MnSOD and BDNF Expression in Neurons of Alzheimer's Disease Hippocampus.
    J Alzheimers Dis. 2024 Apr 26. doi: 10.3233/JAD-249008.
    PubMed    


  973. UM YH, Wang SM, Kang DW, Kim S, et al
    Impact of Apolipoprotein E4 on the Locus Coeruleus Functional Connectivity in Preclinical Alzheimer's Disease.
    J Alzheimers Dis. 2024 Apr 26. doi: 10.3233/JAD-240065.
    PubMed     Abstract available


  974. ELGHANAM Y, Purja S, Kim EY
    Biomarkers as Endpoints in Clinical Trials for Alzheimer's Disease.
    J Alzheimers Dis. 2024 Apr 26. doi: 10.3233/JAD-240008.
    PubMed     Abstract available


  975. DURAN T, Gaussoin SA, Latham LA, Rundle MM, et al
    Examining a Preclinical Alzheimer's Cognitive Composite for Telehealth Administration for Reliability Between In-Person and Remote Cognitive Testing with Neuroimaging Biomarkers.
    J Alzheimers Dis. 2024 Apr 26. doi: 10.3233/JAD-231435.
    PubMed     Abstract available


  976. GARCIA-CARLOS CA, Basurto-Islas G, Perry G, Mondragon-Rodriguez S, et al
    Meta-Analysis in Transgenic Alzheimer's Disease Mouse Models Reveals Opposite Brain Network Effects of Amyloid-beta and Phosphorylated Tau Proteins.
    J Alzheimers Dis. 2024 Apr 26. doi: 10.3233/JAD-231365.
    PubMed     Abstract available


  977. MEMON A, Moore JA, Kang C, Ismail Z, et al
    Visual Functions Are Associated with Biomarker Changes in Alzheimer's Disease.
    J Alzheimers Dis. 2024 Apr 26. doi: 10.3233/JAD-231084.
    PubMed     Abstract available


  978. LIU M, Ma N, Yang X, Sun M, et al
    The Association of Circulating Glucagon-Like Peptide-1 with Cognitive Functions and Biomarkers in Alzheimer's Disease.
    J Alzheimers Dis. 2024 Apr 25. doi: 10.3233/JAD-240001.
    PubMed     Abstract available


  979. NGO S, Jackson AJ, Manivannan M, Young JC, et al
    Real World Financial Mismanagement in Alzheimer's Disease, Frontotemporal Dementia, and Primary Progressive Aphasia.
    J Alzheimers Dis. 2024 Apr 24. doi: 10.3233/JAD-231021.
    PubMed     Abstract available


  980. HUANG Z
    Evidence that Alzheimer's Disease Is a Disease of Competitive Synaptic Plasticity Gone Awry.
    J Alzheimers Dis. 2024 Apr 21. doi: 10.3233/JAD-240042.
    PubMed     Abstract available


  981. DUFF K, Hammers DB, Koppelmans V, King JB, et al
    Short-Term Practice Effects on Cognitive Tests Across the Late Life Cognitive Spectrum and How They Compare to Biomarkers of Alzheimer's Disease.
    J Alzheimers Dis. 2024 Apr 21. doi: 10.3233/JAD-231392.
    PubMed     Abstract available


  982. CHU Y, Xie Q, Meng R, Leng B, et al
    Evaluation of the Quality and Readability of Online Information about Alzheimer's Disease in China.
    J Alzheimers Dis. 2024 Apr 21. doi: 10.3233/JAD-231339.
    PubMed     Abstract available


  983. CETINSOY O, Anyanwu I, Krishnanand H, Natarajan G, et al
    Gene Association Study of the Urokinase Plasminogen Activator and Its Receptor Gene in Alzheimer's Disease.
    J Alzheimers Dis. 2024 Apr 20. doi: 10.3233/JAD-231383.
    PubMed     Abstract available


  984. KIM D, Jamrasi P, Li X, Ahn S, et al
    Effects of Exercise on Urinary AD7c-NTP (Alzheimer-Associated Neuronal Thread Protein) Levels and Cognitive Function Among Active Korean Elderly: A Randomized Controlled Trial.
    J Alzheimers Dis. 2024 Apr 20. doi: 10.3233/JAD-230946.
    PubMed     Abstract available


  985. BUTLER T, Wang X, Chiang G, Xi K, et al
    Reduction in Constitutively Activated Auditory Brainstem Microglia in Aging and Alzheimer's Disease.
    J Alzheimers Dis. 2024 Apr 19. doi: 10.3233/JAD-231312.
    PubMed     Abstract available


  986. KIM M, Song YS, Han K, Bae YJ, et al
    Impaired Glymphatic Flow on Diffusion Tensor MRI as a Marker of Neurodegeneration in Alzheimer's Disease: Correlation with Gray Matter Volume Loss and Cognitive Decline Independent of Cerebral Amyloid Deposition.
    J Alzheimers Dis. 2024 Apr 19. doi: 10.3233/JAD-231131.
    PubMed     Abstract available


  987. CAI J, Xie D, Kong F, Zhai Z, et al
    Effect and Mechanism of Rapamycin on Cognitive Deficits in Animal Models of Alzheimer's Disease: A Systematic Review and Meta-analysis of Preclinical Studies.
    J Alzheimers Dis. 2024 Apr 17. doi: 10.3233/JAD-231249.
    PubMed     Abstract available


  988. SIGHINOLFI G, Mitolo M, Pizzagalli F, Stanzani-Maserati M, et al
    Sulcal Morphometry Predicts Mild Cognitive Impairment Conversion to Alzheimer's Disease.
    J Alzheimers Dis. 2024 Apr 17. doi: 10.3233/JAD-231192.
    PubMed     Abstract available


  989. CHANDRASEKARAN G, Xie SX
    Improving Regression Analysis with Imputation in a Longitudinal Study of Alzheimer's Disease.
    J Alzheimers Dis. 2024 Apr 17. doi: 10.3233/JAD-231047.
    PubMed     Abstract available


  990. DAS S
    Omics Approaches in Alzheimer's Disease Research.
    J Alzheimers Dis. 2024 Apr 16. doi: 10.3233/JAD-240272.
    PubMed    


  991. TAHAMI MONFARED AA, Khachatryan A, Hummel N, Kopiec A, et al
    Assessing Quality of Life, Economic Burden, and Independence Across the Alzheimer's Disease Continuum Using Patient-Caregiver Dyad Surveys.
    J Alzheimers Dis. 2024 Apr 16. doi: 10.3233/JAD-231259.
    PubMed     Abstract available


  992. CHOI YY, Lee JJ, Te Nijenhuis J, Choi KY, et al
    Multi-Ethnic Norms for Volumes of Subcortical and Lobar Brain Structures Measured by Neuro I: Ethnicity May Improve the Diagnosis of Alzheimer's Disease1.
    J Alzheimers Dis. 2024 Apr 16. doi: 10.3233/JAD-231182.
    PubMed     Abstract available


  993. YOO HS, Kim HK, Lee JH, Chun JH, et al
    Association of Basal Forebrain Volume with Amyloid, Tau, and Cognition in Alzheimer's Disease.
    J Alzheimers Dis. 2024 Apr 16. doi: 10.3233/JAD-230975.
    PubMed     Abstract available


  994. KHALED M, Al-Jamal H, Tajer L, El-Mir R, et al
    Alzheimer's Disease in Lebanon: Exploring Genetic and Environmental Risk Factors-A Comprehensive Review.
    J Alzheimers Dis. 2024 Apr 12. doi: 10.3233/JAD-231432.
    PubMed     Abstract available


  995. ETEKOCHAY MO, Amaravadhi AR, Gonzalez GV, Atanasov AG, et al
    Unveiling New Strategies Facilitating the Implementation of Artificial Intelligence in Neuroimaging for the Early Detection of Alzheimer's Disease.
    J Alzheimers Dis. 2024 Apr 12. doi: 10.3233/JAD-231135.
    PubMed     Abstract available


  996. DORADO-MARTINEZ C, Montiel-Flores E, Ordonez-Librado JL, Gutierrez-Valdez AL, et al
    Histological and Memory Alterations in an Innovative Alzheimer's Disease Animal Model by Vanadium Pentoxide Inhalation.
    J Alzheimers Dis. 2024 Apr 12. doi: 10.3233/JAD-230818.
    PubMed     Abstract available


  997. BINI J
    The Importance of PET Imaging to Understanding Whole-Body Cortisol Metabolism in Alzheimer's Disease.
    J Alzheimers Dis. 2024 Apr 11. doi: 10.3233/JAD-231463.
    PubMed     Abstract available


  998. BECKERS E, Riphagen JM, Van Egroo M, Bennett DA, et al
    Sparse Asymmetry in Locus Coeruleus Pathology in Alzheimer's Disease.
    J Alzheimers Dis. 2024 Apr 11. doi: 10.3233/JAD-231328.
    PubMed     Abstract available


  999. SACHDEVA P, Narayanan KB, Sinha JK, Gupta S, et al
    Recent Advances in Drug Delivery Systems Targeting Insulin Signalling for the Treatment of Alzheimer's Disease.
    J Alzheimers Dis. 2024 Apr 6. doi: 10.3233/JAD-231181.
    PubMed     Abstract available


  1000. WIDJAYA MA, Lee SD, Cheng WC, Wu BT, et al
    Effects of Exercise Training on Immune-Related Genes and Pathways in the Cortex of Animal Models of Alzheimer's Disease: A Systematic Review.
    J Alzheimers Dis. 2024 Apr 5. doi: 10.3233/JAD-230803.
    PubMed     Abstract available


  1001. ACQUARONE E, Argyrousi EK, Arancio O, Watterson DM, et al
    The 5HT2b Receptor in Alzheimer's Disease: Increased Levels in Patient Brains and Antagonist Attenuation of Amyloid and Tau Induced Dysfunction.
    J Alzheimers Dis. 2024 Apr 3. doi: 10.3233/JAD-240063.
    PubMed     Abstract available


  1002. AREA-GOMEZ E, Schon EA
    Towards a Unitary Hypothesis of Alzheimer's Disease Pathogenesis.
    J Alzheimers Dis. 2024 Apr 3. doi: 10.3233/JAD-231318.
    PubMed     Abstract available


  1003. DAUAR MT, Picard C, Labonte A, Breitner J, et al
    Contactin 5 and Apolipoproteins Interplay in Alzheimer's Disease.
    J Alzheimers Dis. 2024 Apr 3. doi: 10.3233/JAD-231003.
    PubMed     Abstract available


    March 2024
  1004. BRAGAZZI NL, Boulares A, Garbarino S
    Could the Historical Transition from Segmented to Monophasic Sleep Explain the Modern Insurgence of Alzheimer's Disease and Related Dementias?
    J Alzheimers Dis. 2024 Mar 30. doi: 10.3233/JAD-240154.
    PubMed     Abstract available


  1005. MORENO-RODRIGUEZ M, Perez SE, Martinez-Gardeazabal J, Manuel I, et al
    Frontal Cortex Lipid Alterations During the Onset of Alzheimer's Disease.
    J Alzheimers Dis. 2024 Mar 30. doi: 10.3233/JAD-231485.
    PubMed     Abstract available


  1006. MUELLER SG
    Traumatic Brain Injury and Post-Traumatic Stress Disorder and Their Influence on Development and Pattern of Alzheimer's Disease Pathology in Later Life.
    J Alzheimers Dis. 2024 Mar 29. doi: 10.3233/JAD-231183.
    PubMed     Abstract available


  1007. MATTSSON P, Cselenyi Z, Forsberg Moren A, Freund-Levi Y, et al
    High Contrast PET Imaging of Subcortical and Allocortical Amyloid-beta in Early Alzheimer's Disease Using [11C]AZD2184.
    J Alzheimers Dis. 2024 Mar 29. doi: 10.3233/JAD-231013.
    PubMed     Abstract available


  1008. ROBINSON AC, Bin Rizwan T, Davidson YS, Minshull J, et al
    Self-Reported Late-Life Hypertension Is Associated with a Healthy Cognitive Status and Reduced Alzheimer's Disease Pathology Burden.
    J Alzheimers Dis. 2024 Mar 25. doi: 10.3233/JAD-231429.
    PubMed     Abstract available


  1009. VIJAYAN M, Reddy PH
    Unveiling the Role of Novel miRNA PC-5P-12969 in Alleviating Alzheimer's Disease.
    J Alzheimers Dis. 2024 Mar 25. doi: 10.3233/JAD-231281.
    PubMed     Abstract available


  1010. GELFO F, Petrosini L, Mandolesi L, Landolfo E, et al
    Land/Water Aerobic Activities: Two Sides of the Same Coin. A Comparative Analysis on the Effects in Cognition of Alzheimer's Disease.
    J Alzheimers Dis. 2024 Mar 25. doi: 10.3233/JAD-231279.
    PubMed     Abstract available


  1011. LOVE RWB
    Aniracetam: An Evidence-Based Model for Preventing the Accumulation of Amyloid-beta Plaques in Alzheimer's Disease.
    J Alzheimers Dis. 2024 Mar 25. doi: 10.3233/JAD-231247.
    PubMed     Abstract available


  1012. LI Y, Xu X, Wang P, Chen X, et al
    Association of Cancer History with Lifetime Risk of Dementia and Alzheimer's Disease.
    J Alzheimers Dis. 2024 Mar 22. doi: 10.3233/JAD-231223.
    PubMed     Abstract available


  1013. MATTKE S, Jun H, Chu S, Hanson M, et al
    Disparities in Access to Diagnostic Evaluation for Alzheimer's Disease in Individuals Dually Eligible for Medicare and Medicaid: A Modeling Study.
    J Alzheimers Dis. 2024 Mar 22. doi: 10.3233/JAD-231134.
    PubMed     Abstract available


  1014. ZHANG M, Qu Y, Li Q, Gu C, et al
    Correlation Between Prefrontal Functional Connectivity and the Degree of Cognitive Impairment in Alzheimer's Disease: A Functional Near-Infrared Spectroscopy Study.
    J Alzheimers Dis. 2024 Mar 21. doi: 10.3233/JAD-230648.
    PubMed     Abstract available


  1015. CUMMINGS J
    "Landscape of Phase 2 Trials in Alzheimer's Disease": Perspective on Adaptive Trials.
    J Alzheimers Dis. 2024 Mar 20. doi: 10.3233/JAD-240145.
    PubMed     Abstract available


  1016. SHUI L, Shibata D, Chan KCG, Zhang W, et al
    Longitudinal Relationship Between Brain Atrophy Patterns, Cognitive Decline, and Cerebrospinal Fluid Biomarkers in Alzheimer's Disease Explored by Orthonormal Projective Non-Negative Matrix Factorization.
    J Alzheimers Dis. 2024 Mar 20. doi: 10.3233/JAD-231149.
    PubMed     Abstract available


  1017. POLIS B, Samson AO
    Addressing the Discrepancies Between Animal Models and Human Alzheimer's Disease Pathology: Implications for Translational Research.
    J Alzheimers Dis. 2024 Mar 19. doi: 10.3233/JAD-240058.
    PubMed     Abstract available


  1018. ZHONG P, Cao Q, Yan Z
    Distinct and Convergent Alterations of Entorhinal Cortical Circuits in Two Mouse Models for Alzheimer's Disease and Related Disorders.
    J Alzheimers Dis. 2024 Mar 14. doi: 10.3233/JAD-231413.
    PubMed     Abstract available


  1019. SOARES MARTINS T, Ferreira M, Magalhaes S, Leandro K, et al
    FTIR Spectroscopy and Blood-Derived Extracellular Vesicles Duo in Alzheimer's Disease.
    J Alzheimers Dis. 2024 Mar 14. doi: 10.3233/JAD-231239.
    PubMed     Abstract available


  1020. ALJASSABI A, Zieneldien T, Kim J, Regmi D, et al
    Alzheimer's Disease Immunotherapy: Current Strategies and Future Prospects.
    J Alzheimers Dis. 2024 Mar 14. doi: 10.3233/JAD-231163.
    PubMed     Abstract available


  1021. ZHANG X, Gomez L, Below JE, Naj AC, et al
    An X Chromosome Transcriptome Wide Association Study Implicates ARMCX6 in Alzheimer's Disease.
    J Alzheimers Dis. 2024 Mar 14. doi: 10.3233/JAD-231075.
    PubMed     Abstract available


  1022. SHEN Z, Yang X, Lan Y, Chen G, et al
    The Neuro-Inflammatory Microenvironment: An Important Regulator of Stem Cell Survival in Alzheimer's Disease.
    J Alzheimers Dis. 2024 Mar 13. doi: 10.3233/JAD-231159.
    PubMed     Abstract available


  1023. RAMADAN FA, Arani G, Jafri A, Thompson T, et al
    Mendelian Randomization of Blood Metabolites Suggests Circulating Glutamine Protects Against Late-Onset Alzheimer's Disease.
    J Alzheimers Dis. 2024 Mar 13. doi: 10.3233/JAD-231063.
    PubMed     Abstract available


  1024. BROOKS WH
    Polyamine Dysregulation and Nucleolar Disruption in Alzheimer's Disease.
    J Alzheimers Dis. 2024 Mar 12. doi: 10.3233/JAD-231184.
    PubMed     Abstract available


  1025. CAO J, Tang Y, Chen S, Yu S, et al
    The Hippocampal Subfield Volume Reduction and Plasma Biomarker Changes in Mild Cognitive Impairment and Alzheimer's Disease.
    J Alzheimers Dis. 2024 Mar 12. doi: 10.3233/JAD-231114.
    PubMed     Abstract available


  1026. TRIEU C, van Harten AC, Leeuwis AE, Exalto LG, et al
    Alzheimer's Disease and Cognitive Decline in Patients with Cardiovascular Diseases Along the Heart-Brain Axis.
    J Alzheimers Dis. 2024 Mar 12. doi: 10.3233/JAD-231096.
    PubMed     Abstract available


  1027. ZHAI M, Zhang Y, Yan D, Wang Y, et al
    Genetic Insights into the Association and Causality Between Blood Metabolites and Alzheimer's Disease.
    J Alzheimers Dis. 2024 Mar 12. doi: 10.3233/JAD-230985.
    PubMed     Abstract available


  1028. CESANA BM, Bergh S, Ciccone A, Cognat E, et al
    Predictors of Nursing Home Placement in a Cohort of European People with Alzheimer's Disease and Other Dementia Cases Enrolled in SCU-B or Non SCU-B Centers: The RECage Study.
    J Alzheimers Dis. 2024 Mar 12. doi: 10.3233/JAD-230878.
    PubMed     Abstract available


  1029. CABRERA-LEON Y, Baez PG, Fernandez-Lopez P, Suarez-Araujo CP, et al
    Neural Computation-Based Methods for the Early Diagnosis and Prognosis of Alzheimer's Disease Not Using Neuroimaging Biomarkers: A Systematic Review.
    J Alzheimers Dis. 2024 Mar 10. doi: 10.3233/JAD-231271.
    PubMed     Abstract available


  1030. TERAO I, Kodama W
    Comparative Efficacy, Tolerability, and Acceptability of Donanemab, Lecanemab, Aducanumab, Melatonin, and Aerobic Exercise for a Short Time on Cognitive Function in Mild Cognitive Impairment and Mild Alzheimer's Disease: A Systematic Review and Networ
    J Alzheimers Dis. 2024 Mar 6. doi: 10.3233/JAD-230911.
    PubMed     Abstract available


  1031. MANDAL PK
    Pro-Oxidants and Antioxidants Imbalance in Alzheimer's Disease.
    J Alzheimers Dis. 2024 Mar 4. doi: 10.3233/JAD-240217.
    PubMed    



  1032. Retraction to: Potential Mechanisms Linking Cholesterol to Alzheimer's Disease-like Pathology in Rabbit Brain, Hippocampal Organotypic Slices, and Skeletal Muscle.
    J Alzheimers Dis. 2024 Mar 1. doi: 10.3233/JAD-239016.
    PubMed    


  1033. GOHEL D, Zhang P, Gupta AK, Li Y, et al
    Sildenafil as a Candidate Drug for Alzheimer's Disease: Real-World Patient Data Observation and Mechanistic Observations from Patient-Induced Pluripotent Stem Cell-Derived Neurons.
    J Alzheimers Dis. 2024 Mar 1. doi: 10.3233/JAD-231391.
    PubMed     Abstract available


  1034. YANG J, Liu X, Oveisgharan S, Zammit AR, et al
    Inferring Alzheimer's Disease Pathologic Traits from Clinical Measures in Living Adults.
    J Alzheimers Dis. 2024 Mar 1. doi: 10.3233/JAD-230639.
    PubMed     Abstract available


    February 2024
  1035. WANG CS, Chen PS, Tsai TY, Hou NT, et al
    Cognitive Effect of Transcranial Direct Current Stimulation on Left Dorsolateral Prefrontal Cortex in Mild Alzheimer's Disease: A Randomized, Double-Blind, Cross-Over Small-Scale Exploratory Study.
    J Alzheimers Dis. 2024 Feb 28. doi: 10.3233/JAD-240002.
    PubMed     Abstract available


  1036. LI S, Lan X, Liu Y, Zhou J, et al
    Unlocking the Potential of Repetitive Transcranial Magnetic Stimulation in Alzheimer's Disease: A Meta-Analysis of Randomized Clinical Trials to Optimize Intervention Strategies.
    J Alzheimers Dis. 2024 Feb 28. doi: 10.3233/JAD-231031.
    PubMed     Abstract available


  1037. LU TV, Grill JD, Gillen DL
    Study Partner Type and Adverse Event Reporting in Mild-to-Moderate Alzheimer's Disease Clinical Trials.
    J Alzheimers Dis. 2024 Feb 26. doi: 10.3233/JAD-231283.
    PubMed     Abstract available


  1038. SIGURDSSON EM
    Tau Immunotherapies for Alzheimer's Disease and Related Tauopathies: Status of Trials and Insights from Preclinical Studies.
    J Alzheimers Dis. 2024 Feb 26. doi: 10.3233/JAD-231238.
    PubMed     Abstract available


  1039. GARCIA-ALBERCA JM, de Rojas I, Sanchez-Mejias E, Garrido-Martin D, et al
    An Insertion Within SIRPbeta1 Shows a Dual Effect Over Alzheimer's Disease Cognitive Decline Altering the Microglial Response.
    J Alzheimers Dis. 2024 Feb 26. doi: 10.3233/JAD-231150.
    PubMed     Abstract available


  1040. CHI HC, Ma LZ, Wang ZB, Sheng ZH, et al
    Associations of Frailty with Neuropsychiatric Symptoms of Alzheimer's Disease: A Longitudinal Study.
    J Alzheimers Dis. 2024 Feb 26. doi: 10.3233/JAD-231111.
    PubMed     Abstract available


  1041. ROSSI E, Marrosu F, Saba L
    Music Therapy as a Complementary Treatment in Patients with Dementia Associated to Alzheimer's Disease: A Systematic Review.
    J Alzheimers Dis. 2024 Feb 26. doi: 10.3233/JAD-230852.
    PubMed     Abstract available


  1042. NJOMBORO P, Lekhutlile T
    The Effect of Apathy and Depressive Syndromes on Functional Outcomes in Alzheimer's Disease.
    J Alzheimers Dis. 2024 Feb 26. doi: 10.3233/JAD-230426.
    PubMed     Abstract available


  1043. VERWAERDE P, Estrella C, Burlet S, Barrier M, et al
    First-In-Human Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of AZP2006, A Synthetic Compound for the Treatment of Alzheimer's Disease and Related Diseases.
    J Alzheimers Dis. 2024 Feb 26. doi: 10.3233/JAD-220883.
    PubMed     Abstract available


  1044. KUMARI S, Kaur P, Singh AK, Ashar MS, et al
    Quantification of COX-2 Level in Alzheimer's Disease Patients to Develop Potential Blood-Based Biomarker for Early Diagnosis and Therapeutic Target.
    J Alzheimers Dis. 2024 Feb 24. doi: 10.3233/JAD-231445.
    PubMed     Abstract available


  1045. KAVOOSI S, Shahraki A, Sheervalilou R
    Identification of microRNA-mRNA Regulatory Networks with Therapeutic Values in Alzheimer's Disease by Bioinformatics Analysis.
    J Alzheimers Dis. 2024 Feb 24. doi: 10.3233/JAD-230966.
    PubMed     Abstract available


  1046. SABBIR MG
    Cholinergic Receptor Muscarinic 1 Co-Localized with Mitochondria in Cultured Dorsal Root Ganglion Neurons, and Its Deletion Disrupted Mitochondrial Ultrastructure in Peripheral Neurons: Implications in Alzheimer's Disease.
    J Alzheimers Dis. 2024 Feb 24. doi: 10.3233/JAD-230883.
    PubMed     Abstract available


  1047. CULIBRK RA, Ebbert KA, Yeisley DJ, Chen R, et al
    Impact of Suramin on Key Pathological Features of Sporadic Alzheimer's Disease-Derived Forebrain Neurons.
    J Alzheimers Dis. 2024 Feb 24. doi: 10.3233/JAD-230600.
    PubMed     Abstract available


  1048. KAMEYAMA H, Tagai K, Takasaki E, Kashibayashi T, et al
    Examining Frontal Lobe Asymmetry and Its Potential Role in Aggressive Behaviors in Early Alzheimer's Disease.
    J Alzheimers Dis. 2024 Feb 23. doi: 10.3233/JAD-231306.
    PubMed     Abstract available


  1049. VAISHNAV N, Gonzalez R, Karunungan K, Tyler A, et al
    Creating an Unprotected Class: Addressing Legal Risks in the Era of Biologically-Defined Alzheimer's Disease.
    J Alzheimers Dis. 2024 Feb 23. doi: 10.3233/JAD-230067.
    PubMed     Abstract available


  1050. ADAMS JA, Uryash A, Lopez JR
    Harnessing Passive Pulsatile Shear Stress for Alzheimer's Disease Prevention and Intervention.
    J Alzheimers Dis. 2024 Feb 22. doi: 10.3233/JAD-231010.
    PubMed     Abstract available


  1051. RAPOS PEREIRA F, George N, Dalla Barba G, Dubois B, et al
    The Memory Binding Test Detects Early Subtle Episodic Memory Decline in Preclinical Alzheimer's Disease: A Longitudinal Study.
    J Alzheimers Dis. 2024 Feb 22. doi: 10.3233/JAD-230921.
    PubMed     Abstract available


  1052. COGRAM P, Garduno BM, Ren B, Xu X, et al
    First International Conference on Unconventional Animal Models of Alzheimer's Disease and Aging.
    J Alzheimers Dis. 2024 Feb 20. doi: 10.3233/JAD-249004.
    PubMed     Abstract available


  1053. ACHARYA NK, Grossman HC, Clifford PM, Levin EC, et al
    A Chronic Increase in Blood-Brain Barrier Permeability Facilitates Intraneuronal Deposition of Exogenous Bloodborne Amyloid-Beta1-42 Peptide in the Brain and Leads to Alzheimer's Disease-Relevant Cognitive Changes in a Mouse Model.
    J Alzheimers Dis. 2024 Feb 20. doi: 10.3233/JAD-231028.
    PubMed     Abstract available


  1054. CZUCZWAR SAJ, Kocki J, Miziak B, Bogucki J, et al
    Alpha-, Beta-, and Gamma-Secretase, Amyloid Precursor Protein, and Tau Protein Genes in the Hippocampal CA3 Subfield in an Ischemic Model of Alzheimer's Disease with Survival up to 2 Years.
    J Alzheimers Dis. 2024 Feb 19. doi: 10.3233/JAD-231333.
    PubMed     Abstract available


  1055. RAJABLI F, Seixas AA, Akgun B, Adams LD, et al
    African Ancestry Individuals with Higher Educational Attainment are Resilient to Alzheimer's Disease Measured by pTau181.
    J Alzheimers Dis. 2024 Feb 19. doi: 10.3233/JAD-231116.
    PubMed     Abstract available


  1056. SUN H, Li P, Gao L, Yang J, et al
    Altered Motor Activity Patterns within 10-Minute Timescale Predict Incident Clinical Alzheimer's Disease.
    J Alzheimers Dis. 2024 Feb 19. doi: 10.3233/JAD-230928.
    PubMed     Abstract available


  1057. NELSON D, Thompson KJ, Wang L, Wang Z, et al
    Pericyte Control of Gene Expression in the Blood-Brain Barrier Endothelium: Implications for Alzheimer's Disease.
    J Alzheimers Dis. 2024 Feb 19. doi: 10.3233/JAD-230907.
    PubMed     Abstract available


  1058. GILLS JL, Bubu OM
    Obstructive Sleep Apnea and Alzheimer's Disease Pathology: Is Sleep Architecture the Missing Key?
    J Alzheimers Dis. 2024 Feb 14. doi: 10.3233/JAD-231385.
    PubMed     Abstract available


  1059. KIM SA, Maeda M, Murata F, Fujii T, et al
    Impact of Concurrent Visual and Hearing Impairment on Incident Alzheimer's Disease: The LIFE Study.
    J Alzheimers Dis. 2024 Feb 14. doi: 10.3233/JAD-230806.
    PubMed     Abstract available


  1060. JU IG, Lee S, Kim SH, Im H, et al
    Trichosanthis Semen Exerts Neuroprotective Effects in Alzheimer's Disease Models by Inhibiting Amyloid-beta Accumulation and Regulating the Akt and ERK Signaling Pathways.
    J Alzheimers Dis. 2024 Feb 13. doi: 10.3233/JAD-231124.
    PubMed     Abstract available


  1061. LI Z, Fan Z, Zhang Q
    The Associations of Phosphorylated Tau 181 and Tau 231 Levels in Plasma and Cerebrospinal Fluid with Cognitive Function in Alzheimer's Disease: A Systematic Review and Meta-Analysis.
    J Alzheimers Dis. 2024 Feb 7. doi: 10.3233/JAD-230799.
    PubMed     Abstract available


  1062. GEPHINE L, Roux CM, Freret T, Boulouard M, et al
    Vulnerability of Spatial Pattern Separation in 5xFAD Alzheimer's Disease Mouse Model.
    J Alzheimers Dis. 2024 Feb 2. doi: 10.3233/JAD-231112.
    PubMed     Abstract available


  1063. DE LA MONTE SM, Tong M
    Agent Orange Herbicidal Toxin-Initiation of Alzheimer-Type Neurodegeneration.
    J Alzheimers Dis. 2024 Feb 2. doi: 10.3233/JAD-230881.
    PubMed     Abstract available


  1064. GIULIETTI MV, Fabbietti P, Spatuzzi R, Vespa A, et al
    Effects of Mindfulness Based Interventions in Adults and Older Adults Caregivers of Patients with Early Stage Alzheimer's Disease: A Randomized Pilot Study.
    J Alzheimers Dis. 2024 Feb 2. doi: 10.3233/JAD-230284.
    PubMed     Abstract available


    January 2024
  1065. MONE P, De Luca A, Kansakar U, Santulli G, et al
    Leukocytes and Endothelial Cells Participate in the Pathogenesis of Alzheimer's Disease: Identifying New Biomarkers Mirroring Metabolic Alterations.
    J Alzheimers Dis. 2024 Jan 31. doi: 10.3233/JAD-231464.
    PubMed     Abstract available


  1066. ZHANG X, Haeri M, Swerdlow RH, Wang N, et al
    Loss of Adaptive DNA Breaks in Alzheimer's Disease Brains.
    J Alzheimers Dis. 2024 Jan 31. doi: 10.3233/JAD-231303.
    PubMed     Abstract available


  1067. SIBLE IJ, Nation DA
    Blood Pressure Variability and Plasma Alzheimer's Disease Biomarkers in the SPRINT Trial.
    J Alzheimers Dis. 2024 Jan 31. doi: 10.3233/JAD-230930.
    PubMed     Abstract available


  1068. NOORI A, Jayakumar R, Moturi V, Li Z, et al
    Alzheimer DataLENS: An Open Data Analytics Portal for Alzheimer's Disease Research.
    J Alzheimers Dis. 2024 Jan 31. doi: 10.3233/JAD-230884.
    PubMed     Abstract available


  1069. WHEELER KV, Irimia A, Braskie MN
    Using Neuroimaging to Study Cerebral Amyloid Angiopathy and Its Relationship to Alzheimer's Disease.
    J Alzheimers Dis. 2024 Jan 31. doi: 10.3233/JAD-230553.
    PubMed     Abstract available


  1070. JIAO L, Jing Z, Zhang W, Su X, et al
    Codon Pattern and Context Analysis in Genes Triggering Alzheimer's Disease and Latent Tau Protein Aggregation Post-Anesthesia Exhibited Unique Molecular Patterns Associated with Functional Aspects.
    J Alzheimers Dis. 2024 Jan 30. doi: 10.3233/JAD-231142.
    PubMed     Abstract available


  1071. NG PY, Zhang C, Li H, Baker DJ, et al
    Senescence Targeting Methods Impact Alzheimer's Disease Features in 3xTg Mice.
    J Alzheimers Dis. 2024 Jan 30. doi: 10.3233/JAD-230465.
    PubMed     Abstract available


  1072. CABAN-HOLT A, Cuccaro ML, Lloyd SL, Starks TD, et al
    Attitudes and Perceptions about Brain Donation Among African Americans: Implications for Recruitment into Alzheimer's Disease Research.
    J Alzheimers Dis. 2024 Jan 29. doi: 10.3233/JAD-230461.
    PubMed     Abstract available


  1073. BELKHELFA M, Bekrar S, Rezaig L, Beder N, et al
    Neuroinflammatory Responses Occur in Brain Lesions During Alzheimer's Disease: Postmortem Case Report.
    J Alzheimers Dis. 2024 Jan 23. doi: 10.3233/JAD-230910.
    PubMed     Abstract available


  1074. WEI G, Tian X, Yang H, Luo Y, et al
    Adjunct Methods for Alzheimer's Disease Detection: A Review of Auditory Evoked Potentials.
    J Alzheimers Dis. 2024 Jan 23. doi: 10.3233/JAD-230822.
    PubMed     Abstract available


  1075. TAKASE H, Hamanaka G, Hoshino T, Ohtomo R, et al
    Transcriptomic Profiling Reveals Neuroinflammation in the Corpus Callosum of a Transgenic Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2024 Jan 22. doi: 10.3233/JAD-231049.
    PubMed     Abstract available


  1076. OKINAKA Y, Shinagawa Y, Claussen C, Gul S, et al
    RNA Analysis of Circulating Leukocytes in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2024 Jan 22. doi: 10.3233/JAD-230874.
    PubMed     Abstract available


  1077. SAEED A, Alharazi T, Alshaghdali K, Rezgui R, et al
    Targeting GluR3 in Depression and Alzheimer's Disease: Novel Compounds and Therapeutic Prospects.
    J Alzheimers Dis. 2024 Jan 22. doi: 10.3233/JAD-230821.
    PubMed     Abstract available


  1078. VILLEMAGNE VL, Dore V, Chong L, Kassiou M, et al
    Brain 11beta-Hydroxysteroid Dehydrogenase Type 1 Occupancy by Xanamem Assessed by PET in Alzheimer's Disease and Cognitively Normal Individuals.
    J Alzheimers Dis. 2024 Jan 19. doi: 10.3233/JAD-220542.
    PubMed     Abstract available


  1079. ZHOU J, Zhao M, Yang Z, Chen L, et al
    Exploring the Value of MRI Measurement of Hippocampal Volume for Predicting the Occurrence and Progression of Alzheimer's Disease Based on Artificial Intelligence Deep Learning Technology and Evidence-Based Medicine Meta-Analysis.
    J Alzheimers Dis. 2024 Jan 18. doi: 10.3233/JAD-230733.
    PubMed     Abstract available


  1080. GORHAM IK, Reid DM, Sun J, Zhou Z, et al
    Blood-Based mtDNA Quantification Indicates Population-Specific Differences Associated with Alzheimer's Disease-Related Risk.
    J Alzheimers Dis. 2024 Jan 16. doi: 10.3233/JAD-230880.
    PubMed     Abstract available


  1081. KURANO M, Saito Y, Yatomi Y
    Comprehensive Analysis of Metabolites in Postmortem Brains of Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2024 Jan 13. doi: 10.3233/JAD-230942.
    PubMed     Abstract available


  1082. CHEN M, Wang F, Lei H, Yang Z, et al
    In Silico Insights into Micro-Mechanism Understanding of Extracts of Taxus Chinensis Fruits Against Alzheimer's Disease.
    J Alzheimers Dis. 2024 Jan 12. doi: 10.3233/JAD-231066.
    PubMed     Abstract available


  1083. FORT-AZNAR L, Molina-Porcel L, Ramos-Campoy O, Esteller D, et al
    Misfolded alpha-Synuclein in Autosomal Dominant Alzheimer's Disease.
    J Alzheimers Dis. 2024 Jan 12. doi: 10.3233/JAD-230919.
    PubMed     Abstract available


  1084. SMITH HS, Robinson JO, Levchenko A, Pereira S, et al
    Research Participants' Perspectives on Precision Diagnostics for Alzheimer's Disease.
    J Alzheimers Dis. 2024 Jan 12. doi: 10.3233/JAD-230609.
    PubMed     Abstract available


  1085. HAN Y, Huang C, Pan Y, Gu X, et al
    Single Cell Sequencing Technology and Its Application in Alzheimer's Disease.
    J Alzheimers Dis. 2024 Jan 8. doi: 10.3233/JAD-230861.
    PubMed     Abstract available


  1086. WU LY, Chong JR, Chong JPC, Hilal S, et al
    Serum Placental Growth Factor as a Marker of Cerebrovascular Disease Burden in Alzheimer's Disease.
    J Alzheimers Dis. 2024 Jan 8. doi: 10.3233/JAD-230811.
    PubMed     Abstract available


  1087. ZHANG C, Lei X, Ma W, Long J, et al
    Diagnosis Framework for Probable Alzheimer's Disease and Mild Cognitive Impairment Based on Multi-Dimensional Emotion Features.
    J Alzheimers Dis. 2024 Jan 5. doi: 10.3233/JAD-230703.
    PubMed     Abstract available


  1088. STONE J, Mitrofanis J, Johnstone DM, Robinson SR, et al
    The Catastrophe of Intracerebral Hemorrhage Drives the Capillary-Hemorrhage Dementias, Including Alzheimer's Disease.
    J Alzheimers Dis. 2024 Jan 5. doi: 10.3233/JAD-231202.
    PubMed     Abstract available


  1089. SAFIEH M, Liraz O, Ovadia M, Michaelson D, et al
    The Role of Impaired Receptor Trafficking in Mediating the Pathological Effects of APOE4 in Alzheimer's Disease.
    J Alzheimers Dis. 2024 Jan 5. doi: 10.3233/JAD-230514.
    PubMed     Abstract available


  1090. FAN X, Cai Y, Zhao L, Liu W, et al
    Machine Learning-Derived MRI-Based Neurodegeneration Biomarker for Alzheimer's Disease: A Multi-Database Validation Study.
    J Alzheimers Dis. 2024 Jan 4. doi: 10.3233/JAD-230574.
    PubMed     Abstract available


  1091. VALENTIN-ESCALERA J, Leclerc M, Calon F
    High-Fat Diets in Animal Models of Alzheimer's Disease: How Can Eating Too Much Fat Increase Alzheimer's Disease Risk?
    J Alzheimers Dis. 2024 Jan 4. doi: 10.3233/JAD-230118.
    PubMed     Abstract available


  1092. SELLES MC, Oliveira MM
    The Oxytocin Puzzle: Unlocking Alzheimer's Disease.
    J Alzheimers Dis. 2024 Jan 3. doi: 10.3233/JAD-231127.
    PubMed     Abstract available


  1093. LI J, Yang M, Wei R, Cao Y, et al
    The Predictive Ability of Blood Neurofilament Light Chain in Predicting Cognitive Decline in the Alzheimer's Disease Continuum: A Systematic Review and Meta-Analysis.
    J Alzheimers Dis. 2024 Jan 2. doi: 10.3233/JAD-231080.
    PubMed     Abstract available


  1094. NADEAU PA, Jobin B, Boller B
    Erratum to: Diagnostic Sensitivity and Specificity of Cognitive Tests for Mild Cognitive Impairment and Alzheimer's Disease in Patients with Down Syndrome: A Systematic Review and Meta-Analysis.
    J Alzheimers Dis. 2024;97:521.
    PubMed    



  1095. The Journal of Alzheimer's Disease Is Happy to Announce the Appointment of Paula I. Moreira, PhD, as Co-Editor-in-Chief of the Journal.
    J Alzheimers Dis. 2024;97:1.
    PubMed    


  1096. ANGELIDOU IA, Stocker H, Beyreuther K, Teichmann B, et al
    Validation of the "Perceptions Regarding pRE-Symptomatic Alzheimer's Disease Screening" (PRE-ADS) Questionnaire in the German Population: Attitudes, Motivations, and Barriers to Pre-Symptomatic Dementia Screening.
    J Alzheimers Dis. 2024;97:309-325.
    PubMed     Abstract available


  1097. ZENG Y, Cao S, Pang K, Tang J, et al
    Causal Association Between Sepsis and Neurodegenerative Diseases: A Bidirectional Two-Sample Mendelian Randomization Study.
    J Alzheimers Dis. 2024;97:229-237.
    PubMed     Abstract available


  1098. DE SIMONE MS, Spalletta G, Vecchio D, Bassi A, et al
    The Role of the Anterior Thalamic Nuclei in the Genesis of Memory Disorders in Alzheimer's Disease: An Exploratory Study.
    J Alzheimers Dis. 2024;97:507-519.
    PubMed     Abstract available


  1099. ALSHAHERI DURAZO A, Weigand AJ, Bangen KJ, Membreno R, et al
    Type 2 Diabetes Moderates the Association Between Amyloid and 1-Year Change in Everyday Functioning in Older Veterans.
    J Alzheimers Dis. 2024;97:219-228.
    PubMed     Abstract available


  1100. LOBUE C, Stopschinski BE, Saez Calveras N, Douglas PM, et al
    Blood Markers in Relation to a History of Traumatic Brain Injury Across Stages of Cognitive Impairment in a Diverse Cohort.
    J Alzheimers Dis. 2024;97:345-358.
    PubMed     Abstract available


  1101. GUO Y, Sun Y, Li M, Qi WY, et al
    Amyloid Pathology Modulates the Associations of Neuropsychiatric Symptoms with Cognitive Impairments and Neurodegeneration in Non-Demented Elderly.
    J Alzheimers Dis. 2024;97:471-484.
    PubMed     Abstract available


  1102. LAPEYRE L, Piret J, Rheaume C, Pons V, et al
    Herpes Simplex Virus 1 Infection Does Not Increase Amyloid-beta Pathology in APP/PS1 Mice.
    J Alzheimers Dis. 2024;97:171-178.
    PubMed     Abstract available


  1103. MARTIN J, Reid N, Ward DD, King S, et al
    Investigating Sex Differences in Risk and Protective Factors in the Progression of Mild Cognitive Impairment to Dementia: A Systematic Review.
    J Alzheimers Dis. 2024;97:101-119.
    PubMed     Abstract available


  1104. YANG M, Gan J, Liu S, Yang Y, et al
    Associations Between Plasma Orexin-A Level and Constipation in Cognitive Impairment.
    J Alzheimers Dis. 2024;97:409-419.
    PubMed     Abstract available


  1105. KIM REY, Lee M, Kang DW, Wang SM, et al
    Increased Likelihood of Dementia with Coexisting Atrophy of Multiple Regions of Interest.
    J Alzheimers Dis. 2024;97:259-271.
    PubMed     Abstract available


  1106. NA S, Lee C, Ho S, Hong YJ, et al
    A Longitudinal Study on Memory Enhancement in Subjective Cognitive Decline Patients: Clinical and Neuroimaging Perspectives.
    J Alzheimers Dis. 2024;97:193-204.
    PubMed     Abstract available


  1107. POSSEMIS N, Ter Huurne D, Banning L, Gruters A, et al
    The Reliability and Clinical Validation of Automatically-Derived Verbal Memory Features of the Verbal Learning Test in Early Diagnostics of Cognitive Impairment.
    J Alzheimers Dis. 2024;97:179-191.
    PubMed     Abstract available


  1108. BRUNO JL, Shaw JS, Hosseini SMH
    Toward Personalized Cognitive Training in Older Adults: A Pilot Investigation of the Effects of Baseline Performance and Age on Cognitive Training Outcomes.
    J Alzheimers Dis. 2024;97:327-343.
    PubMed     Abstract available


  1109. DE LA PERRELLE L
    Health Care Is Not Enough to Prevent Dementia.
    J Alzheimers Dis. 2024;97:951-952.
    PubMed     Abstract available


  1110. DIGMA LA, Winer JR, Greicius MD
    Substantial Doubt Remains about the Efficacy of Anti-Amyloid Antibodies.
    J Alzheimers Dis. 2024;97:567-572.
    PubMed     Abstract available


  1111. FRENTZ I, van Arendonk J, Leeuwis AE, Vernooij MW, et al
    Interaction Between Arteriosclerosis and Amyloid-beta on Cognitive Function.
    J Alzheimers Dis. 2024;97:953-961.
    PubMed     Abstract available


  1112. MATERS J, van der Steen JT, de Vugt ME, Bakker C, et al
    Palliative Care in Nursing Home Residents with Young-Onset Dementia: Professional and Family Caregiver Perspectives.
    J Alzheimers Dis. 2024;97:573-586.
    PubMed     Abstract available


  1113. SCHRODER VE, Skrozic A, Erz D, Kaysen A, et al
    Programme Dementia Prevention (pdp): A Nationwide Program for Personalized Prevention in Luxembourg.
    J Alzheimers Dis. 2024;97:791-804.
    PubMed     Abstract available


  1114. DINGLE SE, Milte CM, Daly RM, Torres SJ, et al
    Attitudes and Considerations for Multidomain Lifestyle Approaches to Dementia Prevention: A Qualitative Study.
    J Alzheimers Dis. 2024;97:939-949.
    PubMed     Abstract available


  1115. KOSEL F, Hartley MR, Franklin TB
    Aberrant Cortical Activity in 5xFAD Mice in Response to Social and Non-Social Olfactory Stimuli.
    J Alzheimers Dis. 2024;97:659-677.
    PubMed     Abstract available


  1116. REHMAN H, Ang TFA, Tao Q, Espenilla AL, et al
    Comparison of Commonly Measured Plasma and Cerebrospinal Fluid Proteins and Their Significance for the Characterization of Cognitive Impairment Status.
    J Alzheimers Dis. 2024;97:621-633.
    PubMed     Abstract available


  1117. REN J, Yu Y, Wang Y, Dong Y, et al
    Association Between Urinary Glyphosate Exposure and Cognitive Impairment in Older Adults from NHANES 2013-2014.
    J Alzheimers Dis. 2024;97:609-620.
    PubMed     Abstract available


  1118. MAZZOLA P, Zanetti M, Ferraguzzi G, Villa ML, et al
    Shifting the Paradigm of Nursing Home Care for People with Dementia: The Italian Experience of Il Paese Ritrovato and the Impact of SARS-CoV-2.
    J Alzheimers Dis. 2024;97:741-752.
    PubMed     Abstract available


  1119. BRITZ J, Ojo E, Haque N, Dhukhwa A, et al
    Sex-Dependent Effects of Chronic Circadian Disruption in AbetaPP/PS1 Mice.
    J Alzheimers Dis. 2024;97:855-870.
    PubMed     Abstract available


  1120. GURJAR P, Khan AA, Alanazi AM, Vasil'ev VG, et al
    Molecular Dissection of Herpes Simplex Virus Type 1 to Elucidate Molecular Mechanisms Behind Latency and Comparison of Its Codon Usage Patterns with Genes Modulated During Alzheimer's Disease as a Part of Host-Pathogen Interaction.
    J Alzheimers Dis. 2024;97:1111-1123.
    PubMed     Abstract available


  1121. SCHWINNE M, Alonso A, Roberts BR, Hickle S, et al
    The Association of Alzheimer's Disease-Related Blood-Based Biomarkers with Cognitive Screening Test Performance in the Congolese Population in Kinshasa.
    J Alzheimers Dis. 2024;97:1353-1363.
    PubMed     Abstract available


  1122. ASIAMAH EA, Feng B, Guo R, Yaxing X, et al
    The Contributions of the Endolysosomal Compartment and Autophagy to APOEvarepsilon4 Allele-Mediated Increase in Alzheimer's Disease Risk.
    J Alzheimers Dis. 2024;97:1007-1031.
    PubMed     Abstract available


  1123. PLASSMAN BL, Ford CB, Smith VA, DePasquale N, et al
    Elevated Amyloid-beta PET Scan and Cognitive and Functional Decline in Mild Cognitive Impairment and Dementia of Uncertain Etiology.
    J Alzheimers Dis. 2024;97:1161-1171.
    PubMed     Abstract available


  1124. ROBILLARD JM, Masellis M, Martin SE, Khachaturian AS, et al
    The Return of Biomarker Results in Research: Balancing Complexity, Precision, and Ethical Responsibility.
    J Alzheimers Dis. 2024;97:1083-1090.
    PubMed     Abstract available


  1125. PANZAVOLTA A, Cerami C, Marcone A, Zamboni M, et al
    Diagnostic Performance of Socio-Emotional Informant-Based Questionnaires for the Clinical Detection of the Behavioral Variant of Frontotemporal Dementia.
    J Alzheimers Dis. 2024;97:1249-1260.
    PubMed     Abstract available


  1126. OKAHASHI S, Noguchi T, Ishihara M, Osawa A, et al
    Dyadic Art Appreciation and Self-Expression Program (NCGG-ART) for People with Dementia or Mild Cognitive Impairment and Their Family Caregivers: A Feasibility Study.
    J Alzheimers Dis. 2024;97:1435-1448.
    PubMed     Abstract available


  1127. DU P, Zhang X, Lian X, Holscher C, et al
    O-GlcNAcylation and Its Roles in Neurodegenerative Diseases.
    J Alzheimers Dis. 2024;97:1051-1068.
    PubMed     Abstract available


  1128. SHANG L, Dong L, Huang X, Chu S, et al
    Comorbidity of Dementia: A Cross-Sectional Study of PUMCH Dementia Cohort.
    J Alzheimers Dis. 2024;97:1313-1322.
    PubMed     Abstract available


  1129. ALEGRET M, Garcia-Gutierrez F, Munoz N, Espinosa A, et al
    FACEmemory(R), an Innovative Online Platform for Episodic Memory Pre-Screening: Findings from the First 3,000 Participants.
    J Alzheimers Dis. 2024;97:1173-1187.
    PubMed     Abstract available


  1130. MARIN-MARIN L, Renau-Lagranja J, Avila C, Costumero V, et al
    Depression and Agitation Factors Are Related to Regional Brain Atrophy and Faster Longitudinal Cognitive Decline in Mild Cognitive Impairment.
    J Alzheimers Dis. 2024;97:1341-1351.
    PubMed     Abstract available


  1131. TSENG YT, Chang YL, Chiu YS
    Assessment of Language Function in Older Mandarin-Speaking Adults with Mild Cognitive Impairment using Multifaceted Language Tests.
    J Alzheimers Dis. 2024;97:1189-1209.
    PubMed     Abstract available


  1132. KARAYIANNIS CC, Srikanth V, Beare R, Mehta H, et al
    Type 2 Diabetes and Biomarkers of Brain Structure, Perfusion, Metabolism, and Function in Late Mid-Life: A Multimodal Discordant Twin Study.
    J Alzheimers Dis. 2024;97:1223-1233.
    PubMed     Abstract available


  1133. ZAWISLAK-FORNAGIEL K, Ledwon D, Bugdol M, Grazynska A, et al
    Quantitative EEG Spectral and Connectivity Analysis for Cognitive Decline in Amnestic Mild Cognitive Impairment.
    J Alzheimers Dis. 2024;97:1235-1247.
    PubMed     Abstract available


  1134. FERINI-STRAMBI L
    Which Are the Most Reliable Sleep Parameters that Predict Cognitive Decline and Alzheimer's Disease?
    J Alzheimers Dis. 2024;97:1641-1643.
    PubMed     Abstract available


  1135. KANG J, Park M, Kim T
    Vitamin D Reduces GABA-Positive Astrocytes in the 5xFAD Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2024;97:1939-1950.
    PubMed     Abstract available


  1136. GROECHEL RC, Liu AC, Koton S, Kucharska-Newton AM, et al
    Associations Between Mid-Life Psychosocial Measures and Estimated Late Life Amyloid Burden: The Atherosclerosis Risk in Communities (ARIC)-PET Study.
    J Alzheimers Dis. 2024;97:1901-1911.
    PubMed     Abstract available


  1137. BACHAND AM, Dell LD
    Can Incorrect Analysis of Time-Dependent Exposure Explain Associations between PM2.5 Exposure and Risk of Dementia?
    J Alzheimers Dis. 2024;97:1931-1937.
    PubMed     Abstract available


  1138. VERMEULEN RJ, Roudijk B, Govers TM, Rovers MM, et al
    Prognostic Information on Progression to Dementia: Quantification of the Impact on Quality of Life.
    J Alzheimers Dis. 2024;97:1829-1840.
    PubMed     Abstract available


  1139. HARRIS JL, Wang X, Christian SK, Novikova L, et al
    Traumatic Brain Injury Alters the Trajectory of Age-Related Mitochondrial Change.
    J Alzheimers Dis. 2024;97:1793-1806.
    PubMed     Abstract available


  1140. VALENCIA-OLVERA AC, Balu D, Moore A, Shah M, et al
    APOE2 Heterozygosity Reduces Hippocampal Soluble Amyloid-beta42 Levels in Non-Hyperlipidemic Mice.
    J Alzheimers Dis. 2024;97:1629-1639.
    PubMed     Abstract available


  1141. ZHANG S, Ai H, Wang J, Liu T, et al
    Reduced Prefrontal-Thalamic Theta Flow During Working Memory Retrieval in APP/PS1 Mice.
    J Alzheimers Dis. 2024;97:1737-1749.
    PubMed     Abstract available


  1142. DAI Y, Hsu YC, Fernandes BS, Zhang K, et al
    Disentangling Accelerated Cognitive Decline from the Normal Aging Process and Unraveling Its Genetic Components: A Neuroimaging-Based Deep Learning Approach.
    J Alzheimers Dis. 2024;97:1807-1827.
    PubMed     Abstract available


  1143. HEIKKINEN AL, Paajanen TI, Hanninen T, Tikkanen V, et al
    Neuropsychological Profiles, Etiologies, and Medical Comorbidities in Early-Onset Dementia and Cognitive Impairment: A Memory Outpatient Clinic Cohort Study.
    J Alzheimers Dis. 2024;97:1765-1776.
    PubMed     Abstract available


  1144. VESTIN E, Bostrom G, Olsson J, Elgh F, et al
    Herpes Simplex Viral Infection Doubles the Risk of Dementia in a Contemporary Cohort of Older Adults: A Prospective Study.
    J Alzheimers Dis. 2024;97:1841-1850.
    PubMed     Abstract available


  1145. ARMSTRONG MJ, Barnes LL
    Under-Diagnosis of Dementia with Lewy Bodies in Individuals Racialized as Black: Hypotheses Regarding Potential Contributors.
    J Alzheimers Dis. 2024;97:1571-1580.
    PubMed     Abstract available


  1146. CUI X, Wang J, Wu B, Zhao Q, et al
    Interventions for Persons with Young-Onset Dementia and Their Families: A Scoping Review.
    J Alzheimers Dis. 2024;97:1519-1531.
    PubMed     Abstract available


  1147. FINCH CE, Burstein SM
    Dementia in the Ancient Greco-Roman World Was Minimally Mentioned.
    J Alzheimers Dis. 2024;97:1581-1588.
    PubMed     Abstract available


  1148. SIAFARIKAS N
    Neuropsychiatric and Cognitive Symptoms: Two Sides of the Same Coin?
    J Alzheimers Dis. 2024;98:75-78.
    PubMed     Abstract available


  1149. MATSUZONO K, Mashiko T, Koide R, Yoshizumi H, et al
    Comparison of Prognosis and Cognitive Function of Holistic Neurological Disease: Tochigi Neurological Disease Cohort Study.
    J Alzheimers Dis. 2024;98:275-285.
    PubMed     Abstract available


  1150. NALLAPU BT, Petersen KK, Lipton RB, Davatzikos C, et al
    Plasma Biomarkers as Predictors of Progression to Dementia in Individuals with Mild Cognitive Impairment.
    J Alzheimers Dis. 2024;98:231-246.
    PubMed     Abstract available


  1151. PRABHAKARAN D, Grant C, Pedraza O, Caselli R, et al
    Machine Learning Predicts Conversion from Normal Aging to Mild Cognitive Impairment Using Medical History, APOE Genotype, and Neuropsychological Assessment.
    J Alzheimers Dis. 2024;98:83-94.
    PubMed     Abstract available


  1152. ROSS JP, Post SG, Scheinfeld L
    Lucidity in the Deeply Forgetful: A Scoping Review.
    J Alzheimers Dis. 2024;98:3-11.
    PubMed     Abstract available


  1153. PUTIGNANO S, Forgione L, Fusco M, Giacummo A, et al
    Early Detection Screening of Cognitive Decline in Patients Over 60 Years: ELDERCARE Study.
    J Alzheimers Dis. 2024;98:145-150.
    PubMed     Abstract available


  1154. BALLENGER J, George DR, Whitehouse PJ
    Digging Deeper: What Can We Really Learn about Dementia from History?
    J Alzheimers Dis. 2024;98:417-419.
    PubMed     Abstract available


  1155. ORR ME
    A Need for Refined Senescence Biomarkers and Measures of Senolytics in the Brain.
    J Alzheimers Dis. 2024;98:411-415.
    PubMed     Abstract available


  1156. SHIMADA H, Doi T, Tsutsumimoto K, Makino K, et al
    Elevated Risk of Dementia Diagnosis in Older Adults with Low Frequencies and Durations of Social Conversation.
    J Alzheimers Dis. 2024;98:659-669.
    PubMed     Abstract available


  1157. ZHANG XX, Wang HR, Meng-Wei, Hu YZ, et al
    Association of Vitamin D Levels with Risk of Cognitive Impairment and Dementia: A Systematic Review and Meta-Analysis of Prospective Studies.
    J Alzheimers Dis. 2024;98:373-385.
    PubMed     Abstract available


  1158. WANG J, Leong IT, Johnson MK, Pei Y, et al
    What Matters to Chinese and Korean American Dementia Caregivers: Navigating Cultural Influences in Dementia Care from Caregivers' Perspectives.
    J Alzheimers Dis. 2024;98:519-538.
    PubMed     Abstract available


  1159. VERA R, Hong N, Jiang B, Liang G, et al
    Effects of Intranasal Dantrolene Nanoparticles on Brain Concentration and Behavior in PS19 Tau Transgenic Mice.
    J Alzheimers Dis. 2024;98:549-562.
    PubMed     Abstract available


  1160. GREENBLATT CL, Lathe R
    Vaccines and Dementia: Part II. Efficacy of BCG and Other Vaccines Against Dementia.
    J Alzheimers Dis. 2024;98:361-372.
    PubMed     Abstract available


  1161. WANG Y, Wang S, Wu J, Liu X, et al
    Causal Association Between Allergic Diseases and Dementia: Evidence from Multivariate Mendelian Randomization Study.
    J Alzheimers Dis. 2024;98:505-517.
    PubMed     Abstract available


  1162. PARKER DC, Whitson HE, Smith PJ, Kraus VB, et al
    Anti-CMV IgG Seropositivity is Associated with Plasma Biomarker Evidence of Amyloid-beta Accumulation.
    J Alzheimers Dis. 2024;98:593-600.
    PubMed     Abstract available


  1163. HAN SL, Ou YN, Han BL, Guo HH, et al
    Total Tau Protein Mediates the Association of Ischemic Cerebrovascular Disease with Cognitive Decline.
    J Alzheimers Dis. 2024;98:1133-1143.
    PubMed     Abstract available


  1164. COGUT V, McNeely TL, Bussian TJ, Graves SI, et al
    Caloric Restriction Improves Spatial Learning Deficits in Tau Mice.
    J Alzheimers Dis. 2024;98:925-940.
    PubMed     Abstract available


  1165. TSENG WI, Hsu YC, Huang LK, Hong CT, et al
    Brain Age Is Associated with Cognitive Outcomes of Cholinesterase Inhibitor Treatment in Patients with Mild Cognitive Impairment.
    J Alzheimers Dis. 2024;98:1095-1106.
    PubMed     Abstract available


  1166. MARTINEZ-DUBARBIE F, Lopez-Garcia S, Lage C, Di Molfetta G, et al
    Plasma Phosphorylated Tau 231 Increases at One-Year Intervals in Cognitively Unimpaired Subjects.
    J Alzheimers Dis. 2024;98:1029-1042.
    PubMed     Abstract available


  1167. O'SHEA DM, Camacho S, Ezzeddine R, Besser L, et al
    The Mediating Role of Cortical Atrophy on the Relationship between the Resilience Index and Cognitive Function: Findings from the Healthy Brain Initiative.
    J Alzheimers Dis. 2024;98:1017-1027.
    PubMed     Abstract available


  1168. PODGER L, Stewart WF, Serrano D, Lipton RB, et al
    Application of a Novel Endpoint Staging Framework: Proof of Concept in the AMBAR Study.
    J Alzheimers Dis. 2024;98:1079-1094.
    PubMed     Abstract available


  1169. CEYZERIAT K, Jaques E, Gloria Y, Badina A, et al
    Low-Dose Radiation Therapy Impacts Microglial Inflammatory Response without Modulating Amyloid Load in Female TgF344-AD Rats.
    J Alzheimers Dis. 2024;98:1001-1016.
    PubMed     Abstract available


  1170. PAPADIMITRIOU A, Dawson AZ, Thorgerson A, Bhandari S, et al
    Understanding the Relationship Between Wealth and Cognitive Function by Race/Ethnicity Among Older United States Adults with Diabetes.
    J Alzheimers Dis. 2024;98:1145-1155.
    PubMed     Abstract available


  1171. SANCHEZ-SOBLECHERO A, Lopez-Garcia S, Lage C, Fernandez-Matarrubia M, et al
    Where Should I Draw the Line: PET-Driven, Data-Driven, or Manufacturer Cut-Off?
    J Alzheimers Dis. 2024;98:957-967.
    PubMed     Abstract available


  1172. BERGAMINO M, Keeling E, McElvogue M, Schaefer SY, et al
    White Matter Microstructure Analysis in Subjective Memory Complaints and Cognitive Impairment: Insights from Diffusion Kurtosis Imaging and Free-Water DTI.
    J Alzheimers Dis. 2024;98:863-884.
    PubMed     Abstract available



  1173. Erratum to: Ubiquitin Specific Protease 13 Regulates Tau Accumulation and Clearance in Models of Alzheimer's Disease.
    J Alzheimers Dis. 2024;98:1543-1546.
    PubMed    


  1174. JANBEK J, Laursen TM, Frimodt-Moller N, Magyari M, et al
    Risk of Major Types of Dementias Following Hospital-Diagnosed Infections and Autoimmune Diseases.
    J Alzheimers Dis. 2024;98:1503-1514.
    PubMed     Abstract available


  1175. CHEN Y, Su Y, Wu J, Chen K, et al
    Combining Blood-Based Biomarkers and Structural MRI Measurements to Distinguish Persons with and without Significant Amyloid Plaques.
    J Alzheimers Dis. 2024;98:1415-1426.
    PubMed     Abstract available


  1176. GALANKIN TL, Bespalov AY, Moebius HY
    Clusterization of Behavioral and Psychological Symptoms of Dementia as Assessed by Neuropsychiatric Inventory: A Case Against the Use of Principal Component Analysis.
    J Alzheimers Dis. 2024;98:1483-1491.
    PubMed     Abstract available


  1177. HOJJATI SH, Chiang GC, Butler TA, de Leon M, et al
    Remote Associations Between Tau and Cortical Amyloid-beta Are Stage-Dependent.
    J Alzheimers Dis. 2024;98:1467-1482.
    PubMed     Abstract available


  1178. CALDERON-GARCIDUENAS L, Ayala A, Mukherjee PS
    2024 United States Elections: Air Pollution, Neurodegeneration, Neuropsychiatric, and Neurodevelopmental Disorders. Who Cares?
    J Alzheimers Dis. 2024;98:1277-1282.
    PubMed     Abstract available


  1179. SYED RA, Hayat M, Qaiser H, Uzair M, et al
    Aging-Related Protein Alterations in the Brain.
    J Alzheimers Dis. 2024;99.
    PubMed     Abstract available


  1180. ALROUJI M, Yasmin S, Furkan M, Alhumaydhi FA, et al
    Unveiling the Molecular Interactions Between Human Transferrin and Limonene: Natural Compounds in Alzheimer's Disease Therapeutics.
    J Alzheimers Dis. 2024;99:333-343.
    PubMed     Abstract available


  1181. MORROW CB, Pontone GM
    Exploring Psychosis in Neurodegenerative Dementia: Connecting Symptoms to Neurobiology.
    J Alzheimers Dis. 2024;99:101-103.
    PubMed     Abstract available


  1182. CRESSOT C, Vrillon A, Lilamand M, Francisque H, et al
    Psychosis in Neurodegenerative Dementias: A Systematic Comparative Review.
    J Alzheimers Dis. 2024;99:85-99.
    PubMed     Abstract available


  1183. ESPAY AJ, Herrup K, Imbimbo BP, Kepp KP, et al
    Recalibrating the Risk-Benefit Profiles of Lecanemab and Donanemab: Scales, Immunoreactivity, and Changes in Amyloid-beta42.
    J Alzheimers Dis. 2024;99:877-881.
    PubMed     Abstract available


  1184. TAVARES-JUNIOR JWL, Ciurleo GCV, Feitosa EAAF, Oria RB, et al
    The Clinical Aspects of COVID and Alzheimer's Disease: A Round-Up of Where Things Stand and Are Headed.
    J Alzheimers Dis. 2024;99:1159-1171.
    PubMed     Abstract available


  1185. SUGANUMA T, Hatori S, Chen CK, Hori S, et al
    Caffeoylquinic Acid Mitigates Neuronal Loss and Cognitive Decline in 5XFAD Mice Without Reducing the Amyloid-beta Plaque Burden.
    J Alzheimers Dis. 2024;99:1285-1301.
    PubMed     Abstract available


  1186. WANG T, Zhang W, Maclin JMA, Xu H, et al
    Novel Panel of Long Noncoding RNAs as Diagnostic Biomarkers for Amnestic Mild Cognitive Impairment in Peripheral Blood.
    J Alzheimers Dis. 2024;99:1385-1396.
    PubMed     Abstract available


  1187. XIONG R, Li B, Yu H, Fan T, et al
    Urolithin A Inhibits Anterior Basolateral Amygdala to Ventral Hippocampal CA1 Circuit to Ameliorate Amyloid-beta-Impaired Social Ability.
    J Alzheimers Dis. 2024;99:1303-1316.
    PubMed     Abstract available


  1188. LEE CS, Ferguson AN, Gibbons LE, Walker R, et al
    Eye Adult Changes in Thought (Eye ACT) Study: Design and Report on the Inaugural Cohort.
    J Alzheimers Dis. 2024;100:309-320.
    PubMed     Abstract available


  1189. MENG H, Lv X, Zhang R, Feng Y, et al
    Occurrence and Risk Factors for Cognitive Decline Shared by Couples: A Systematic Review and Meta-Analysis.
    J Alzheimers Dis. 2024;100:29-40.
    PubMed     Abstract available


  1190. GIBBONS LE, Mobley T, Mayeda ER, Lee CS, et al
    How Generalizable Are Findings from a Community-Based Prospective Cohort Study? Extending Estimates from the Adult Changes in Thought Study to Its Source Population.
    J Alzheimers Dis. 2024;100:163-174.
    PubMed     Abstract available


  1191. SHI Q, Liu WS, Liu F, Zeng YX, et al
    The Etiology of Rapidly Progressive Dementia: A 3-Year Retrospective Study in a Tertiary Hospital in China.
    J Alzheimers Dis. 2024;100:77-85.
    PubMed     Abstract available


  1192. SANNEMANN L, Bartels C, Brosseron F, Buerger K, et al
    Symptomatic Clusters Related to Amyloid Positivity in Cognitively Unimpaired Individuals.
    J Alzheimers Dis. 2024;100:193-205.
    PubMed     Abstract available


  1193. ZUKOWSKI LA, Brinkerhoff SA, Levin I, Herter TM, et al
    Amyloid-beta Deposition Predicts Grocery Shopping Performance in Older Adults Without Cognitive Impairment.
    J Alzheimers Dis. 2024;100:53-75.
    PubMed     Abstract available



  1194. Robert Rissman, PhD, is the recipient of the 2024 Alzheimer Award.
    J Alzheimers Dis. 2024;100:377-378.
    PubMed    


  1195. KRIZANOVIC N, Jokisch M, Jockel KH, Schmidt B, et al
    Sex-Specific Differences in Serum Kallikrein-8 (KLK8): An Exploratory Study.
    J Alzheimers Dis. 2024;100:495-507.
    PubMed     Abstract available


  1196. HOWARD E, Moody JN, Prieto S, Hayes JP, et al
    Higher Cerebrospinal Fluid Levels of Amyloid-beta40 Following Traumatic Brain Injury Relate to Confrontation Naming Performance.
    J Alzheimers Dis. 2024;100:539-550.
    PubMed     Abstract available


  1197. HE Q, Wang W, Xiong Y, Tao C, et al
    Potential Biomarkers in Cerebrospinal Fluid and Plasma for Dementia.
    J Alzheimers Dis. 2024;100:603-611.
    PubMed     Abstract available


  1198. LOEFFLER DA
    Approaches for Increasing Cerebral Efflux of Amyloid-beta in Experimental Systems.
    J Alzheimers Dis. 2024;100:379-411.
    PubMed     Abstract available


  1199. LENG F, Hinz R, Gentleman S, Dani M, et al
    Combined Neuroinflammation and Amyloid PET Markers in Predicting Disease Progression in Cognitively Impaired Subjects.
    J Alzheimers Dis. 2024;100:973-986.
    PubMed     Abstract available


  1200. FRANK B, Walsh M, Hurley L, Groh J, et al
    Cognition Mediates the Association Between Cerebrospinal Fluid Biomarkers of Amyloid and P-Tau and Neuropsychiatric Symptoms.
    J Alzheimers Dis. 2024;100:1055-1073.
    PubMed     Abstract available


  1201. FU J, Wei Q, Chen X, Lai X, et al
    Analysis of the Association Between Pathogen Exposure and the Risk of Dementia.
    J Alzheimers Dis. 2024;100:961-972.
    PubMed     Abstract available


  1202. SCHWERTHOFFER D, Haselwarter T, Grimmer T
    Obstructive Sleep Apnea Among Patients with Mild Cognitive Impairment.
    J Alzheimers Dis. 2024;100:809-823.
    PubMed     Abstract available


  1203. YU W, Zhuang S, Zhan M, Chen Y, et al
    Deubiquitinating Enzyme USP19 Regulates Ferroptosis and Mitochondrial Damage in SH-SY5Y Cells by Targeting the NOX4 Protein.
    J Alzheimers Dis. 2024;100:799-808.
    PubMed     Abstract available


  1204. DENG C, Cai Q, Zhang J, Chang K, et al
    Generation and Characterization of a Novel Knockin Mouse Model Expressing PSEN1 D385A: Implications for Investigating Herbal Drug Effects in gamma-Secretase Activity.
    J Alzheimers Dis. 2024;100:825-841.
    PubMed     Abstract available


  1205. MACE RA, Lyons C, Cohen JE, Ritchie C, et al
    Optimizing the Implementation of a Lifestyle Dementia Prevention Intervention for Older Patients in an Academic Healthcare System.
    J Alzheimers Dis. 2024;100:1237-1259.
    PubMed     Abstract available


  1206. LEPPING RJ, Hess BJ, Taylor JM, Hanson-Abromeit D, et al
    Inconsistent Music-Based Intervention Reporting in Dementia Studies: A Systematic Mapping Review.
    J Alzheimers Dis. 2024;100:1145-1159.
    PubMed     Abstract available


  1207. MARIN A, Turk KW, Schiloski K, Vives-Rodriguez A, et al
    The Use of Event Related Potentials to Predict Amyloid PET Status Among Patients from a Memory Disorders Clinic.
    J Alzheimers Dis. 2024;100:1195-1208.
    PubMed     Abstract available


  1208. FROMM D, Dalton SG, Brick A, Olaiya G, et al
    The Case of the Cookie Jar: Differences in Typical Language Use in Dementia.
    J Alzheimers Dis. 2024;100:1417-1434.
    PubMed     Abstract available


  1209. CORREIA SC, Perry G, Moreira PI
    Fueling Alzheimer's Disease: Where Does Immunometabolism Stand?
    J Alzheimers Dis. 2024;100.
    PubMed     Abstract available


  1210. PETERSEN ME, Zhang F, Hall JR, Julovich D, et al
    Characterization of Ptau181 Among a Diverse Community-Based Cohort: A HABS-HD Study.
    J Alzheimers Dis. 2024;100.
    PubMed     Abstract available


  1211. ARENDASH GW, Lin X, Cao C
    Enhanced Brain Clearance of Tau and Amyloid-beta in Alzheimer's Disease Patients by Transcranial Radiofrequency Wave Treatment: A Central Role of Vascular Endothelial Growth Factor (VEGF).
    J Alzheimers Dis. 2024;100.
    PubMed     Abstract available


  1212. POUDEL P, Frost SM, Eslick S, Sohrabi HR, et al
    Hyperspectral Retinal Imaging as a Non-Invasive Marker to Determine Brain Amyloid Status.
    J Alzheimers Dis. 2024;100.
    PubMed     Abstract available


  1213. GOGOLA A, Cohen AD, Snitz B, Minhas D, et al
    Implementation and Assessment of Tau Thresholds in Non-Demented Individuals as Predictors of Cognitive Decline in Tau Imaging Studies.
    J Alzheimers Dis. 2024;100.
    PubMed     Abstract available


  1214. LEINENGA G, Padmanabhan P, Gotz J
    Improving Cognition Without Clearing Amyloid: Effects of Tau and Ultrasound Neuromodulation.
    J Alzheimers Dis. 2024;100.
    PubMed     Abstract available


  1215. PERRY G
    JAD's Glorious 100 Volumes.
    J Alzheimers Dis. 2024;100.
    PubMed    


  1216. ALLDRED MJ, Pidikiti H, Ibrahim KW, Lee SH, et al
    Hippocampal CA1 Pyramidal Neurons Display Sublayer and Circuitry Dependent Degenerative Expression Profiles in Aged Female Down Syndrome Mice.
    J Alzheimers Dis. 2024;100.
    PubMed     Abstract available


  1217. ZHANG J, Zhang Y, Zhang Y, Yao J, et al
    The Association of Brain Insulin Resistance with Anesthesia/Surgery-Induced Cognitive Deterioration Is Female-Specific in 5XFAD Transgenic Mice.
    J Alzheimers Dis. 2024;101:183-195.
    PubMed     Abstract available


  1218. LASTUKA A, Bliss E, Breshock MR, Iannucci VC, et al
    Societal Costs of Dementia: 204 Countries, 2000-2019.
    J Alzheimers Dis. 2024;101:277-292.
    PubMed     Abstract available


  1219. ZHANG Y, Li Y, Song S, Li Z, et al
    Predicting Conversion Time from Mild Cognitive Impairment to Dementia with Interval-Censored Models.
    J Alzheimers Dis. 2024;101:147-157.
    PubMed     Abstract available


  1220. SATERNOS H, Hamlett ED, Guzman S, Head E, et al
    Unique Pathology in the Locus Coeruleus of Individuals with Down Syndrome.
    J Alzheimers Dis. 2024;101:541-561.
    PubMed     Abstract available


  1221. ALLE MC, Joseph C, Antoine P
    Involuntary Autobiographical Memory in Alzheimer's Disease: A Double-Edged Way of Remembering the Past?
    J Alzheimers Dis. 2024;101:961-969.
    PubMed     Abstract available


  1222. SAIDO TC
    Obituary for the late Yasuo Ihara.
    J Alzheimers Dis. 2024;101:1027-1028.
    PubMed    


  1223. PEREIRA HR, Diogo VS, Prata D, Ferreira HA, et al
    Detecting Amyloid Positivity Using Morphometric Magnetic Resonance Imaging.
    J Alzheimers Dis. 2024;101:1293-1305.
    PubMed     Abstract available


  1224. LINGENBERG A, Herrmann FR, Armand S, Peron J, et al
    Forget About Memory: Disentangling the Amnestic Syndrome in Idiopathic Normal Pressure Hydrocephalus.
    J Alzheimers Dis. 2024;101:1205-1216.
    PubMed     Abstract available


  1225. BECKMANN MN
    Did Reagan Decline?
    J Alzheimers Dis. 2024;101:1261-1266.
    PubMed     Abstract available


  1226. WANG J, Xu L, Chen X, Wu J, et al
    Correlation Analysis of ApoB, ApoA1, and ApoB/ApoA1 with Cortical Morphology in Patients with Memory Complaints.
    J Alzheimers Dis. 2024;101:1137-1150.
    PubMed     Abstract available


  1227. SATO K, Niimi Y, Ihara R, Iwata A, et al
    Adverse Events as a Cause of Unblinding of Allocated Arms in Anti-Amyloid Therapy Trials: A Meta-Analysis of the Predictive Value.
    J Alzheimers Dis. 2024;101:1127-1132.
    PubMed     Abstract available


  1228. HAMEDANI M, Caneva S, Mancardi GL, Ali PA, et al
    Toward Quantitative Neurology: Sensors to Assess Motor Deficits in Dementia.
    J Alzheimers Dis. 2024;101:1083-1106.
    PubMed     Abstract available


  1229. MOREIRA PI, Avila J, Galimberti D, Pappolla MA, et al
    Therapeutic Trials in Alzheimer's Disease: Where Are We Now?
    J Alzheimers Dis. 2024;101.
    PubMed    


  1230. SAYFULLAEVA J, McLoughlin J, Kwakowsky A
    Hormone Replacement Therapy and Alzheimer's Disease: Current State of Knowledge and Implications for Clinical Use.
    J Alzheimers Dis. 2024;101.
    PubMed     Abstract available


  1231. CROOK H, Edison P
    Incretin Mimetics as Potential Disease Modifying Treatment for Alzheimer's Disease.
    J Alzheimers Dis. 2024;101.
    PubMed     Abstract available


  1232. BROWN A, Bayley PJ
    The Therapeutic Potential of Yoga for Alzheimer's Disease: A Critical Review.
    J Alzheimers Dis. 2024;101.
    PubMed     Abstract available


  1233. ROBERTS JA, Varma VR, Jones A, Thambisetty M, et al
    Drug Repurposing for Effective Alzheimer's Disease Medicines: Existing Methods and Novel Pharmacoepidemiological Approaches.
    J Alzheimers Dis. 2024;101.
    PubMed     Abstract available


  1234. PAPPOLLA MA, Martins RN, Poeggeler B, Omar RA, et al
    Oxidative Stress in Alzheimer's Disease: The Shortcomings of Antioxidant Therapies.
    J Alzheimers Dis. 2024;101.
    PubMed     Abstract available


  1235. TUSZYNSKI MH
    Growth Factor Gene Therapy for Alzheimer's Disease.
    J Alzheimers Dis. 2024;101.
    PubMed     Abstract available


  1236. TAHMI M, Benitez R, Luchsinger JA
    Metformin as a Potential Prevention Strategy for Alzheimer's Disease and Alzheimer's Disease Related Dementias.
    J Alzheimers Dis. 2024;101.
    PubMed     Abstract available


  1237. SUN MK, Alkon DL
    Treating Alzheimer's Disease: Focusing on Neurodegenerative Consequences.
    J Alzheimers Dis. 2024;101.
    PubMed     Abstract available


  1238. PAPPOLLA MA, Refolo L, Sambamurti K, Zambon D, et al
    Hypercholesterolemia and Alzheimer's Disease: Unraveling the Connection and Assessing the Efficacy of Lipid-Lowering Therapies.
    J Alzheimers Dis. 2024;101.
    PubMed     Abstract available


  1239. TRIUMBARI EKA, Chiaravalloti A, Schillaci O, Mercuri NB, et al
    Positron Emission Tomography/Computed Tomography Imaging in Therapeutic Clinical Trials in Alzheimer's Disease: An Overview of the Current State of the Art of Research.
    J Alzheimers Dis. 2024;101.
    PubMed     Abstract available


  1240. VINA J, Borras C, Mas-Bargues C
    Genistein, A Phytoestrogen, Delays the Transition to Dementia in Prodromal Alzheimer's Disease Patients.
    J Alzheimers Dis. 2024;101.
    PubMed     Abstract available


  1241. HOILUND-CARLSEN PF, Alavi A, Barrio JR
    PET/CT/MRI in Clinical Trials of Alzheimer's Disease.
    J Alzheimers Dis. 2024;101.
    PubMed     Abstract available


  1242. NOORDA K, Noorda K, Sabbagh MN, Bertelson J, et al
    Amyloid-Directed Antibodies: Past, Present, and Future.
    J Alzheimers Dis. 2024;101.
    PubMed     Abstract available


  1243. GABUZYAN R, Lee C, Nygaard HB
    Ketogenic Approaches for the Treatment of Alzheimer's Disease.
    J Alzheimers Dis. 2024;101.
    PubMed     Abstract available


  1244. DU B, Chen K, Wang W, Lei P, et al
    Targeting Metals in Alzheimer's Disease: An Update.
    J Alzheimers Dis. 2024;101.
    PubMed     Abstract available


  1245. MEIJER L, Chretien E, Ravel D
    Leucettinib-21, a DYRK1A Kinase Inhibitor as Clinical Drug Candidate for Alzheimer's Disease and Down Syndrome.
    J Alzheimers Dis. 2024;101.
    PubMed     Abstract available


  1246. DE LA MONTE SM
    Conquering Insulin Network Dysfunctions in Alzheimer's Disease: Where Are We Today?
    J Alzheimers Dis. 2024;101.
    PubMed     Abstract available


  1247. YASSINE HN, Carrasco AS, Badie DS
    Designing Newer Omega-3 Supplementation Trials for Cognitive Outcomes: A Systematic Review Guided Analysis.
    J Alzheimers Dis. 2024;101.
    PubMed     Abstract available


  1248. KUCK MJ, Begde A, Hawkins K, Hogervorst E, et al
    Alzheimer's Disease and (Phyto) Estrogen Treatment: Modification of Effects by Age, Type of Treatment, and Duration of Use.
    J Alzheimers Dis. 2024;101.
    PubMed     Abstract available


  1249. MORATO X, Tartari JP, Pytel V, Boada M, et al
    Pharmacodynamic and Clinical Effects of Ginkgo Biloba Extract EGb 761 and Its Phytochemical Components in Alzheimer's Disease.
    J Alzheimers Dis. 2024;101.
    PubMed     Abstract available


  1250. ALGHAMDI M, Braidy N
    Supplementation with NAD+ Precursors for Treating Alzheimer's Disease: A Metabolic Approach.
    J Alzheimers Dis. 2024;101.
    PubMed     Abstract available


  1251. ALGHAMDI M, Braidy N
    Functional Magnetic Resonance Imaging in Alzheimer's Disease Drug Trials: A Mini-Review.
    J Alzheimers Dis. 2024;101.
    PubMed     Abstract available


  1252. WATKINS EA, Vassar R
    BACE Inhibitor Clinical Trials for Alzheimer's Disease.
    J Alzheimers Dis. 2024;101.
    PubMed     Abstract available


  1253. LI H, Xiang Q, Ren R, Wang G, et al
    Acupuncture as a Complementary Therapy for Alzheimer's Disease.
    J Alzheimers Dis. 2024;101.
    PubMed     Abstract available


  1254. FELDMAN HH, Messer K, Qiu Y, Sabbagh M, et al
    Varoglutamstat: Inhibiting Glutaminyl Cyclase as a Novel Target of Therapy in Early Alzheimer's Disease.
    J Alzheimers Dis. 2024;101.
    PubMed     Abstract available


  1255. CURRAIS A, Raschke W, Maher P
    CMS121, a Novel Drug Candidate for the Treatment of Alzheimer's Disease and Age-Related Dementia.
    J Alzheimers Dis. 2024;101.
    PubMed     Abstract available


  1256. THITILERTDECHA P, Brimson JM
    CT1812, a Small Molecule Sigma-2 Receptor Antagonist for Alzheimer's Disease Treatment: A Systematic Review of Available Clinical Data.
    J Alzheimers Dis. 2024;101.
    PubMed     Abstract available


  1257. MORRONI F, Caccamo A
    Advances and Challenges in Gene Therapy for Alzheimer's Disease.
    J Alzheimers Dis. 2024;101.
    PubMed     Abstract available


  1258. STEINBACH MJ, Denburg NL
    Melatonin in Alzheimer's Disease: Literature Review and Therapeutic Trials.
    J Alzheimers Dis. 2024;101.
    PubMed     Abstract available


  1259. EYOB E, Shaw JS, Bakker A, Munro C, et al
    A Randomized-Controlled Trial Targeting Cognition in Early Alzheimer's Disease by Improving Sleep with Trazodone (REST).
    J Alzheimers Dis. 2024;101.
    PubMed     Abstract available


  1260. VASHISTH K, Sharma S, Ghosh S, Babu MA, et al
    Immunotherapy in Alzheimer's Disease: Current Status and Future Directions.
    J Alzheimers Dis. 2024;101.
    PubMed     Abstract available


  1261. BENUSSI A, Borroni B
    Brain Stimulation in Alzheimer's Disease Trials.
    J Alzheimers Dis. 2024;101.
    PubMed     Abstract available


    December 2023
  1262. AHMED T, Zhang P, Kumar K
    Equilibrium of Dietary Patterns Between Alzheimer's Disease Patients and Healthy People: A Comprehensive Analysis Using Multiple Factor Analysis and Classification Modeling.
    J Alzheimers Dis. 2023 Dec 30. doi: 10.3233/JAD-230634.
    PubMed     Abstract available


  1263. RICCI F, Martorana A, Bonomi CG, Serafini C, et al
    Effect of Vascular Risk Factors on Blood-Brain Barrier and Cerebrospinal Fluid Biomarkers Along the Alzheimer's Disease Continuum: A Retrospective Observational Study.
    J Alzheimers Dis. 2023 Dec 29. doi: 10.3233/JAD-230792.
    PubMed     Abstract available


  1264. ALMKVIST O, Larsson M, Graff C
    Odor Identification Across Time in Mutation Carriers and Non-Carriers in Autosomal-Dominant Alzheimer's Disease.
    J Alzheimers Dis. 2023 Dec 29. doi: 10.3233/JAD-230618.
    PubMed     Abstract available


  1265. ZHANG E, Dai F
    Diagnostic Model for Alzheimer's Disease Based on PANoptosis-Related Genes.
    J Alzheimers Dis. 2023 Dec 28. doi: 10.3233/JAD-231103.
    PubMed     Abstract available


  1266. WEINBERG MS, He Y, Kivisakk P, Arnold SE, et al
    Effect of Metformin on Plasma and Cerebrospinal Fluid Biomarkers in Non-Diabetic Older Adults with Mild Cognitive Impairment Related to Alzheimer's Disease.
    J Alzheimers Dis. 2023 Dec 27. doi: 10.3233/JAD-230899.
    PubMed     Abstract available


  1267. FAN X, Li H, Liu L, Zhang K, et al
    Early Diagnosing and Transformation Prediction of Alzheimer's Disease Using Multi-Scaled Self-Attention Network on Structural MRI Images with Occlusion Sensitivity Analysis.
    J Alzheimers Dis. 2023 Dec 27. doi: 10.3233/JAD-230705.
    PubMed     Abstract available


  1268. MIYANO T, Ayukawa Y, Anada T, Takahashi I, et al
    Association Between Reduced Posterior Occlusal Contact and Alzheimer's Disease Onset in Older Japanese Adults: Results from the LIFE Study.
    J Alzheimers Dis. 2023 Dec 27. doi: 10.3233/JAD-230449.
    PubMed     Abstract available


  1269. MORIN P, Aguilar BJ, Li X, Chen J, et al
    Alzheimer's Disease Stage Transitions Among United States Veterans.
    J Alzheimers Dis. 2023 Dec 23. doi: 10.3233/JAD-230850.
    PubMed     Abstract available


  1270. MAHZARNIA A, Lutz MW, Badea A
    A Continuous Extension of Gene Set Enrichment Analysis Using the Likelihood Ratio Test Statistics Identifies Vascular Endothelial Growth Factor as a Candidate Pathway for Alzheimer's Disease via ITGA5.
    J Alzheimers Dis. 2023 Dec 23. doi: 10.3233/JAD-230934.
    PubMed     Abstract available


  1271. GE Y, AlObaidi AS, Kuchel GA, Bartley JM, et al
    Dysfunctional Bladder Morphology and Functional Impairments Are Identified in the Alzheimer's Disease APPNL-G-F/NL-G-F Murine Model.
    J Alzheimers Dis. 2023 Dec 23. doi: 10.3233/JAD-230547.
    PubMed     Abstract available


  1272. ROBINSON CG, Coleman T, Buciuc M, Singh NA, et al
    Behavioral and Neuropsychiatric Differences Across Two Atypical Alzheimer's Disease Variants: Logopenic Progressive Aphasia and Posterior Cortical Atrophy.
    J Alzheimers Dis. 2023 Dec 22. doi: 10.3233/JAD-230652.
    PubMed     Abstract available


  1273. EL HAFFAF LM, Ronat L, Cannizzaro A, Hanganu A, et al
    Associations Between Hyperactive Neuropsychiatric Symptoms and Brain Morphology in Mild Cognitive Impairment and Alzheimer's Disease.
    J Alzheimers Dis. 2023 Dec 22. doi: 10.3233/JAD-220857.
    PubMed     Abstract available


  1274. LI KY, Lin BT, Hsu ST, Chien CF, et al
    Quetiapine Oral Solution in Alzheimer's Disease: Efficacy and Dosage Insights from a Real-World Retrospective Study.
    J Alzheimers Dis. 2023 Dec 20. doi: 10.3233/JAD-231007.
    PubMed     Abstract available


  1275. LOJO-RAMIREZ JA, Guerra-Gomez M, Marin-Cabanas AM, Fernandez-Rodriguez P, et al
    Correlation Between Amyloid PET Imaging and Discordant Cerebrospinal Fluid Biomarkers Results in Patients with Suspected Alzheimer's Disease.
    J Alzheimers Dis. 2023 Dec 19. doi: 10.3233/JAD-230744.
    PubMed     Abstract available


  1276. KEIZER HG, Brands R, Oosting RS, Seinen W, et al
    The Carnitine Palmitoyl-Transferase 2 Cascade Hypothesis for Alzheimer's Disease.
    J Alzheimers Dis. 2023 Dec 18. doi: 10.3233/JAD-230991.
    PubMed     Abstract available


  1277. PARK YS, Joo HJ, Jang YS, Jeon H, et al
    Socioeconomic Status and Dementia Risk Among Intensive Care Unit Survivors: Using National Health Insurance Cohort in Korea.
    J Alzheimers Dis. 2023 Dec 18. doi: 10.3233/JAD-230715.
    PubMed     Abstract available


  1278. BAPAT R, Ma D, Duong TQ
    Predicting Four-Year's Alzheimer's Disease Onset Using Longitudinal Neurocognitive Tests and MRI Data Using Explainable Deep Convolutional Neural Networks.
    J Alzheimers Dis. 2023 Dec 16. doi: 10.3233/JAD-230893.
    PubMed     Abstract available


  1279. JANG YJ, Choi MG, Yoo BJ, Lee KJ, et al
    Interaction Between a High-Fat Diet and Tau Pathology in Mice: Implications for Alzheimer's Disease.
    J Alzheimers Dis. 2023 Dec 11. doi: 10.3233/JAD-230927.
    PubMed     Abstract available


  1280. MALOTAUX V, Colmant L, Quenon L, Huyghe L, et al
    Suspecting Non-Alzheimer's Pathologies and Mixed Pathologies: A Comparative Study Between Brain Metabolism and Tau Images.
    J Alzheimers Dis. 2023 Dec 11. doi: 10.3233/JAD-230696.
    PubMed     Abstract available


  1281. UKRAINTSEVA S, Duan H, Holmes R, Bagley O, et al
    Patterns of Aging Changes in Bodyweight May Predict Alzheimer's Disease.
    J Alzheimers Dis. 2023 Dec 11. doi: 10.3233/JAD-220998.
    PubMed     Abstract available


  1282. ANSCHUETZ A, Schwab K, Harrington CR, Wischik CM, et al
    A Meta-Analysis on Presynaptic Changes in Alzheimer's Disease.
    J Alzheimers Dis. 2023 Dec 8. doi: 10.3233/JAD-231034.
    PubMed     Abstract available


  1283. DA X, Hempel E, Ou Y, Rowe OE, et al
    Noninvasive Gamma Sensory Stimulation May Reduce White Matter and Myelin Loss in Alzheimer's Disease.
    J Alzheimers Dis. 2023 Dec 8. doi: 10.3233/JAD-230506.
    PubMed     Abstract available


  1284. NGUYEN SA, Oughli HA, Lavretsky H
    Use of Complementary and Integrative Medicine for Alzheimer's Disease and Cognitive Decline.
    J Alzheimers Dis. 2023 Dec 7. doi: 10.3233/JAD-230710.
    PubMed     Abstract available


  1285. SCHMUED L, Maloney B, Schmued C, Lahiri DK, et al
    Treatment with 1, 10 Phenanthroline-5-Amine Reduced Amyloid Burden in a Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2023 Dec 7. doi: 10.3233/JAD-221285.
    PubMed     Abstract available


    November 2023
  1286. HAO N, Bai X, Hu A, Zhao G, et al
    Assessing the Global, Regional, and National Impact of High Body Mass Index on Alzheimer's Disease and Other Dementias Between 1990 and 2019.
    J Alzheimers Dis. 2023 Nov 30. doi: 10.3233/JAD-230827.
    PubMed     Abstract available


  1287. LI Y, Chen X, Zhou M, Feng S, et al
    Microglial TLR4/NLRP3 Inflammasome Signaling in Alzheimer's Disease.
    J Alzheimers Dis. 2023 Nov 30. doi: 10.3233/JAD-230273.
    PubMed     Abstract available


  1288. CARPI M, Fernandes M, Mercuri NB, Liguori C, et al
    Sleep Biomarkers for Predicting Cognitive Decline and Alzheimer's Disease: A Systematic Review of Longitudinal Studies.
    J Alzheimers Dis. 2023 Nov 29. doi: 10.3233/JAD-230933.
    PubMed     Abstract available


  1289. WANG Y, Jiang R, Li M, Wang Z, et al
    Characteristics of T Cells in Single-Cell Datasets of Peripheral Blood and Cerebrospinal Fluid in Alzheimer's Disease Patients.
    J Alzheimers Dis. 2023 Nov 27. doi: 10.3233/JAD-230784.
    PubMed     Abstract available


  1290. ZHANG X, Wu P, Zhao Y
    COVID-19 in Relation to Alzheimer's Disease: Mendelian Randomization Analyses Add to Multiple Lines of Evidence.
    J Alzheimers Dis. 2023 Nov 24. doi: 10.3233/JAD-231151.
    PubMed     Abstract available


  1291. CHU C, Low YLC, Ma L, Wang Y, et al
    How Can We Use Mathematical Modeling of Amyloid-beta in Alzheimer's Disease Research and Clinical Practices?
    J Alzheimers Dis. 2023 Nov 24. doi: 10.3233/JAD-230938.
    PubMed     Abstract available


  1292. KAWARABAYASHI T, Nakamura T, Miyashita K, Segawa T, et al
    Clinical Evaluation of Cerebrospinal Fluid p217tau and Neurofilament Light Chain Levels in Patients with Alzheimer's Disease or Other Neurological Diseases.
    J Alzheimers Dis. 2023 Nov 23. doi: 10.3233/JAD-230419.
    PubMed     Abstract available


  1293. MELENDEZ JC, Satorres E, Pitarque A, Escudero J, et al
    Transcranial Direct Current Stimulation Intervention in Alzheimer's Disease and Its Follow-Up.
    J Alzheimers Dis. 2023 Nov 22. doi: 10.3233/JAD-230826.
    PubMed     Abstract available


  1294. WANG X, Huang R, Huang B, Li X, et al
    S1PR2 Regulates Autophagy Through the AKT/mTOR Pathway to Promote Pathological Damage in Alzheimer's Disease.
    J Alzheimers Dis. 2023 Nov 22. doi: 10.3233/JAD-230533.
    PubMed     Abstract available


  1295. JOHNSON CE, Duncan MJ, Murphy MP
    Sex and Sleep Disruption as Contributing Factors in Alzheimer's Disease.
    J Alzheimers Dis. 2023 Nov 22. doi: 10.3233/JAD-230527.
    PubMed     Abstract available


  1296. SPAMPINATO MV, Ulber JL, Fayyaz H, Sullivan A, et al
    Neuropsychiatric Symptoms and In Vivo Alzheimer's Biomarkers in Mild Cognitive Impairment.
    J Alzheimers Dis. 2023 Nov 22. doi: 10.3233/JAD-220835.
    PubMed     Abstract available


  1297. WHITE JP, Schembri A, Prenn-Gologranc C, Ondrus M, et al
    Sensitivity of Individual and Composite Test Scores from the Cogstate Brief Battery to Mild Cognitive Impairment and Dementia Due to Alzheimer's Disease.
    J Alzheimers Dis. 2023 Nov 21. doi: 10.3233/JAD-230352.
    PubMed     Abstract available


  1298. LEWIS JE, McDaniel HR, Woolger JM, Khan SA, et al
    The Characterization of the Th1/Th2 Ratio in Moderate-Severe Alzheimer's Disease Patients and Its Response to an Aloe Polymannose-Based Dietary Supplement.
    J Alzheimers Dis. 2023 Nov 20. doi: 10.3233/JAD-230659.
    PubMed     Abstract available


  1299. MONLLOR P, Kumar P, Lloret MA, Ftara A, et al
    Multifactorial Causation of Alzheimer's Disease Due to COVID-19.
    J Alzheimers Dis. 2023 Nov 20. doi: 10.3233/JAD-230396.
    PubMed     Abstract available


  1300. EL KADIRI W, Perrignon-Sommet M, Delpont B, Graber M, et al
    Changes in Taste Perception in Patients with Minor and Major Cognitive Impairment Linked to Alzheimer's Disease Recorded by Gustatory Evoked Potentials.
    J Alzheimers Dis. 2023 Nov 20. doi: 10.3233/JAD-230270.
    PubMed     Abstract available


  1301. TETZLOFF KA, Duffy JR, Clark HM, Pham NTT, et al
    Amyloid and Tau PET Positivity in Progressive Agrammatic Aphasia and Apraxia of Speech.
    J Alzheimers Dis. 2023 Nov 20. doi: 10.3233/JAD-230912.
    PubMed     Abstract available


  1302. ZHANG F, Petersen M, Johnson L, Hall J, et al
    Comorbidities Incorporated to Improve Prediction for Prevalent Mild Cognitive Impairment and Alzheimer's Disease in the HABS-HD Study.
    J Alzheimers Dis. 2023 Nov 18. doi: 10.3233/JAD-230755.
    PubMed     Abstract available


  1303. DING P, Gurney M, Perry G, Xu R, et al
    Association of COVID-19 with Risk and Progression of Alzheimer's Disease: Non-Overlapping Two-Sample Mendelian Randomization Analysis of 2.6 Million Subjects.
    J Alzheimers Dis. 2023 Nov 18. doi: 10.3233/JAD-230632.
    PubMed     Abstract available


  1304. GIUNTI E, Collu R, Daley S, Querfurth H, et al
    Reduction of Phosphorylated Tau in Alzheimer's Disease Induced Pluripotent Stem Cell-Derived Neuro-Spheroids by Rho-Associated Coiled-Coil Kinase Inhibitor Fasudil.
    J Alzheimers Dis. 2023 Nov 18. doi: 10.3233/JAD-230551.
    PubMed     Abstract available


  1305. LIU YB, Wang XJ, Tan L, Tan CC, et al
    PICALM Variation Moderates the Relationships of APOE varepsilon4 with Alzheimer's Disease Cerebrospinal Biomarkers and Memory Function Among Non-Demented Population.
    J Alzheimers Dis. 2023 Nov 18. doi: 10.3233/JAD-230516.
    PubMed     Abstract available


  1306. LAI D, Zhang M, Li R, Zhang C, et al
    Identifying Genes Associated with Alzheimer's Disease Using Gene-Based Polygenic Risk Score.
    J Alzheimers Dis. 2023 Nov 18. doi: 10.3233/JAD-230510.
    PubMed     Abstract available


  1307. BOZKURT AS, Yilmaz SG
    Ferroptotic Potency of ISM1 Expression in the Drug-Induced Alzheimer's Disease-Like Phenotype Under the Influence of Betulin.
    J Alzheimers Dis. 2023 Nov 17. doi: 10.3233/JAD-230940.
    PubMed     Abstract available


  1308. LI JQ, Zhong XL, Song JH, Chi S, et al
    Associations Between TREML2 Gene Variants and Alzheimer's Disease: Biomarkers, Neuroimage, and Cognition.
    J Alzheimers Dis. 2023 Nov 17. doi: 10.3233/JAD-230936.
    PubMed     Abstract available


  1309. LOPES BOSCHETTI JC, Soares KL, Carvalho GR, Filho ACV, et al
    CGAs-Rich Conilon Coffee Consumption Improves Cognition and Reduces Oxidative Stress in Elderly with Alzheimer's Disease: A Pilot Study.
    J Alzheimers Dis. 2023 Nov 17. doi: 10.3233/JAD-230843.
    PubMed     Abstract available


  1310. YANG Z, Banks SJ, Ritter AR, Cummings JL, et al
    Microglial Imaging in Alzheimer's Disease and Its Relationship to Brain Amyloid: A Human 18F-GE180 PET Study.
    J Alzheimers Dis. 2023 Nov 17. doi: 10.3233/JAD-230631.
    PubMed     Abstract available


  1311. WU W, Shen A, Lee I, Miranda-Morales EG, et al
    Changes of tRNA-Derived Fragments by Alzheimer's Disease in Cerebrospinal Fluid and Blood Serum.
    J Alzheimers Dis. 2023 Nov 17. doi: 10.3233/JAD-230412.
    PubMed     Abstract available


  1312. ZENG XX, Zeng JB
    Systems Medicine as a Strategy to Deal with Alzheimer's Disease.
    J Alzheimers Dis. 2023 Nov 16. doi: 10.3233/JAD-230739.
    PubMed     Abstract available


  1313. TAO S, Fan W, Liu J, Wang T, et al
    NLRP3 Inflammasome: An Emerging Therapeutic Target for Alzheimer's Disease.
    J Alzheimers Dis. 2023 Nov 16. doi: 10.3233/JAD-230567.
    PubMed     Abstract available


  1314. CERNOTOVA D, Hruzova K, Levcik D, Svoboda J, et al
    Linking Social Cognition, Parvalbumin Interneurons, and Oxytocin in Alzheimer's Disease: An Update.
    J Alzheimers Dis. 2023 Nov 16. doi: 10.3233/JAD-230333.
    PubMed     Abstract available


  1315. SNYTNIKOVA O, Telegina D, Savina E, Tsentalovich Y, et al
    Quantitative Metabolomic Analysis of the Rat Hippocampus: Effects of Age and of the Development of Alzheimer's Disease-Like Pathology.
    J Alzheimers Dis. 2023 Nov 13. doi: 10.3233/JAD-230706.
    PubMed     Abstract available


  1316. FERNANDO MG, Silva R, Fernando WMADB, de Silva HA, et al
    Effect of Virgin Coconut Oil Supplementation on Cognition of Individuals with Mild-to-Moderate Alzheimer's Disease in Sri Lanka (VCO-AD Study): A Randomized Placebo-Controlled Trial.
    J Alzheimers Dis. 2023 Nov 13. doi: 10.3233/JAD-230670.
    PubMed     Abstract available


  1317. MATSUMOTO H, Tagai K, Endo H, Matsuoka K, et al
    Association of Tooth Loss with Alzheimer's Disease Tau Pathologies Assessed by Positron Emission Tomography.
    J Alzheimers Dis. 2023 Nov 11. doi: 10.3233/JAD-230581.
    PubMed     Abstract available


  1318. FREDERIKSEN KS, Lanctot KL, Weidner W, Hahn-Pedersen JH, et al
    A Literature Review on the Burden of Alzheimer's Disease on Care Partners.
    J Alzheimers Dis. 2023 Nov 11. doi: 10.3233/JAD-230487.
    PubMed     Abstract available


  1319. SHINAGAWA H, Ohuchi K, Goto Y, Hashimoto K, et al
    Vacuolar Protein-Sorting Proteins Are Reduced Even Before Cognitive Decline in a Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2023 Nov 10. doi: 10.3233/JAD-230686.
    PubMed     Abstract available


  1320. AZAMI H, Daftarifard E, Humeau-Heurtier A, Fernandez A, et al
    Assessment and Comparison of Nonlinear Measures in Resting-State Magnetoencephalograms in Alzheimer's Disease and Mild Cognitive Impairment.
    J Alzheimers Dis. 2023 Nov 10. doi: 10.3233/JAD-230544.
    PubMed     Abstract available


  1321. LY M, Yu GZ, Chwa WJ, Raji CA, et al
    Paving the Way for Alzheimer's Disease Prevention: A Systematic Review of Global Open-Access Neuroimaging Datasets in Healthy Individuals.
    J Alzheimers Dis. 2023 Nov 6. doi: 10.3233/JAD-230738.
    PubMed     Abstract available


  1322. LI K, Rashid T, Li J, Honnorat N, et al
    Postmortem Brain Imaging in Alzheimer's Disease and Related Dementias: The South Texas Alzheimer's Disease Research Center Repository.
    J Alzheimers Dis. 2023 Nov 6. doi: 10.3233/JAD-230389.
    PubMed     Abstract available


  1323. MANI S, Dubey R, Lai IC, Babu MA, et al
    Oxidative Stress and Natural Antioxidants: Back and Forth in the Neurological Mechanisms of Alzheimer's Disease.
    J Alzheimers Dis. 2023 Nov 2. doi: 10.3233/JAD-220700.
    PubMed     Abstract available


  1324. PERRON J, Scramstad C, Hyun Ko J
    Analysis of Costs for Imaging-Assisted Pharmaceutical Intervention in Alzheimer's Disease with Lecanemab: Snapshot of the First 3 Years.
    J Alzheimers Dis. 2023 Nov 1. doi: 10.3233/JAD-230633.
    PubMed     Abstract available


    October 2023
  1325. FUJISAWA C, Umegaki H, Sugimoto T, Nakashima H, et al
    Relationship Between Non-Cognitive Intrinsic Capacity and Activities of Daily Living According to Alzheimer's Disease Stage.
    J Alzheimers Dis. 2023 Oct 30. doi: 10.3233/JAD-230786.
    PubMed     Abstract available


  1326. YANG J, Shi X, Wang Y, Ma M, et al
    Multi-Target Neuroprotection of Thiazolidinediones on Alzheimer's Disease via Neuroinflammation and Ferroptosis.
    J Alzheimers Dis. 2023 Oct 30. doi: 10.3233/JAD-230593.
    PubMed     Abstract available


  1327. SALHI L, Al Taep Y, Salmon E, Van Hede D, et al
    How Periodontitis or Periodontal Bacteria Can Influence Alzheimer's Disease Features? A Systematic Review of Pre-Clinical Studies.
    J Alzheimers Dis. 2023 Oct 30. doi: 10.3233/JAD-230478.
    PubMed     Abstract available


  1328. GRANT WB, Blake SM
    Diet's Role in Modifying Risk of Alzheimer's Disease: History and Present Understanding.
    J Alzheimers Dis. 2023 Oct 28. doi: 10.3233/JAD-230418.
    PubMed     Abstract available


  1329. DONG Y, Hou T, Li Y, Liu R, et al
    Plasma Amyloid-beta, Total Tau, and Neurofilament Light Chain Across the Alzheimer's Disease Clinical Spectrum: A Population-Based Study.
    J Alzheimers Dis. 2023 Oct 26. doi: 10.3233/JAD-230932.
    PubMed     Abstract available


  1330. ALROUJI M, Majrashi TA, Alhumaydhi FA, Zari A, et al
    Unveiling Phytoconstituents with Inhibitory Potential Against Tyrosine-Protein Kinase Fyn: A Comprehensive Virtual Screening Approach Targeting Alzheimer's Disease.
    J Alzheimers Dis. 2023 Oct 26. doi: 10.3233/JAD-230828.
    PubMed     Abstract available


  1331. INGANNATO A, Bessi V, Chiari A, Salvatori D, et al
    GRN Missense Variants and Familial Alzheimer's Disease: Two Case Reports.
    J Alzheimers Dis. 2023 Oct 21. doi: 10.3233/JAD-230689.
    PubMed     Abstract available


  1332. BEN KHEDHER MR, Haddad M, Fulop T, Laurin D, et al
    Implication of Circulating Extracellular Vesicles-Bound Amyloid-beta42 Oligomers in the Progression of Alzheimer's Disease.
    J Alzheimers Dis. 2023 Oct 11. doi: 10.3233/JAD-230823.
    PubMed     Abstract available


  1333. HOANG MT, Kareholt I, Schon P, von Koch L, et al
    The Impact of Educational Attainment and Income on Long-Term Care for Persons with Alzheimer's Disease and Other Dementias: A Swedish Nationwide Study.
    J Alzheimers Dis. 2023 Oct 11. doi: 10.3233/JAD-230388.
    PubMed     Abstract available


  1334. TZENG IS
    Examination of Matching Methods, Sparse Effects, and Limitations in a Nationwide Database Study on Alzheimer's Disease.
    J Alzheimers Dis. 2023 Oct 9. doi: 10.3233/JAD-230701.
    PubMed     Abstract available


  1335. LEE A, Shan D, Castle D, Rajji TK, et al
    Landscape of Phase II Trials in Alzheimer's Disease.
    J Alzheimers Dis. 2023 Oct 9. doi: 10.3233/JAD-230660.
    PubMed     Abstract available


  1336. BUCHMAN AS, Leurgans SE, Kim N, Agrawal S, et al
    Alzheimer's Disease Pathology Outside of the Cerebrum Is Related to a Higher Odds of Dementia.
    J Alzheimers Dis. 2023 Oct 9. doi: 10.3233/JAD-230223.
    PubMed     Abstract available


  1337. JIANG J, Hong Y, Li W, Wang A, et al
    Chain Mediation Analysis of the Effects of Nutrition and Cognition on the Association of Apolipoprotein E varepsilon4 with Neuropsychiatric Symptoms in Alzheimer's Disease.
    J Alzheimers Dis. 2023 Oct 6. doi: 10.3233/JAD-230577.
    PubMed     Abstract available


  1338. XUE W, He W, Yan M, Zhao H, et al
    Exploring Shared Biomarkers of Myocardial Infarction and Alzheimer's Disease via Single-Cell/Nucleus Sequencing and Bioinformatics Analysis.
    J Alzheimers Dis. 2023 Oct 6. doi: 10.3233/JAD-230559.
    PubMed     Abstract available


  1339. XIA S, Chen H, Tang T
    Risk of Death from Alzheimer's Disease Associated with Brain Tumor, Glioma, and Glioblastoma.
    J Alzheimers Dis. 2023 Oct 6. doi: 10.3233/JAD-230554.
    PubMed     Abstract available


  1340. LI A, Du J, Cai Y, Chen X, et al
    Body Mass Index Decrease Has a Distinct Association with Alzheimer's Disease Pathophysiology in APOE varepsilon4 Carriers and Non-Carriers.
    J Alzheimers Dis. 2023 Oct 6. doi: 10.3233/JAD-230446.
    PubMed     Abstract available


  1341. BIAN Z, Hu X, Liu X, Yu H, et al
    Protective Effects of Rivaroxaban on White Matter Integrity and Remyelination in a Mouse Model of Alzheimer's Disease Combined with Cerebral Hypoperfusion.
    J Alzheimers Dis. 2023 Oct 6. doi: 10.3233/JAD-230413.
    PubMed     Abstract available


  1342. ROACH JC, Rapozo MK, Hara J, Glusman G, et al
    A Remotely Coached Multimodal Lifestyle Intervention for Alzheimer's Disease Ameliorates Functional and Cognitive Outcomes.
    J Alzheimers Dis. 2023 Oct 6. doi: 10.3233/JAD-230403.
    PubMed     Abstract available


  1343. KIM M, Yi D, Byun MS, Ahn H, et al
    Development of a Cognitive Composite for Preclinical Alzheimer's Disease in Korean Older Adults.
    J Alzheimers Dis. 2023 Oct 5. doi: 10.3233/JAD-230263.
    PubMed     Abstract available


  1344. AKUSHEVICH I, Yashkin A, Ukraintseva S, Yashin AI, et al
    The Construction of a Multidomain Risk Model of Alzheimer's Disease and Related Dementias.
    J Alzheimers Dis. 2023 Oct 5. doi: 10.3233/JAD-221292.
    PubMed     Abstract available


  1345. KETCHUM FB, Erickson CM, Basche KE, Chin NA, et al
    Informing Disclosure: Efficacy of a Brief Educational Intervention on Research Participants' Knowledge about Alzheimer's Disease Biomarkers.
    J Alzheimers Dis. 2023 Oct 3. doi: 10.3233/JAD-230732.
    PubMed     Abstract available


  1346. BREDESEN DE, Toups K, Hathaway A, Gordon D, et al
    Precision Medicine Approach to Alzheimer's Disease: Rationale and Implications.
    J Alzheimers Dis. 2023 Oct 3. doi: 10.3233/JAD-230467.
    PubMed     Abstract available


  1347. UKRAINTSEVA S, Duan M, Simanek AM, Holmes R, et al
    Vaccination Against Pneumonia May Provide Genotype-Specific Protection Against Alzheimer's Disease.
    J Alzheimers Dis. 2023 Oct 3. doi: 10.3233/JAD-230088.
    PubMed     Abstract available


  1348. LIU CC, Wang QH, Xin JY, Liu YH, et al
    Association of Adipokines with Alzheimer's Disease in a Chinese Cohort.
    J Alzheimers Dis. 2023 Oct 3. doi: 10.3233/JAD-220860.
    PubMed     Abstract available


    September 2023
  1349. BARBA L, Otto M, Abu-Rumeileh S
    The Underestimated Relevance of Alzheimer's Disease Copathology in Amyotrophic Lateral Sclerosis.
    J Alzheimers Dis. 2023 Sep 30. doi: 10.3233/JAD-230900.
    PubMed     Abstract available


  1350. GONZALEZ-MADRID A, Calfio C, Gonzalez A, Luttges V, et al
    Toward Prevention and Reduction of Alzheimer's Disease.
    J Alzheimers Dis. 2023 Sep 30. doi: 10.3233/JAD-230454.
    PubMed     Abstract available


  1351. LIU Y, Shen Y
    Applications of Nanoparticles in Alzheimer's Disease.
    J Alzheimers Dis. 2023 Sep 30. doi: 10.3233/JAD-230098.
    PubMed     Abstract available


  1352. HUANG Y, Driedonks TAP, Cheng L, Turchinovich A, et al
    Small RNA Profiles of Brain Tissue-Derived Extracellular Vesicles in Alzheimer's Disease.
    J Alzheimers Dis. 2023 Sep 28. doi: 10.3233/JAD-230872.
    PubMed     Abstract available


  1353. GUILLIOT S, Gauthier S, Touchon J, Soto ME, et al
    Lithium, a Treatment Option for Alzheimer's Disease? A Review of Existing Evidence and Discussion on Future Perspectives.
    J Alzheimers Dis. 2023 Sep 28. doi: 10.3233/JAD-230568.
    PubMed     Abstract available


  1354. POLIN C, Gelle T, Auditeau E, Adou C, et al
    Repetitive Behaviors in Alzheimer's Disease: A Systematic Review and Meta-Analysis.
    J Alzheimers Dis. 2023 Sep 28. doi: 10.3233/JAD-230380.
    PubMed     Abstract available


  1355. DALY T
    Improving Clinical Trials of Antioxidants in Alzheimer's Disease.
    J Alzheimers Dis. 2023 Sep 28. doi: 10.3233/JAD-230308.
    PubMed     Abstract available


  1356. IKANGA J, Hickle S, Schwinne M, Epenge E, et al
    Association Between Hippocampal Volume and African Neuropsychology Memory Tests in Adult Individuals with Probable Alzheimer's Disease in Democratic Republic of Congo.
    J Alzheimers Dis. 2023 Sep 28. doi: 10.3233/JAD-230206.
    PubMed     Abstract available


  1357. ROGERS JT, Cahill CM
    Iron Responsiveness to Lysosomal Disruption: A Novel Pathway to Alzheimer's Disease.
    J Alzheimers Dis. 2023 Sep 25. doi: 10.3233/JAD-230953.
    PubMed     Abstract available


  1358. BRAMEN JE, Siddarth P, Popa ES, Kress GT, et al
    Impact of Eating a Carbohydrate-Restricted Diet on Cortical Atrophy in a Cross-Section of Amyloid Positive Patients with Alzheimer's Disease: A Small Sample Study.
    J Alzheimers Dis. 2023 Sep 22. doi: 10.3233/JAD-230458.
    PubMed     Abstract available


  1359. CHOW TE, Veziris CR, Mundada N, Martinez-Arroyo AI, et al
    Medial Temporal Lobe Tau Aggregation Relates to Divergent Cognitive and Emotional Empathy Abilities in Alzheimer's Disease.
    J Alzheimers Dis. 2023 Sep 22. doi: 10.3233/JAD-230367.
    PubMed     Abstract available


  1360. QEADAN F, McCunn A, Tingey B, Price R, et al
    Exploring the Association Between Opioid Use Disorder and Alzheimer's Disease and Dementia Among a National Sample of the U.S. Population.
    J Alzheimers Dis. 2023 Sep 21. doi: 10.3233/JAD-230714.
    PubMed     Abstract available


  1361. DINNERSTEIN E
    Erratum to: The Time for Combination Therapy Research in Alzheimer's Disease is Now.
    J Alzheimers Dis. 2023 Sep 20. doi: 10.3233/JAD-239010.
    PubMed    


  1362. SUN Y, Moghekar A, Soldan A, Pettigrew C, et al
    Cerebrospinal Fluid Alzheimer's Disease Biomarker Patterns of Change Prior to the Onset of Mild Cognitive Impairment.
    J Alzheimers Dis. 2023 Sep 20. doi: 10.3233/JAD-230807.
    PubMed     Abstract available


  1363. ALKON DL, Sun MK, Tuchman AJ, Thompson RE, et al
    Advanced Alzheimer's Disease Patients Show Safe, Significant, and Persistent Benefit in 6-Month Bryostatin Trial.
    J Alzheimers Dis. 2023 Sep 19. doi: 10.3233/JAD-230868.
    PubMed     Abstract available


  1364. LEIBY AC, Scambray KA, Nguyen HL, Basith F, et al
    Characterizing Limbic-Predominant Age-Related TDP-43 Encephalopathy Without Alzheimer's Disease and Lewy Body Dementia in the Oldest Old: A Case Series.
    J Alzheimers Dis. 2023 Sep 19. doi: 10.3233/JAD-230238.
    PubMed     Abstract available


  1365. LARDELLI M, Baer L, Hin N, Allen A, et al
    The Use of Zebrafish in Transcriptome Analysis of the Early Effects of Mutations Causing Early Onset Familial Alzheimer's Disease and Other Inherited Neurodegenerative Conditions.
    J Alzheimers Dis. 2023 Sep 16. doi: 10.3233/JAD-230522.
    PubMed     Abstract available


  1366. ZHANG Y, Xue Y, Wang L, Han Z, et al
    rs56405341 Variant Associates with Expression of C4orf33 and C4orf33 Was Downregulated in Alzheimer's Disease and Progressive Supranuclear Palsy.
    J Alzheimers Dis. 2023 Sep 16. doi: 10.3233/JAD-230327.
    PubMed     Abstract available


  1367. MERLO S, Costa L, Chiechio S, Busceti CL, et al
    Increased Heat Pain Tolerance but Hyperalgesia to Tonic Inflammatory Pain in the CRND8 Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2023 Sep 16. doi: 10.3233/JAD-230148.
    PubMed     Abstract available


  1368. BLUSZTAJN JK, Aytan N, Rajendiran T, Mellott TJ, et al
    Cerebral Gray and White Matter Monogalactosyl Diglyceride Levels Rise with the Progression of Alzheimer's Disease.
    J Alzheimers Dis. 2023 Sep 14. doi: 10.3233/JAD-230543.
    PubMed     Abstract available


  1369. PARRENO TORRES A, Roncero-Parra C, Borja AL, Mateo-Sotos J, et al
    Inter-Hospital Advanced and Mild Alzheimer's Disease Classification Based on Electroencephalogram Measurements via Classical Machine Learning Algorithms.
    J Alzheimers Dis. 2023 Sep 14. doi: 10.3233/JAD-230525.
    PubMed     Abstract available


  1370. SAKURAI K, Kaneda D, Morimoto S, Uchida Y, et al
    Asymmetric Cerebral Peduncle Atrophy: A Simple Diagnostic Clue for Distinguishing Frontotemporal Lobar Degeneration from Alzheimer's Disease.
    J Alzheimers Dis. 2023 Sep 14. doi: 10.3233/JAD-230441.
    PubMed     Abstract available


  1371. NIK AKHTAR S, Lu Q
    RhoA-LIMK Signaling Axis Reveals Rostral-Caudal Plane and Spatial Dysregulation in the Brain of Alzheimer's Disease Mouse Models.
    J Alzheimers Dis. 2023 Sep 14. doi: 10.3233/JAD-230408.
    PubMed     Abstract available


  1372. O'BRYANT SE, Zhang F, Johnson LA, Hall J, et al
    Precision Medicine for Preventing Alzheimer's Disease: Analysis of the ADAPT Study.
    J Alzheimers Dis. 2023 Sep 14. doi: 10.3233/JAD-230317.
    PubMed     Abstract available


  1373. YANG Y, Li M, Leng B, Yao R, et al
    Alzheimer's Disease Biomarkers and Complement Proteins Mediate the Impact of Sleep Fragmentation on Cognitive Impairment in Obstructive Sleep Apnea Patients Without Dementia.
    J Alzheimers Dis. 2023 Sep 14. doi: 10.3233/JAD-221288.
    PubMed     Abstract available


  1374. TANG H, Sun Y, Fachim HA, Cheung TKD, et al
    Elevated Expression of Two Pore Potassium Channel THIK-1 in Alzheimer's Disease: An Inflammatory Mechanism.
    J Alzheimers Dis. 2023 Sep 12. doi: 10.3233/JAD-230616.
    PubMed     Abstract available


  1375. WITUCKI L, Borowczyk K, Suszynska-Zajczyk J, Warzych E, et al
    Deletion of the Homocysteine Thiolactone Detoxifying Enzyme Bleomycin Hydrolase, in Mice, Causes Memory and Neurological Deficits and Worsens Alzheimer's Disease-Related Behavioral and Biochemical Traits in the 5xFAD Model of Alzheimer's Disease.
    J Alzheimers Dis. 2023 Sep 12. doi: 10.3233/JAD-230578.
    PubMed     Abstract available


  1376. GUIEYSSE T, Lamothe R, Houot M, Razafimahatratra S, et al
    Detecting Anosognosia from the Prodromal Stage of Alzheimer's Disease.
    J Alzheimers Dis. 2023 Sep 12. doi: 10.3233/JAD-230552.
    PubMed     Abstract available


  1377. FERNANDES C, Montalvo G, Caligiuri M, Pertsinakis M, et al
    Handwriting Changes in Alzheimer's Disease: A Systematic Review.
    J Alzheimers Dis. 2023 Sep 12. doi: 10.3233/JAD-230438.
    PubMed     Abstract available


  1378. XU X, Wang H, Zhang QY, Meng XY, et al
    Dissecting Mitochondrial Mechanisms of Alzheimer's Disease Using Gene Dependency Network and Its Implications for Discovering Nutrients Combatting the Disease.
    J Alzheimers Dis. 2023 Sep 12. doi: 10.3233/JAD-230366.
    PubMed     Abstract available


  1379. LARDELLI M
    An Alternative View of Familial Alzheimer's Disease Genetics.
    J Alzheimers Dis. 2023 Sep 12. doi: 10.3233/JAD-230313.
    PubMed     Abstract available


  1380. DE LA MONTE SM
    Malignant Brain Aging: The Formidable Link Between Dysregulated Signaling Through Mechanistic Target of Rapamycin Pathways and Alzheimer's Disease (Type 3 Diabetes).
    J Alzheimers Dis. 2023 Sep 11. doi: 10.3233/JAD-230555.
    PubMed     Abstract available


  1381. FORTEL I, Zhan L, Ajilore O, Wu Y, et al
    Disrupted Excitation-Inhibition Balance in Cognitively Normal Individuals at Risk of Alzheimer's Disease.
    J Alzheimers Dis. 2023 Sep 11. doi: 10.3233/JAD-230035.
    PubMed     Abstract available


  1382. DAVIDSON S, Allenback G, Decourt B, Sabbagh MN, et al
    Type 2 Diabetes Comorbidity and Cognitive Decline in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2023 Sep 9. doi: 10.3233/JAD-230489.
    PubMed     Abstract available


  1383. FUKUDA H, Kanzaki H, Murata F, Maeda M, et al
    Disease Burden and Progression in Patients with New-Onset Mild Cognitive Impairment and Alzheimer's Disease Identified from Japanese Claims Data: Evidence from the LIFE Study.
    J Alzheimers Dis. 2023 Sep 9. doi: 10.3233/JAD-230471.
    PubMed     Abstract available


  1384. ZIYAD SR, Altulyan M, Alharbi M
    SHMAD: A Smart Health Care System to Monitor Alzheimer's Disease Patients.
    J Alzheimers Dis. 2023 Sep 9. doi: 10.3233/JAD-230402.
    PubMed     Abstract available


  1385. NAKAMURA Y, Narita K, Kim R, Nishiyama K, et al
    Long-Term Safety, Tolerability, and Efficacy of a Transdermal Donepezil Patch in Patients with Severe Alzheimer's Disease.
    J Alzheimers Dis. 2023 Sep 9. doi: 10.3233/JAD-230386.
    PubMed     Abstract available


  1386. VERDE F, Aiello EN, Adobbati L, Poletti B, et al
    Coexistence of Amyotrophic Lateral Sclerosis and Alzheimer's Disease: Case Report and Review of the Literature.
    J Alzheimers Dis. 2023 Sep 7. doi: 10.3233/JAD-230562.
    PubMed     Abstract available


  1387. DU Y, Chen X, Zhang B, Jin X, et al
    Identification of Copper Metabolism Related Biomarkers, Polygenic Prediction Model, and Potential Therapeutic Agents in Alzheimer's Disease.
    J Alzheimers Dis. 2023 Sep 5. doi: 10.3233/JAD-230565.
    PubMed     Abstract available


  1388. LEHMANN DJ, Elshorbagy A, Hurley MJ
    Many Paths to Alzheimer's Disease: A Unifying Hypothesis Integrating Biological, Chemical, and Physical Risk Factors.
    J Alzheimers Dis. 2023 Sep 5. doi: 10.3233/JAD-230295.
    PubMed     Abstract available


  1389. KOPPELMANS V, Ruitenberg MFL, Schaefer SY, King JB, et al
    Delayed and More Variable Unimanual and Bimanual Finger Tapping in Alzheimer's Disease: Associations with Biomarkers and Applications for Classification.
    J Alzheimers Dis. 2023 Sep 4. doi: 10.3233/JAD-221297.
    PubMed     Abstract available


  1390. ADEWALE BA, Coker MM, Ogunniyi A, Kalaria RN, et al
    Biomarkers and Risk Assessment of Alzheimer's Disease in Low- and Middle-Income Countries.
    J Alzheimers Dis. 2023 Sep 4. doi: 10.3233/JAD-221030.
    PubMed     Abstract available


  1391. MAKRI M, Gkioka M, Moraitou D, Fidani L, et al
    Attitudes, Motivations, and Barriers to Pre-Symptomatic Alzheimer's Disease Screening: Development and Validation of the 'Perceptions regarding pRE-symptomatic Alzheimer's Disease Screening' (PRE-ADS) Questionnaire.
    J Alzheimers Dis. 2023 Sep 1. doi: 10.3233/JAD-220954.
    PubMed     Abstract available


    August 2023
  1392. LI Z, Wu H, Ji Y, Shi Z, et al
    Toward Reagent-Free Discrimination of Alzheimer's Disease Using Blood Plasma Spectral Digital Biomarkers and Machine Learning.
    J Alzheimers Dis. 2023 Aug 28. doi: 10.3233/JAD-230248.
    PubMed     Abstract available


  1393. GEZEN-AK D, Dursun E
    Vitamin D, a Secosteroid Hormone and Its Multifunctional Receptor, Vitamin D Receptor, in Alzheimer's Type Neurodegeneration.
    J Alzheimers Dis. 2023 Aug 28. doi: 10.3233/JAD-230214.
    PubMed     Abstract available


  1394. ZHANG J, Liu Q, Zhang H, Dai M, et al
    Uncovering the System Vulnerability and Criticality of Human Brain Under Dynamical Neuropathological Events in Alzheimer's Disease.
    J Alzheimers Dis. 2023 Aug 28. doi: 10.3233/JAD-230027.
    PubMed     Abstract available


  1395. FAZLOLLAHI A, Lee S, Coleman F, McCann E, et al
    Increased Resolution of Structural MRI at 3T Improves Estimation of Regional Cortical Degeneration in Individual Dementia Patients Using Surface Thickness Maps.
    J Alzheimers Dis. 2023 Aug 28. doi: 10.3233/JAD-230030.
    PubMed     Abstract available


  1396. UCHIDA Y, Onda K, Hou Z, Troncoso JC, et al
    Microstructural Neurodegeneration of the Entorhinal-Hippocampus Pathway along the Alzheimer's Disease Continuum.
    J Alzheimers Dis. 2023 Aug 25. doi: 10.3233/JAD-230452.
    PubMed     Abstract available


  1397. WU Y, Eisel ULM
    Microglia-Astrocyte Communication in Alzheimer's Disease.
    J Alzheimers Dis. 2023 Aug 25. doi: 10.3233/JAD-230199.
    PubMed     Abstract available


  1398. SCHORK NJ, Elman JA
    Pathway-Specific Polygenic Risk Scores Correlate with Clinical Status and Alzheimer's Disease-Related Biomarkers.
    J Alzheimers Dis. 2023 Aug 25. doi: 10.3233/JAD-230548.
    PubMed     Abstract available


  1399. BEI J, Miranda-Morales EG, Gan Q, Qiu Y, et al
    Circulating Exosomes from Alzheimer's Disease Suppress Vascular Endothelial-Cadherin Expression and Induce Barrier Dysfunction in Recipient Brain Microvascular Endothelial Cell.
    J Alzheimers Dis. 2023 Aug 25. doi: 10.3233/JAD-230347.
    PubMed     Abstract available


  1400. SATTAROV R, Toresson H, Orbjorn C, Mattsson-Carlgren N, et al
    Direct Conversion of Fibroblast into Neurons for Alzheimer's Disease Research: A Systematic Review.
    J Alzheimers Dis. 2023 Aug 25. doi: 10.3233/JAD-230119.
    PubMed     Abstract available


  1401. HEIDARZADEH N, Ratte S
    'Eye-Tracking' with Words for Alzheimer's Disease Detection: Time Alignment of Words Enunciation with Image Regions During Image Description Tasks.
    J Alzheimers Dis. 2023 Aug 25. doi: 10.3233/JAD-220711.
    PubMed     Abstract available


  1402. LI J, Mountz EJ, Mizuno A, Shah AM, et al
    Functional Asymmetry During Working Memory and Its Association with Markers of Alzheimer's Disease in Cognitively Normal Older Adults.
    J Alzheimers Dis. 2023 Aug 24. doi: 10.3233/JAD-230379.
    PubMed     Abstract available


  1403. RAMOS C, Madrigal C, Aguirre-Acevedo DC, Giraldo-Chica M, et al
    Psychological Status of the Participants in Alzheimer's Prevention Initiative Autosomal Dominant Alzheimer's Disease Colombia.
    J Alzheimers Dis. 2023 Aug 24. doi: 10.3233/JAD-220941.
    PubMed     Abstract available


  1404. JIANG J, Wang A, Liu Y, Yao Z, et al
    Spatiotemporal Characteristics of Regional Brain Perfusion Associated with Neuropsychiatric Symptoms in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2023 Aug 23. doi: 10.3233/JAD-230499.
    PubMed     Abstract available


  1405. KIM DY, Kim JS, Seo YS, Park WY, et al
    Evaluation of Efficacy and Safety Using Low Dose Radiation Therapy with Alzheimer's Disease: A Protocol for Multicenter Phase II Clinical Trial.
    J Alzheimers Dis. 2023 Aug 23. doi: 10.3233/JAD-230241.
    PubMed     Abstract available


  1406. ABYADEH M, Yadav VK, Kaya A
    Common Molecular Signatures Between Coronavirus Infection and Alzheimer's Disease Reveal Targets for Drug Development.
    J Alzheimers Dis. 2023 Aug 22. doi: 10.3233/JAD-230684.
    PubMed     Abstract available


  1407. JANN K, Boudreau J, Albrecht D, Cen SY, et al
    FMRI Complexity Correlates with Tau-PET and Cognitive Decline in Late-Onset and Autosomal Dominant Alzheimer's Disease.
    J Alzheimers Dis. 2023 Aug 18. doi: 10.3233/JAD-220851.
    PubMed     Abstract available


  1408. MAMELAK M
    The Alzheimer's Disease Brain, Its Microvasculature, and NADPH Oxidase.
    J Alzheimers Dis. 2023 Aug 14. doi: 10.3233/JAD-230415.
    PubMed     Abstract available


  1409. KATISKO K, Kruger J, Soppela H, Hartikainen P, et al
    Psychopharmacological Medication Use in Frontotemporal Dementia at the Time of Diagnosis: Comparison with Alzheimer's Disease.
    J Alzheimers Dis. 2023 Aug 12. doi: 10.3233/JAD-230494.
    PubMed     Abstract available


  1410. KOBRO-FLATMOEN A, Hormann TM, Gouras G
    Intracellular Amyloid-beta in the Normal Rat Brain and Human Subjects and Its relevance for Alzheimer's Disease.
    J Alzheimers Dis. 2023 Aug 10. doi: 10.3233/JAD-230349.
    PubMed     Abstract available


  1411. YANG H, Wang W, Jia L, Qin W, et al
    Erratum to: The Effect of Chronic Cerebral Hypoperfusion on Blood-Brain Barrier Permeability in a Transgenic Alzheimer's Disease Mouse Model (PS1V97L).
    J Alzheimers Dis. 2023 Aug 8. doi: 10.3233/JAD-239007.
    PubMed    


  1412. WANG X, Sundermann EE, Buckley RF, Reas ET, et al
    Sex Differences in the Associations of Obesity with Tau, Amyloid PET, and Cognitive Outcomes in Preclinical Alzheimer's Disease: Cross-Sectional A4 Study.
    J Alzheimers Dis. 2023 Aug 7. doi: 10.3233/JAD-230466.
    PubMed     Abstract available


  1413. KENKPEN AK, Storey JJ, Olson ER, Guden TE, et al
    Developing Connections Between LINC00298 RNA and Alzheimer's Disease Through Mapping Its Interactome and Through Biochemical Characterization.
    J Alzheimers Dis. 2023 Aug 7. doi: 10.3233/JAD-230057.
    PubMed     Abstract available


  1414. HARRIS K, Ling Y, Bukhbinder AS, Chen L, et al
    The Impact of Routine Vaccinations on Alzheimer's Disease Risk in Persons 65 Years and Older: A Claims-Based Cohort Study using Propensity Score Matching.
    J Alzheimers Dis. 2023 Aug 7. doi: 10.3233/JAD-221231.
    PubMed     Abstract available


  1415. CONTI E, Grana D, Angiulli F, Karantzoulis A, et al
    TSPO Modulates Oligomeric Amyloid-beta-Induced Monocyte Chemotaxis: Relevance for Neuroinflammation in Alzheimer's Disease.
    J Alzheimers Dis. 2023 Aug 5. doi: 10.3233/JAD-230239.
    PubMed     Abstract available


  1416. CAI HY, Yang D, Qiao J, Yang JT, et al
    Erratum to: A GLP-1/GIP Dual Receptor Agonist DA4-JC Effectively Attenuates Cognitive Impairment and Pathology in the APP/PS1/Tau Model of Alzheimer's Disease.
    J Alzheimers Dis. 2023 Aug 2. doi: 10.3233/JAD-239006.
    PubMed    


  1417. QAISER H, Uzair M, Al-Regaiey K, Rafiq S, et al
    Role of Thioredoxin System in Regulating Cellular Redox Status in Alzheimer's Disease.
    J Alzheimers Dis. 2023 Aug 1. doi: 10.3233/JAD-230394.
    PubMed     Abstract available


  1418. MENDEZ MF
    Can Speaking More Than One Language Help Prevent Alzheimer's Disease?
    J Alzheimers Dis. 2023 Aug 1. doi: 10.3233/JAD-230285.
    PubMed     Abstract available


  1419. SONG S, Asken B, Armstrong MJ, Yang Y, et al
    Predicting Progression to Clinical Alzheimer's Disease Dementia Using the Random Survival Forest.
    J Alzheimers Dis. 2023 Aug 1. doi: 10.3233/JAD-230208.
    PubMed     Abstract available


  1420. BACHMAN SL, Blankenship JM, Busa M, Serviente C, et al
    Capturing Measures That Matter: The Potential Value of Digital Measures of Physical Behavior for Alzheimer's Disease Drug Development.
    J Alzheimers Dis. 2023 Aug 1. doi: 10.3233/JAD-230152.
    PubMed     Abstract available


  1421. BAUMARD J
    Is Shadowing Behavior Caused by Body Representation Disorders and Apraxia?
    J Alzheimers Dis. 2023 Aug 1. doi: 10.3233/JAD-230731.
    PubMed     Abstract available


    July 2023
  1422. LA BARBERA L, D'Amelio M
    Alzheimer's Disease and Sex-Dependent Alterations in the Striatum: A Lesson from a Mouse Model.
    J Alzheimers Dis. 2023 Jul 28. doi: 10.3233/JAD-230681.
    PubMed     Abstract available


  1423. LIN Y, Hu T, Cheng L, Chen Y, et al
    Causal Effects of Plasma Haptoglobin Levels on Alzheimer's Disease: A Two-Sample Mendelian Randomization Study.
    J Alzheimers Dis. 2023 Jul 26. doi: 10.3233/JAD-230159.
    PubMed     Abstract available


  1424. LEITAO ADG, Spencer B, Sarsoza F, Ngolab J, et al
    Hippocampal Reduction of alpha-Synuclein via RNA Interference Improves Neuropathology in Alzheimer's Disease Mice.
    J Alzheimers Dis. 2023 Jul 25. doi: 10.3233/JAD-230232.
    PubMed     Abstract available


  1425. VICENTE MC, Paneghini JL, Stabile AM, Amorim M, et al
    Inhibition of Pro-Inflammatory Microglia with Minocycline Improves Cognitive and Sleep-Wake Dysfunction Under Respiratory Stress in a Sporadic Model for Alzheimer's Disease.
    J Alzheimers Dis. 2023 Jul 25. doi: 10.3233/JAD-230151.
    PubMed     Abstract available


  1426. NADEAU PA, Jobin B, Boller B
    Diagnostic Sensitivity and Specificity of Cognitive Tests for Mild Cognitive Impairment and Alzheimer's Disease in Patients with Down Syndrome: A Systematic Review and Meta-Analysis.
    J Alzheimers Dis. 2023 Jul 25. doi: 10.3233/JAD-220991.
    PubMed     Abstract available


  1427. VOSSEL K
    Putting the Brakes on Accelerated Cognitive Decline in Alzheimer's Disease with Epileptic Activity.
    J Alzheimers Dis. 2023 Jul 24. doi: 10.3233/JAD-230613.
    PubMed     Abstract available


  1428. WHITE LR, Corrada MM, Kawas CH, Cholerton BA, et al
    Neuropathologic Changes of Alzheimer's Disease and Related Dementias: Relevance to Future Prevention.
    J Alzheimers Dis. 2023 Jul 24. doi: 10.3233/JAD-230331.
    PubMed     Abstract available


  1429. NOWRANGI MA, Outen JD, Kim J, Avramopoulos D, et al
    Neuropsychiatric Symptoms of Alzheimer's Disease: An Anatomic-Genetic Framework for Treatment Development.
    J Alzheimers Dis. 2023 Jul 24. doi: 10.3233/JAD-221247.
    PubMed     Abstract available



  1430. Henning Tiemeier, MD, PhD, and Rosanne Freak-Poli, PhD, are the recipients of the 2023 Alzheimer Award.
    J Alzheimers Dis. 2023 Jul 20. doi: 10.3233/JAD-239005.
    PubMed    


  1431. LI J, Zeng Q, Luo X, Li K, et al
    Decoupling of Regional Cerebral Blood Flow and Brain Function Along the Alzheimer's Continuum.
    J Alzheimers Dis. 2023 Jul 20. doi: 10.3233/JAD-230503.
    PubMed     Abstract available


  1432. LOPEZ-MARTOS D, Brugulat-Serrat A, Canas-Martinez A, Canals-Gispert L, et al
    Reference Data for Attentional, Executive, Linguistic, and Visual Processing Tests Obtained from Cognitively Healthy Individuals with Normal Alzheimer's Disease Cerebrospinal Fluid Biomarker Levels.
    J Alzheimers Dis. 2023 Jul 20. doi: 10.3233/JAD-230290.
    PubMed     Abstract available


  1433. KILPATRICK LA, Siddarth P, Krause-Sorio B, Milillo MM, et al
    Impact of Yoga Versus Memory Enhancement Training on Hippocampal Connectivity in Older Women at Risk for Alzheimer's Disease.
    J Alzheimers Dis. 2023 Jul 19. doi: 10.3233/JAD-221159.
    PubMed     Abstract available


  1434. STALLARD E, Kociolek A, Jin Z, Ryu H, et al
    Validation of a Multivariate Prediction Model of the Clinical Progression of Alzheimer's Disease in a Community-Dwelling Multiethnic Cohort.
    J Alzheimers Dis. 2023 Jul 19. doi: 10.3233/JAD-220811.
    PubMed     Abstract available


  1435. YU Y, Xia X, Meng X, Li D, et al
    Plasma Phosphorylated Tau181 and Amyloid-beta42 in Dementia with Lewy Bodies Compared with Alzheimer's Disease and Cognitively Healthy People.
    J Alzheimers Dis. 2023 Jul 18. doi: 10.3233/JAD-230085.
    PubMed     Abstract available


  1436. HARTLEY SL, Fleming V, Schworer EK, Peven J, et al
    Timing of Alzheimer's Disease by Intellectual Disability Level in Down Syndrome.
    J Alzheimers Dis. 2023 Jul 17. doi: 10.3233/JAD-230200.
    PubMed     Abstract available


  1437. PUENTES-DIAZ N, Chaparro D, Reyes-Marquez V, Morales-Morales D, et al
    Computational Evaluation of the Potential Pharmacological Activity of Salen-Type Ligands in Alzheimer's Disease.
    J Alzheimers Dis. 2023 Jul 15. doi: 10.3233/JAD-230542.
    PubMed     Abstract available


  1438. OLMOS-VILLASENOR R, Sepulveda-Silva C, Julio-Ramos T, Fuentes-Lopez E, et al
    Phonological and Semantic Fluency in Alzheimer's Disease: A Systematic Review and Meta-Analysis.
    J Alzheimers Dis. 2023 Jul 15. doi: 10.3233/JAD-221272.
    PubMed     Abstract available


  1439. CHENG C, Yang C, Jia C, Wang Q, et al
    The Role of Cerebellum in Alzheimer's Disease: A Forgotten Research Corner.
    J Alzheimers Dis. 2023 Jul 14. doi: 10.3233/JAD-230381.
    PubMed     Abstract available


  1440. CHUM PP, Bishara MA, Solis SR, Behringer EJ, et al
    Cerebrovascular miRNAs Track Early Development of Alzheimer's Disease and Target Molecular Markers of Angiogenesis and Blood Flow Regulation.
    J Alzheimers Dis. 2023 Jul 14. doi: 10.3233/JAD-230300.
    PubMed     Abstract available


  1441. CHEN R, Morris BJ, Donlon TA, Ross GW, et al
    Incidence of Alzheimer's Disease in Men with Late-Life Hypertension Is Ameliorated by FOXO3 Longevity Genotype.
    J Alzheimers Dis. 2023 Jul 14. doi: 10.3233/JAD-230350.
    PubMed     Abstract available


  1442. XU Y, Vasiljevic E, Deming YK, Jonaitis EM, et al
    Effect of Pathway-Specific Polygenic Risk Scores for Alzheimer's Disease (AD) on Rate of Change in Cognitive Function and AD-Related Biomarkers Among Asymptomatic Individuals.
    J Alzheimers Dis. 2023 Jul 14. doi: 10.3233/JAD-230097.
    PubMed     Abstract available


  1443. TIO ES, Hohman TJ, Milic M, Bennett DA, et al
    Testing a Polygenic Risk Score for Morphological Microglial Activation in Alzheimer's Disease and Aging.
    J Alzheimers Dis. 2023 Jul 10. doi: 10.3233/JAD-230434.
    PubMed     Abstract available


  1444. KUDO S, Funayama M, Kurose S, Shimizu Y, et al
    Shadowing Behavior May Be Associated with an Inability to Recognize the External World: A Case Report of Shadowing in a Patient with Posterior Cortical Atrophy.
    J Alzheimers Dis. 2023 Jul 10. doi: 10.3233/JAD-230257.
    PubMed     Abstract available


  1445. MIGUEL L, Gervais J, Nicolas G, Lecourtois M, et al
    SorLA Protective Function Is Restored by Improving SorLA Protein Maturation in a Subset of Alzheimer's Disease-Associated SORL1 Missense Variants.
    J Alzheimers Dis. 2023 Jul 8. doi: 10.3233/JAD-230211.
    PubMed     Abstract available


  1446. YANG Y, Lv J, Bai H, Ren L, et al
    Periodontal Status and Saliva Metabolic Signature in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2023 Jul 7. doi: 10.3233/JAD-230291.
    PubMed     Abstract available


  1447. XIA ZD, Ma RX, Wen JF, Zhai YF, et al
    Pathogenesis, Animal Models, and Drug Discovery of Alzheimer's Disease.
    J Alzheimers Dis. 2023 Jul 5. doi: 10.3233/JAD-230326.
    PubMed     Abstract available


  1448. MAO M, Wang C, Hou T, Han X, et al
    Ventricular Electrocardiographic Signatures Associated with Dementia and Plasma Alzheimer's Disease Biomarkers in Older Adults: A Population-Based Study.
    J Alzheimers Dis. 2023 Jul 5. doi: 10.3233/JAD-230056.
    PubMed     Abstract available


  1449. ZHANG HQ, Chau ACM, Shea YF, Chiu PK, et al
    Disrupted Structural White Matter Network in Alzheimer's Disease Continuum, Vascular Dementia, and Mixed Dementia: A Diffusion Tensor Imaging Study.
    J Alzheimers Dis. 2023 Jul 3. doi: 10.3233/JAD-230341.
    PubMed     Abstract available


    June 2023
  1450. CAI HY, Hou SJ, Wen R, Feng QF, et al
    Causal Association Between mTOR-Dependent Protein Levels and Alzheimer's Disease: A Mendelian Randomization Study.
    J Alzheimers Dis. 2023 Jun 30. doi: 10.3233/JAD-230128.
    PubMed     Abstract available


  1451. AKADA K, Koyama N, Miura Y, Takahashi K, et al
    Nationwide Database Analysis of Risk Factors Associated with Decreased Activities of Daily Living in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2023 Jun 30. doi: 10.3233/JAD-230106.
    PubMed     Abstract available


  1452. HANSEN SB
    Cholesterol's Function and Origin in the Alzheimer's Disease Brain.
    J Alzheimers Dis. 2023 Jun 29. doi: 10.3233/JAD-230538.
    PubMed     Abstract available


  1453. MOBASHERI K, Zaefizadeh M, Ghobeh M, Eidi A, et al
    Synthesis of Novel Magnetic Quercetin-Neuropeptide Nanocomposite as a Smart Nano-Drug Shuttle System: Investigation of Its Effect on Behavior, Histopathological Characteristics, and Expression of MAPT and APP Genes in Alzheimer's Disease Rats.
    J Alzheimers Dis. 2023 Jun 29. doi: 10.3233/JAD-221095.
    PubMed     Abstract available


  1454. MERTEN N, Pinto AA, Paulsen AJ, Chen Y, et al
    Associations of Midlife Lifestyle and Health Factors with Long-Term Changes in Blood-Based Biomarkers of Alzheimer's Disease and Neurodegeneration.
    J Alzheimers Dis. 2023 Jun 28. doi: 10.3233/JAD-221287.
    PubMed     Abstract available


  1455. SCHAFER HACKENHAAR F, Josefsson M, Nordin Adolfsson A, Landfors M, et al
    Sixteen-Year Longitudinal Evaluation of Blood-Based DNA Methylation Biomarkers for Early Prediction of Alzheimer's Disease.
    J Alzheimers Dis. 2023 Jun 27. doi: 10.3233/JAD-230039.
    PubMed     Abstract available


  1456. CHHIMPA N, Singh N, Puri N, Kayath HP, et al
    The Novel Role of Mitochondrial Citrate Synthase and Citrate in the Pathophysiology of Alzheimer's Disease.
    J Alzheimers Dis. 2023 Jun 27. doi: 10.3233/JAD-220514.
    PubMed     Abstract available


  1457. KANG JM, Shin JH, Kim WR, Seo S, et al
    Effects of the APOEvarepsilon4 Allele on the Relationship Between Tau and Amyloid-beta in Early- and Late-Onset Alzheimer's Disease.
    J Alzheimers Dis. 2023 Jun 24. doi: 10.3233/JAD-230339.
    PubMed     Abstract available


  1458. SORRENTINO F, Fenoglio C, Sacchi L, Serpente M, et al
    Klotho Gene Expression Is Decreased in Peripheral Blood Mononuclear Cells in Patients with Alzheimer's Disease and Frontotemporal Dementia.
    J Alzheimers Dis. 2023 Jun 24. doi: 10.3233/JAD-230322.
    PubMed     Abstract available


  1459. ALVES SS, de Oliveira JAC, Lazarini-Lopes W, Servilha-Menezes G, et al
    Audiogenic Seizures in the Streptozotocin-Induced Rat Alzheimer's Disease Model.
    J Alzheimers Dis. 2023 Jun 24. doi: 10.3233/JAD-230153.
    PubMed     Abstract available


  1460. ZHANG J, Gao S, Liu W
    Bioinformatics-Based Analysis of Circadian Rhythm Regulation Mechanisms in Alzheimer's Disease.
    J Alzheimers Dis. 2023 Jun 23. doi: 10.3233/JAD-230177.
    PubMed     Abstract available


  1461. AUDRONYTE E, Pakulaite-Kazliene G, Sutnikiene V, Kaubrys G, et al
    Odor Discrimination as a Marker of Early Alzheimer's Disease.
    J Alzheimers Dis. 2023 Jun 23. doi: 10.3233/JAD-230077.
    PubMed     Abstract available


  1462. KULMINSKI AM, Feng F, Loiko E, Nazarian A, et al
    Prevailing Antagonistic Risks in Pleiotropic Associations with Alzheimer's Disease and Diabetes.
    J Alzheimers Dis. 2023 Jun 22. doi: 10.3233/JAD-230397.
    PubMed     Abstract available


  1463. JEONG SH, Cha J, Jung JH, Yun M, et al
    Occipital Amyloid Deposition Is Associated with Rapid Cognitive Decline in the Alzheimer's Disease Continuum.
    J Alzheimers Dis. 2023 Jun 22. doi: 10.3233/JAD-230187.
    PubMed     Abstract available


  1464. HAUTECLOQUE-RAYSZ G, Sellal F, Bousiges O, Phillipi N, et al
    Epileptic Prodromal Alzheimer's Disease Treated with Antiseizure Medications: Medium-Term Outcome of Seizures and Cognition.
    J Alzheimers Dis. 2023 Jun 22. doi: 10.3233/JAD-221197.
    PubMed     Abstract available


  1465. BELAN AFR, Pais MV, Camargo MVZA, Sant'Ana LCFG, et al
    Diagnostic Performance of an Eye-Tracking Assisted Visual Inference Language Test in the Assessment of Cognitive Decline due to Alzheimer's Disease.
    J Alzheimers Dis. 2023 Jun 21. doi: 10.3233/JAD-230250.
    PubMed     Abstract available


  1466. CHEN W, Lin C, Su F, Fang Y, et al
    Early Diagnosis of Mild Cognitive Impairment due to Alzheimer's Disease Using a Composite of MemTrax and Blood Biomarkers.
    J Alzheimers Dis. 2023 Jun 21. doi: 10.3233/JAD-230182.
    PubMed     Abstract available


  1467. FU XX, Wei B, Cao HM, Duan R, et al
    Telmisartan Alleviates Alzheimer's Disease-Related Neuropathologies and Cognitive Impairments.
    J Alzheimers Dis. 2023 Jun 19. doi: 10.3233/JAD-230133.
    PubMed     Abstract available


  1468. ORTI-CASAN N, Wajant H, Kuiperij HB, Hooijsma A, et al
    Activation of TNF Receptor 2 Improves Synaptic Plasticity and Enhances Amyloid-beta Clearance in an Alzheimer's Disease Mouse Model with Humanized TNF Receptor 2.
    J Alzheimers Dis. 2023 Jun 19. doi: 10.3233/JAD-221230.
    PubMed     Abstract available


  1469. BOLLINGER RM, Gabel M, Coble DW, Chen SW, et al
    Retention of Study Partners in Longitudinal Studies of Alzheimer Disease.
    J Alzheimers Dis. 2023 Jun 18. doi: 10.3233/JAD-230079.
    PubMed     Abstract available


  1470. NAKAMURA Y, Omori T, Kim R, Nishiyama K, et al
    Efficacy and Safety of a Transdermal Donepezil Patch in Patients with Mild to Moderate Alzheimer's Disease: Open-Label, Extension Study.
    J Alzheimers Dis. 2023 Jun 14. doi: 10.3233/JAD-230387.
    PubMed     Abstract available


  1471. YAN R, Wang W, Yang W, Huang M, et al
    Mitochondria-Related Candidate Genes and Diagnostic Model to Predict Late-Onset Alzheimer's Disease and Mild Cognitive Impairment.
    J Alzheimers Dis. 2023 Jun 13. doi: 10.3233/JAD-230314.
    PubMed     Abstract available


  1472. JIANG WR, Wu W, Yang LJ, Yang W, et al
    Alteration of Cognitive Function in Aging and Alzheimer's Disease Mice Is Related to Dysfunction of the Neuroimmune System.
    J Alzheimers Dis. 2023 Jun 13. doi: 10.3233/JAD-230292.
    PubMed     Abstract available


  1473. MANSOR NI, Ling KH, Rosli R, Hassan Z, et al
    Centella asiatica (L.) Urban. Attenuates Cell Damage in Hydrogen Peroxide-Induced Oxidative Stress in Transgenic Murine Embryonic Stem Cell Line-Derived Neural-Like Cells: A Preliminary Study for Potential Treatment of Alzheimer's Disease.
    J Alzheimers Dis. 2023 Jun 13. doi: 10.3233/JAD-221233.
    PubMed     Abstract available


  1474. XU GY, Liu YH, Zeng XQ, Chen DW, et al
    The Diagnostic Potential of Circulating Autoantibodies to Amyloid-beta in Alzheimer's Disease.
    J Alzheimers Dis. 2023 Jun 12. doi: 10.3233/JAD-230252.
    PubMed     Abstract available


  1475. QAISAR R, Karim A, Iqbal MS, Alkahtani SA, et al
    ACE Inhibitors Improve Skeletal Muscle by Preserving Neuromuscular Junctions in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2023 Jun 12. doi: 10.3233/JAD-230201.
    PubMed     Abstract available


  1476. PATEL S, Wei J, Shi Z, Rifkin AS, et al
    Refining Risk for Alzheimer's Disease Among Heterozygous APOEvarepsilon4 Carriers.
    J Alzheimers Dis. 2023 Jun 12. doi: 10.3233/JAD-230156.
    PubMed     Abstract available


  1477. PEAVY GM
    Can't Have One Without the Other: Study Partner Retention in Alzheimer's Disease Research.
    J Alzheimers Dis. 2023 Jun 10. doi: 10.3233/JAD-230455.
    PubMed     Abstract available


  1478. VANNINEN A, Lukkarinen H, Kokkola T, Koivisto AM, et al
    Cerebrospinal Fluid Diagnostics of Alzheimer's Disease in Patients with Idiopathic Normal Pressure Hydrocephalus.
    J Alzheimers Dis. 2023 Jun 10. doi: 10.3233/JAD-230144.
    PubMed     Abstract available


  1479. MILANO C, Hoxhaj D, Del Chicca M, Pascazio A, et al
    Alzheimer's Disease and Neurosyphilis: Meaningful Commonalities and Differences of Clinical Phenotype and Pathophysiological Biomarkers.
    J Alzheimers Dis. 2023 Jun 9. doi: 10.3233/JAD-230170.
    PubMed     Abstract available


  1480. HU D, Dong X, Wang Q, Liu M, et al
    PCP4 Promotes Alzheimer's Disease Pathogenesis by Affecting Amyloid-beta Protein Precursor Processing.
    J Alzheimers Dis. 2023 Jun 8. doi: 10.3233/JAD-230192.
    PubMed     Abstract available


  1481. ZHANG X, Liu Y, Huang M, Gunewardena S, et al
    Landscape of Double-Stranded DNA Breaks in Postmortem Brains from Alzheimer's Disease and Non-Demented Individuals.
    J Alzheimers Dis. 2023 Jun 8. doi: 10.3233/JAD-230316.
    PubMed     Abstract available


  1482. RUDGE JD
    The Lipid Invasion Model: Growing Evidence for This New Explanation of Alzheimer's Disease.
    J Alzheimers Dis. 2023 Jun 3. doi: 10.3233/JAD-221175.
    PubMed     Abstract available


    May 2023
  1483. SUN L, Ye KX, Wong HLK, Wang L, et al
    The Effects of Medium Chain Triglyceride for Alzheimer's Disease Related Cognitive Impairment: A Systematic Review and Meta-Analysis.
    J Alzheimers Dis. 2023 May 23. doi: 10.3233/JAD-230406.
    PubMed     Abstract available


  1484. HAZAN J, Liu K, Fox N, Howard R, et al
    Advancing Diagnostic Certainty in Alzheimer's Disease: A Synthesis of the Diagnostic Process.
    J Alzheimers Dis. 2023 May 23. doi: 10.3233/JAD-230186.
    PubMed     Abstract available


  1485. FINDLEY CA, McFadden SA, Cox MF, Sime LN, et al
    Prodromal Glutamatergic Modulation with Riluzole Impacts Glucose Homeostasis and Spatial Cognition in Alzheimer's Disease Mice.
    J Alzheimers Dis. 2023 May 23. doi: 10.3233/JAD-221245.
    PubMed     Abstract available


  1486. LI D, Yu YY, Hu N, Zhang M, et al
    Composite Indices of the Color-Picture Version of Boston Naming Test Have Better Discriminatory Power: Reliability and Validity in a Chinese Sample with Diverse Neurodegenerative Diseases.
    J Alzheimers Dis. 2023 May 23. doi: 10.3233/JAD-221227.
    PubMed     Abstract available


  1487. GONZALEZ A, Calfio C, Luttges V, Gonzalez-Madrid A, et al
    The Multifactorial Etiopathogenesis of Alzheimer's Disease: Neuroinflammation as the Major Contributor.
    J Alzheimers Dis. 2023 May 20. doi: 10.3233/JAD-230150.
    PubMed     Abstract available


  1488. LIU M, Li M, He J, He Y, et al
    Chiral Amino Acid Profiling in Serum Reveals Potential Biomarkers for Alzheimer's Disease.
    J Alzheimers Dis. 2023 May 20. doi: 10.3233/JAD-230142.
    PubMed     Abstract available


  1489. JARHOLM JA, Bjornerud A, Dalaker TO, Akhavi MS, et al
    Medial Temporal Lobe Atrophy in Predementia Alzheimer's Disease: A Longitudinal Multi-Site Study Comparing Staging and A/T/N in a Clinical Research Cohort.
    J Alzheimers Dis. 2023 May 20. doi: 10.3233/JAD-221274.
    PubMed     Abstract available


  1490. LIU J, Xie Y, Lu Y, Zhao Z, et al
    APP/PS1 Gene-Environmental Cadmium Interaction Aggravates the Progression of Alzheimer's Disease in Mice via the Blood-Brain Barrier, Amyloid-beta, and Inflammation.
    J Alzheimers Dis. 2023 May 20. doi: 10.3233/JAD-221205.
    PubMed     Abstract available


  1491. KARIMA S, Aghamollaii V, Mahmoodi Baram S, Balenci L, et al
    Boswellic Acids Improve Clinical Cognitive Scores and Reduce Systemic Inflammation in Patients with Mild to Moderate Alzheimer's Disease.
    J Alzheimers Dis. 2023 May 20. doi: 10.3233/JAD-221026.
    PubMed     Abstract available


  1492. MI Z, Abrahamson EE, Ryu AY, Malek-Ahmadi M, et al
    Vesicular Glutamate Transporter Changes in the Cortical Default Mode Network During the Clinical and Pathological Progression of Alzheimer's Disease.
    J Alzheimers Dis. 2023 May 19. doi: 10.3233/JAD-221063.
    PubMed     Abstract available


  1493. PUOYAN-MAJD S, Parnow A, Rashno M, Heidarimoghadam R, et al
    The Protective Effects of High-Intensity Interval Training Combined with Q10 Supplementation on Learning and Memory Impairments in Male Rats with Amyloid-beta-Induced Alzheimer's Disease.
    J Alzheimers Dis. 2023 May 18. doi: 10.3233/JAD-230096.
    PubMed     Abstract available


  1494. MORI H, Yoshino Y, Iga JI, Ochi S, et al
    Aberrant Expression of GABA-Related Genes in the Hippocampus of 3xTg-AD Model Mice from the Early to End Stages of Alzheimer's Disease.
    J Alzheimers Dis. 2023 May 18. doi: 10.3233/JAD-230078.
    PubMed     Abstract available


  1495. HUI HYH, Ran AR, Dai JJ, Cheung CY, et al
    Deep Reinforcement Learning-Based Retinal Imaging in Alzheimer's Disease: Potential and Perspectives.
    J Alzheimers Dis. 2023 May 18. doi: 10.3233/JAD-230055.
    PubMed     Abstract available


  1496. ELZAYAT EM, Shahien SA, El-Sherif AA, Hosney M, et al
    miRNAs and Stem Cells as Promising Diagnostic and Therapeutic Targets for Alzheimer's Disease.
    J Alzheimers Dis. 2023 May 18. doi: 10.3233/JAD-221298.
    PubMed     Abstract available


  1497. QUERRY M, Blanc F, Bousiges O, Philippi N, et al
    Memory Outcome in Prodromal and Mild Dementia with Lewy Bodies and Alzheimer's Disease: A Longitudinal Study.
    J Alzheimers Dis. 2023 May 18. doi: 10.3233/JAD-221243.
    PubMed     Abstract available


  1498. GONZALEZ C, Mimmack KJ, Amariglio RE, Becker JA, et al
    Associations of the Harvard Automated Phone Task and Alzheimer's Disease Pathology in Cognitively Normal Older Adults: Preliminary Findings.
    J Alzheimers Dis. 2023 May 18. doi: 10.3233/JAD-220885.
    PubMed     Abstract available


  1499. VOLLOCH V, Rits-Volloch S
    Effect of Lecanemab in Early Alzheimer's Disease: Mechanistic Interpretation in the Amyloid Cascade Hypothesis 2.0 Perspective.
    J Alzheimers Dis. 2023 May 16. doi: 10.3233/JAD-230164.
    PubMed     Abstract available


  1500. ORTNER M, Lanz K, Goldhardt O, Muller-Sarnowski F, et al
    Elecsys Cerebrospinal Fluid Immunoassays Accurately Detect Alzheimer's Disease Regardless of Concomitant Small Vessel Disease.
    J Alzheimers Dis. 2023 May 16. doi: 10.3233/JAD-221187.
    PubMed     Abstract available


  1501. WHEELERA CJ
    Evolutionary Selection of APOEvarepsilon4 Encourages Increased Focus on Immunity in Alzheimer's Disease.
    J Alzheimers Dis. 2023 May 13. doi: 10.3233/JAD-230390.
    PubMed     Abstract available


  1502. DINNERSETIN E
    The Time for Combination Therapy Research in Alzheimer's Disease is Now.
    J Alzheimers Dis. 2023 May 13. doi: 10.3233/JAD-230254.
    PubMed    


  1503. HIROTA Y, Sakakibara Y, Takei K, Nishijima R, et al
    Alzheimer's Disease-Related Phospho-Tau181 Signals Are Localized to Demyelinated Axons of Parvalbumin-Positive GABAergic Interneurons in an App Knock-In Mouse Model of Amyloid-beta Pathology.
    J Alzheimers Dis. 2023 May 13. doi: 10.3233/JAD-230121.
    PubMed     Abstract available


  1504. WHITE LR
    If Midlife Brain Injury Is a Risk Factor for Alzheimer's Disease and Related Dementias, What Is the Neuropathologic Mechanism?
    J Alzheimers Dis. 2023 May 12. doi: 10.3233/JAD-230332.
    PubMed     Abstract available


  1505. TOPPING M, Kim J, Fletcher J
    Area-Level Infant Mortality Exposure in Early Life and Alzheimer's Disease Mortality: Examining Variation Based on Age, Sex, and Place of Birth.
    J Alzheimers Dis. 2023 May 12. doi: 10.3233/JAD-230086.
    PubMed     Abstract available


  1506. BALIETTI M, Casoli T, Giorgetti B, Colangeli R, et al
    Generation and Characterization of the First Murine Model of Alzheimer's Disease with Mutated AbetaPP Inserted in a BALB/c Background (C.B6/J-APPswe).
    J Alzheimers Dis. 2023 May 11. doi: 10.3233/JAD-230195.
    PubMed     Abstract available


  1507. CARLOS AF, Machulda MM, Rutledge MH, Nguyen AT, et al
    Comparison of Clinical, Genetic, and Pathologic Features of Limbic and Diffuse Transactive Response DNA-Binding Protein 43 Pathology in Alzheimer's Disease Neuropathologic Spectrum.
    J Alzheimers Dis. 2023 May 11. doi: 10.3233/JAD-221094.
    PubMed     Abstract available


  1508. EIKELBOOM WS, van den Berg E, Coesmans M, Goudzwaard JA, et al
    Effects of the DICE Method to Improve Timely Recognition and Treatment of Neuropsychiatric Symptoms in Early Alzheimer's Disease at the Memory Clinic: The BEAT-IT Study.
    J Alzheimers Dis. 2023 May 10. doi: 10.3233/JAD-230116.
    PubMed     Abstract available


  1509. LIN H, Pan T, Wang M, Ge J, et al
    Metabolic Asymmetry Relates to Clinical Characteristics and Brain Network Abnormalities in Alzheimer's Disease.
    J Alzheimers Dis. 2023 May 10. doi: 10.3233/JAD-221258.
    PubMed     Abstract available


  1510. YAN Y, Wu Y, Xiao G, Wang L, et al
    White Matter Changes as an Independent Predictor of Alzheimer's Disease.
    J Alzheimers Dis. 2023 May 9. doi: 10.3233/JAD-221037.
    PubMed     Abstract available


  1511. CHENG J, Zheng H, Liu C, Jin J, et al
    Age-Associated UBE2O Reduction Promotes Neuronal Death in Alzheimer's Disease.
    J Alzheimers Dis. 2023 May 6. doi: 10.3233/JAD-221143.
    PubMed     Abstract available


  1512. LI Y, Chang J, Chen X, Liu J, et al
    Advances in the Study of APOE and Innate Immunity in Alzheimer's Disease.
    J Alzheimers Dis. 2023 May 5. doi: 10.3233/JAD-230179.
    PubMed     Abstract available


  1513. VIG V, Garg I, Tuz-Zahra F, Xu J, et al
    Vitreous Humor Biomarkers Reflect Pathological Changes in the Brain for Alzheimer's Disease and Chronic Traumatic Encephalopathy.
    J Alzheimers Dis. 2023 May 5. doi: 10.3233/JAD-230167.
    PubMed     Abstract available


  1514. SACCHI L, Contarino VE, Siggillino S, Carandini T, et al
    Banks of the Superior Temporal Sulcus in Alzheimer's Disease: A Pilot Quantitative Susceptibility Mapping Study.
    J Alzheimers Dis. 2023 May 5. doi: 10.3233/JAD-230095.
    PubMed     Abstract available


  1515. BLUSZTAJN JK, Slack BE
    Accelerated Breakdown of Phosphatidylcholine and Phosphatidylethanolamine Is a Predominant Brain Metabolic Defect in Alzheimer's Disease.
    J Alzheimers Dis. 2023 May 5. doi: 10.3233/JAD-230061.
    PubMed     Abstract available


  1516. ABBATE C
    The Adult Neurogenesis Theory of Alzheimer's Disease.
    J Alzheimers Dis. 2023 May 5. doi: 10.3233/JAD-221279.
    PubMed     Abstract available


  1517. HUGGINS LKL, Min SH, Kaplan S, Wei J, et al
    Meta-Analysis of Variations in Association between APOE varepsilon4 and Alzheimer's Disease and Related Dementias Across Hispanic Regions of Origin.
    J Alzheimers Dis. 2023 May 5. doi: 10.3233/JAD-221167.
    PubMed     Abstract available


  1518. MOYAERT P, Beun S, Achten E, Clement P, et al
    Effect of Acetylcholinesterase Inhibitors on Cerebral Perfusion and Cognition: A Systematic Review.
    J Alzheimers Dis. 2023 May 5. doi: 10.3233/JAD-221125.
    PubMed     Abstract available


  1519. BEADELL AV, Zhang Z, Capuano AW, Bennett DA, et al
    Genome-Wide Mapping Implicates 5-Hydroxymethylcytosines in Diabetes Mellitus and Alzheimer's Disease.
    J Alzheimers Dis. 2023 May 5. doi: 10.3233/JAD-221113.
    PubMed     Abstract available


    April 2023
  1520. HSIAO WW, Angela S, Le TN, Ku CC, et al
    Evolution of Detecting Early Onset of Alzheimer's Disease: From Neuroimaging to Optical Immunoassays.
    J Alzheimers Dis. 2023 Apr 28. doi: 10.3233/JAD-221202.
    PubMed     Abstract available


  1521. PRESS DZ, Musaeus CS, Zhao L, Breton J, et al
    Levetiracetam Increases Hippocampal Blood Flow in Alzheimer's Disease as Measured by Arterial Spin Labelling MRI.
    J Alzheimers Dis. 2023 Apr 26. doi: 10.3233/JAD-220614.
    PubMed     Abstract available


  1522. ZHANG K, Du X, Gao Y, Liu S, et al
    Mesenchymal Stem Cells for Treating Alzheimer's Disease: Cell Therapy and Chemical Reagent Pretreatment.
    J Alzheimers Dis. 2023 Apr 21. doi: 10.3233/JAD-221253.
    PubMed     Abstract available


  1523. LIU R, Zhang L, You H
    Insulin Resistance and Impaired Branched-Chain Amino Acid Metabolism in Alzheimer's Disease.
    J Alzheimers Dis. 2023 Apr 21. doi: 10.3233/JAD-221147.
    PubMed     Abstract available


  1524. LIEW Y, Retinasamy T, Arulsamy A, Ali I, et al
    Neuroinflammation: A Common Pathway in Alzheimer's Disease and Epilepsy.
    J Alzheimers Dis. 2023 Apr 17. doi: 10.3233/JAD-230059.
    PubMed     Abstract available


  1525. LIANG J, LeFleur B, Hussainy S, Perry G, et al
    Gene Co-Expression Analysis of Multiple Brain Tissues Reveals Correlation of FAM222A Expression with Multiple Alzheimer's Disease-Related Genes.
    J Alzheimers Dis. 2023 Apr 17. doi: 10.3233/JAD-221241.
    PubMed     Abstract available


  1526. OTOKI Y, Yu D, Shen Q, Sahlas DJ, et al
    Quantitative Lipidomic Analysis of Serum Phospholipids Reveals Dissociable Markers of Alzheimer's Disease and Subcortical Cerebrovascular Disease.
    J Alzheimers Dis. 2023 Apr 17. doi: 10.3233/JAD-220795.
    PubMed     Abstract available


  1527. SINGH M, Jindal D, Kumar R, Pancham P, et al
    Molecular Docking and Network Pharmacology Interaction Analysis of Gingko Biloba (EGB761) Extract with Dual Target Inhibitory Mechanism in Alzheimer's Disease.
    J Alzheimers Dis. 2023 Apr 12. doi: 10.3233/JAD-221222.
    PubMed     Abstract available


  1528. WILLIAMS E, Mutlu-Smith M, Alex A, Chin XW, et al
    Mid-Adulthood Cognitive Training Improves Performance in a Spatial Task but Does Not Ameliorate Hippocampal Pathology in a Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2023 Apr 12. doi: 10.3233/JAD-221185.
    PubMed     Abstract available


  1529. STARK J, Hiersche KJ, Yu JC, Hasselbach AN, et al
    Partial Least Squares Regression Analysis of Alzheimer's Disease Biomarkers, Modifiable Health Variables, and Cognitive Change in Older Adults with Mild Cognitive Impairment.
    J Alzheimers Dis. 2023 Apr 12. doi: 10.3233/JAD-221084.
    PubMed     Abstract available


  1530. HENDRIE HC
    Screening and Assessment for Alzheimer's Disease in the Days of Biological Biomarkers.
    J Alzheimers Dis. 2023 Apr 10. doi: 10.3233/JAD-230215.
    PubMed     Abstract available


  1531. TIAN J, Stucky C, Wang T, Muma NA, et al
    Mitochondrial Dysfunction Links to Impaired Hippocampal Serotonin Release in a Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2023 Apr 10. doi: 10.3233/JAD-230072.
    PubMed     Abstract available


  1532. ZHAO Z, Wang J, Wang Y, Liu X, et al
    18F-AV45 PET and MRI Reveal the Influencing Factors of Alzheimer's Disease Biomarkers in Subjective Cognitive Decline Population.
    J Alzheimers Dis. 2023 Apr 10. doi: 10.3233/JAD-221251.
    PubMed     Abstract available


  1533. EITHZ N, Sorensen J, Sopina L
    Healthcare Costs in the Year Before and After Alzheimer's Disease Diagnosis: A Danish Register-Based Matched Cohort Study.
    J Alzheimers Dis. 2023 Apr 10. doi: 10.3233/JAD-220821.
    PubMed     Abstract available


  1534. JIA J, Zhang Y, Shi Y, Yina X, et al
    Erratum to: A 19-Year-Old Adolescent with Probable Alzheimer's Disease.
    J Alzheimers Dis. 2023 Apr 5. doi: 10.3233/JAD-239001.
    PubMed    


  1535. MAO C, You H, Hou B, Chu S, et al
    Differentiation of Alzheimer's Disease from Frontotemporal Dementia and Mild Cognitive Impairment Based on Arterial Spin Labeling Magnetic Resonance Imaging: A Pilot Cross-Sectional Study from PUMCH Dementia Cohort.
    J Alzheimers Dis. 2023 Apr 4. doi: 10.3233/JAD-221023.
    PubMed     Abstract available


  1536. SULHEIM E, WiderOe M, Back M, Nilsson KPR, et al
    Contrast Enhanced Magnetic Resonance Imaging of Amyloid-beta Plaques in a Murine Alzheimer's Disease Model.
    J Alzheimers Dis. 2023 Apr 3. doi: 10.3233/JAD-220198.
    PubMed     Abstract available


  1537. QIAN L, Bian W, Wang D, Ming Z, et al
    Adeno-Associated Virus-Mediated Immunotherapy Based on Bispecific Tandem scFv for Alzheimer's Disease.
    J Alzheimers Dis. 2023 Apr 1. doi: 10.3233/JAD-221088.
    PubMed     Abstract available


  1538. NAGARAJA N, Wang WE, Duara R, DeKosky ST, et al
    Mediation of Reduced Hippocampal Volume by Cerebral Amyloid Angiopathy in Pathologically Confirmed Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2023 Apr 1. doi: 10.3233/JAD-220624.
    PubMed     Abstract available


    March 2023
  1539. SAKURAI K, Kaneda D, Morimoto S, Uchida Y, et al
    Voxel-Based and Surface-Based Morphometry Analysis in Patients with Pathologically Confirmed Argyrophilic Grain Disease and Alzheimer's Disease.
    J Alzheimers Dis. 2023 Mar 25. doi: 10.3233/JAD-230068.
    PubMed     Abstract available


  1540. RAHMANI F, Ghezzi L, Tosti V, Liu J, et al
    Twelve Weeks of Intermittent Caloric Restriction Diet Mitigates Neuroinflammation in Midlife Individuals with Multiple Sclerosis: A Pilot Study with Implications for Prevention of Alzheimer's Disease.
    J Alzheimers Dis. 2023 Mar 25. doi: 10.3233/JAD-221007.
    PubMed     Abstract available


  1541. ZIYAD SR, Alharbi M, Altulyan M
    Artificial Intelligence Model for Alzheimer's Disease Detection with Convolution Neural Network for Magnetic Resonance Images.
    J Alzheimers Dis. 2023 Mar 23. doi: 10.3233/JAD-221250.
    PubMed     Abstract available


  1542. SUN Y, Hu HY, Hu H, Huang LY, et al
    Cerebral Small Vessel Disease Burden Predicts Neurodegeneration and Clinical Progression in Prodromal Alzheimer's Disease.
    J Alzheimers Dis. 2023 Mar 23. doi: 10.3233/JAD-221207.
    PubMed     Abstract available


  1543. FORTEA J, Garcia-Arcelay E, Terrancle A, Galvez B, et al
    Attitudes of Neurologists Toward the Use of Biomarkers in the Diagnosis of Early Alzheimer's Disease.
    J Alzheimers Dis. 2023 Mar 23. doi: 10.3233/JAD-221160.
    PubMed     Abstract available


  1544. WIDJAYA MA, Cheng YJ, Kuo YM, Liu CH, et al
    Transcriptomic Analyses of Exercise Training in Alzheimer's Disease Cerebral Cortex.
    J Alzheimers Dis. 2023 Mar 23. doi: 10.3233/JAD-221139.
    PubMed     Abstract available


  1545. NAKAMURA T, Kawarabayashi T, Ueda T, Shimomura S, et al
    Plasma ApoE4 Levels Are Lower than ApoE2 and ApoE3 Levels, and Not Associated with Plasma Abeta 40/42 Ratio as a Biomarker of Amyloid-beta Amyloidosis in Alzheimer's Disease.
    J Alzheimers Dis. 2023 Mar 23. doi: 10.3233/JAD-220996.
    PubMed     Abstract available


  1546. HOOK G, Kindy M, Hook V
    Cathepsin B Deficiency Improves Memory Deficits and Reduces Amyloid-beta in hAbetaPP Mouse Models Representing the Major Sporadic Alzheimer's Disease Condition.
    J Alzheimers Dis. 2023 Mar 21. doi: 10.3233/JAD-221005.
    PubMed     Abstract available


  1547. FILLENBAUM GG, Mohs R
    CERAD (Consortium to Establish a Registry for Alzheimer's Disease) Neuropsychology Assessment Battery: 35 Years and Counting.
    J Alzheimers Dis. 2023 Mar 13. doi: 10.3233/JAD-230026.
    PubMed     Abstract available


  1548. BAYAT S, Roe CM, Schindler S, Murphy SA, et al
    Everyday Driving and Plasma Biomarkers in Alzheimer's Disease: Leveraging Artificial Intelligence to Expand Our Diagnostic Toolkit.
    J Alzheimers Dis. 2023 Mar 13. doi: 10.3233/JAD-221268.
    PubMed     Abstract available


  1549. DOLCET-NEGRE MM, Imaz Aguayo L, de Eulate RG, Marti-Andres G, et al
    Predicting Conversion from Subjective Cognitive Decline to Mild Cognitive Impairment and Alzheimer's Disease Dementia Using Ensemble Machine Learning.
    J Alzheimers Dis. 2023 Mar 13. doi: 10.3233/JAD-221002.
    PubMed     Abstract available


  1550. MOON SW, Byun MS, Yi D, Kim MJ, et al
    Low Ankle-Brachial Index Relates to Alzheimer-Signature Cerebral Glucose Metabolism in Cognitively Impaired Older Adults.
    J Alzheimers Dis. 2023 Mar 13. doi: 10.3233/JAD-220911.
    PubMed     Abstract available


  1551. MAN S, Chen B, Zhang Y, Xu H, et al
    The Associations Between Cataracts and Alzheimer's Disease: A Bidirectional Two-Sample Mendelian Randomization Study.
    J Alzheimers Dis. 2023 Mar 10. doi: 10.3233/JAD-221137.
    PubMed     Abstract available


  1552. GOLAS AC, Salwierz P, Rajji TK, Bowie CR, et al
    Assessing the Role of Past Depression in Patients with Mild Cognitive Impairment, with and without Biomarkers for Alzheimer's Disease.
    J Alzheimers Dis. 2023 Mar 10. doi: 10.3233/JAD-221097.
    PubMed     Abstract available


  1553. HE Y, Li J, Yi L, Li X, et al
    Octadecaneuropeptide Ameliorates Cognitive Impairments Through Inhibiting Oxidative Stress in Alzheimer's Disease Models.
    J Alzheimers Dis. 2023 Mar 6. doi: 10.3233/JAD-221115.
    PubMed     Abstract available


  1554. HOLLENBENDERS Y, Pobiruchin M, Reichenbach A
    Two Routes to Alzheimer's Disease Based on Differential Structural Changes in Key Brain Regions.
    J Alzheimers Dis. 2023 Mar 6. doi: 10.3233/JAD-221061.
    PubMed     Abstract available


  1555. BONOMI CG, Assogna M, Di Donna MG, Bernocchi F, et al
    Cerebrospinal Fluid sTREM-2, GFAP, and beta-S100 in Symptomatic Sporadic Alzheimer's Disease: Microglial, Astrocytic, and APOE Contributions Along the Alzheimer's Disease Continuum.
    J Alzheimers Dis. 2023 Mar 6. doi: 10.3233/JAD-221010.
    PubMed     Abstract available


  1556. XU S, Xie L, Zhang Y, Wu X, et al
    Inferior Frontal Sulcal Hyperintensity on FLAIR Is Associated with Small Vessel Disease but not Alzheimer's Disease Pathology.
    J Alzheimers Dis. 2023 Mar 6. doi: 10.3233/JAD-220843.
    PubMed     Abstract available


  1557. XU Y, Zheng F, Zhong Q, Zhu Y, et al
    Ketogenic Diet as a Promising Non-Drug Intervention for Alzheimer's Disease: Mechanisms and Clinical Implications.
    J Alzheimers Dis. 2023 Mar 4. doi: 10.3233/JAD-230002.
    PubMed     Abstract available


  1558. GARCIA-ESCOBAR G, Puig-Pijoan A, Puente-Periz V, Fernandez-Lebrero A, et al
    NEURONORMA Cognitive Battery Associations with Cerebrospinal Fluid Amyloid-beta and Tau Levels in the Continuum of Alzheimer's Disease.
    J Alzheimers Dis. 2023 Mar 4. doi: 10.3233/JAD-220930.
    PubMed     Abstract available


  1559. SHAH J, Rahman Siddiquee MM, Krell-Roesch J, Syrjanen JA, et al
    Neuropsychiatric Symptoms and Commonly Used Biomarkers of Alzheimer's Disease: A Literature Review from a Machine Learning Perspective.
    J Alzheimers Dis. 2023 Mar 3. doi: 10.3233/JAD-221261.
    PubMed     Abstract available


  1560. LIU H, Reynolds GP, Wei X
    The Influence of Agricultural Work and Plasma Uric Acid on Hospital Admission for Alzheimer's Disease.
    J Alzheimers Dis. 2023 Mar 2. doi: 10.3233/JAD-221226.
    PubMed     Abstract available


    February 2023
  1561. LOUGHMAN A, Adler C, Macpherson H
    Unlocking Modifiable Risk Factors for Alzheimer's Disease: Does the Oral Microbiome Hold Some of the Keys?
    J Alzheimers Dis. 2023 Feb 27. doi: 10.3233/JAD-220760.
    PubMed     Abstract available


  1562. SOTO-MERCADO V, Mendivil-Perez M, Velez-Pardo C, Jimenez-Del-Rio M, et al
    Neuroprotective Effect of Combined Treatment with Epigallocatechin 3-Gallate and Melatonin on Familial Alzheimer's Disease PSEN1 E280A Cerebral Spheroids Derived from Menstrual Mesenchymal Stromal Cells.
    J Alzheimers Dis. 2023 Feb 24. doi: 10.3233/JAD-220903.
    PubMed     Abstract available


  1563. ATWOOD CS, Perry G
    Russian Roulette with Alzheimer's Disease Patients: Do the Cognitive Benefits of Lecanemab Outweigh the Risk of Edema and Stroke?
    J Alzheimers Dis. 2023 Feb 22. doi: 10.3233/JAD-230040.
    PubMed     Abstract available


  1564. WALKER JM, Gonzales MM, Goette W, Farrell K, et al
    Cognitive and Neuropsychological Profiles in Alzheimer's Disease and Primary Age-Related Tauopathy and the Influence of Comorbid Neuropathologies.
    J Alzheimers Dis. 2023 Feb 21. doi: 10.3233/JAD-230022.
    PubMed     Abstract available


  1565. DEMARSHALL CA, Viviano J, Emrani S, Thayasivam U, et al
    Early Detection of Alzheimer's Disease-Related Pathology Using a Multi-Disease Diagnostic Platform Employing Autoantibodies as Blood-Based Biomarkers.
    J Alzheimers Dis. 2023 Feb 21. doi: 10.3233/JAD-221091.
    PubMed     Abstract available


  1566. ACOSTA-BAENA N, Lopera-Gomez CM, Jaramillo-Elorza MC, Velilla-Jimenez L, et al
    Early Depressive Symptoms Predict Faster Dementia Progression in Autosomal-Dominant Alzheimer's Disease.
    J Alzheimers Dis. 2023 Feb 18. doi: 10.3233/JAD-221294.
    PubMed     Abstract available


  1567. YIN W, Wan K, Zhu W, Zhou X, et al
    Bilateral Hippocampal Volume Mediated the Relationship Between Plasma BACE1 Concentration and Memory Function in the Early Stage of Alzheimer's Disease: A Cross-Sectional Study.
    J Alzheimers Dis. 2023 Feb 18. doi: 10.3233/JAD-221174.
    PubMed     Abstract available


  1568. DING P, Gorenflo MP, Zhu X, Xu R, et al
    Aspirin Use and Risk of Alzheimer's Disease: A 2-Sample Mendelian Randomization Study.
    J Alzheimers Dis. 2023 Feb 18. doi: 10.3233/JAD-220787.
    PubMed     Abstract available


    January 2023
  1569. MASCARENHAS FONSECA L, Sage Chaytor N, Olufadi Y, Buchwald D, et al
    Intraindividual Cognitive Variability and Magnetic Resonance Imaging in Aging American Indians: Data from the Strong Heart Study.
    J Alzheimers Dis. 2023;91:1395-1407.
    PubMed     Abstract available


  1570. SACRIPANTE R, Girtler N, Doglione E, Nobili F, et al
    Forgetting Rates of Prose Memory in Mild Cognitive Impairment.
    J Alzheimers Dis. 2023;91:1385-1394.
    PubMed     Abstract available


  1571. HAYS WEEKS CC, Zlatar ZZ, Meloy MJ, Shin DD, et al
    APOE Genotype Modifies the Association of Fusiform Gyrus Cerebral Metabolic Rate of Oxygen Consumption and Object Naming Performance.
    J Alzheimers Dis. 2023;91:1371-1383.
    PubMed     Abstract available


  1572. JANSE A, van de Rest O, de Groot LCPGM, Witkamp RF, et al
    The Association of Vitamin D Status with Mild Cognitive Impairment and Dementia Subtypes: A Cross-Sectional Analysis in Dutch Geriatric Outpatients.
    J Alzheimers Dis. 2023;91:1359-1369.
    PubMed     Abstract available


  1573. MARIN-MARIN L, Miro-Padilla A, Costumero V
    Structural But Not Functional Connectivity Differences within Default Mode Network Indicate Conversion to Dementia.
    J Alzheimers Dis. 2023;91:1483-1494.
    PubMed     Abstract available


  1574. LIU C, Lee SH, Loewenstein DA, Galvin JE, et al
    Early Amnestic Mild Cognitive Impairment Is Associated with Reduced Total Cerebral Blood Flow with no Brain Tissue Loss.
    J Alzheimers Dis. 2023;91:1313-1322.
    PubMed     Abstract available


  1575. HUQUE H, Eramudugolla R, Chidiac B, Ee N, et al
    Could Country-Level Factors Explain Sex Differences in Dementia Incidence and Prevalence? A Systematic Review and Meta-Analysis.
    J Alzheimers Dis. 2023;91:1231-1241.
    PubMed     Abstract available


  1576. BOUGES S, Fischer BL, Norton DL, Wyman MF, et al
    Effect of Metabolic Syndrome Risk Factors on Processing Speed and Executive Function in Three Racialized Groups.
    J Alzheimers Dis. 2023;92:285-294.
    PubMed     Abstract available


  1577. YOSHIDA M, Uemura T, Mizoi M, Waragai M, et al
    Urinary Amino Acid-Conjugated Acrolein and Taurine as New Biomarkers for Detection of Dementia.
    J Alzheimers Dis. 2023;92:361-369.
    PubMed     Abstract available


  1578. BAEZ S, Trujillo-Llano C, de Souza LC, Lillo P, et al
    Moral Emotions and Their Brain Structural Correlates Across Neurodegenerative Disorders.
    J Alzheimers Dis. 2023;92:153-169.
    PubMed     Abstract available


  1579. HUANG Z
    A Function of Amyloid-beta in Mediating Activity-Dependent Axon/Synapse Competition May Unify Its Roles in Brain Physiology and Pathology.
    J Alzheimers Dis. 2023;92:29-57.
    PubMed     Abstract available


  1580. GRASSET L, Power MC, Crivello F, Tzourio C, et al
    How Traumatic Brain Injury History Relates to Brain Health MRI Markers and Dementia Risk: Findings from the 3C Dijon Cohort.
    J Alzheimers Dis. 2023;92:183-193.
    PubMed     Abstract available


  1581. CORRERO II AN, Gauthreaux K, Perales-Puchalt J, Chen YC, et al
    Cognitive Aging with Dementia, Mild Cognitive Impairment, or No Impairment: A Comparison of Same- and Mixed-Sex Couples.
    J Alzheimers Dis. 2023;92:109-128.
    PubMed     Abstract available


  1582. MOEBIUS HJ, Church KJ
    The Case for a Novel Therapeutic Approach to Dementia: Small Molecule Hepatocyte Growth Factor (HGF/MET) Positive Modulators.
    J Alzheimers Dis. 2023;92:1-12.
    PubMed     Abstract available


  1583. YANG M, Qi R, Liu Y, Shen X, et al
    Casein Kinase 1delta Phosphorylates TDP-43 and Suppresses Its Function in Tau mRNA Processing.
    J Alzheimers Dis. 2023;91:1527-1539.
    PubMed     Abstract available


  1584. ONO R, Sakurai T, Sugimoto T, Uchida K, et al
    Mortality Risks and Causes of Death by Dementia Types in a Japanese Cohort with Dementia: NCGG-STORIES.
    J Alzheimers Dis. 2023;92:487-498.
    PubMed     Abstract available


  1585. GABRIELLI AP, Weidling I, Ranjan A, Wang X, et al
    Mitochondria Profoundly Influence Apolipoprotein E Biology.
    J Alzheimers Dis. 2023;92:591-604.
    PubMed     Abstract available


  1586. TAN YJ, Siow I, Saffari SE, Ting SKS, et al
    Plasma Soluble ST2 Levels Are Higher in Neurodegenerative Disorders and Associated with Poorer Cognition.
    J Alzheimers Dis. 2023;92:573-580.
    PubMed     Abstract available


  1587. ROYALL DR, Palmer RF
    Multiple Adipokines Predict Dementia Severity as Measured by delta: Replication Across Biofluids and Cohorts.
    J Alzheimers Dis. 2023;92:639-652.
    PubMed     Abstract available


  1588. MANN FD, Clouston SAP, Cuevas A, Waszczuk MA, et al
    Genetic Liability, Exposure Severity, and Post-Traumatic Stress Disorder Predict Cognitive Impairment in World Trade Center Responders.
    J Alzheimers Dis. 2023;92:701-712.
    PubMed     Abstract available


  1589. TANG M, Su N, Zhang D, Dai Y, et al
    The Differential Effects of APOEvarepsilon4 on Cerebral Volumetric Structures in Different Lifespan in Community-Dwelling Populations.
    J Alzheimers Dis. 2023;92:691-700.
    PubMed     Abstract available


  1590. GYLLENHAMMAR M, Rennie A, Padilla DF, Wallert J, et al
    The Association Between Temporal Atrophy and Episodic Memory Is Moderated by Education in a Multi-Center Memory Clinic Sample.
    J Alzheimers Dis. 2023;92:605-614.
    PubMed     Abstract available


  1591. JOHNSON CN, McCoin CS, Kueck PJ, Hawley AG, et al
    Relationship of Muscle Apolipoprotein E Expression with Markers of Cellular Stress, Metabolism, and Blood Biomarkers in Cognitively Healthy and Impaired Older Adults.
    J Alzheimers Dis. 2023;92:1027-1035.
    PubMed     Abstract available


  1592. TARAWNEH HY, Jayakody DMP, Verma S, Dore V, et al
    Auditory Event-Related Potentials in Older Adults with Subjective Memory Complaints.
    J Alzheimers Dis. 2023;92:1093-1109.
    PubMed     Abstract available


  1593. KANIA B, Sotelo A, Ty D, Wisco JJ, et al
    The Prevention of Inflammation and the Maintenance of Iron and Hepcidin Homeostasis in the Gut, Liver, and Brain Pathologies.
    J Alzheimers Dis. 2023;92:769-789.
    PubMed     Abstract available


  1594. LI QY, Li XM, Hu HY, Ma YH, et al
    Associations of Lung Function Decline with Risks of Cognitive Impairment and Dementia: A Meta-Analysis and Systematic Review.
    J Alzheimers Dis. 2023;92:853-873.
    PubMed     Abstract available


  1595. WELBERRY HJ, Chau T, Heffernan M, San Jose JC, et al
    Factors Associated with Participation in a Multidomain Web-Based Dementia Prevention Trial: Evidence from Maintain Your Brain (MYB).
    J Alzheimers Dis. 2023;92:959-974.
    PubMed     Abstract available


  1596. KIM BS, Jun S, Kim H
    Cognitive Trajectories and Associated Biomarkers in Patients with Mild Cognitive Impairment.
    J Alzheimers Dis. 2023;92:803-814.
    PubMed     Abstract available


  1597. ZHANG F, Niu L, Zhong R, Li S, et al
    Chronic Sleep Disturbances Alters Sleep Structure and Tau Phosphorylation in AbetaPP/PS1 AD Mice and Their Wild-Type Littermates.
    J Alzheimers Dis. 2023;92:1341-1355.
    PubMed     Abstract available


  1598. BUKHBINDER AS, Hinojosa M, Harris K, Li X, et al
    Population-Based Mini-Mental State Examination Norms in Adults of Mexican Heritage in the Cameron County Hispanic Cohort.
    J Alzheimers Dis. 2023;92:1323-1339.
    PubMed     Abstract available


  1599. KAWAKATSU S, Kobayashi R
    Towards Improved Clinical Diagnosis of Argyrophilic Grain Disease Using Brain Imaging.
    J Alzheimers Dis. 2023;93:389-392.
    PubMed     Abstract available


  1600. PARKA A, Volbracht C, Hall B, Bastlund JF, et al
    Visual Evoked Potentials as an Early-Stage Biomarker in the rTg4510 Tauopathy Mouse Model.
    J Alzheimers Dis. 2023;93:247-262.
    PubMed     Abstract available


  1601. GAO Y, Liu Y, Zhang Y, Wang Y, et al
    Olfactory Threshold Test as a Quick Screening Tool for Cognitive Impairment: Analysis of Two Independent Cohorts.
    J Alzheimers Dis. 2023;93:169-178.
    PubMed     Abstract available


  1602. TETLOW AM, Jackman BM, Alhadidy MM, Perumal V, et al
    Influence of Host Age on Intracranial AAV9 TauP301L Induced Tauopathy.
    J Alzheimers Dis. 2023;93:365-378.
    PubMed     Abstract available


  1603. RODRIGUES MARTINS D, Vandermeeren M, Van Kolen K, Brepoels E, et al
    Development and Characterization of Mouse-Specific Anti-Tau Monoclonal Antibodies: Relevance for Analysis of Murine Tau in Cerebrospinal Fluid.
    J Alzheimers Dis. 2023;93:151-167.
    PubMed     Abstract available


  1604. LV X, Chu M, Liu Y, Jing D, et al
    Neurofunctional Correlates of Activities of Daily Living in Patients with Posterior Cortical Atrophy.
    J Alzheimers Dis. 2023;93:295-305.
    PubMed     Abstract available


  1605. JANG S, Chorna N, Rodriguez-Graciani KM, Inyushin M, et al
    The Effects of Amyloid-beta on Metabolomic Profiles of Cardiomyocytes and Coronary Endothelial Cells.
    J Alzheimers Dis. 2023;93:307-319.
    PubMed     Abstract available


  1606. LANOOIJ SD, Eisel ULM, van der Zee EA, Kas MJH, et al
    Variation in Group Composition Alters an Early-Stage Social Phenotype in hAPP-Transgenic J20 Mice.
    J Alzheimers Dis. 2023;93:211-224.
    PubMed     Abstract available


  1607. UMFLEET LG, Bilder RM, Loring DW, Thames A, et al
    The Future of Cognitive Screening in Neurodegenerative Diseases.
    J Alzheimers Dis. 2023;93:47-59.
    PubMed     Abstract available


  1608. KREBS C, Brill E, Minkova L, Federspiel A, et al
    Investigating Compensatory Brain Activity in Older Adults with Subjective Cognitive Decline.
    J Alzheimers Dis. 2023;93:107-124.
    PubMed     Abstract available


  1609. WEIDUNG B, Lovheim H, Littbrand H, Wahlin J, et al
    Temporal Dementia and Cognitive Impairment Trends in the Very Old in the 21st Century.
    J Alzheimers Dis. 2023;93:61-74.
    PubMed     Abstract available


  1610. GRISANTI SG, Massa F, Chincarini A, Pretta S, et al
    Discrepancy Between Patient and Caregiver Estimate of Apathy Predicts Dementia in Patients with Amnestic Mild Cognitive Impairment.
    J Alzheimers Dis. 2023;93:75-86.
    PubMed     Abstract available


  1611. FLETCHER E
    Multifactorial Modeling of Cognitive Trajectories Using an Advanced Regression Technique: Improving Our Understanding of Biomarkers and Modifiable Variables that Support Cognition.
    J Alzheimers Dis. 2023;93:815-819.
    PubMed     Abstract available


  1612. CASTELLANI RJ, Shanes ED, McCord M, Reish NJ, et al
    Neuropathology of Anti-Amyloid-beta Immunotherapy: A Case Report.
    J Alzheimers Dis. 2023;93:803-813.
    PubMed     Abstract available


  1613. XIAO Y, Liao L, Huang K, Yao S, et al
    Coupling Between Hippocampal Parenchymal Fraction and Cortical Grey Matter Atrophy at Different Stages of Cognitive Decline.
    J Alzheimers Dis. 2023;93:791-801.
    PubMed     Abstract available


  1614. HICKEY M, Hueg TK, Priskorn L, Uldbjerg CS, et al
    Depression in Mid- and Later-Life and Risk of Dementia in Women: A Prospective Study within the Danish Nurses Cohort.
    J Alzheimers Dis. 2023;93:779-789.
    PubMed     Abstract available


  1615. CHEN CD, Ponisio MR, Lang JA, Flores S, et al
    Comparing Tau PET Visual Interpretation with Tau PET Quantification, Cerebrospinal Fluid Biomarkers, and Longitudinal Clinical Assessment.
    J Alzheimers Dis. 2023;93:765-777.
    PubMed     Abstract available


  1616. HATTORI Y, Saito S, Nakaoku Y, Ogata S, et al
    Taxifolin for Cognitive Preservation in Patients with Mild Cognitive Impairment or Mild Dementia.
    J Alzheimers Dis. 2023;93:743-754.
    PubMed     Abstract available


  1617. ZHANG LY, Wang DZ, Wang J, Guo L, et al
    Associations of Serum Antimicrobial Peptide LL-37 with Longitudinal Cognitive Decline and Neurodegeneration Among Older Adults with Memory Complaints.
    J Alzheimers Dis. 2023;93:595-603.
    PubMed     Abstract available


  1618. AGUILAR-BARBERA M, Soler-Girabau P, Tabuenca-Martin AI, Prieto-Del Val L, et al
    Fortasyn Connect Improves Neuropsychiatric Symptoms in Patients with Mild Cognitive Impairment and Dementia: Results from a Retrospective Real-World Study.
    J Alzheimers Dis. 2023;93:621-631.
    PubMed     Abstract available


  1619. SIBLE IJ, Nation DA
    Visit-to-Visit Blood Pressure Variability and Cognitive Decline in Apolipoprotein varepsilon4 Carriers versus Apolipoprotein varepsilon3 Homozygotes.
    J Alzheimers Dis. 2023;93:533-543.
    PubMed     Abstract available


  1620. BISWAS R, Kawas C, Montine TJ, Bukhari SA, et al
    Superior Global Cognition in Oldest-Old Is Associated with Resistance to Neurodegenerative Pathologies: Results from The 90+ Study.
    J Alzheimers Dis. 2023;93:561-575.
    PubMed     Abstract available


  1621. BROOK ES, D'Alonzo ZJ, Lam V, Chan DC, et al
    Plasma Amyloid-beta Homeostasis Is Associated with Body Mass Index and Weight Loss in People with Overweight and Obesity.
    J Alzheimers Dis. 2023;93:653-664.
    PubMed     Abstract available


  1622. RHYU JM, Park J, Shin BS, Kim YE, et al
    A Novel c.800G>C Variant of the ITM2B Gene in Familial Korean Dementia.
    J Alzheimers Dis. 2023;93:403-409.
    PubMed     Abstract available


  1623. DUFF K, Wan L, Embree L, Hoffman JM, et al
    Change in the Quick Dementia Rating System Across Time in Older Adults with and without Cognitive Impairment.
    J Alzheimers Dis. 2023;93:449-457.
    PubMed     Abstract available


  1624. ZHANG J, Zhang T, Wang Y, Yao L, et al
    Galpha13-Mediated Signaling Cascade Is Related to the Tau Pathology Caused by Anesthesia and Surgery in 5XFAD Transgenic Mice.
    J Alzheimers Dis. 2023;93:545-560.
    PubMed     Abstract available


  1625. IMAI A, Matsuoka T, Narumoto J
    Emotional Dysregulation in Mild Behavioral Impairment Is Associated with Reduced Cortical Thickness in the Right Supramarginal Gyrus.
    J Alzheimers Dis. 2023;93:521-532.
    PubMed     Abstract available


  1626. ZHENG YB, Sun J, Shi L, Su SZ, et al
    Association of Caffeine Consumption and Brain Amyloid Positivity in Cognitively Normal Older Adults.
    J Alzheimers Dis. 2023;93:483-493.
    PubMed     Abstract available


  1627. NOBLE JM, Papapanou PN
    With Teeth, Broken, or Fixed: The Challenges of Linking Periodontitis, Neuroepidemiology, and Biomarkers of Disease.
    J Alzheimers Dis. 2023;93:991-994.
    PubMed     Abstract available


  1628. GOLLOP C, Zingel R, Jacob L, Smith L, et al
    Incidence of Newly-Diagnosed Dementia After COVID-19 Infection versus Acute Upper Respiratory Infection: A Retrospective Cohort Study.
    J Alzheimers Dis. 2023;93:1033-1040.
    PubMed     Abstract available


  1629. FAN J, Zhu Z, Chen Y, Yang C, et al
    SORL1 rs1699102 Moderates the Effect of Sex on Language Network.
    J Alzheimers Dis. 2023;93:1051-1063.
    PubMed     Abstract available


  1630. WU J, Su Y, Chen Y, Zhu W, et al
    A Surface-Based Federated Chow Test Model for Integrating APOE Status, Tau Deposition Measure, and Hippocampal Surface Morphometry.
    J Alzheimers Dis. 2023;93:1153-1168.
    PubMed     Abstract available


  1631. JIANG C, Wang Y, Dong Y, Liu R, et al
    Associations of Microvascular Dysfunction with Mild Cognitive Impairment and Cognitive Function Among Rural-Dwelling Older Adults in China.
    J Alzheimers Dis. 2023;93:1111-1124.
    PubMed     Abstract available


  1632. MARSHALL AJ, Gaubert A, Kapoor A, Tan A, et al
    Blood-Derived Progenitor Cells Are Depleted in Older Adults with Cognitive Impairment: A Role for Vascular Resilience?
    J Alzheimers Dis. 2023;93:1041-1050.
    PubMed     Abstract available


  1633. NIJSKENS C, Henstra M, Rhodius-Meester H, Yasar S, et al
    Cardiovascular Risk Management in Persons with Dementia.
    J Alzheimers Dis. 2023;93:879-889.
    PubMed     Abstract available


  1634. GIBBONS LE, Power MC, Walker RL, Kumar RG, et al
    Association of Traumatic Brain Injury with Late Life Neuropathological Outcomes in a Community-Based Cohort.
    J Alzheimers Dis. 2023;93:949-961.
    PubMed     Abstract available


  1635. SMITH CJ, Ashford JW
    Apolipoprotein varepsilon4-Associated Protection Against Pediatric Enteric Infections Is a Survival Advantage in Pre-Industrial Populations.
    J Alzheimers Dis. 2023;93:907-918.
    PubMed     Abstract available


  1636. BAUERNSCHMIDT D, Hirt J, Langer G, Meyer G, et al
    Technology-Based Counselling for People with Dementia and Their Informal Carers: A Systematic Review and Meta-Analysis.
    J Alzheimers Dis. 2023;93:891-906.
    PubMed     Abstract available


  1637. PILONIETA G, Pisu M, Martin RC, Shan L, et al
    Specialist Availability and Drug Adherence in Older Adults with Dementia Across Regions of the United States.
    J Alzheimers Dis. 2023;93:927-937.
    PubMed     Abstract available


  1638. XIANG Q, Andersen SL, Sweigart B, Gunn S, et al
    Signatures of Neuropsychological Test Results in the Long Life Family Study: A Cluster Analysis.
    J Alzheimers Dis. 2023;93:1457-1469.
    PubMed     Abstract available


  1639. BEST MN, Lim Y, Ferenc NN, Kim N, et al
    Extracellular Tau Oligomers Damage the Axon Initial Segment.
    J Alzheimers Dis. 2023;93:1425-1441.
    PubMed     Abstract available


  1640. XU S, Ren Y, Liu R, Li Y, et al
    Prevalence and Progression of Subjective Cognitive Decline Among Rural Chinese Older Adults: A Population-Based Study.
    J Alzheimers Dis. 2023;93:1355-1368.
    PubMed     Abstract available


  1641. YANG F, Yang L, Fang X, Deng Y, et al
    Increased Cerebrospinal Fluid Levels of Soluble Triggering Receptor Expressed on Myeloid Cells 2 and Chitinase-3-Like Protein 1 in Idiopathic Normal-Pressure Hydrocephalus.
    J Alzheimers Dis. 2023;93:1341-1354.
    PubMed     Abstract available


  1642. NALLAPU BT, Petersen KK, Lipton RB, Grober E, et al
    Association of Alcohol Consumption with Cognition in Older Population: The A4 Study.
    J Alzheimers Dis. 2023;93:1381-1393.
    PubMed     Abstract available


  1643. ANDERSSON MJ, Stone J
    Best Medicine for Dementia: The Life-Long Defense of the Brain.
    J Alzheimers Dis. 2023;94:51-66.
    PubMed     Abstract available


  1644. DI J, Nelson RS, Jicha GA, Moga DC, et al
    Urinary Incontinence in a Community-Based Autopsy Cohort Is Associated with Limbic Predominant Age-Related TDP-43 Encephalopathy Neuropathologic Changes.
    J Alzheimers Dis. 2023;94:333-346.
    PubMed     Abstract available


  1645. MEDURI G, Guillemeau K, Daguinot C, Dounane O, et al
    Concomitant Neuronal Tau Deposition and FKBP52 Decrease Is an Early Feature of Different Human and Experimental Tauopathies.
    J Alzheimers Dis. 2023;94:313-331.
    PubMed     Abstract available


  1646. SINHA N, Fausto BA, Mander B, Gluck MA, et al
    High-Quality Sleep Mitigates ABCA7-Related Generalization Deficits in Healthy Older African Americans.
    J Alzheimers Dis. 2023;94:281-290.
    PubMed     Abstract available


  1647. BUAWANGPONG N, Pinyopornpanish K, Phinyo P, Jiraporncharoen W, et al
    Effect of Comorbidities on Ten-Year Survival in Patients with Dementia.
    J Alzheimers Dis. 2023;94:163-175.
    PubMed     Abstract available


  1648. DE ANDA-DURAN I, Kolachalama VB, Carmichael OT, Hwang PH, et al
    Midlife Neuropsychological Profiles and Associated Vascular Risk: The Bogalusa Heart Study.
    J Alzheimers Dis. 2023;94:101-113.
    PubMed     Abstract available


  1649. LOUGHREY DG, Leroi I
    Understanding the Association Between Sensory Impairment and Dementia: Toward Informing Future Research and Health Policy.
    J Alzheimers Dis. 2023;94:597-599.
    PubMed     Abstract available


  1650. OLIVEIRA FF
    Looking Behind the Curtain: Patient Stratification According to Genetic or Demographic Factors May Yield Unexpected Results in Studies of Neurodegenerative Diseases.
    J Alzheimers Dis. 2023;94:777-780.
    PubMed     Abstract available


  1651. CURTIS ME, Smith T, Nenov M, Blass BE, et al
    Retromer Stabilization Improves Cognitive Function and Synaptic Plasticity in a Mouse Model of Down Syndrome.
    J Alzheimers Dis. 2023;94:513-518.
    PubMed     Abstract available


  1652. LI B, Shi K, Ren C, Kong M, et al
    Detection of Tau-PET Positivity in Clinically Diagnosed Mild Cognitive Impairment with Multidimensional Features.
    J Alzheimers Dis. 2023;94:627-640.
    PubMed     Abstract available


  1653. TOCCACELI BLASI M, Valletta M, Trebbastoni A, D'Antonio F, et al
    Sundowning in Patients with Dementia: Identification, Prevalence, and Clinical Correlates.
    J Alzheimers Dis. 2023;94:601-610.
    PubMed     Abstract available


  1654. WANG J, Wang M, Ren S, Huang L, et al
    The Effect of Gender and APOE varepsilon4 Status on Brain Amyloid-beta Deposition in Different Age Groups of Mild Cognitively Impaired Individuals: A PET-CT Study.
    J Alzheimers Dis. 2023;94:763-775.
    PubMed     Abstract available


  1655. FARINA FR, Booi L, Occhipinti JA, Quoidbach V, et al
    Young Adult Brain Capital: A New Opportunity for Dementia Prevention.
    J Alzheimers Dis. 2023;94:415-423.
    PubMed     Abstract available


  1656. MAURER A, Himmel G, Lange C, Mathies F, et al
    Individualized Summary Assessment of Detailed Neuropsychological Testing for the Etiological Diagnosis of Newly Detected Cognitive Impairment in Hospitalized Geriatric Patients.
    J Alzheimers Dis. 2023;94:559-584.
    PubMed     Abstract available


  1657. EDWARDS L, Thomas KR, Weigand AJ, Edmonds EC, et al
    White Matter Hyperintensity Volume and Amyloid-PET Synergistically Impact Memory Independent of Tau-PET in Older Adults Without Dementia.
    J Alzheimers Dis. 2023;94:695-707.
    PubMed     Abstract available


  1658. CHOU OHI, Zhou J, Li L, Chan JSK, et al
    The Association Between Neutrophil-Lymphocyte Ratio and Variability with New-Onset Dementia: A Population-Based Cohort Study.
    J Alzheimers Dis. 2023;94:547-557.
    PubMed     Abstract available


  1659. LI T, Pappas C, Klinedinst B, Pollpeter A, et al
    Associations Between Insulin-Like Growth Factor-1 and Resting-State Functional Connectivity in Cognitively Unimpaired Midlife Adults.
    J Alzheimers Dis. 2023;94.
    PubMed     Abstract available


  1660. KOSTEV K
    Sex-Related Differences in the Association Between Body Mass Index and Dementia Risk.
    J Alzheimers Dis. 2023;94:961-962.
    PubMed     Abstract available


  1661. CASTELBLANCO-TORO SM, Jurado-Delgado J, Meneses-Bernal JF, Santacruz-Escudero JM, et al
    Fear of Falling as a Behavioral Symptom in Neurocognitive Impaired Patients: Evidence from an Underrepresented Population.
    J Alzheimers Dis. 2023;94:1197-1207.
    PubMed     Abstract available


  1662. CUBERO-PLAZAS L, Sancho-Cantus D, de la Rubia Orti JE, Prieto-Contreras L, et al
    Impact of Family Function on the Quality of Life and Health Perception of Non-Institutionalized Dementia Patients.
    J Alzheimers Dis. 2023;94:963-975.
    PubMed     Abstract available


  1663. PANZA F, Solfrizzi V, Sardone R, Dibello V, et al
    Depressive and Biopsychosocial Frailty Phenotypes: Impact on Late-life Cognitive Disorders.
    J Alzheimers Dis. 2023;94:879-898.
    PubMed     Abstract available


  1664. BAYRAM E, Holden SK, Fullard M, Armstrong MJ, et al
    Race and Ethnicity in Lewy Body Dementia: A Narrative Review.
    J Alzheimers Dis. 2023;94:861-878.
    PubMed     Abstract available


  1665. WANG G, Li DY, Vance DE, Li W, et al
    Alcohol Use Disorder as a Risk Factor for Cognitive Impairment.
    J Alzheimers Dis. 2023;94:899-907.
    PubMed     Abstract available


  1666. CAILLAUD M, Maltezos S, Hudon C, Mellah S, et al
    Hippocampal Volume and Episodic Associative Memory Identify Memory Risk in Subjective Cognitive Decline Individuals in the CIMA-Q Cohort, Regardless of Cognitive Reserve Level and APOE4 Status.
    J Alzheimers Dis. 2023;94:1047-1056.
    PubMed     Abstract available


  1667. CHWA WJ, Lopez OL, Longstreth WT, Dai W, et al
    Longitudinal Patterns of Brain Changes in a Community Sample in Relation to Aging and Cognitive Status.
    J Alzheimers Dis. 2023;94:1035-1045.
    PubMed     Abstract available


  1668. SANDISON H, Callan NGL, Rao RV, Phipps J, et al
    Observed Improvement in Cognition During a Personalized Lifestyle Intervention in People with Cognitive Decline.
    J Alzheimers Dis. 2023;94:993-1004.
    PubMed     Abstract available


  1669. LI D, Yang H, Lyu M, Wang J, et al
    Acupuncture Therapy on Dementia: Explained with an Integrated Analysis on Therapeutic Targets and Associated Mechanisms.
    J Alzheimers Dis. 2023;94.
    PubMed     Abstract available


  1670. GOTTSCHALK WK, Mahon S, Hodgson D, Barrera J, et al
    The APOE-TOMM40 Humanized Mouse Model: Characterization of Age, Sex, and PolyT Variant Effects on Gene Expression.
    J Alzheimers Dis. 2023;94:1563-1576.
    PubMed     Abstract available


  1671. SUSAC J, Vukojevic J, Debogovic S, Bajic Z, et al
    Share of and Absolute Costs of Informal Care in Five Subpopulations of Outpatients with Dementia in Croatia: A Latent Profile Analysis.
    J Alzheimers Dis. 2023;94:1417-1430.
    PubMed     Abstract available


  1672. BAYER TA, Jiang L, Erqou S, Kunicki ZJ, et al
    Incidence of New Dementia Diagnosis in Veterans Admitted to Nursing Homes After Heart Failure Hospitalization.
    J Alzheimers Dis. 2023;94:1397-1404.
    PubMed     Abstract available


  1673. LANSDELL TA, Xu H, Galligan JJ, Dorrance AM, et al
    Effects of Striatal Amyloidosis on the Dopaminergic System and Behavior: A Comparative Study in Male and Female 5XFAD Mice.
    J Alzheimers Dis. 2023;94:1361-1375.
    PubMed     Abstract available


  1674. YABUUCHI K, Kimura N, Masuda T, Matsubara E, et al
    Comparison of Brain Amyloid Deposition and Cortical Glucose Metabolism Between Clinic- and Community-Based Cohort.
    J Alzheimers Dis. 2023;95:299-306.
    PubMed     Abstract available


  1675. HUANG L, Li Y, Wu J, Chen N, et al
    Shanghai Cognitive Screening: A Mobile Cognitive Assessment Tool Using Voice Recognition to Detect Mild Cognitive Impairment and Dementia in the Community.
    J Alzheimers Dis. 2023;95:227-236.
    PubMed     Abstract available


  1676. CASTILLO C, Bravo-Arrepol G, Wendt A, Saez-Orellana F, et al
    Neuroprotective Properties of Eudesmin on a Cellular Model of Amyloid-beta Peptide Toxicity.
    J Alzheimers Dis. 2023;94.
    PubMed     Abstract available


  1677. NORRIS CM
    Is It Time to Repurpose Calcineurin Inhibitors for the Treatment of Cognitive Impairment and Dementia?
    J Alzheimers Dis. 2023;95:599-602.
    PubMed     Abstract available


  1678. PANIKKAR D, Vivek S, Crimmins E, Faul J, et al
    Pre-Analytical Variables Influencing Stability of Blood-Based Biomarkers of Neuropathology.
    J Alzheimers Dis. 2023;95:735-748.
    PubMed     Abstract available


  1679. PASSMORE SR, Longhurst C, Gerbitz A, Green-Harris G, et al
    "I Want to Know Everything ... ": The Return of Research Results and the Importance of Transparency in the Acceptability of Lumbar Punctures for African American Older Adults.
    J Alzheimers Dis. 2023;95:663-675.
    PubMed     Abstract available


  1680. ROSALES-LAGARDE A, Cubero-Rego L, Menendez-Conde F, Rodriguez-Torres EE, et al
    Dissociation of Arousal Index Between REM and NREM Sleep in Elderly Adults with Cognitive Impairment, No Dementia: A Pilot Study.
    J Alzheimers Dis. 2023;95:477-491.
    PubMed     Abstract available


  1681. VOLGMAN AS, Engelstein E, Aggarwal NT
    Vascular Cognitive Impairment: A Little Bit of Good News for Women or Bad News for Men?
    J Alzheimers Dis. 2023;95:407-409.
    PubMed     Abstract available


  1682. MIYAWAKI CE, McClellan A, Bouldin ED, Brohard C, et al
    Feasibility and Efficacy of Life Review Delivered by Virtually-Trained Family Caregivers.
    J Alzheimers Dis. 2023;95:573-583.
    PubMed     Abstract available


  1683. MACYCZKO JR, Wang N, Lu W, Jeevaratnam S, et al
    Upregulation of sFRP1 Is More Profound in Female than Male 5xFAD Mice and Positively Associated with Amyloid Pathology.
    J Alzheimers Dis. 2023;95:399-405.
    PubMed     Abstract available


  1684. BOGDAN A, Fabre R, Desmidt T, Golebiowski J, et al
    Different Trajectories of Apathy and Depression Among Subjective Cognitive Impairment Individuals with or without Conversion to Dementia: Results from the Memento Cohort in France.
    J Alzheimers Dis. 2023;95:415-426.
    PubMed     Abstract available


  1685. GUEVARA JE, Kurniadi NE, Duff K
    Assessing Longitudinal Cognitive Change in Mild Cognitive Impairment Using Estimated Standardized Regression-Based Formulas.
    J Alzheimers Dis. 2023;95:509-521.
    PubMed     Abstract available


  1686. NG PY, Zhang C, Li H, Baker DJ, et al
    Senescent Microglia Represent a Subset of Disease-Associated Microglia in P301S Mice.
    J Alzheimers Dis. 2023;95:493-507.
    PubMed     Abstract available


  1687. LOPES DAS NEVES P, Duraes J, Silva-Spinola A, Lima M, et al
    Serum Neurofilament Light Chain in the Diagnostic Evaluation of Patients with Cognitive Symptoms in the Neurological Consultation of a Tertiary Center.
    J Alzheimers Dis. 2023;95:391-397.
    PubMed     Abstract available


  1688. DALY T
    JAD: A Forum for Philosophy in Science.
    J Alzheimers Dis. 2023;95:411-413.
    PubMed     Abstract available


  1689. HUA S, Peters BA, Lee S, Fitzgerald K, et al
    Gut Microbiota and Cognitive Function Among Women Living with HIV.
    J Alzheimers Dis. 2023;95:1147-1161.
    PubMed     Abstract available


  1690. COSTA T, Premi E, Liloia D, Cauda F, et al
    Unleashing the Power of Bayesian Re-Analysis: Enhancing Insights into Lecanemab (Clarity AD) Phase III Trial Through Informed t-Test.
    J Alzheimers Dis. 2023;95:1059-1065.
    PubMed     Abstract available


  1691. POZZI FE, Appollonio I, Ferrarese C, Tremolizzo L, et al
    Can Traditional Board Games Prevent or Slow Down Cognitive Impairment? A Systematic Review and Meta-Analysis.
    J Alzheimers Dis. 2023;95:829-845.
    PubMed     Abstract available


  1692. AL-LAHHAM R, Mendez N
    Tau Loss of Function, by Deletion or Aggregation, Contributes to Peripheral Insulin Resistance.
    J Alzheimers Dis. 2023;95:1041-1058.
    PubMed     Abstract available


  1693. VASSILAKI M, Fu S, Christenson LR, Garg M, et al
    Characterizing Performance Gaps of a Code-Based Dementia Algorithm in a Population-Based Cohort of Cognitive Aging.
    J Alzheimers Dis. 2023;95:931-940.
    PubMed     Abstract available


  1694. DI GIOIA C, Santonico M, Zompanti A, Sabatini A, et al
    Detecting Dementia by Saliva Analysis: A Fingerprinting Unobtrusive Method Based on a Fast and Cheap Sensor System.
    J Alzheimers Dis. 2023;95:1067-1075.
    PubMed     Abstract available


  1695. FLEISCHMAN DA, Arfanakis K, Zhang S, Leurgans SE, et al
    Acculturation in Context and Brain Health in Older Latino Adults: A Diffusion Tensor Imaging Study.
    J Alzheimers Dis. 2023;95:1585-1595.
    PubMed     Abstract available


  1696. WANG S, Liu S, Ke S, Zhou W, et al
    APOEvarepsilon4 Status and Plasma p-tau181 Levels May Influence Memory and Executive Function Decline in Older Adults Without Dementia.
    J Alzheimers Dis. 2023;95:1509-1518.
    PubMed     Abstract available


  1697. WATTS A, Haneline S, Welsh-Bohmer KA, Wu J, et al
    TOMM40 '523 Genotype Distinguishes Patterns of Cognitive Improvement for Executive Function in APOEvarepsilon3 Homozygotes.
    J Alzheimers Dis. 2023;95:1697-1707.
    PubMed     Abstract available


  1698. AMOFA-HO PA, Stickel AM, Chen R, Kobayashi LC, et al
    The Mediating Roles of Neurobiomarkers in the Relationship Between Education and Late-Life Cognition.
    J Alzheimers Dis. 2023;95:1405-1416.
    PubMed     Abstract available


  1699. MARCOLINI S, Rojczyk P, Seitz-Holland J, Koerte IK, et al
    Posttraumatic Stress and Traumatic Brain Injury: Cognition, Behavior, and Neuroimaging Markers in Vietnam Veterans.
    J Alzheimers Dis. 2023;95:1427-1448.
    PubMed     Abstract available


  1700. WANG R, Kuang C, Guo C, Chen Y, et al
    Automatic Detection of Putative Mild Cognitive Impairment from Speech Acoustic Features in Mandarin-Speaking Elders.
    J Alzheimers Dis. 2023;95:901-914.
    PubMed     Abstract available


  1701. DAAMEN M, Scheef L, Li S, Grothe MJ, et al
    Cortical Amyloid Burden Relates to Basal Forebrain Volume in Subjective Cognitive Decline.
    J Alzheimers Dis. 2023;95:1013-1028.
    PubMed     Abstract available


  1702. CODY SL, Miller GH, Fazeli PL, Wang G, et al
    Preventing Neurocognitive Decline in Adults Aging with HIV: Implications for Practice and Research.
    J Alzheimers Dis. 2023;95:753-768.
    PubMed     Abstract available


  1703. KEPP KP, Sensi SL, Johnsen KB, Barrio JR, et al
    The Anti-Amyloid Monoclonal Antibody Lecanemab: 16 Cautionary Notes.
    J Alzheimers Dis. 2023;94:497-507.
    PubMed     Abstract available


  1704. SAJI N, Ishihara Y, Murotani K, Uchiyama A, et al
    Cross-Sectional Analysis of Periodontal Disease and Cognitive Impairment Conducted in a Memory Clinic: The Pearl Study.
    J Alzheimers Dis. 2023;96:369-380.
    PubMed     Abstract available


  1705. DATLOW LY, King J, Leventhal M, Wallace TC, et al
    Association of Pork Intake with Cognitive Performance in Older Adults Enrolled in the National Health and Nutrition Examination Survey (NHANES), 2011-2014 Data Cycles.
    J Alzheimers Dis. 2023;96:351-358.
    PubMed     Abstract available


  1706. PACHECO PACHADO M, Casas AI, Elbatreek MH, Nogales C, et al
    Re-Addressing Dementia by Network Medicine and Mechanism-Based Molecular Endotypes.
    J Alzheimers Dis. 2023;96:47-56.
    PubMed     Abstract available


  1707. CHEN S, Huang W, He T, Zhang M, et al
    Exploring the Causality Between Plasma Brain-Derived Neurotrophic Factor and Neurological Diseases: A Mendelian Randomization Study.
    J Alzheimers Dis. 2023;96:135-148.
    PubMed     Abstract available


  1708. UTZ J, Olm P, Jablonowski J, Siegmann EM, et al
    Reconceptualization of the Erlangen Score for the Assessment of Dementia Risk: The ERlangen Score.
    J Alzheimers Dis. 2023;96:265-275.
    PubMed     Abstract available


  1709. HAMMERS DB, Lin JH, Polsinelli AJ, Logan PE, et al
    Criterion Validation of Tau PET Staging Schemes in Relation to Cognitive Outcomes.
    J Alzheimers Dis. 2023;96:197-214.
    PubMed     Abstract available


  1710. DING H, Mandapati A, Hamel AP, Karjadi C, et al
    Multimodal Machine Learning for 10-Year Dementia Risk Prediction: The Framingham Heart Study.
    J Alzheimers Dis. 2023;96:277-286.
    PubMed     Abstract available


  1711. LINDH-RENGIFO M, Jonasson SB, Ullen S, Palmqvist S, et al
    Effects of Brain Pathologies on Spatiotemporal Gait Parameters in Patients with Mild Cognitive Impairment.
    J Alzheimers Dis. 2023;96:161-171.
    PubMed     Abstract available


  1712. CAVUOTO MG, Robinson SR, O'Donoghue FJ, Barnes M, et al
    Associations Between Amyloid Burden, Hypoxemia, Sleep Architecture, and Cognition in Obstructive Sleep Apnea.
    J Alzheimers Dis. 2023;96:149-159.
    PubMed     Abstract available


  1713. SMITH GS, Kuwabara H, Yan H, Nassery N, et al
    Serotonin Degeneration and Amyloid-beta Deposition in Mild Cognitive Impairment: Relationship to Cognitive Deficits.
    J Alzheimers Dis. 2023;96:215-227.
    PubMed     Abstract available



  1714. Erratum to: Medial Temporal Lobe Atrophy in Predementia Alzheimer's Disease: A Longitudinal Multi-Site Study Comparing Staging and A/T/N in a Clinical Research Cohort.
    J Alzheimers Dis. 2023;96:859-860.
    PubMed    


  1715. BAHRANI AA, Abner EL, DeCarli CS, Barber JM, et al
    Multi-Site Cross-Site Inter-Rater and Test-Retest Reliability and Construct Validity of the MarkVCID White Matter Hyperintensity Growth and Regression Protocol.
    J Alzheimers Dis. 2023;96:683-693.
    PubMed     Abstract available


  1716. KARJADI C, Xue C, Cordella C, Kiran S, et al
    Fusion of Low-Level Descriptors of Digital Voice Recordings for Dementia Assessment.
    J Alzheimers Dis. 2023;96:507-514.
    PubMed     Abstract available


  1717. LI J, Weiss J, Rajadhyaksha A, Acosta D, et al
    Dementia Attributable Healthcare Utilizations in the Caribbean versus United States.
    J Alzheimers Dis. 2023;96:801-811.
    PubMed     Abstract available


  1718. MICHOPOULOU S, Prosser A, Dickson J, Guy M, et al
    Perfusion Imaging and Inflammation Biomarkers Provide Complementary Information in Alzheimer's Disease.
    J Alzheimers Dis. 2023;96:1317-1327.
    PubMed     Abstract available


  1719. ZHOU J, Wang ZB, Sun Y, Fu Y, et al
    Cerebrospinal Fluid Complement 4 Levels Were Associated with Alzheimer's Disease Pathology and Cognition in Non-Demented Elderly.
    J Alzheimers Dis. 2023;96:1071-1081.
    PubMed     Abstract available


  1720. CHWA WJ, Raji CA, Toups K, Hathaway A, et al
    Longitudinal White and Gray Matter Response to Precision Medicine-Guided Intervention for Alzheimer's Disease.
    J Alzheimers Dis. 2023;96:1051-1058.
    PubMed     Abstract available


  1721. TU MC, Chung HW, Hsu YH, Yang JJ, et al
    Neurovascular Correlates of Cobalamin, Folate, and Homocysteine in Dementia.
    J Alzheimers Dis. 2023;96:1329-1338.
    PubMed     Abstract available


  1722. BROSENS N, Samouil D, Stolker S, Katsika EV, et al
    Early Life Stress Enhances Cognitive Decline and Alters Synapse Function and Interneuron Numbers in Young Male APP/PS1 Mice.
    J Alzheimers Dis. 2023;96:1097-1113.
    PubMed     Abstract available


  1723. ZHU Y, Olchanski N, Cohen JT, Freund KM, et al
    Life-Sustaining Treatments Among Medicare Beneficiaries with and without Dementia at the End of Life.
    J Alzheimers Dis. 2023;96:1183-1193.
    PubMed     Abstract available


  1724. BERNARDES C, Lima M, Duro D, Silva-Spinola A, et al
    Montreal Cognitive Assessment in Mild Cognitive Impairment: Relationship with Cerebrospinal Fluid Biomarkers and Conversion to Dementia.
    J Alzheimers Dis. 2023;96:1173-1182.
    PubMed     Abstract available


  1725. NAISMITH SL, Michaelian JC, Santos C, Mehrani I, et al
    Tackling Dementia Together via The Australian Dementia Network (ADNeT): A Summary of Initiatives, Progress and Plans.
    J Alzheimers Dis. 2023;96:913-925.
    PubMed     Abstract available


  1726. KOULOUSAKIS P, Willems E, Schepers M, Rombaut B, et al
    Exogenous Oxytocin Administration Restores Memory in Female APP/PS1 Mice.
    J Alzheimers Dis. 2023;96:1207-1219.
    PubMed     Abstract available


  1727. HEALY E
    Impact of the MIND Diet on Cognition in Individuals with Dementia.
    J Alzheimers Dis. 2023;96:967-977.
    PubMed     Abstract available


  1728. ZHAO B, Ou YN, Zhang XY, Fu Y, et al
    Differential Associations of APOEvarepsilon2 and APOEvarepsilon4 Genotypes with Cerebrospinal Fluid Biomarkers of Alzheimer's Disease in Individuals Without Dementia.
    J Alzheimers Dis. 2023;96:1813-1825.
    PubMed     Abstract available


  1729. ROBINSON MJ, Newbury S, Singh K, Leonenko Z, et al
    The Interplay Between Cholesterol and Amyloid-beta on HT22 Cell Viability, Morphology, and Receptor Tyrosine Kinase Signaling.
    J Alzheimers Dis. 2023;96:1663-1683.
    PubMed     Abstract available


  1730. TIAN J, Du E, Jia K, Wang T, et al
    Elevated Ghrelin Promotes Hippocampal Ghrelin Receptor Defects in Humanized Amyloid-beta Knockin Mice During Aging.
    J Alzheimers Dis. 2023;96:1579-1592.
    PubMed     Abstract available


  1731. SLUGGETT JK, Air T, Cations M, Caughey GE, et al
    Clinical Quality Indicators for Monitoring Hospitalizations Among Older People with Dementia Accessing Aged Care Services.
    J Alzheimers Dis. 2023;96:1747-1758.
    PubMed     Abstract available


  1732. GAO Y, Duan X, Li W, Zhang X, et al
    Elevated Homocysteine Levels and Hypertension Relate to Cognitive Impairment via Increased White Matter Hyperintensity Volume.
    J Alzheimers Dis. 2023;96:1739-1746.
    PubMed     Abstract available


  1733. YOON J, Sasaki K, Tateoka K, Arai T, et al
    Evaluation of Cognitive and Physical Function Among Older Adults by Their Physical Activity: A Cross-Sectional Kasama Study, Japan.
    J Alzheimers Dis. 2023;96:1801-1812.
    PubMed     Abstract available


  1734. SOLIS-URRA P, Rodriguez-Ayllon M, Alvarez-Ortega M, Molina-Hidalgo C, et al
    Physical Performance and Amyloid-beta in Humans: A Systematic Review and Meta-Analysis of Observational Studies.
    J Alzheimers Dis. 2023;96:1427-1439.
    PubMed     Abstract available


  1735. GARCIA-ALBERCA JM, de la Rosa MD, Solo de Zaldivar P, Ledesma M, et al
    Effect of Nordic Sensi(R) Chair on Behavioral and Psychological Symptoms of Dementia in Nursing Homes Residents: A Randomized Controlled Trial.
    J Alzheimers Dis. 2023;96:1609-1622.
    PubMed     Abstract available


  1736. SHORT MI, Fohner AE, Skjellegrind HK, Beiser A, et al
    Proteome Network Analysis Identifies Potential Biomarkers for Brain Aging.
    J Alzheimers Dis. 2023;96:1767-1780.
    PubMed     Abstract available


  1737. BRICENO EM, Dhakal U, Sharma U, Adhikari N, et al
    Neuropsychological Assessment of Older Adults in Nepal for Population-Based Dementia Ascertainment: Needs, Challenges, and Opportunities.
    J Alzheimers Dis. 2023;96:1339-1352.
    PubMed     Abstract available


  1738. AXELSSON ANDREN E, Kettunen P, Bjerke M, Rolstad S, et al
    Diagnostic Performance of Cerebrospinal Fluid Neurofilament Light Chain and Soluble Amyloid-beta Protein Precursor beta in the Subcortical Small Vessel Type of Dementia.
    J Alzheimers Dis. 2023;96:1515-1528.
    PubMed     Abstract available


  1739. AGARWAL P, Ford CN, Leurgans SE, Beck T, et al
    Dietary Sugar Intake Associated with a Higher Risk of Dementia in Community-Dwelling Older Adults.
    J Alzheimers Dis. 2023;95:1417-1425.
    PubMed     Abstract available


  1740. SEJUNAITE K, Gaucher F, Lanza C, Riepe MW, et al
    Clock Drawing Test: Types of Errors and Accuracy in Early Cognitive Screening.
    J Alzheimers Dis. 2023;95:1597-1608.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum